0001493152-24-011843.txt : 20240329 0001493152-24-011843.hdr.sgml : 20240329 20240329060718 ACCESSION NUMBER: 0001493152-24-011843 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 95 CONFORMED PERIOD OF REPORT: 20231231 FILED AS OF DATE: 20240329 DATE AS OF CHANGE: 20240329 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DSwiss Inc CENTRAL INDEX KEY: 0001652561 STANDARD INDUSTRIAL CLASSIFICATION: PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS [2844] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 474215595 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 333-208083 FILM NUMBER: 24801875 BUSINESS ADDRESS: STREET 1: UNIT 18-11, 18-12 & 18-01, TOWER A, STREET 2: VERTICAL BUSINESS SUITE, BANGSAR SOUTH, CITY: KUALA LUMPUR STATE: N8 ZIP: 59200 BUSINESS PHONE: (603)2770-4032 MAIL ADDRESS: STREET 1: UNIT 18-11, 18-12 & 18-01, TOWER A, STREET 2: VERTICAL BUSINESS SUITE, BANGSAR SOUTH, CITY: KUALA LUMPUR STATE: N8 ZIP: 59200 10-K 1 form10-k.htm
false FY 0001652561 No 0001652561 2023-01-01 2023-12-31 0001652561 2023-06-30 0001652561 2023-12-31 0001652561 2022-12-31 0001652561 2022-01-01 2022-12-31 0001652561 us-gaap:CommonStockMember 2021-12-31 0001652561 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001652561 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001652561 us-gaap:RetainedEarningsMember 2021-12-31 0001652561 us-gaap:NoncontrollingInterestMember 2021-12-31 0001652561 2021-12-31 0001652561 us-gaap:CommonStockMember 2022-12-31 0001652561 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001652561 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001652561 us-gaap:RetainedEarningsMember 2022-12-31 0001652561 us-gaap:NoncontrollingInterestMember 2022-12-31 0001652561 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001652561 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001652561 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-12-31 0001652561 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001652561 us-gaap:NoncontrollingInterestMember 2022-01-01 2022-12-31 0001652561 us-gaap:CommonStockMember 2023-01-01 2023-12-31 0001652561 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-12-31 0001652561 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-12-31 0001652561 us-gaap:RetainedEarningsMember 2023-01-01 2023-12-31 0001652561 us-gaap:NoncontrollingInterestMember 2023-01-01 2023-12-31 0001652561 us-gaap:CommonStockMember 2023-12-31 0001652561 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001652561 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001652561 us-gaap:RetainedEarningsMember 2023-12-31 0001652561 us-gaap:NoncontrollingInterestMember 2023-12-31 0001652561 DQWS:DSwissHoldingLimitedMember country:HK 2023-12-31 0001652561 DQWS:DSwissSdnBhdMember country:MY 2023-12-31 0001652561 country:MY DQWS:DSwissBiotechMember 2023-12-31 0001652561 country:HK DQWS:DSwissBiotechMember 2023-01-17 2023-01-18 0001652561 country:HK DQWS:DSwissBiotechMember 2023-01-18 0001652561 DQWS:DSwissHKLimitedMember 2023-01-18 0001652561 DQWS:DSwissHoldingLimitedMember 2023-01-01 2023-12-31 0001652561 DQWS:DSwissHKLimitedMember 2023-01-01 2023-12-31 0001652561 DQWS:DSwissSdnBhdMember 2023-01-01 2023-12-31 0001652561 DQWS:DSwissBiotechSdnBhdMember 2023-01-01 2023-12-31 0001652561 DQWS:ComputerAndSoftwareMember 2023-12-31 0001652561 us-gaap:FurnitureAndFixturesMember 2023-12-31 0001652561 us-gaap:OfficeEquipmentMember 2023-12-31 0001652561 DQWS:MotorVehiclesMember 2023-12-31 0001652561 DQWS:YearEndMYRMember 2023-12-31 0001652561 DQWS:YearEndMYRMember 2022-12-31 0001652561 DQWS:YearAverageMYRMember 2023-12-31 0001652561 DQWS:YearAverageMYRMember 2022-12-31 0001652561 DQWS:YearEndHKMember 2023-12-31 0001652561 DQWS:YearEndHKMember 2022-12-31 0001652561 DQWS:YearAverageHKMember 2023-12-31 0001652561 DQWS:YearAverageHKMember 2022-12-31 0001652561 DQWS:YearEndRMBMember 2023-12-31 0001652561 DQWS:YearEndRMBMember 2022-12-31 0001652561 DQWS:YearAverageRMBMember 2023-12-31 0001652561 DQWS:YearAverageRMBMember 2022-12-31 0001652561 DQWS:ManagementServicesAgreementIMember DQWS:DSwissHKLimitedMember 2016-06-26 2016-06-27 0001652561 DQWS:DSwissHKLimitedMember 2023-01-18 2023-01-18 0001652561 DQWS:ComputerAndSoftwareMember 2022-12-31 0001652561 us-gaap:FurnitureAndFixturesMember 2022-12-31 0001652561 us-gaap:OfficeEquipmentMember 2022-12-31 0001652561 DQWS:MotorVehiclesMember 2022-12-31 0001652561 DQWS:FirstFinanceLeaseAgreementMember 2023-01-01 2023-12-31 0001652561 DQWS:SecondFinanceLeaseAgreementMember 2023-01-01 2023-12-31 0001652561 country:US 2023-01-01 2023-12-31 0001652561 country:US 2022-01-01 2022-12-31 0001652561 country:SC 2023-01-01 2023-12-31 0001652561 country:SC 2022-01-01 2022-12-31 0001652561 country:HK 2023-01-01 2023-12-31 0001652561 country:HK 2022-01-01 2022-12-31 0001652561 country:MY 2023-01-01 2023-12-31 0001652561 country:MY 2022-01-01 2022-12-31 0001652561 DQWS:UnitedStatesOfAmericaMember 2023-12-31 0001652561 DQWS:UnitedStatesOfAmericaMember 2022-12-31 0001652561 DQWS:SeychellesMember 2023-12-31 0001652561 DQWS:SeychellesMember 2022-12-31 0001652561 DQWS:HongKongMember 2023-12-31 0001652561 DQWS:HongKongMember 2022-12-31 0001652561 DQWS:MalaysiaMember 2023-12-31 0001652561 DQWS:MalaysiaMember 2022-12-31 0001652561 DQWS:PeoplesRepublicOfChinaPRCMember 2023-12-31 0001652561 DQWS:PeoplesRepublicOfChinaPRCMember 2022-12-31 0001652561 DQWS:UnitedStatesOfAmericaMember 2023-01-01 2023-12-31 0001652561 DQWS:DSwissHKLimitedMember DQWS:HongKongMember 2023-01-01 2023-12-31 0001652561 DQWS:DSwissHKLimitedMember DQWS:HongKongMember 2023-12-31 0001652561 DQWS:DSwissSdnBhdandDSwissBiotechSdnBhdMember DQWS:MalaysiaMember srt:MinimumMember 2023-01-01 2023-12-31 0001652561 DQWS:DSwissSdnBhdandDSwissBiotechSdnBhdMember DQWS:MalaysiaMember srt:MaximumMember 2023-01-01 2023-12-31 0001652561 DQWS:DSwissSdnBhdandDSwissBiotechSdnBhdMember DQWS:MalaysiaMember 2023-12-31 0001652561 DQWS:DSwissSdnBhdandDSwissBiotechSdnBhdMember DQWS:MalaysiaMember 2023-01-01 2023-12-31 0001652561 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember DQWS:CustomerAMember 2023-01-01 2023-12-31 0001652561 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember DQWS:CustomerAMember 2022-01-01 2022-12-31 0001652561 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember DQWS:CustomerAMember 2023-12-31 0001652561 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember DQWS:CustomerAMember 2022-12-31 0001652561 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember DQWS:CustomerBMember 2023-01-01 2023-12-31 0001652561 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember DQWS:CustomerBMember 2022-01-01 2022-12-31 0001652561 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember DQWS:CustomerBMember 2023-12-31 0001652561 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember DQWS:CustomerBMember 2022-12-31 0001652561 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember DQWS:CustomerCMember 2023-01-01 2023-12-31 0001652561 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember DQWS:CustomerCMember 2022-01-01 2022-12-31 0001652561 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember DQWS:CustomerCMember 2023-12-31 0001652561 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember DQWS:CustomerCMember 2022-12-31 0001652561 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember DQWS:CustomerDMember 2023-01-01 2023-12-31 0001652561 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember DQWS:CustomerDMember 2022-01-01 2022-12-31 0001652561 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember DQWS:CustomerDMember 2023-12-31 0001652561 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember DQWS:CustomerDMember 2022-12-31 0001652561 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember DQWS:CustomerEMember 2023-01-01 2023-12-31 0001652561 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember DQWS:CustomerEMember 2022-01-01 2022-12-31 0001652561 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember DQWS:CustomerEMember 2023-12-31 0001652561 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember DQWS:CustomerEMember 2022-12-31 0001652561 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember DQWS:CustomersMember 2023-01-01 2023-12-31 0001652561 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember DQWS:CustomersMember 2022-01-01 2022-12-31 0001652561 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember DQWS:CustomersMember 2023-12-31 0001652561 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember DQWS:CustomersMember 2022-12-31 0001652561 us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember DQWS:VendorAMember 2023-01-01 2023-12-31 0001652561 us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember DQWS:VendorAMember 2022-01-01 2022-12-31 0001652561 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember DQWS:VendorAMember 2023-12-31 0001652561 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember DQWS:VendorAMember 2022-12-31 0001652561 us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember DQWS:VendorBMember 2023-01-01 2023-12-31 0001652561 us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember DQWS:VendorBMember 2022-01-01 2022-12-31 0001652561 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember DQWS:VendorBMember 2023-12-31 0001652561 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember DQWS:VendorBMember 2022-12-31 0001652561 us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember DQWS:VendorCMember 2023-01-01 2023-12-31 0001652561 us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember DQWS:VendorCMember 2022-01-01 2022-12-31 0001652561 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember DQWS:VendorCMember 2023-12-31 0001652561 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember DQWS:VendorCMember 2022-12-31 0001652561 us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember DQWS:VendorsMember 2023-01-01 2023-12-31 0001652561 us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember DQWS:VendorsMember 2022-01-01 2022-12-31 0001652561 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember DQWS:VendorsMember 2023-12-31 0001652561 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember DQWS:VendorsMember 2022-12-31 0001652561 us-gaap:AccountingStandardsUpdate201602Member 2022-01-01 0001652561 us-gaap:AccountingStandardsUpdate201602Member 2023-01-01 2023-12-31 0001652561 us-gaap:AccountingStandardsUpdate201602Member 2022-01-01 2022-12-31 0001652561 DQWS:RelatedPartyAMember 2023-01-01 2023-12-31 0001652561 DQWS:RelatedPartyAMember 2022-01-01 2022-12-31 0001652561 DQWS:RelatedPartyBMember 2023-01-01 2023-12-31 0001652561 DQWS:RelatedPartyBMember 2022-01-01 2022-12-31 0001652561 DQWS:RelatedPartyCMember 2023-01-01 2023-12-31 0001652561 DQWS:RelatedPartyCMember 2022-01-01 2022-12-31 0001652561 DQWS:RelatedPartyAMember 2023-12-31 0001652561 DQWS:NVMember 2023-01-01 2023-12-31 0001652561 DQWS:NVMember 2023-12-31 0001652561 country:SC 2023-12-31 0001652561 country:HK 2023-12-31 0001652561 country:MY 2023-12-31 0001652561 DQWS:NVMember 2022-01-01 2022-12-31 0001652561 DQWS:NVMember 2022-12-31 0001652561 country:SC 2022-12-31 0001652561 country:HK 2022-12-31 0001652561 country:MY 2022-12-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares DQWS:Integer iso4217:MYR xbrli:shares iso4217:MYR xbrli:pure

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-K

 

☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For The Fiscal Year Ended December 31, 2023

 

or

 

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from _______________ to _______________

 

Commission File Number 333-208083

 

DSwiss, Inc.

(Exact name of registrant issuer as specified in its charter)

 

Nevada   47-4215595

(State or other jurisdiction of

incorporation or organization)

  

(I.R.S. Employer

Identification No.)

 

Unit 18-11, 18-12 & 18-01, Tower A, Vertical Business Suite,

Avenue 3, Bangsar South, No.8 Jalan Kerinchi, 59200, Kuala Lumpur, Malaysia.

(Address of principal executive offices, including zip code)

 

Registrant’s phone number, including area code (603) 2770-4032

 

Securities registered pursuant to Section 12(b) of the Securities Exchange Act: None

 

Securities registered pursuant to Section 12(g) of the Securities Exchange Act: None

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.

 

Yes ☐ No ☒

 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.

 

Yes ☐ No ☒

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

 

Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (section 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

 

YES ☐ NO ☒

 

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§ 229.405 of this chapter) is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large Accelerated Filer ☐ Accelerated Filer ☐ Non-accelerated Filer ☐ Smaller reporting company ☒ Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ☐

 

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

 

Yes ☐ No ☒

 

The aggregate market value of the Company’s common stock held by non-affiliates computed by reference to the closing bid price of the Company’s common stock, as of the last business day of the registrant’s most recently completed second fiscal quarter:

 

Not Applicable

 

APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY

PROCEEDINGS DURING THE PRECEDING FIVE YEARS:

 

Indicate by check mark whether the registrant has filed all documents and reports required to be filed by Sections 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court.

 

Not Applicable

 

APPLICABLE ONLY TO CORPORATE REGISTRANTS

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

 

Class   Outstanding at December 31, 2023
Common Stock, $.0001 par value   206,904,585

 

 

 

 

 

 

DSwiss, Inc.

FORM 10-K

For the Fiscal Year Ended December 31, 2023

Index

 

    Page #
PART I    
     
Item 1. Business 2
Item 1A. Risk Factors 10
Item 1B. Unresolved Staff Comments 10
Item 1C. Cybersecurity 10
Item 2. Properties 11
Item 3. Legal Proceedings 11
Item 4. Mine Safety Disclosure 11
     
PART II    
     
Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 11
Item 6. Selected Financial Data 13
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations 13
Item 7A. Quantitative and Qualitative Disclosures About Market Risk 19
Item 8. Financial Statements and Supplementary Data 19
Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure 20
Item 9A. Controls and Procedures 20
Item 9B. Other Information 21
     
PART III    
     
Item 10. Directors, Executive Officers and Corporate Governance 22
Item 11. Executive Compensation 24
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 26
Item 13. Certain Relationships and Related Transactions, and Director Independence 27
Item 14. Principal Accounting Fees and Services 28
     
PART IV    
     
Item 15. Exhibits, Financial Statement Schedules 28
     
SIGNATURES 29

 

 

 

 

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

This Annual Report on Form 10-K contains forward-looking statements. These forward-looking statements are not historical facts but rather are based on current expectations, estimates and projections. We may use words such as “anticipate,” “expect,” “intend,” “plan,” “believe,” “foresee,” “estimate” and variations of these words and similar expressions to identify forward-looking statements. These statements are not guarantees of future performance and are subject to certain risks, uncertainties and other factors, some of which are beyond our control, are difficult to predict and could cause actual results to differ materially from those expressed or forecasted. These risks and uncertainties include the following:

 

  ● The availability and adequacy of our cash flow to meet our requirements;
     
  ● Economic, competitive, demographic, business and other conditions in our local and regional markets;
     
  ● Changes or developments in laws, regulations or taxes in our industry;
     
  ● Actions taken or omitted to be taken by third parties including our suppliers and competitors, as well as legislative, regulatory, judicial and other governmental authorities;
     
  ● Competition in our industry;
     
  ● The loss of or failure to obtain any license or permit necessary or desirable in the operation of our business;
     
  ● Changes in our business strategy, capital improvements or development plans;
     
  ● The availability of additional capital to support capital improvements and development; and
     
  ● Other risks identified in this report and in our other filings with the Securities and Exchange Commission or the SEC.

 

This report should be read completely and with the understanding that actual future results may be materially different from what we expect. The forward-looking statements included in this report are made as of the date of this report and should be evaluated with consideration of any changes occurring after the date of this Report. We will not update forward-looking statements even though our situation may change in the future and we assume no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.

 

Use of Defined Terms

 

Except as otherwise indicated by the context, references in this Report to:

 

  ● The “Company,” “we,” “us,” or “our,” “DSwiss” are references to DSwiss, Inc., a Nevada corporation.
     
  ● “Common Stock” refers to the common stock, par value $.0001, of the Company;
     
  ● “U.S. dollar,” “$” and “US$” refer to the legal currency of the United States;
     
  ● “Securities Act” refers to the Securities Act of 1933, as amended; and
     
  ● “Exchange Act” refers to the Securities Exchange Act of 1934, as amended.

 

1

 

 

PART I

 

ITEM 1. BUSINESS

 

Corporate History

 

DSwiss, Inc., a Nevada corporation (“the Company”) was incorporated under the laws of the State of Nevada on May 28, 2015.

 

DSwiss, Inc. operates through its wholly-owned subsidiary, DSwiss Holding Limited, a Company organized under the laws of Seychelles.

 

The principal activity of the Company and its subsidiaries is to supply high-quality health and beauty products, including beverages to assist in weight management, anti-aging products, and immune system products designed to improve the overall health system in our body.

 

We have currently conducted our business through DSwiss Sdn Bhd, a private limited liability company, incorporated in Malaysia. DSwiss Holding Limited, incorporated in Seychelles is an investment holding company with 100% equity interest in DSwiss (HK) Limited, a company incorporated in Hong Kong, which subsequent hold 100% equity interest in DSwiss Sdn. Bhd. We have invested in DSwiss Biotech Sdn. Bhd., a Company incorporated in Malaysia and owned a 40% equity interest. On January 18, 2023, DSwiss (HK) Limited acquired 150,000 shares, representing 60% equity interest in DSwiss Biotech Sdn. Bhd., from the other party with consideration of RM 1. After such acquisition, DSwiss Biotech Sdn. Bhd. became a wholly owned subsidiary of DSwiss (HK) Limited.

 

The Company, through its subsidiaries, mainly supplies high quality beauty products. Details of the Company’s subsidiaries:

 

  Company name   Place and date of incorporation   Particulars of issued capital   Principal activities   Proportional of ownership interest and voting power held
1. DSwiss Holding Limited   Seychelles,
May 28, 2015		   1 share of ordinary share of US$1 each   Investment holding   100%
                   
2. DSwiss (HK) Limited   Hong Kong,
May 28, 2015		   1 share of ordinary share of HK$1 each   Supply of beauty products   100%
                   
3. DSwiss Sdn Bhd   Malaysia,
March 10, 2011		   2 shares of ordinary share of RM 1 each   Supply of beauty products   100%
                   
4. DSwiss Biotech Sdn Bhd   Malaysia,
March 17, 2016		   250,000 shares of ordinary share of RM 1 each   Supply of biotech products   100%

 

Business Overview

 

One of the leading one-stop Turnkey Private Label ODM/OEM service provider, DSwiss is a premier biotech nutraceutical firm that offers premium healthcare, skincare, and personal care products. At DSwiss, we procure excellent and precise formulation using the finest natural ingredients, developing effective solutions with alluring favours in a variety of forms. DSwiss addresses a distinct demand in the market for a manufacturer who could ensure the quality of the ingredient sources and offer efficient one-stop service from raw material, product development, manufacturing and packaging.

 

Since our founding, we have experienced tremendous growth in Malaysia. We offer exceptional lifestyle solutions to consumers all over the world thanks to our over 10 years of continuous innovation and work in the health and beauty business. Our company’s Chief Executive Officer, Vincent Leong has led it with a strong hand, and as a result, our products are now consumed around the world, such as Malaysia, Singapore, Indonesia, Hong Kong, Australia, Taiwan, Macau, and China. With the help of our distributors, we have so far extended throughout Asia, and we are adamant about extending our geographic reach into untapped markets.

 

With a team of professionals at the helm, DSwiss is assured of providing the best products and attending client’s needs from consultations to products. To fulfil customer needs, we carry out research and development based on our philosophy of “creating beauty, health, and the ecosystem”. Our cutting-edge research and development team has always been exploring new product lines and integrating the most recent science and technology, which will enable us to produce more evidence-based, high-value added formulations and products and maintain our competitive position in the market.

 

2

 

 

With our extensive years of expertise in the OEM and ODM services industry, we offer comprehensive solutions to our customers. In addition to business consultancy, DSwiss offers useful guidance on current market trends as we all as marketing solutions and support to assist our clients’ business endeavours. Versatility and reliability are evidently the driving principles behind DSwiss, who manufactures products using high-grade ingredients and materials at every stage of research, development, and production.

 

As advocates of natural and high-quality active ingredients, we actively seek for and select the best ingredients, as we are dedicated to adhering to policies under rigorous quality control and assurance criteria, thereby maximizing the safety and efficacy of our products. We dedicate ourselves to maintaining the highest standard in our products in order to provide assurance and a continual commitment to producing high-quality products in accordance with the strict specifications and guidelines specified out by Ministry of Health (“MOH”) Malaysia. Each step of production process has quality control built in and implemented. We guarantee the highest quality product using precise production techniques and specialised equipment, promising ongoing improvements and enhancements based on customer feedback. DSwiss takes pride in offering the best results in customisable solutions for health supplements and beauty product manufacturing.

 

Talent Development in Diverse Expertise

 

DSwiss has assembled a strong team and strategic partners of manufacturing and R&D facilities across the world to meet the need for the most cost-effective and high-quality product and service. DSwiss embraces every new opportunity as an incentive to forge a partnership with its customers by working with them to develop and produce their customised unique formulation.

 

In the previous year, we expanded our professional team of nutritionists, scientists, laboratory technicians, customer relationship executives, operation teams, and graphic designer. This team collaborates to manufacture innovative natural health and beauty products with the best ingredients and formulas while adhering to legal standards. To strengthen the product’s unique selling point, our committed team works together both internally and with our clients to create concept, packaging and product graphics that are exceptionally inventive and creative.

 

Currently, we are carrying out our future plan from the previous year in Talent and Product Development, which involves studying and developing new formulas to the market. Market analysis literature research and product testing for overall efficacy and compliance with JAKIM Halal and Malaysian Ministry of Health criteria are all necessary for such development. Our professionals manage the entire process, including the sourcing of raw materials, production, quality control, stability and safety test, lab testing by third-party labs, packaging and shipping.

 

With our experience and knowledge, we have further increased our ODM/OEM clientele in 2023 and have also improve our brand’s recognition within the sector. Today, manufacturers must possess more specialised knowledge, R&D experience, and cutting-edge technologies due to the rapidly increasing demand for high-quality products. Our goal at DSwiss is to be a solid and trustworthy service provider and partner for individuals who are dedicated to the success of their brands of health and beauty products.

 

Moving forward, the development of DSwiss will continue to be fuelled by our future goal of becoming the global pioneer in healthcare and skincare/personal care brand manufacturer. Whilst DSwiss has always prioritized in expanding business within Asia, we definitely intend to eventually take our brand worldwide. With the mission of being the world’s leading biotechnology firm for health and beauty, we strive to lead the industry with innovative technologies, one-stop solution of manufacturing, creative packaging and exceptional customer service.

 

3

 

 

Our ODM/OEM Services

 

Overview

 

  Ø We are Turnkey Private Label Manufacturing Services provider for nutraceutical and skincare/ personal care ODM/OEM products.
  Ø Provides a one-stop services ranges from research and development of custom formulation, manufacturing and production, packaging and shipping including import and export and all licenses needed. We also provide premium services, strict lab testing and quality control, with efficient production
  Ø Our professionals provide custom formulation that are scientifically-proven and naturally-effective, high-value added formulations and products
  Ø Our production facilities are in compliance with national and international standards including GMP (Good Manufacturing Practices), HACCP (Hazard Analysis and Critical Control Point), JAKIM Halal, ISO and MESTI.

 

Consultation

 

 

 

With the experiences working with different clients, we have experienced tremendous growth. We provide helpful assistance on how to manage a successful and efficient business in all areas, as well as advice on the most recent market trends and best practices. We offer excellent marketing solutions and support in addition to business consultancy to help with your business endeavors.

 

Unique Customised Formulations and Ingredient Sourcing

 

 

 

Our innovative in-house R&D team will perform comprehensive study to provide specialized formula and individualized services. Only the best ingredients and resources sourced and chosen from reliable vendors. In order to maximize the security and efficiency of our products, we are dedicated to adhering to stringent quality control and assurance criteria.

 

4

 

 

Design and Packaging

 

 

 

Our committed teams work together both internally and externally with clients to create inventive packaging and product visuals that will strengthen the unique selling points.

 

In accordance with the standards established by the Ministry of Health, our services include consultation on packaging (text, label and graphics), the sustainability of the packaging materials, product stability, and shelf life

 

Regulatory Service

 

 

 

In order for your product to efficiently launch on the market, our knowledgeable and committed team of regulatory specialists will assist with various documentations and applications from Ministry of Health (Malaysia), HALAL (Malaysia) and other regulatory bodies.

 

5

 

 

Production and Quality Assurance

 

 

 

Our products are subjected to stringent quality and safety control that adheres to our GMP requirements. We make every effort to guarantee that finished products and raw materials are tested promptly and according to our internal laboratory’s standards. Based on the needs of our customers, our well-equipped factory has a variety of machines that can produce a variety of dosage forms and containers.

 

Each procedure has quality control built in and used. We guarantee that our clients receive the highest quality goods and services while constantly making improvements and additions thanks to our exact production methods and specialized equipment.

 

Logistics & Delivery

 

 

 

We take pride in offering comprehensive service. Our team makes sure that every product is delivered on time and in the finest condition possible.

 

6

 

 

Products and Formulations

 

Functional Food

 

 

 

Functional food, also known as nutraceuticals are foods that provide positive health effects beyond basic nutrition. For instance, with additional benefits such as promoting body function, reduce the risk of disease, and overall health improvement.

 

  Ø Fortified with nutrients, minerals, vitamins and bioactive compounds that promote good health including avoid nutritional deficiencies, maintain intake of adequate nutrients, and maintain good physiological functions.
  Ø Our experienced and professional food technologies and scientist team would formulate the food supplement in which they come in different forms (powder, liquid, chewable tablets, jellies, tea-bags, capsules and gummies).
  Ø Aims to formulate with natural, effective, proprietary standardized extracts and scientifically proven ingredients.

 

Skincare Products

 

 

 

 

  Ø Skincare products are essential to fulfil people’s pursuit of beauty with a range of practices that enhances and care for skin integrity, conditions and appearance.
  Ø Experienced R&D team aims to formulate with effective ingredients that are naturally effective and scientifically-proven to possess beautifying functions; and at the same time safe with the use of appropriate type and amount. For example, free from banned substances, heavy metals and allergens.
  Ø Able to provides skincare product in various forms like serum, toner, cleanser, essence, cream, facial mask, gel, lotion to meet specialized needs.

 

7

 

 

Personal Care Products

 

 

 

  Ø Personal care products describe a range of consumable products intended to maintain personal hygiene, personal grooming or for beautification purposes. Such products include cosmetics, shower gel, shampoo, soap, scrub, exfoliant, toothpaste, gel, sunscreen, conditioner and lotion.
  Ø The application of personal care products can be used any intended body parts such as skin, nails, hair, lips, oral or external genital organs.
  Ø Can be introduced: rubbed, poured, sprinkled, sprayed, or directly applied in order to cleanse, beautifying, altering appearance or maintain personal hygiene like protect from germs, prevent bad odor, and keep in good condition.

 

Pet-Care Products

 

 

 

  Ø Adhering to the philosophy of equality of life, we ventured into the sector of pet-care products with the aim to provides comprehensive care to beloved pets with the intention to improve pet’s quality of life.
  Ø Provides pet-care products including pet shampoo intended to hygiene, grooming and beautification.
  Ø Customized formulation that are suitable for specific needs of pets requirement such as mild and gentle to sensitive animal’s skin that are different from a human, but at the same time effective to address health issues or to improve conditions.

 

8

 

 

Pet Wellness Supplement

 

 

 

  Ø With an increasing emphasis on pet health and well-being, we recognize the opportunity to provide premium-quality supplements tailored to address the specific needs of pets.
     
  Ø Leveraging our expertise in research and product development, we are committed to formulating innovative solutions that promote the overall health and vitality of companion animals such as dogs and cats. We aim to deliver innovative solutions that address common health concerns among pets, thereby enriching the lives of both pets and their owners.
     
  Ø One of our recently developed products is a comprehensive pet wellness supplement targeting skin, joint, and immune health. This carefully formulated supplement combines a synergistic blend of key ingredients known for their beneficial effects on these specific areas of pet health.

 

Trademark

 

The Company owned several trademark registers under its subsidiaries in respective jurisdiction of which the subsidiary is operates.

 

  ● Cambodia
  ● Malaysia
  ● Singapore
  ● China
  ● Hong Kong
  ● India
  ● Myanmar
  ● Vietnam
  ● EUIPO

 

Future Plan

 

Marketing Campaign and Publicity Enhancement

 

The Company is actively seeking opportunity to increase the market share of beauty and health industry locally and overseas, which requires continuous spending on marketing campaign primarily via social media and other online e-commerce platform which already in place currently to ensure the company product exposure and brand awareness.

 

Future marketing campaign and publicity enhancement will be conduct thru but not limited to following:

 

  1. Work closely with Professional biotech and life sciences partner to straighten our advantages.
  2. Work closely with new retail tech partner to increase our sales and exposure.
  3. Providing the complete provider solution in biotechnology, nutraceutical, skincare for turnkey private label manufacturing services

 

Human Resources and Talent Development

 

Taking into consideration of the aforementioned development, the company is well aware that with existing manpower is far from sufficient to the materialization of future plan, thus spending on human resources and talent development is inevitable, including but not limited to internal admin and operation, sales and marketing, accounting and finance as well as top management.

 

Merger and Acquisition

 

The Company is actively seeking opportunity to merge and acquire potential target company to derive extraordinary synergies in multiple segments but limited to healthcare, bio-technology, beauty slimming and wellness, food science and related industries. The management believe that organic growth itself is incapable of coping with the expectation of shareholders in the current dynamic business environment, thus via merger and acquisition the Company can create greater value to every stakeholder not limited to shareholders.

 

9

 

 

Marketing

 

We recognise the growing trend of social media and because of that, the management had decided to place a higher priority on social media for our marketing strategy. Coupled with the extensive networks we had built since our inception, the nature of our job has become easier and efficient to reach out to our clients. But, perhaps the most imperative to our success is the ability to connect with our customers and receive their feedback directly. From the feedback we received, we can understand our customer’s demands better and make further improvements. As a result, our customers’ base has been growing exponentially and resulted in a robust brand image of our company.

 

Competition

 

The beauty and healthcare industry are highly competitive, we might be in disadvantage competing with competitor who greater reserve or access to capital than we do to carry out operations and marketing efforts. We hope to maintain our competitive advantage by utilizing the experience, knowledge, and expertise of our current staff as well as offering exemplary our customer service. Besides, we would like to explore the functional medicine and homeopathic supplements for complementary health and integrative health market needs.

 

Customers

 

For the year ended December 31, 2023, the Company has generated $1,470,071 revenue from clients under the ordinary course of business of the Company. The revenue mainly represented OEM/ODM sales of Nutraceutical / Skincare and Medical Consumable Supplies to clients.

 

Employees

 

As of December 31, 2023, the Company has eleven (11) full time employees including Mr. Leong Ming Chia who is our Chief Executive Officer, director, secretary and treasurer that works full time.

 

Currently, our CEO all have the flexibility to work on our business up to 70 hours per week, but are prepared to devote more time if necessary.

 

We do not presently have pension, health, annuity, insurance, stock options, profit sharing, or similar benefit plans; however, we may adopt plans in the future. There are presently no personal benefits available to our Officers, Directors or employees.

 

Government Regulation

 

We are subject to the laws and regulations of the jurisdictions in which we operate, which may include business licensing requirements, income taxes and payroll taxes. In general, the development and operation of our business is not subject to special regulatory and supervisory requirements.

 

ITEM 1A. RISK FACTORS

 

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide the information under this item.

 

ITEM 1B. UNRESOLVED STAFF COMMENTS

 

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide the information under this item.

 

ITEM 1C. CYBERSECURITY

 

Risk management and strategy

 

DSwiss, Inc. acknowledges the crucial necessity of establishing, executing, and sustaining strong cybersecurity measures to secure our information systems. This is undertaken to uphold the confidentiality, integrity, and accessibility of our data.

 

We plan to strategically incorporate cybersecurity risk management into all our comprehensive risk management framework, fostering a corporate culture that prioritizes cybersecurity at all levels. This integration shall be done in stages so as to guarantee that cybersecurity factors are ingrained in our decision-making processes throughout the organization. We plan to incorporate a risk management team to collaborate closely with the IT department, consistently assessing and mitigating cybersecurity risks in alignment with our business goals and operational requirements.

 

We recognize the intricate and ever-changing nature of cybersecurity threats. To address this, we shall collaborate with external experts, including cybersecurity assessors, consultants, and auditors. This cooperation shall involve regular audits, threat assessments, and consultations to enhance our security measures. These efforts ensure that our cybersecurity strategies adhere to industry best practices and remain effective in safeguarding our systems.

 

Understanding the potential risks associated with third-party service providers, we shall implemented stringent processes to oversee and manage these concerns. We shall conduct thorough security assessments before engaging with any third-party provider and maintain ongoing monitoring to ensure compliance with our cybersecurity standards. This involves quarterly assessments by our management and continuous evaluations by our security engineers. This approach is designed to mitigate the risks of data breaches or other security incidents originating from third-party sources.

 

We have not encountered cybersecurity issues that have significantly impacted our operational performance or financial status.

 

Governance

 

The Board of Directors is fully aware of the vital importance of managing cybersecurity risks. To ensure effective governance in handling these risks, the Board shall implement a strong oversight mechanisms. This reflects our understanding of the significant impact these threats can have on operational integrity and stakeholder confidence.

 

Our Board of Directors is tasked with overseeing data privacy and cybersecurity risks. They regularly review the Company’s cybersecurity program with management, evaluating the adequacy of controls and security for our information technology systems. Additionally, they assess the Company’s response plan in case of a security breach affecting these systems. Annually, the Board of Directors receives updates on potential cybersecurity incidents, data privacy, and compliance programs, engaging in active discussions with management on cybersecurity risks.

 

10

 

 

ITEM 2. PROPERTIES

 

Our principal executive office is located at Unit 18-11, 18-12 & 18-01, Tower A, Vertical Business Suite, Avenue 3, Bangsar South, No. 8, Jalan Kerinchi, 59200, Kuala Lumpur, Malaysia. This location has been rented by DSwiss Sdn Bhd for a 24-month period from January 1, 2022 to December 31, 2023, for an initial deposit of MYR 67,200 and additional monthly payments in the amount of MYR 16,800 over the course of the lease. The office lease is ended on December 31, 2023.

 

As of December 31, 2023, the tenancy agreement had expired, a new and fresh tenancy agreement for renewal term has yet to be executed. The lease on premises had continued on a month- to-month basis which is terminable by the end of each month.

 

In July 2018, the Company obtained a loan in the principal amount of MYR250,000 (approximately $60,479) from Public Bank Berhad, a financial institution in Malaysia, to finance the acquisition of a motor vehicle. The loan bears interest at the base lending rate less 2.38% per annum, is payable in 83 monthly instalments of MYR3,473 (approximately $840) each and a final monthly instalment of MYR3,391 (approximately $820) and matures in June 2025.

 

As of December 31, 2023, the Company has an outstanding loan to be settle for aforementioned acquisition of motor vehicle of MYR62,432 (approximately $13,603), of which MYR 41,676 (approximately $9,081) to be settled in 12 instalments in year 2024 and MYR20,756 (approximately $4,523) to be settled in 6 instalments after year 2024.

 

In December 2021, the Company had obtained another loan financing in the principal amount of MYR180,000 (approximately $43,134) from Public Bank Berhad, a financial institution in Malaysia, to finance the acquisition of a motor vehicle. The loan bears interest at the base lending rate less 2.04% per annum, is payable in 60 monthly instalments of MYR3,306 (approximately $792) each and matures in December 2026.

 

As of December 31, 2023, the Company has an outstanding loan to be settle for aforementioned acquisition of motor vehicle of MYR115,710 (approximately $25,213), of which MYR39,672 (approximately $8,644) to be settled in 12 instalments in year 2024 and MYR76,038 (approximately $16,569) to be settled in 23 instalments after year 2024.

 

Loan acquired for the acquisition of motor vehicle mentioned above are denominated in MYR, of which subjected to the fluctuation in reporting currency.

 

ITEM 3. LEGAL PROCEEDINGS

 

From time to time, we may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. Litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business. There are currently no pending legal proceedings or claims that we believe will have a material adverse effect on our business, financial condition or operating results. None of our directors, officers or affiliates is involved in a proceeding adverse to our business or has a material interest adverse to our business.

 

ITEM 4. MINE SAFETY DISCLOSURES

 

Not applicable.

 

PART II

 

ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

 

Our common stock is currently quoted on the OTC Pink under the trading symbol “DQWS.”

 

Trading in stocks quoted on the OTC Pink is often thin and is characterized by wide fluctuations in trading prices due to many factors that may have little to do with a company’s operations or business prospects. We cannot assure you that there will be a market for our common stock in the future.

 

For the periods indicated, the following table sets forth the high and low bid prices per share of common stock based on inter-dealer prices, without retail mark-up, mark-down or commission and may not represent actual transactions.

 

11

 

 

Fiscal Year 2023  Highest Bid   Lowest Bid 
First Quarter  $0.15   $0.01 
Second Quarter  $0.15   $0.10 
Third Quarter  $0.11   $0.10 
Fourth Quarter  $0.20   $0.03 

 

Holders

 

As of December 31, 2023, we had 206,904,585 shares of our Common Stock par value, $.0001 issued and outstanding. There were 426 beneficial owners of our Common Stock.

 

Transfer Agent and Registrar

 

The transfer agent for our capital stock is VStock Transfer, LLC, with an address at 18, Lafayette Place, Woodmere, New York 11598 and telephone number is +1 (212)828-8436.

 

Penny Stock Regulations

 

The Securities and Exchange Commission has adopted regulations which generally define “penny stock” to be an equity security that has a market price of less than $5.00 per share. Our Common Stock, when and if a trading market develops, may fall within the definition of penny stock and be subject to rules that impose additional sales practice requirements on broker-dealers who sell such securities to persons other than established customers and accredited investors (generally those with assets in excess of $1,000,000, or annual incomes exceeding $200,000 individually, or $300,000, together with their spouse).

 

For transactions covered by these rules, the broker-dealer must make a special suitability determination for the purchase of such securities and have received the purchaser’s prior written consent to the transaction. Additionally, for any transaction, other than exempt transactions, involving a penny stock, the rules require the delivery, prior to the transaction, of a risk disclosure document mandated by the Securities and Exchange Commission relating to the penny stock market. The broker-dealer also must disclose the commissions payable to both the broker-dealer and the registered representative, current quotations for the securities and, if the broker-dealer is the sole market-maker, the broker-dealer must disclose this fact and the broker-dealer’s presumed control over the market. Finally, monthly statements must be sent disclosing recent price information for the penny stock held in the account and information on the limited market in penny stocks. Consequently, the “penny stock” rules may restrict the ability of broker-dealers to sell our Common Stock and may affect the ability of investors to sell their Common Stock in the secondary market.

 

In addition to the “penny stock” rules promulgated by the Securities and Exchange Commission, the Financial Industry Regulatory Authority (“FINRA”) has adopted rules that require that in recommending an investment to a customer, a broker-dealer must have reasonable grounds for believing that the investment is suitable for that customer. Prior to recommending speculative low-priced securities to their non-institutional customers, broker-dealers must make reasonable efforts to obtain information about the customer’s financial status, tax status, investment objectives and other information. Under interpretations of these rules, FINRA believes that there is a high probability that speculative low-priced securities will not be suitable for at least some customers. The FINRA requirements make it more difficult for broker-dealers to recommend that their customers buy our common stock, which may limit the investors’ ability to buy and sell our stock.

 

Dividend Policy

 

Any future determination as to the declaration and payment of dividends on shares of our Common Stock will be made at the discretion of our board of directors out of funds legally available for such purpose. We are under no contractual obligations or restrictions to declare or pay dividends on our shares of Common Stock. In addition, we currently have no plans to pay such dividends. Our board of directors currently intends to retain all earnings for use in the business for the foreseeable future.

 

Equity Compensation Plan Information

 

Currently, there is no equity compensation plan in place.

 

12

 

 

Unregistered Sales of Equity Securities

 

Currently, there is no unregistered sales of equity securities.

 

Purchases of Equity Securities by the Registrant and Affiliated Purchasers

 

We have not repurchased any shares of our common stock during the fiscal year ended December 31, 2023.

 

ITEM 6. SELECTED FINANCIAL DATA

 

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide the information under this item.

 

ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The following discussion of our financial condition and results of operations should be read in conjunction with our audited consolidated financial statements and the notes to those financial statements appearing elsewhere in this Report.

 

Certain statements in this Report constitute forward-looking statements. These forward-looking statements include statements, which involve risks and uncertainties, regarding, among other things, (a) our projected sales, profitability, and cash flows, (b) our growth strategy, (c) anticipated trends in our industry, (d) our future financing plans, and (e) our anticipated needs for, and use of, working capital. They are generally identifiable by use of the words “may,” “will,” “should,” “anticipate,” “estimate,” “plan,” “potential,” “project,” “continuing,” “ongoing,” “expects,” “management believes,” “we believe,” “we intend,” or the negative of these words or other variations on these words or comparable terminology. In light of these risks and uncertainties, there can be no assurance that the forward-looking statements contained in this filing will in fact occur. You should not place undue reliance on these forward-looking statements.

 

The forward-looking statements speak only as of the date on which they are made, and, except to the extent required by federal securities laws, we undertake no obligation to update any forward-looking statements to reflect events or circumstances after the date on which the statements are made or to reflect the occurrence of unanticipated events.

 

Overview

 

DSwiss, Inc., a Nevada corporation (“the Company”) was incorporated under the laws of the State of Nevada on May 28, 2015. DSwiss Holding Limited owns 100% of DSwiss (HK) Limited, a Hong Kong Company, which owns 100% of DSwiss Sdn Bhd, the operating Malaysia Company of which is described below. In 2016, DSwiss (HK) Limited invested in DSwiss Biotech Sdn Bhd, incorporated in Malaysia, and owned 40% equity interest. We have incorporated a new company namely DSwiss International Trading (Shenzhen) Limited in China, with 100% equity interest owned by DSwiss (HK) Limited. On November 9, 2020, DSwiss International Trading (Shenzhen) Limited was officially deregistered. On January 18, 2023, DSwiss (HK) Limited acquired 150,000 shares, representing 60% equity interest in DSwiss Biotech Sdn. Bhd., from the other party with consideration of RM 1. After such acquisition, DSwiss Biotech Sdn. Bhd. became a wholly owned subsidiary of DSwiss (HK) Limited.

 

Our Company is a beauty supply company formed with the goal of supplying high quality beauty products directly to our clients. Our beauty supplies include, but are not limited to, beverages to assist in burning and reducing fat, anti-aging creams, and products designed to improve the overall health and physical appearance of our clients. Currently we supply our products in Malaysia, Singapore, Indonesia, Hong Kong and China. However, we have intentions to expand to Myanmar, Macau, Vietnam and Cambodia, and subsequent to that we will make efforts to expand throughout the world a premier biotech-nutraceutical company, supplying high-quality health and beauty products, including beverages to assist in weight management, anti-aging creams, and products designed to improve the overall health system in our body.

 

At this time, we operate exclusively online through our website: http://www.dswissbeauty.com/

 

Our Company continuously strives to improve the already high standard of our goods and services through ongoing research and market development. We are going to penetrate into South East Asia markets through the recruitment of distributors and via the social media like Facebook and Instagram. We foresee to spend a substantial amount in marketing and advertising in the coming year. At DSwiss we are determined to bring new products to markets that we have not yet explored.

 

13

 

 

Products which meet the definition of a functional food and cosmetics related products need to be registered or notified with the Drug Control Authority (DCA), Ministry of Health Malaysia. Manufacturing, marketing, importation and the sale of unregistered products is a violation of the Drug Control Regulations and Cosmetics Act 1984 of Malaysia and enforcement action can be taken.

 

At DSwiss, research and development is an ongoing effort whose purpose is to ensure our products on the forefront of quality and effectiveness. Equipped with state-of-the-art machinery, our innovative research and development team are constantly exploring on new development and product lines that will enable us to provide the highest quality standard and remain competitive in the industry.

 

DSwiss’s products are certified and approved by the Ministry of Health (“MOH”) Malaysia. Due to the stringent requirements from MOH Malaysia, we strive to upkeep the highest possible standard in our products to provide assurance and as a prove of our continuing commitment to providing quality products.

 

We always strive to offer products as high quality as possible, and hope that this assurance from an esteemed regulatory body will also serve to prove our continuing commitment to providing quality goods.

 

DSwiss have own brand Quantum Resonant Magnetic Analyzer which is DSwiss Quantum Resonant Magnetic Analyzer. DSwiss Quantum Resonant Magnetic Analyzer is a Hi-tech innovation project, which is related to medical, bio-informatics, electronic engineering, etc. It is based on quantum medical, and scientifically analyzes the human cell’s weak magnetic field collected by advanced electronic device. The analyzer can work out the customer’s health situation and main problem. According to the checking result, the analyzer can figure out the reasonable treatment recommendation. The quantum resonant magnetic analyzer is the individualized guide of comprehensive healthy consulting and updated healthy sciences, and its characteristics and advantages are comprehensive, non-invasive, practical, simple, quick, economical and easy to popularize. We can see DSwiss Quantum Resonant Magnetic Analyzer can help our customers to more concern about their health and skin condition.

 

Our expected growth is planned to occur primarily through the implementation of our social media marketing strategy. DSwiss already has a strong relationship with social media (eg. Facebook, Instagram and Wechat). The global presence social media has helped provide to us has been an invaluable resource, and as we continue to expand our business operations and spread our brand awareness, we intend to primarily utilize social media to reach our customers. The benefits of social media are countless, but perhaps the most imperative to our future success is our ability to connect with customers directly, to receive their feedback almost instantaneously. On that note, the feedback we have received from our clients has been overwhelmingly positive, which has helped us to create a robust brand image.

 

While DSwiss has been focused almost exclusively upon pursuing operations within Asia, we do have plans to expand outward and become a household name across the world. Our strategy to do so going forward is by forming partnerships with local companies in various countries that may be willing to stock our products or promote them to their own customers. We believe that by forging strategic relationships and partnerships we can expand our operations across the globe at a greater pace and with greater certainty than we would if we tried to expand on our own.

 

Results of Operations

 

Revenues for the year ended December 31, 2023 and 2022

 

The Company generated revenue of $1,470,071 and $1,849,047 for the year ended December 31, 2023 and 2022 respectively. Revenue has decreased by $378,976 which is a 20.5% decrease comparatively. The revenue mainly represented OEM/ODM sales of Nutraceutical and Skincare Supplies to the customers.

 

Cost of Revenue and Gross Margin

 

Cost of revenue for the Company year ended December 31, 2023, amounted to $1,110,846 as compared to $1,404,054 for the year ended December 31, 2022. The decrease of $293,208 in cost of revenue was in line with the decrease in revenue. As a result, the gross profit has decreased from $444,993 for the year ended December 31, 2022 to $359,225 for the year ended December 31, 2023.

 

14

 

 

Gross margin of the Company has increased from 24.06% in year ended December 31, 2022 to 24.18% in year ended December 31, 2023, which is a net increase of 0.12%.

 

Cost of revenue comprise of freight-in, cost of goods purchased and packing material cost.

 

Operating Expenses

 

Selling, general and administrative expenses for the year ended December 31, 2023 and 2022 amounted to $367,647 and $402,412 respectively, the decrease of $34,765 which is 8.64% lower comparatively.

 

Operating expenses for the year ended December 31, 2023 and 2022 amounted to $1,342 and $1,303 respectively, the increase of $39 which is 2.99% higher comparatively.

 

Other Income

 

The Company recorded an amount of $6,904 and $4,823 as other income for the year ended December 31, 2023 and 2022 respectively. This income is derived from the interest income earned and exchange gain.

 

Net Loss and Net Loss Margin

 

Net loss for the year ended December 31, 2023 was $49,535 as compared to $2,937 for the year ended December 31, 2022. The increase in net loss of $46,598 was resulted from the decrease in revenue. Taking into the loss for the year ended December 31, 2023, the accumulated loss for the Company has increased from $1,324,002 to $1,410,153.

 

Liquidity and Capital Resources

 

As of December 31, 2023, we had working capital surplus of $21,848 consisting of cash and cash equivalent of $249,110 as compared to working capital surplus of $16,426 and our cash and cash equivalent of $214,269 as of December 31, 2022.

 

Net cash generated from operating activities for the year ended December 31, 2023 was $45,295 as compared to net cash generated from operating activities of $22,428 for the year ended December 31, 2022. The increase in cash generated from operating activities are mainly resulted from the increase in accounts payable.

 

Net cash used in investing activity for the year ended December 31, 2023 was $372 as compared to net cash used in investing activity for the year ended 2022 were $62,075. The cash used in investing activities are mainly for purchase of plant and equipment.

 

Net cash used in financing activities for the year ended December 31, 2023 was $15,890 as compared to net cash used in financing activities $53,955 for the year ended December 31, 2022. The net cash used in financing activities are mainly for the repayment to a director of Company.

 

The revenues generated from our current business operations alone was sufficient to fund our operations or planned growth. However, we will consider acquiring additional funding to continue to operate our business, and to further expand our business. Sources of additional capital through various financing transactions or arrangements with third parties may include equity or debt financing, bank loans or revolving credit facilities. We may not be successful in locating suitable financing transactions in the time period required or at all, and we may not obtain the capital we require by other means. Our inability to raise additional funds when required may have a negative impact on our operations, business development and financial results.

 

Critical Accounting Policies and Estimates

 

Leases

 

The company determines if an arrangement is a lease at inception. Operating leases are included in operating in operating lease right-of-use (“ROU”) as assets, operating lease non-current liabilities, and operating lease current liabilities in our consolidated balance sheet. Finance leases are property and equipment, other current liabilities, and other non-current liabilities in the consolidated balance sheet.

 

15

 

 

ROU assets represent the right to use an asset for the lease term and lease liability represent the obligation to make lease payment arising from the lease. Operating lease ROU assets and liabilities are recognized at the commencement date based on the present value of lease payments over lease term. As most of the leases doesn’t provide an implicit rate. The company generally use the incremental borrowing rate on the estimated rate of interest for collateralized borrowing over a similar term of the lease payments at commencement date. The operating ROU asset also includes any lease payments made and exclude lease incentives. Lease expense for lease payment is recognized on a straight -line basis over lease term. The Company adopted Public Bank Berhad’s base rate lending rate as a reference for discount rate.

 

Leases that transfer substantially all the rewards and risks of ownership to the lessee, other than legal title, are accounted for as finance leases. Substantially all of the risks or benefits of ownership are deemed to have been transferred if any one of the four criteria is met: (i) transfer of ownership to the lessee at the end of the lease term, (ii) the lease containing a bargain purchase option, (iii) the lease term exceeding 75% of the estimated economic life of the leased asset, (iv) the present value of the minimum lease payments exceeding 90% of the fair value. At the inception of a finance lease, the Company as the lessee records an asset and an obligation at an amount equal to the present value of the minimum lease payments. The leased asset is amortized over the shorter of the lease term or its estimated useful life if title does not transfer to the Company, while the leased asset is depreciated in accordance with the Company’s depreciation policy if the title is to eventually transfer to the Company. The periodic rent payments made during the lease term are allocated between a reduction in the obligation and interest element using the effective interest method in accordance with the provisions of ASC Topic 835-30, “Imputation of Interest”.

 

Use of estimates

 

In preparing these consolidated financial statements, management makes estimates and assumptions that affect the reported amounts of assets and liabilities in the balance sheets, and revenues and expenses during the periods reported. Actual results may differ from these estimates.

 

Cash and cash equivalents

 

Cash and cash equivalents are carried at cost and represent cash on hand, demand deposits placed with banks or other financial institutions and all highly liquid investments with an original maturity of three months or less as of the purchase date of such investments.

 

Revenue recognition

 

In accordance with the Accounting Standard Codification Topic 605 “Revenue Recognition” (“ASC 605”), the Company recognizes revenue when the following four criteria are met: (1) delivery has occurred or services rendered; (2) persuasive evidence of an arrangement exists; (3) there are no continuing obligations to the customer; and (4) the collection of related accounts receivable is probable.

 

Revenue is measured at the fair value of the consideration received or receivable, net of discounts and taxes applicable to the revenue.

 

Revenue from supplies of beauty products is recognized when title and risk of loss are transferred and there are no continuing obligations to the customer. Title and the risks and rewards of ownership transfer to and accepted by the customer when the products are collected by the customer at the Company’s office. Revenue is recorded net of sales discounts, returns, allowances, and other adjustments that are based upon management’s best estimates and historical experience and are provided for in the same period as the related revenues are recorded. Based on limited operating history, management estimates that there was no sale return for the period reported.

 

Cost of revenues

 

Cost of revenues includes the purchase cost of retail goods for re-sale to customers and the packing materials (such as boxes). It excludes purchasing and receiving costs, inspection costs, warehousing costs, internal transfer costs and other costs of distribution network in cost of revenues.

 

16

 

 

Shipping and handling fees

 

Shipping and handling fees, if billed to customers, are included in revenue. Shipping and handling fees associated with inbound and outbound freight are expensed as incurred and included in selling and distribution expenses.

 

Shipping and handling fees are expensed as incurred for the year ended December 31, 2023 were $ 5 while for the year ended December 31, 2022 were $ 63.

 

Selling, general and administrative expenses

 

Selling, general and administrative expenses are primarily comprised of travelling and accommodation fees such as petrol, toll and parking and shipping and handling fees.

 

Cash and cash equivalents

 

Cash and cash equivalents are carried at cost and represent cash on hand, demand deposits placed with banks or other financial institutions and all highly liquid investments with an original maturity of three months or less as of the purchase date of such investments.

 

Inventories

 

Inventories consisting of products available for sell, are stated at the lower of cost or market value. Cost of inventory is determined using the first-in, first-out (FIFO) method. Inventory reserve is recorded to write down the cost of inventory to the estimated market value due to slow-moving merchandise and damaged goods, which is dependent upon factors such as historical and forecasted consumer demand, and promotional environment. The Company takes ownership, risks and rewards of the products purchased. Write downs are recorded in cost of revenues in the Condensed Consolidated Statements of Operations and Comprehensive Income.

 

Property and equipment

 

Property and equipment are stated at cost less accumulated depreciation and impairment. Depreciation of plant, equipment and software are calculated on the straight-line method over their estimated useful lives or lease terms generally as follows:

 

Classification   Estimated useful lives
Computer and software   5 years
Furniture and Fittings   5 years
Office equipment   10 years
Motor vehicle   5 years

 

Intangible assets

 

Intangible assets are stated at cost less accumulated amortization. Intangible assets represented the registration costs of trademarks in Malaysia and Hong Kong which are amortized on a straight-line basis over a useful life of ten years.

 

The Company follows ASC Topic 350 in accounting for intangible assets, which requires impairment losses to be recorded when indicators of impairment are present and the undiscounted cash flows estimated to be generated by the assets are less than the assets’ carrying amounts. There were no impairment losses recorded on intangible assets for the year ended December 31, 2023.

 

Income taxes

 

Income taxes are determined in accordance with the provisions of ASC Topic 740, “Income Taxes” (“ASC Topic 740”). Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted income tax rates expected to apply to taxable income in the periods in which those temporary differences are expected to be recovered or settled. Any effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.

 

17

 

 

ASC 740 prescribes a comprehensive model for how companies should recognize, measure, present, and disclose in their financial statements uncertain tax positions taken or expected to be taken on a tax return. Under ASC 740, tax positions must initially be recognized in the financial statements when it is more likely than not the position will be sustained upon examination by the tax authorities. Such tax positions must initially and subsequently be measured as the largest amount of tax benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the tax authority assuming full knowledge of the position and relevant facts.

 

The Company conducts major businesses in Malaysia. The Company is subject to tax in these jurisdictions. As a result of its business activities, the Company will file tax returns that are subject to examination by the foreign tax authority.

 

The Company did not have any unrecognized tax positions or benefits and there was no effect on the financial conditions or results of operations for the year ended December 31, 2023 and year ended December 31, 2022. The Company and its subsidiary are subject to local and various foreign tax jurisdictions. The Company’s tax returns remain open subject to examination by major tax jurisdictions.

 

Net profit per share

 

The Company calculates net profit per share in accordance with ASC Topic 260 “Earnings per share”. Basic profit per share is computed by dividing the net profit by the weighted average number of common shares outstanding during the period. Diluted profit per share is computed similar to basic profit per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common stock equivalents had been issued and if the additional common shares were dilutive.

 

Foreign currencies translation

 

Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency using the applicable exchange rates at the balance sheet dates. The resulting exchange differences are recorded in the Condensed Consolidated Statements of Operations and Comprehensive Income.

 

The reporting currency of the Company is United States Dollars (“US$”) and the accompanying financial statements have been expressed in US$. In addition, the Company’s subsidiaries and VIEs in Malaysia, Hong Kong and China maintains their books and record in their local currency, Ringgits Malaysia (“MYR”), Hong Kong Dollars (“HK$”) and Chinese Renminbi (“RMB”) respectively, which is functional currency as being the primary currency of the economic environment in which the entity operates.

 

In general, for consolidation purposes, assets and liabilities of its subsidiaries whose functional currency is not US$ are translated into US$, in accordance with ASC Topic 830-30, “Translation of Financial Statement”, using the exchange rate on the balance sheet date. Revenues and expenses are translated at average rates prevailing during the period. The gains and losses resulting from translation of financial statements of foreign subsidiary are recorded as a separate component of accumulated other comprehensive income within the statements of stockholders’ equity.

 

Translation of amounts from MYR into US$1, HK$ into US$1 and RMB into US$1 has been made at the following exchange rates for the respective periods:

 

   As of and for the year ended December 31, 
   2023   2022 
         
Year-end MYR : US$1 exchange rate   4.59    4.42 
Year-average MYR : US$1 exchange rate   4.56    4.41 
Year-end HK$ : US$1 exchange rate   7.81    7.81 
Year-average HK$ : US$1 exchange rate   7.83    7.83 
Year-end RMB : US$1 exchange rate   7.10    6.92 
Year-average RMB : US$1 exchange rate   7.08    6.75 

 

18

 

 

Related parties

 

Parties, which can be a corporation or individual, are considered to be related if the Company has the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operating decisions. Companies are also considered to be related if they are subject to common control or common significant influence.

 

Fair value of financial instruments:

 

The carrying value of the Company’s financial instruments: cash and cash equivalents, accounts payable and accrued liabilities, and amount due to a director approximate at their fair values because of the short-term nature of these financial instruments.

 

The Company also follows the guidance of the ASC Topic 820-10, “Fair Value Measurements and Disclosures” (“ASC 820-10”), with respect to financial assets and liabilities that are measured at fair value. ASC 820-10 establishes a three-tier fair value hierarchy that prioritizes the inputs used in measuring fair value as follows:

 

  Level 1: Observable inputs such as quoted prices in active markets;
   
  Level 2: Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and
   
  Level 3: Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.

 

Fair value estimates are made at a specific point in time based on relevant market information about the financial instrument. These estimates are subjective in nature and involve uncertainties and matters of significant judgment and, therefore, cannot be determined with precision. Changes in assumptions could significantly affect the estimates.

 

Recent accounting pronouncements

 

FASB issues various Accounting Standards Updates relating to the treatment and recording of certain accounting transactions. On June 10, 2014, the Financial Accounting Standards Board issued Accounting Standards Update (ASU) No. 2014-10, Development Stage Entities (Topic 915) Elimination of Certain Financial Reporting Requirements, including an Amendment to Variable Interest Entities Guidance in Topic 810, Consolidation, which eliminates the concept of a development stage entity (DSE) entirely from current accounting guidance. The Company has elected adoption of this standard, which eliminates the designation of DSEs and the requirement to disclose results of operations and cash flows since inception.

 

The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and do not believe the future adoption of any such pronouncements may be expected to cause a material impact on its financial condition or the results of its operations.

 

In May 2019, the FASB issued ASU 2019-05, which is an update to ASU Update No. 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which introduced the expected credit losses methodology for the measurement of credit losses on financial assets measured at amortized cost basis, replacing the previous incurred loss methodology. The amendments in Update 2016-13 added Topic 326, Financial Instruments—Credit Losses, and made several consequential amendments to the Codification. The amendments in this Update address those stakeholders’ concerns by providing an option to irrevocably elect the fair value option for certain financial assets previously measured at amortized cost basis. For those entities, the targeted transition relief will increase comparability of financial statement information by providing an option to align measurement methodologies for similar financial assets. Furthermore, the targeted transition relief also may reduce the costs for some entities to comply with the amendments in Update 2016-13 while still providing financial statement users with decision-useful information. In November 2019, the FASB issued ASU No. 2019-10, which to update the effective date of ASU No. 2016-13 for private companies, not-for-profit organizations and certain smaller reporting companies applying for credit losses, leases, and hedging standard. The new effective date for these preparers is for fiscal years beginning after December 15, 2022. ASU 2019-05 is effective for the Company for annual and interim reporting periods beginning January 1, 2023 as the Company is qualified as a smaller reporting company. The Company is currently evaluating the impact ASU 2019-05 may have on its consolidated financial statements.

 

Off-Balance Sheet Arrangements

 

As of December 31, 2023, we have no significant off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in our financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to our stockholders.

 

ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide the information under this item.

 

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

 

The financial statements required by this item are located in PART IV of this Annual Report.

 

19

 

 

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

 

None.

 

ITEM 9A. CONTROLS AND PROCEDURES

 

Disclosures Control and Procedures

 

Our management is responsible for establishing and maintaining adequate internal control over financial reporting. Internal control over financial reporting is defined in Rule 13a-15(f) or 15d-15(f) promulgated under the Exchange Act as a process designed by, or under the supervision of, the company’s principal executive and principal financial officers and effected by the company’s board of directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with accounting principles generally accepted in the United States of America and includes those policies and procedures that:

 

  ● Pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of the assets of the company;
     
  ● Provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with accounting principles generally accepted in the United States of America and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and
     
  ● Provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the company’s assets that could have a material effect on the financial statements.

 

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. All internal control systems, no matter how well designed, have inherent limitations. Therefore, even those systems determined to be effective can provide only reasonable assurance with respect to financial statement preparation and presentation. Because of the inherent limitations of internal control, there is a risk that material misstatements may not be prevented or detected on a timely basis by internal control over financial reporting. However, these inherent limitations are known features of the financial reporting process. Therefore, it is possible to design into the process safeguards to reduce, though not eliminate, this risk.

 

As of December 31, 2023, management assessed the effectiveness of our internal control over financial reporting based on the criteria for effective internal control over financial reporting established in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”) and SEC guidance on conducting such assessments. Based on such evaluation, the Company’s management concluded that, during the period covered by this Report, internal controls and procedures over were not effective. This was due to deficiencies that existed in the design or operation of our internal controls over financial reporting that adversely affected our internal controls and that may be considered to be material weaknesses.

 

Identified Material Weakness

 

A material weakness in internal control over financial reporting is a control deficiency, or combination of control deficiencies, that results in more than a remote likelihood that a material misstatement of the financial statements will not be prevented or detected.

 

Management identified the following material weakness during its assessment of internal controls over financial reporting as of December 31, 2023.

 

1. We do not have Written Policies & Procedures – Due to lack of written policies and procedures for accounting and financial reporting with respect to the requirements and application of both US GAAP and SEC guidelines, the Company did not establish a formal process to close our books monthly and account for all transactions and thus failed to properly record the Private Placement or disclose such transactions in its SEC filings in a timely manner.
   
2. We do not have adequate segregation of duties and effective risk assessment – Lack of segregation of duties and effective risk assessment may cause the Company to face the likelihood of fraud or theft, due to poor oversight, governance and review to detect errors.

 

20

 

 

Accordingly, the Company concluded that these control deficiencies resulted in a reasonable possibility that a material misstatement of the annual or interim financial statements will not be prevented or detected on a timely basis by the company’s internal controls.

 

As a result of the material weaknesses described above, management has concluded that the Company did not maintain effective internal control over financial reporting as of December 31, 2023 based on criteria established in Internal Control—Integrated Framework issued by COSO.

 

Management’s Remediation Initiatives

 

In an effort to remediate the identified material weaknesses and other deficiencies and enhance our internal controls, we have initiated, or plan to initiate, the following series of measures:

 

1. We plan to create a position to segregate duties consistent with control objectives and will increase our personnel resources and technical accounting expertise within the accounting function when funds are available to us. The accounting personnel is responsible for reviewing the financing activities, facilitate the approval of the financing, record the information regarding the financing, and submit SEC filing related documents to our legal counsel in order to comply with the filing requirements of SEC.
   
2. We plan to prepare written policies and procedures for accounting and financial reporting to establish a formal process to close our books monthly on an accrual basis and account for all transactions, including equity and debt transactions.
   
3. We intend to add staff members to our management team for making sure that information required to be disclosed in our reports filed and submitted under the Exchange Act is recorded, processed, summarized and reported as and when required and will the staff members will have segregated responsibilities with regard to these responsibilities.

 

We anticipate that these initiatives will be at least partially, if not fully, implemented by the end of fiscal year 2023.

 

Changes in internal controls over financial reporting

 

There was no change in our internal controls over financial reporting that occurred during the period covered by this Report, which has materially affected, or is reasonably likely to materially affect, our internal controls over financial reporting:

 

This annual report does not include an attestation report of the Company’s registered independent public accounting firm regarding internal control over financial reporting. Management’s report was not subject to attestation by the Company’s registered independent public accounting firm pursuant to rules of the Securities and Exchange Commission that permit the Company to provide only management’s report in this Annual Report on Form 10-K.

 

ITEM 9B. OTHER INFORMATION

 

None.

 

21

 

 

PART III

 

ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

 

Our executive officer’s and director’s and their respective ages as of the date hereof are as follows:

 

NAME   AGE   POSITION
Leong Ming Chia   41   Chief Executive Officer, President, Secretary, Treasurer, Director
Wong Sui Ting   51   Director

 

Set forth below is a brief description of the background and business experience of our executive officer and director for the past five years.

 

Leong Ming Chia - President, Chief Executive Officer, Chief Financial Officer, Secretary, Treasurer, Director

 

Mr. Leong achieved an Advanced Diploma of Microelectronics & Physics from TAR College in 2003 as well as a Bachelor’s Degree of Microelectronics & Physics from Campbell University in 2005. In 2007 Mr. Leong joined Tradenex, which is a subsidiary of the Federation of Malaysian Manufacturers, as part of their sales and marketing department. Mr Leong was responsible for developing a marketing plan, overseeing the execution and evaluating the results across B2B, B2C and retail sales channels in order to enable inter-enterprise connectivity, communication and collaboration along the business value chain. From March 2009 onward Mr. Leong was appointed as a committee member of Cross Border Business Association in Hong Kong, promoting cross border trade and opportunities. Since January 2012 Mr. Leong joined DSwiss Sdn Bhd as a Business Development Advisor where Mr Leong developed a set of marketing tool and is bringing the company from traditional sales model to e-commerce model. In September 2015, Mr. Leong was also appointed as the chief executive officer and director of the Company.

 

On May 31, 2017, upon the resignation of Mr. Chua Lee Yee resignation as a Chief Financial Officer, Secretary, Treasurer and Director, Mr. Leong has taken over the position as a Chief Financial Officer, Secretary and treasurer along with existing position as the Chief Executive Officer, President and Director.

 

Mr. Leong’s experience in the marketing and business development have led the Board of Director to reach the conclusion that he should serve as a Director of the Company.

 

Wong Sui Ting - Director

 

Mr. Wong serves as a Director in the Company. Mr. Wong holds a Bachelor of Business (Accounting) from Monash University since year 1995. Also, he is an Associate Member of Malaysia Institute of Accountancy (MIA, Chartered Accountant) since 1999 and CPA Australia since 1998. Mr. Wong co-founded Qinetics Solutions Sdn Bhd in 2000 and acts as Chief Financial Officer since the establishment. He was tasked with overseeing and managing the overall financial affairs and operations of Qinetics, playing an active role in corporate decisions and strategies. In 2011, Mr. Wong co-founded and acts as Chief Executive Officer of Forum Digital Sdn Bhd. His responsibility in the company is to oversee the operation and in charge of business development of the company.

 

Mr. Wong’s experience in accounting and the financial industry, as well as his knowledge of business development, has led the Board of director to reach the conclusion that he should serve as the director of the Company. On May 31, 2017, Mr. Wong was appointed as the director of the Company.

 

Corporate Governance

 

The Company promotes accountability for adherence to honest and ethical conduct; endeavors to provide full, fair, accurate, timely and understandable disclosure in reports and documents that the Company files with the Securities and Exchange Commission (the “SEC”) and in other public communications made by the Company; and strives to be compliant with applicable governmental laws, rules and regulations. The Company has not formally adopted a written code of business conduct and ethics that governs the Company’s employees, officers and Directors as the Company is not required to do so.

 

In lieu of an Audit Committee, the Company’s Board of Directors, is responsible for reviewing and making recommendations concerning the selection of outside auditors, reviewing the scope, results and effectiveness of the annual audit of the Company’s financial statements and other services provided by the Company’s independent public accountants. The Board of Directors, the Chief Executive Officer and the Chief Financial Officer of the Company review the Company’s internal accounting controls, practices and policies.

 

22

 

 

Committees of the Board

 

Our Company currently does not have nominating, compensation, or audit committees or committees performing similar functions nor does our Company have a written nominating, compensation or audit committee charter. Our Directors believes that it is not necessary to have such committees, at this time, because the Director(s) can adequately perform the functions of such committees.

 

Audit Committee Financial Expert

 

Our Board of Directors has determined that we do not have a board member that qualifies as an “audit committee financial expert” as defined in Item 407(D)(5) of Regulation S-K, nor do we have a Board member that qualifies as “independent” as the term is used in Item 7(d)(3)(iv)(B) of Schedule 14A under the Securities Exchange Act of 1934, as amended, and as defined by Rule 4200(a)(14) of the FINRA Rules.

 

We believe that our Director(s) are capable of analyzing and evaluating our financial statements and understanding internal controls and procedures for financial reporting. The Director(s) of our Company does not believe that it is necessary to have an audit committee because management believes that the Board of Directors can adequately perform the functions of an audit committee. In addition, we believe that retaining an independent Director who would qualify as an “audit committee financial expert” would be overly costly and burdensome and is not warranted in our circumstances given the stage of our development and the fact that we have not generated any positive cash flows from operations to date.

 

Involvement in Certain Legal Proceedings

 

Our Directors and our Executive officers have not been involved in any of the following events during the past ten years:

 

1. bankruptcy petition filed by or against any business of which such person was a general partner or executive officer either at the time of the bankruptcy or within two years prior to that time;
2. any conviction in a criminal proceeding or being subject to a pending criminal proceeding (excluding traffic violations and other minor offenses);
3. being subject to any order, judgment, or decree, not subsequently reversed, suspended or vacated, of any court of competent jurisdiction, permanently or temporarily enjoining, barring, suspending or otherwise limiting his/her involvement in any type of business, securities or banking activities; or
4. being found by a court of competent jurisdiction (in a civil action), the Commission or the Commodity Futures Trading Commission to have violated a federal or state securities or commodities law, and the judgment has not been reversed, suspended, or vacated.
5. Such person was found by a court of competent jurisdiction in a civil action or by the Commission to have violated any Federal or State securities law, and the judgment in such civil action or finding by the Commission has not been subsequently reversed, suspended, or vacated;
6. Such person was found by a court of competent jurisdiction in a civil action or by the Commodity Futures Trading Commission to have violated any Federal commodities law, and the judgment in such civil action or finding by the Commodity Futures Trading Commission has not been subsequently reversed, suspended or vacated;
7. Such person was the subject of, or a party to, any Federal or State judicial or administrative order, judgment, decree, or finding, not subsequently reversed, suspended or vacated, relating to an alleged violation of:(i) Any Federal or State securities or commodities law or regulation; or(ii) Any law or regulation respecting financial institutions or insurance companies including, but not limited to, a temporary or permanent injunction, order of disgorgement or restitution, civil money penalty or temporary or permanent cease-and-desist order, or removal or prohibition order; or(iii) Any law or regulation prohibiting mail or wire fraud or fraud in connection with any business entity; or
8. Such person was the subject of, or a party to, any sanction or order, not subsequently reversed, suspended or vacated, of any self-regulatory organization (as defined in Section 3(a)(26) of the Exchange Act (15 U.S.C. 78c(a)(26))), any registered entity (as defined in Section 1(a)(29) of the Commodity Exchange Act (7 U.S.C. 1(a)(29))), or any equivalent exchange, association, entity or organization that has disciplinary authority over its members or persons associated with a member.

 

Code of Ethics

 

We have not adopted a formal Code of Ethics. The Board of Directors evaluated the business of the Company and the number of employees and determined that since the business is operated by a small number of persons, general rules of fiduciary duty and federal and state criminal, business conduct and securities laws are adequate ethical guidelines. In the event our operations, employees and/or Directors expand in the future, we may take actions to adopt a formal Code of Ethics.

 

23

 

 

Shareholder Proposals

 

Our Company does not have any defined policy or procedural requirements for shareholders to submit recommendations or nominations for Directors. The Board of Directors believes that, given the stage of our development, a specific nominating policy would be premature and of little assistance until our business operations develop to a more advanced level. Our Company does not currently have any specific or minimum criteria for the election of nominees to the Board of Directors and we do not have any specific process or procedure for evaluating such nominees. The Board of Directors will assess all candidates, whether submitted by management or shareholders, and make recommendations for election or appointment.

 

A shareholder who wishes to communicate with our Board of Directors may do so by directing a written request addressed to our President, at the address appearing on the first page of this Information Statement.

 

ITEM 11. EXECUTIVE COMPENSATION

 

The following table sets forth information concerning the compensation of our Chief Executive Officer, and the executive officers who served at the end of the year ended December 31, 2023, for services rendered in all capacities to us.

 

Summary Compensation Table:

 

Name and Principal Position  Period  Salary ($)   Bonus ($)   Stock Awards ($)   Option Awards ($)   Non-Equity Incentive Plan Compensation ($)   Nonqualified Deferred Compensation Earnings
($)		   All Other Compensation ($)   Total ($) 
Leong Ming Chia, Chief Executive Officer,  For the year ended December 31, 2023   39,439    9,311         -         -            -            -    6,338    55,088 
President, Secretary, Treasurer, Director (1)  For the year ended December 31, 2022   27,240    5,675    -    -    -    -    4,279    37,194 
                                            
Wong Sui Ting,  For the year ended December 31, 2023   -    -    -    -    -    -    -    - 
Director (2)  For the year ended December 31, 2022   -    -    -    -    -    -    -    - 

 

(1) On September 8, 2015 Leong Ming Chia was appointed Chief Executive Officer, President and a member of our Board of Directors. On May 31, 2017, upon the resignation of Chua Lee Yee from the position of Chief Financial Officer, Treasurer, Secretary and Director, Leong Ming Chia replaced Chua Lee Yee as the Chief Financial Officer, Treasurer and Secretary of the company.
(2) On May 31, 2015 Wong Sui Ting was appointed as a member of our Board of Director.

 

24

 

 

Narrative Disclosure to Summary Compensation Table

 

There are no arrangements or plans in which we provide pension, retirement or similar benefits for directors or executive officers. Our directors and executive officers may receive stock options at the discretion of our board of directors in the future. We do not have any material bonus or profit-sharing plans pursuant to which cash or non-cash compensation is or may be paid to our directors or executive officers, except that stock options may be granted at the discretion of our board of directors from time to time. We have no plans or arrangements in respect of remuneration received or that may be received by our executive officers to compensate such officers in the event of termination of employment (as a result of resignation, retirement, change of control) or a change of responsibilities following a change of control.

 

Stock Option Grants

 

We have not granted any stock options to our executive officers since our incorporation.

 

Compensation of Directors

 

The table below summarizes all compensation of our directors as of December 31, 2023.

 

Name and Principal Position  Period  Salary ($)   Bonus ($)   Stock Awards ($)   Option Awards ($)   Non-Equity Incentive Plan Compensation ($)   Nonqualified Deferred Compensation Earnings ($)   All Other Compensation ($)   Total ($) 
Leong Ming Chia, Chief Executive Officer,  For the year ended December 31, 2023   39,439    9,311          -          -           -           -    6,338    55,088 
President, Secretary, Treasurer, Director (1)  For the year ended December 31, 2022   27,240    5,675    -    -    -    -    4,279    37,194 
                                            
Wong Sui Ting,  For the year ended December 31, 2022   -    -    -    -    -    -    -    - 
Director (2)  For the year ended December 31, 2021   -    -    -    -    -    -    -    - 

 

(1) On September 8, 2015 Leong Ming Chia was appointed Chief Executive Officer, President and a member of our Board of Directors. On May 31, 2017, upon the resignation of Chua Lee Yee from the position of Chief Financial Officer, Treasurer, Secretary and Director, Leong Ming Chia replaced Chua Lee Yee as the Chief Financial Officer, Treasurer and Secretary of the company.
(2) On May 31, 2015 Wong Sui Ting was appointed as a member of our Board of Director.

 

Employment Agreements

 

We do not have an employment or consulting agreement with any officers or Directors.

 

25

 

 

Compensation Discussion and Analysis

 

Director Compensation

 

Presently only Leong Ming Chia receives fee for his service as a member of the Board of Directors. The Board of Directors reserves the right in the future to award the members of the Board of Directors cash or stock-based consideration for their services to the Company, which awards, if granted shall be in the sole determination of the Board of Directors.

 

Executive Compensation Philosophy

 

Our Board of Directors determines the compensation given to our executive officers in their sole determination. Our Board of Directors reserves the right to pay our executive or any future executives a salary, and/or issue them shares of common stock in consideration for services rendered and/or to award incentive bonuses which are linked to our performance, as well as to the individual executive officer’s performance. This package may also include long-term stock based compensation to certain executives, which is intended to align the performance of our executives with our long-term business strategies. Additionally, while our Board of Directors has not granted any performance base stock options to date, the Board of Directors reserves the right to grant such options in the future, if the Board in its sole determination believes such grants would be in the best interests of the Company.

 

Incentive Bonus

 

The Board of Directors may grant incentive bonuses to our executive officer and/or future executive officers in its sole discretion, if the Board of Directors believes such bonuses are in the Company’s best interest, after analyzing our current business objectives and growth, if any, and the amount of revenue we are able to generate each month, which revenue is a direct result of the actions and ability of such executives.

 

Long-term, Stock Based Compensation

 

In order to attract, retain and motivate executive talent necessary to support the Company’s long-term business strategy we may award our executive and any future executives with long-term, stock-based compensation in the future, at the sole discretion of our Board of Directors, which we do not currently have any immediate plans to award.

 

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

 

As of December 31, 2023, the Company has 206,904,585 shares of common stock issued and outstanding, which number of issued and outstanding shares of common stock have been used throughout this report.

 

The following table sets forth, as of December 31, 2023 certain information with regard to the record and beneficial ownership of the Company’s common stock by (i) each person known to the Company to be the record or beneficial owner of more than 5% of the Company’s common stock, (ii) each director of the Company, (iii) each of the named executive officers, and (iv) all executive officers and directors of the Company as a group:

 

Title of Class  Name of beneficial owner(i)  Shares of Common Stock Beneficially Owned   Percent of Class 
            
Common Stock  Leong Ming Chia (i), (ii), (iii)   62,906,493    30.40%
              
Common Stock  Wong Sui Ting (ii)   50,000    0.02%
              
   All of the officers and directors as a group (iv)   62,956,493    30.42%
              
5% Shareholders             
Common Stock  Greenpro Venture Capital Limited (i)   15,159,157    7.33%
Common Stock  Hew Yuen Foong (i)   33,000,000    15.95%
Common Stock  Teo Jen Jiang (i)   44,000,000    21.27%
Common Stock  Siow Kock Yong (i)   32,874,393    15.89%

 

26

 

 

Beneficial ownership has been determined in accordance with Rule 13d-3 under the Exchange Act. Under this rule, certain shares may be deemed to be beneficially owned by more than one person (if, for example, persons share the power to vote or the power to dispose of the shares). In addition, shares are deemed to be beneficially owned by a person if the person has the right to acquire shares (for example, upon exercise of an option or warrant) within 60 days of the date as of which the information is provided. In computing the percentage ownership of any person, the amount of shares is deemed to include the amount of shares beneficially owned by such person by reason of such acquisition rights. As a result, the percentage of outstanding shares of any person as shown in the following table does not necessarily reflect the person’s actual voting power at any particular date.

 

(1) Beneficial ownership is determined in accordance with the rules of the Securities and Exchange Commission and generally includes voting or investment power with respect to securities. Beneficial ownership also includes shares of stock subject to options and warrants currently exercisable or exercisable within 60 days of the date of this table. In determining the percent of common stock owned by a person or entity as of the date of this Report, (a) the numerator is the number of shares of the class beneficially owned by such person or entity, including shares which may be acquired within 60 days on exercise of warrants or options and conversion of convertible securities, and (b) the denominator is the sum of (i) the total shares of common stock outstanding on as of the date of this Annual Report (206,904,585 shares), and (ii) the total number of shares that the beneficial owner may acquire upon exercise of the derivative securities. Unless otherwise stated, each beneficial owner has sole power to vote and dispose of its shares.
(2) Based on the total issued and outstanding shares of 206,904,585 as of the date of this Annual Report.

 

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, DIRECTOR INDEPENDENCE

 

Related Party Transactions

 

For the years ended December 31, 2023 and December 31, 2022, the Company has the following transactions with related party:

 

  

For the year ended
December 31, 2023

(Audited)

  

For the year ended
December 31, 2022

(Audited)

 
Professional Fees:          
- Related party A  $13,001   $12,226 
           
Sales          
- Related party B  $-   $386,232 
- Related party C   48,366    24,261 

 

The related party A is a wholly owned subsidiary of a 7.33% shareholder of the Company.

 

The related party B’s director and shareholder is the founder of the Company. Founder of the Company resigned as director of company B on October 02, 2022 and is no longer a shareholder of company B.

 

The related party C’s director is the founder of the Company.

 

The related party transaction is generally transacted in an arm-length basis at the current market value in the normal course of business.

 

Review, Approval and Ratification of Related Party Transactions

 

Given our small size and limited financial resources, we have not adopted formal policies and procedures for the review, approval or ratification of transactions, such as those described above, with our executive officer(s), Director(s) and significant stockholders. We intend to establish formal policies and procedures in the future, once we have sufficient resources and have appointed additional Directors, so that such transactions will be subject to the review, approval or ratification of our Board of Directors, or an appropriate committee thereof. On a moving forward basis, our Directors will continue to approve any related party transaction.

 

27

 

 

ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES

 

Below is the aggregate amount of fees billed for professional services rendered by our principal accountants with respect to our last two fiscal years.

 

   For the Year Ended
December 31, 2023		   For the Year Ended
December 31, 2022		 
Audit fees  $23,000   $22,700 
Audit related fees   -    - 
Total  $23,000   $22,700 

 

The category of “Audit fees” includes fees for our annual audit, quarterly reviews and services rendered in connection with regulatory filings with the SEC, such as the issuance of comfort letters and consents.

 

The category of “Audit-related fees” includes employee benefit plan audits, internal control reviews and accounting consultation.

 

All of the professional services rendered by principal accountants for the audit of our annual financial statements that are normally provided by the accountant in connection with statutory and regulatory filings or engagements for last two fiscal years were approved by our board of directors.

 

PART IV

 

ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES

 

(a) Financial Statements

 

The following are filed as part of this report:

 

Financial Statements

 

The following financial statements of DSwiss, Inc. and Report of Independent Registered Public Accounting Firm are presented in the “F” pages of this Report:

 

  Page
   
Index F-1
   
Report of Independent Registered Public Accounting Firm F-2
   
Financial Statements  
   
Consolidated Balance Sheets F-3
   
Consolidated Statements of Operations and Comprehensive Income F-4
   
Consolidated Statements of Changes in Stockholders’ Equity F-5
   
Consolidated Statements of Cash Flows F-6
   
Notes to Consolidated Financial Statements F-7 – F-20

 

(b) Exhibits

 

The following exhibits are filed or “furnished” herewith:

 

3.1 Articles of Incorporation**
   
3.2 Bylaws**
   
31.1 Rule 13(a)-14(a)/15(d)-14(a) Certification of principal executive officer*
   
32.1 Section 1350 Certification of principal executive officer*
   
101.INS Inline XBRL Instance Document
   
101.SCH Inline XBRL Taxonomy Extension Schema Document
   
101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document
   
101.DEF Inline XBRL Taxonomy Extension Definition Linkbase Document
   
101.LAB Inline XBRL Taxonomy Extension Label Linkbase Document
   
101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document
   
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

* Filed herewith.

 

** As filed in the Registrant’s Registration Statement on Form S-1 Amendment No.8 (File No. 333-208083) on July 20, 2016.

 

28

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  DSWISS, INC.
  (Name of Registrant)
     
Date: March 29, 2024    
  By: /s/ Leong Ming Chia
  Title: President, Chief Executive Officer, Chief Finance Officer, Secretary, Treasurer, Director
   

Principal Executive Officer

Principal Financial Officer

 

29

 

 

INDEX TO FINANCIAL STATEMENTS

 

  Page
Financial Statements  
   
Report of Independent Registered Public Accounting Firm F-2
   
Consolidated Balance Sheets F-3
   
Consolidated Statements of Operations and Comprehensive Income F-4
   
Consolidated Statements of Changes in Stockholders’ Equity F-5
   
Consolidated Statements of Cash Flows F-6
   
Notes to Consolidated Financial Statements F-7 - F-20

 

F-1

 

 

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

The Board of Directors and Stockholders of DSwiss, Inc.

Unit 18-11, 18-12 & 18-01, Tower A,

Vertical Business Suite, Avenue 3, Bangsar South,

No. 8, Jalan Kerinchi, 59200, Kuala Lumpur,

Malaysia

 

Opinion on the Financial Statements

 

We have audited the accompanying consolidated balance sheets of DSwiss, Inc. (“the Company”) as of December 31, 2022 and December 31, 2023 and the related consolidated statements of operations and consolidated comprehensive income, consolidated statements of changes in stockholders’ equity, and consolidated statements of cash flows for the year ended of December 31, 2022 and December 31, 2023 and the related consolidated notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2022 and December 31, 2023, and the results of its operations and its cash flows for the year ended of December 31, 2022 and December 31, 2023, in conformity with accounting principles generally accepted in the United States of America.

 

Basis for Opinion

 

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

 

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.

 

Going Concern

 

The financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 2 to the financial statements, as at December 31, 2023 the Company has suffered an accumulated deficit of $1,410,153. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. Management’s plans in regard to these matters also are described in Note 2. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

Critical Audit Matters

 

Critical audit matters are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to those charged with governance that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgements. We determined that there are no critical matters.

 

/s/ JP CENTURION & PARTNERS PLT  
JP CENTURION & PARTNERS PLT (PCAOB: 6723)  
We have served as the Company’s auditor since 2020.  
   
Kuala Lumpur, Malaysia  
Date: March 29, 2024  

 

F-2

 

 

DSWISS, INC.

CONSOLIDATED BALANCE SHEETS

AS OF DECEMBER 31, 2023 and 2022

(Currency expressed in United States Dollars (“US$”), except for number of shares)

(Audited)

 

           
   As of December 31, 
   2023   2022 
ASSETS          
CURRENT ASSETS          
Cash and cash equivalents  $249,110   $214,269 
Accounts receivable   36,148    17,492 
Other receivables, prepaid expenses, and deposit   24,532    21,749 
Tax recoverable   299    745 
Inventories   6,872    7,483 
           
Total current assets   316,961    261,738 
           
NON-CURRENT ASSETS          
Property and equipment, net   48,105    72,179 
Intangible assets, net   2,427    3,459 
Operating lease right-of-use assets, net   -    44,548 
           
Total non-current assets   50,532    120,186 
           
TOTAL ASSETS  $367,493   $381,924 
           
LIABILITIES AND STOCKHOLDERS’ EQUITY          
CURRENT LIABILITIES          
Accounts payable  $99,360   $29,539 
Other payables and accrued liabilities   174,714    154,710 
Finance lease liability   21,039    16,515 
Operating lease liability   -    44,548 
           
Total current liabilities   295,113    245,312 
           
NON-CURRENT LIABILITY          
Finance lease liability   15,965    38,461 
           
Total non-current liability   15,965    38,461 
           
TOTAL LIABILITIES   311,078    283,773 
           
STOCKHOLDERS’ EQUITY          
Preferred stock, $0.0001 par value, 200,000,000 shares authorized, None issued and outstanding   -    - 
Common stock, $0.0001 par value, 600,000,000 shares authorized, 206,904,585 shares and 206,904,585 shares issued and outstanding as of December 31, 2023 and 2022 respectively   20,690    20,690 
Additional paid-in capital   1,395,426    1,395,426 
Accumulated other comprehensive income/(loss)   50,452    (5,846)
Accumulated deficit   (1,410,153)   (1,324,002)
           
TOTAL DSWISS, INC. STOCKHOLDERS’ EQUITY   56,415    86,268 
NON-CONTROLLING INTEREST   -    11,883 
TOTAL STOCKHOLDERS’ EQUITY   56,415    98,151 
           
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY  $367,493   $381,924 

 

See accompanying notes to consolidated financial statements.

 

F-3

 

 

DSWISS, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME

FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022

(Currency expressed in United States Dollars (“US$”), except for number of shares)

(Audited)

 

           
   For the year ended
December 31, 2023		   For the year ended
December 31, 2022		 
REVENUE  $1,470,071   $1,849,047 
           
COST OF REVENUE   (1,110,846)   (1,404,054)
           
GROSS PROFIT   359,225    444,993 
           
OTHER INCOME   6,904    4,823 
           
SELLING, GENERAL AND ADMINISTRATIVE EXPENSES   (367,647)   (402,412)
           
OPERATING EXPENSES   (1,342)   (1,303)
           
FINANCE COST   (2,919)   (6,212)
           
LEASE EXPENSES   (43,099)   (42,310)
           
LOSS BEFORE INCOME TAX  $(48,878)  $(2,421)
           
INCOME TAXES PROVISION   (657)   (516)
           
NET LOSS   (49,535)   (2,937)
           
Non-Controlling Interests   -    (11,354)
Other comprehensive income:          
- Foreign currency translation adjustment   56,298    27,139 
COMPREHENSIVE INCOME  $6,763   $12,848 
           
Net loss per share- Basic and diluted   (0.0002)   (0.0001)
           
Weighted average number of common shares outstanding - Basic and diluted  $206,904,585   $206,904,585 

 

See accompanying notes to consolidated financial statements.

 

F-4

 

 

DSWISS, INC.

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY

FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022

(Currency expressed in United States Dollars (“US$”), except for number of shares)

(Audited)

 

                                    
   COMMON STOCK   ADDITIONAL  

ACCUMULATED

OTHER

      NON-     
  

Number of

shares

   Amount  

PAID-IN

CAPITAL

  

COMPREHENSIVE

(LOSSES)/GAINS

  

ACCUMULATED LOSSES

  

CONTROLLING

INTEREST

  

TOTAL

EQUITY

 
Balance as of December 31, 2021   206,904,585    20,690    1,395,426    (32,985)   (1,309,711)   589    74,009 
Foreign currency translation adjustment   -    -    -    27,139    -    (60)   27,079 
Net gain    -    -    -    -    (14,291)   11,354    (2,937)
Balance as of December 31, 2022   206,904,585    20,690    1,395,426    (5,846)   (1,324,002)   11,883    98,151 
Foreign currency translation adjustment   -    -    -    56,298    -    -    56,298 
Changes in ownership interests in an associate   -    -    -    -    (36,616)   (11,883)   (48,499)
Net loss   -    -    -    -    (49,535)   -    (49,535)
                                    
Balance as of December 31, 2023   206,904,585    20,690    1,395,426    50,452    (1,410,153)   -    56,415 

 

See accompanying notes to consolidated financial statements

 

F-5

 

 

DSWISS, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022

(Currency expressed in United States Dollars (“US$”))

(Audited)

 

           
   For the year ended
December 31, 2023		   For the year ended
December 31, 2022		 
CASH FLOWS FROM OPERATING ACTIVITIES:          
Loss before tax  $(48,878)  $(2,421)
Adjustments to reconcile net loss to net cash generated from operating activities:          
Depreciation and amortization   64,933    72,441 
Amortization for intangible assets   1,030    1,029 
Changes in operating assets and liabilities:          
Accounts receivable   26,440    (15,551)
Accounts payable   25,180    14,702 
Inventories   329    8,707 
Other payables and accrued liabilities   22,967    (42,440)
Other receivables, prepaid expenses, and deposit   (3,606)   28,995 
Reduction in lease liability   (42,862)   (42,212)
Cash generated from operating activities  $45,533   $23,250 
Taxation paid   (238)   (822)
Net cash generated from operating activities  $45,295   $22,428 
           
CASH FLOWS FROM INVESTING ACTIVITIES:          
Purchase of property and equipment   (373)   (14,376)
Disposal of property and equipment   1    - 
Net cash used in investing activities  $(372)  $(14,376)
           
CASH FLOWS FROM FINANCING ACTIVITIES:          
Repayment to directors   -    (38,284)
Repayment of finance lease   (15,890)   (15,671)
Net cash used in financing activities  $(15,890)  $(53,955)
           
Effect of exchange rate changes on cash and cash equivalents   5,808    25,626 
           
Net change in cash and cash equivalents   34,841    (20,277)
Cash and cash equivalents, beginning of year   214,269    234,546 
           
CASH AND CASH EQUIVALENTS, END OF YEAR  $249,110   $214,269 
SUPPLEMENTAL CASH FLOWS INFORMATION          
Income taxes paid  $238   $141 
Interest paid  $406   $421 

 

See accompanying notes to consolidated financial statements.

 

F-6

 

 

DSWISS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

1. ORGANIZATION AND BUSINESS BACKGROUND

 

DSwiss, Inc., a Nevada corporation (“the Company”) was incorporated under the laws of the State of Nevada on May 28, 2015.

 

DSwiss, Inc. operates through its wholly owned subsidiary, DSwiss Holding Limited, a Company organized under the laws of Seychelles.

 

The principal activity of the Company and its subsidiaries is to supply high-quality health and beauty products, including beverages to assist in weight management, anti-aging creams, and products designed to improve the overall health system in our body.

 

We have historically conducted our business through DSwiss Sdn Bhd, a private limited liability company, incorporated in Malaysia. DSwiss Holding Limited, incorporated in Seychelles, is an investment holding company with 100% equity interest in DSwiss (HK) Limited, a company incorporated in Hong Kong, which subsequent hold 100% equity interest in DSwiss Sdn. Bhd. On August 31, 2015, DSwiss, Inc. was restructured to be the holding company parent to, and succeed to the operations of, DSwiss Holding Limited. The former unit holder of DSwiss Holding Limited became the unit holder of DSwiss, Inc. and DSwiss Holding Limited became a wholly-owned subsidiary of DSwiss, Inc. This transaction was accounted for as a transaction among entities under common control and the assets, liabilities, revenues and expenses of DSwiss Holding Limited were carried over to and combined with DSwiss, Inc. at historical cost, and as if the transfer occurred at the beginning of the period. Prior periods have been retrospectively adjusted for comparative purposes.

 

We have invested in DSwiss Biotech Sdn Bhd, a Company incorporated in Malaysia, and owned 40% equity interest. On January 18, 2023, DSwiss (HK) Limited acquired 150,000 shares, representing 60% equity interest in DSwiss Biotech Sdn. Bhd., from the other party with consideration of RM 1. After such acquisition, DSwiss Biotech Sdn. Bhd. became a wholly owned subsidiary of DSwiss (HK) Limited.

 

The Company, through its subsidiaries, mainly supplies high quality beauty products. Details of the Company’s subsidiaries:

 

  Company name  

Place and date of

incorporation

   Particulars of issued capital   Principal activities  

Proportional of ownership

interest and

voting power

held

1. DSwiss Holding Limited  

Seychelles,

May 28, 2015

   1 share of ordinary share of US$1 each   Investment holding   100%
                   
2. DSwiss (HK) Limited  

Hong Kong,

May 28, 2015

   1 share of ordinary share of HK$1 each   Supply of beauty products   100%
                   
3. DSwiss Sdn Bhd  

Malaysia,

March 10, 2011

   2 shares of ordinary share of RM 1 each   Supply of beauty products   100%
                   
4. DSwiss Biotech Sdn Bhd  

Malaysia,

March 17, 2016

   250,000 shares of ordinary share of RM 1 each   Supply of biotech products   100%

 

F-7

 

 

DSWISS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

Business Overview

 

One of the leading one-stop ODM/OEM manufacturing companies, DSwiss is a premier biotech nutraceutical firm that offers premium healthcare, skincare, and personal care products. At DSwiss, we procure excellent and precise formulation using the finest natural ingredients, developing effective solutions with alluring favours in a variety of forms. DSwiss addresses a distinct demand in the market for a manufacturer who could ensure the quality of the ingredient sources and offer efficient one-stop service from raw material, product development, manufacturing and packaging.

 

Since our founding, we have experienced tremendous growth in Malaysia. We offer exceptional lifestyle solutions to consumers all over the world thanks to our over 10 years of continuous innovation and work in the health and beauty business. Our company’s Chief Executive Officer, Vincent Leong has led it with a strong hand, and as a result, our products are now consumed around the world, such as Malaysia, Singapore, Indonesia, Hong Kong, Australia, Taiwan, Macau, and China. With the help of our distributors, we have so far extended throughout Asia, and we are adamant about extending our geographic reach into untapped markets.

 

With a team of professionals at the helm, DSwiss is assured of providing the best products and attending client’s needs from consultations to products. To fulfil customer needs, we carry out research and development based on our philosophy of “creating beauty, health, and the ecosystem”. Our cutting-edge research and development team has always been exploring new product lines and integrating the most recent science and technology, which will enable us to produce more evidence-based, high-value added formulations and products and maintain our competitive position in the market.

 

With our extensive years of expertise in the OEM and ODM services industry, we offer comprehensive solutions to our customers. In addition to business consultancy, DSwiss offers useful guidance on current market trends as we all as marketing solutions and support to assist our clients’ business endeavours. Versatility and reliability are evidently the driving principles behind DSwiss, who manufactures products using high-grade ingredients and materials at every stage of research, development, and production.

 

As advocates of natural and high-quality active ingredients, we actively seek for and select the best ingredients, as we are dedicated to adhering to policies under rigorous quality control and assurance criteria, thereby maximizing the safety and efficacy of our products. We dedicate ourselves to maintaining the highest standard in our products in order to provide assurance and a continual commitment to producing high-quality products in accordance with the strict specifications and guidelines specified out by Ministry of Health (“MOH”) Malaysia. Each step of production process has quality control built in and implemented. We guarantee the highest quality product using precise production techniques and specialised equipment, promising ongoing improvements and enhancements based on customer feedback. DSwiss takes pride in offering the best results in customisable solutions for health supplements and beauty product manufacturing.

 

2. GOING CONCERN UNCERTAINTIES

 

The accompanying financial statements have been prepared using the going concern basis of accounting, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business.

 

As of December 31, 2023, the Company suffered an accumulated deficit of $1,410,153. The continuation of the Company as a going concern through December 31, 2023 is dependent upon improving the profitability and the continuing financial support from its major stockholders. Management believes the existing major shareholders or external financing will provide the additional cash to meet the Company’s obligations as they become due.

 

There is no assurance that the Company will able to maintain profitable in the future, which raise substantial doubt about the Company’s ability to continue as a going concern. These financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result in the Company not being able to continue as a going concern.

 

3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

The accompanying consolidated financial statements reflect the application of certain significant accounting policies as described in this note and elsewhere in the accompanying consolidated financial statements and notes.

 

Basis of presentation

 

These accompanying consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“US GAAP”).

 

Basis of consolidation

 

The condensed consolidated financial statements include the accounts of the Company and its subsidiaries in which the Company is the primary beneficiary. All inter-company accounts and transactions have been eliminated upon consolidation.

 

F-8

 

 

DSWISS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

Use of estimates

 

In preparing these consolidated financial statements, management makes estimates and assumptions that affect the reported amounts of assets and liabilities in the balance sheets, and revenues and expenses during the periods reported. Actual results may differ from these estimates.

 

Cash and cash equivalents

 

Cash and cash equivalents are carried at cost and represent cash on hand, time deposits placed with banks or other financial institutions and all highly liquid investments with an original maturity of six months or less as of the purchase date of such investments.

 

Property and equipment

 

Property and equipment are stated at cost less accumulated depreciation and impairment. Depreciation of plant, equipment and software are calculated on the straight-line method over their estimated useful lives or lease terms generally as follows:

 

Classification  Estimated useful lives
Computer and software  5 years
Furniture and Fittings  5 years
Office equipment  10 years
Motor vehicle  5 years

 

Intangible assets

 

Intangible assets are stated at cost less accumulated amortization. Intangible assets represented the registration costs of trademarks in Malaysia and Hong Kong which are amortized on a straight-line basis over a useful life of ten years.

 

The Company follows ASC Topic 350 in accounting for intangible assets, which requires impairment losses to be recorded when indicators of impairment are present and the undiscounted cash flows estimated to be generated by the assets are less than the assets’ carrying amounts. There were no impairment losses recorded on intangible assets for the year ended December 31, 2023.

 

F-9

 

 

DSWISS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

Leases

 

The company determines if an arrangement is a lease at inception. Operating leases are included in operating in operating lease right-of-use (“ROU”) as assets, operating lease non-current liabilities, and operating lease current liabilities in our consolidated balance sheet. Finance leases are property and equipment, other current liabilities, and other non-current liabilities in the consolidated balance sheet.

 

ROU assets represent the right to use an asset for the lease term and lease liability represent the obligation to make lease payment arising from the lease. Operating lease ROU assets and liabilities are recognized at the commencement date based on the present value of lease payments over lease term. As most of the leases doesn’t provide an implicit rate. The company generally use the incremental borrowing rate on the estimated rate of interest for collateralized borrowing over a similar term of the lease payments at commencement date. The operating ROU asset also includes any lease payments made and exclude lease incentives. Lease expense for lease payment is recognized on a straight -line basis over lease term. The Company adopted Public Bank Berhad’s base rate lending rate as a reference for discount rate.

 

Leases that transfer substantially all the rewards and risks of ownership to the lessee, other than legal title, are accounted for as finance leases. Substantially all of the risks or benefits of ownership are deemed to have been transferred if any one of the four criteria is met: (i) transfer of ownership to the lessee at the end of the lease term, (ii) the lease containing a bargain purchase option, (iii) the lease term exceeding 75% of the estimated economic life of the leased asset, (iv) the present value of the minimum lease payments exceeding 90% of the fair value. At the inception of a finance lease, the Company as the lessee records an asset and an obligation at an amount equal to the present value of the minimum lease payments. The leased asset is amortized over the shorter of the lease term or its estimated useful life if title does not transfer to the Company, while the leased asset is depreciated in accordance with the Company’s depreciation policy if the title is to eventually transfer to the Company. The periodic rent payments made during the lease term are allocated between a reduction in the obligation and interest element using the effective interest method in accordance with the provisions of ASC Topic 835-30, “Imputation of Interest”.

 

Inventories

 

Inventories consisting of products available for sell, are stated at the lower of cost or market value. Cost of inventory is determined using the first-in, first-out (FIFO) method. Inventory reserve is recorded to write down the cost of inventory to the estimated market value due to slow-moving merchandise and damaged goods, which is dependent upon factors such as historical and forecasted consumer demand, and promotional environment. The Company takes ownership, risks and rewards of the products purchased. Write downs are recorded in cost of revenues in the Condensed Consolidated Statements of Operations and Comprehensive Income.

 

Revenue recognition

 

The Company follows the guidance of Accounting Standards Codification (ASC) 606, Revenue from Contracts. ASC 606 creates a five-step model that requires entities to exercise judgment when considering the terms of contracts, which includes (1) identifying the contracts or agreements with a customer, (2) identifying our performance obligations in the contract or agreement, (3) determining the transaction price, (4) allocating the transaction price to the separate performance obligations, and (5) recognizing revenue as each performance obligation is satisfied. The Company only applies the five-step model to contracts when it is probable that the Company will collect the consideration it is entitled to in exchange for the services it transfers to its clients.

 

Revenue from trading of retail goods is recognized when title and risk of loss are transferred and there are no continuing obligations to the customer. Title and the risks and rewards of ownership transfer to and accepted by the customer when the products are collected by the customer at the Company’s office. Revenue is recorded net of sales discounts, returns, allowances, and other adjustments that are based upon management’s best estimates and historical experience and are provided for in the same period as the related revenues are recorded.

 

The Company mainly derives its revenue from the sale of healthy food products. Generally, the Company recognizes revenue when OEM, Home brand and medical consumables products are sold and accepted by the customers and there are no continuing obligations to the customer.

 

F-10

 

 

DSWISS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

Cost of revenue

 

Cost of revenue includes the purchase cost of retail goods for re-sale to customers and packing materials (such as boxes). It excludes purchasing and receiving costs, inspection costs, warehousing costs, internal transfer costs and other costs of distribution network in cost of revenues.

 

Shipping and handling fees

 

Shipping and handling fees, if billed to customers, are included in revenue. Shipping and handling fees associated with inbound and outbound freight are expensed as incurred and included in selling and distribution expenses.

 

Selling and distribution expenses

 

Selling and distribution expenses are primarily comprised of travelling and accommodation, transportation fees such as petrol, toll and parking and shipping and handling fees.

 

Income taxes

 

The provision of income taxes is determined in accordance with the provisions of ASC Topic 740, “Income Taxes” (“ASC 740”). Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted income tax rates expected to apply to taxable income in the periods in which those temporary differences are expected to be recovered or settled. Any effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.

 

ASC 740 prescribes a comprehensive model for how companies should recognize, measure, present, and disclose in their financial statements uncertain tax positions taken or expected to be taken on a tax return. Under ASC 740, tax positions must initially be recognized in the financial statements when it is more likely than not the position will be sustained upon examination by the tax authorities. Such tax positions must initially and subsequently be measured as the largest amount of tax benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the tax authority assuming full knowledge of the position and relevant facts.

 

The Company conducts much of its businesses activities in Hong Kong and is subject to tax in this jurisdiction. As a result of its business activities, the Company will file separate tax returns that are subject to examination by the foreign tax authorities.

 

Net profit per share

 

The Company calculates net profit per share in accordance with ASC Topic 260 “Earnings per share”. Basic profit per share is computed by dividing the net profit by the weighted average number of common shares outstanding during the period. Diluted profit per share is computed similar to basic profit per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common stock equivalents had been issued and if the additional common shares were dilutive.

 

F-11

 

 

DSWISS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

Foreign currencies translation

 

Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency using the applicable exchange rates at the balance sheet dates. The resulting exchange differences are recorded in the Condensed Consolidated Statements of Operations and Comprehensive Income

 

The reporting currency of the Company is United States Dollars (“US$”) and the accompanying financial statements have been expressed in US$. In addition, the Company’s subsidiaries and VIEs in Malaysia, Hong Kong and China maintains their books and record in their local currency, Ringgits Malaysia (“MYR”), Hong Kong Dollars (“HK$”) and Chinese Renminbi (“RMB”) respectively, which is functional currency as being the primary currency of the economic environment in which the entity operates.

 

In general, for consolidation purposes, assets and liabilities of its subsidiaries whose functional currency is not US$ are translated into US$, in accordance with ASC Topic 830-30, “Translation of Financial Statement”, using the exchange rate on the balance sheet date. Revenues and expenses are translated at average rates prevailing during the period. The gains and losses resulting from translation of financial statements of foreign subsidiary are recorded as a separate component of accumulated other comprehensive income within the statements of stockholders’ equity.

 

Translation of amounts from MYR into US$1, HK$ into US$1 and RMB into US$1 has been made at the following exchange rates for the respective periods:

 

   As of and for the year ended
December 31,		 
   2023   2022 
         
Year-end MYR : US$1 exchange rate   4.59    4.42 
Year-average MYR : US$1 exchange rate   4.56    4.41 
Year-end HK$ : US$1 exchange rate   7.81    7.81 
Year-average HK$ : US$1 exchange rate   7.83    7.83 
Year-end RMB : US$1 exchange rate   7.10    6.92 
Year-average RMB : US$1 exchange rate   7.08    6.75 

 

Related parties

 

Parties, which can be a corporation or individual, are considered to be related if the Company has the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operating decisions. Companies are also considered to be related if they are subject to common control or common significant influence.

 

Fair value of financial instruments:

 

The carrying value of the Company’s financial instruments: cash and cash equivalents, subscription receivables, prepayment and deposits, accounts payable, and other payables and accrued liabilities approximate at their fair values because of the short-term nature of these financial instruments.

 

F-12

 

 

DSWISS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

The Company also follows the guidance of the ASC Topic 820-10, “Fair Value Measurements and Disclosures” (“ASC 820-10”), with respect to financial assets and liabilities that are measured at fair value. ASC 820-10 establishes a three-tier fair value hierarchy that prioritizes the inputs used in measuring fair value as follows:

 

  Level 1: Observable inputs such as quoted prices in active markets;
   
  Level 2: Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and
   
  Level 3: Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.

 

Fair value estimates are made at a specific point in time based on relevant market information about the financial instrument. These estimates are subjective in nature and involve uncertainties and matters of significant judgment and, therefore, cannot be determined with precision. Changes in assumptions could significantly affect the estimates.

 

Recently Adopted Accounting Standards

 

In June 2016, the FASB issued Accounting Standards Update No. 2016-13, Financial Instruments – Credit Losses (Topics 326): Measurement of Credit Losses on Financial Instruments, which introduced the expected credit losses methodology for the measurement of credit losses on financial assets measured at amortized cost basis, replacing the previous incurred loss methodology. In November 2019, the FASB issued ASU 2019-10 highlighted the adoption timeline. For smaller reporting entities, Topic 326 is effective for annual periods beginning after December 15, 2022, including interim period within those fiscal years, of which is effective for the Company on January 1, 2023 as the Company is qualified as a smaller reporting company. The adoption of this standard did not have a material impact on the Company’s consolidated financial statements.

 

Credit loss rate is determined by historical collection based on aging schedule, adjusted for current conditions using reasonable and supportable forecast. Based on the aging categorization and the adjusted loss per category, an allowance for credit losses is calculated by multiplying the adjusted loss rate with the amortized cost in the respective age category.

 

F-13

 

 

DSWISS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

4. VIE STRUCTURE AND ARRANGEMENTS

 

On June 27, 2016, DSwiss (HK) Limited (“DSHK”) entered into a Management Services Agreement (the “Management Services Agreement I”) which entitles DSHK to substantially entitled to all of the economic benefits of DSwiss Biotech Sdn Bhd (“DSBT”) in consideration of services provided by DSHK to DSBT. Pursuant to the Management Services Agreement I, DSHK has the exclusive right to provide to DSBT management, financial and other services related to the operation of DSBT’s business, and DSBT is required to take all commercially reasonable efforts to permit and facilitate the provision of the services provided by DSHK. As compensation for providing the services, DSHK is entitled to receive a fee from DSBT, upon demand, equal to 100% of the annual net profits of DSBT during the term of the Management Services Agreement I. DSHK may also request, on ad hoc basis, quarterly payments of the aggregate fee, which payments will be credited against DSBT’s future payment obligations.

 

The Management Services Agreement I also provides DSHK, or its designee, with a right of first refusal to acquire all or any portion of the equity of DSBT upon any proposal by the sole shareholder of DSBT to transfer such equity. In addition, at the sole discretion of DSHK, DSBT is obligated to transfer to DSHK, or its designee, any part or all of the business, personnel, assets and operations of DSBT which may be lawfully conducted, employed, owned or operated by DSHK, including:

 

(a) business opportunities presented to, or available to DSBT may be pursued and contracted for in the name of DSHK rather than DSBT, and at its discretion, DSHK may employ the resources of DSBT to secure such opportunities;

 

(b) any tangible or intangible property of DSBT, any contractual rights, any personnel, and any other items or things of value held by DSBT may be transferred to DSHK at book value;

 

(c) real property, personal or intangible property, personnel, services, equipment, supplies and any other items useful for the conduct of the business may be obtained by DSHK by acquisition, lease, license or otherwise, and made available to DSBT on terms to be determined by agreement between DSHK and DSBT;

 

(d) contracts entered into in the name of DSBT may be transferred to DSHK, or the work under such contracts may be subcontracted, in whole or in part, to DSHK, on terms to be determined by agreement between DSHK and DSBT; and

 

(e) any changes to, or any expansion or contraction of, the business may be carried out in the exercise of the sole discretion of DSHK, and in the name of and at the expense of, DSHK; provided, however, that none of the foregoing may cause or have the effect of terminating (without being substantially replaced under the name of DSHK) or adversely affecting any license, permit or regulatory status of DSBT.

 

In addition, DSHK entered into certain agreements with Jervey Choon, (the “DSBT shareholder”), including

 

(i) a Call Option Agreement allowing DSHK to acquire the shares of DSBT as permitted by Malaysia laws;
   
(ii) a Shareholders’ Voting Rights Proxy Agreement that provides DSHK with the voting rights of the DSBT; and
   
(ii) an Equity Pledge Agreement that pledges the shares in DSBT.

 

This VIE structure provides DSHK, a wholly-owned subsidiary of DSwiss Holding Limited, which is the wholly-owned subsidiary of DSwiss Inc, with control over the operations and benefits of DSBT without having a direct equity ownership in DSBT.

 

On January 18, 2023, DSwiss (HK) Limited acquired 150,000 shares, representing 60% equity interest in DSwiss Biotech Sdn. Bhd., from the other party with consideration of RM 1. After such acquisition, DSwiss Biotech Sdn. Bhd. became a wholly owned subsidiary of DSwiss (HK) Limited.

 

F-14

 

 

DSWISS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

5. STOCKHOLDERS’ EQUITY

 

As of December 31, 2023 and 2022, the Company had a total of 206,904,585 and 206,904,585 of its common stock issued and outstanding. There are no shares of preferred stock issued and outstanding.

 

6. PROPERTY AND EQUIPMENT

 

  

As of

December 31, 2023

  

As of

December 31, 2022

 
Computer and software  $102,064   $105,535 
Furniture and fittings   6,144    6,144 
Office equipment   21,525    21,152 
Motor vehicle   135,868    135,868 
Total property and equipment   265,601   $268,699 
Accumulated depreciation   (205,600)   (187,236)
Effect of translation exchange   (11,896)   (9,284)
Property and equipment, net  $48,105   $72,179 

 

Depreciation expense for the year ended December 31, 2023 and December 31, 2022 were $21,833 and $30,131, respectively.

 

7. INTANGIBLE ASSETS

 

  

As of

December 31, 2023

  

As of

December 31, 2022

 
Trademarks  $12,077   $12,077 
Amortization   (9,194)   (8,164)
Effect of translation exchange   (456)   (454)
Intangible assets, net  $2,427   $3,459 

 

Amortization for the year ended December 31, 2023 and December 31, 2022 were $1,030 and $1,029, respectively.

 

8. OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS

 

  

As of

December 31, 2023

  

As of

December 31, 2022

 
Other receivables  $5,460   $- 
Prepaid expenses   1,932    2,080 
Deposits   17,140    19,669 
Total other receivables, prepaid expenses and deposits  $24,532   $21,749 

 

9. INVENTORIES

 

  

As of

December 31, 2023

  

As of

December 31, 2022

 
Finished goods, at cost  $6,872   $7,483 
Total inventories  $6,872   $7,483 

 

F-15

 

 

DSWISS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

10. OTHER PAYABLES AND ACCRUED LIABILITIES

 

  

As of

December 31, 2023

  

As of

December 31, 2022

 
Other payables  $114,964   $100,385 
Accrued audit fees   30,207    20,266 
Accrued other expenses   15,222    16,683 
Accrued professional fees   14,321    17,376 
Total payables and accrued liabilities  $174,714   $154,710 

 

11. FINANCE LEASE LIABILITIES

 

The Company purchased motor vehicles with finance lease. The first finance lease agreement commenced on July 31, 2018 with the effective interest rate of 3.62% per annum, due through June, 2025, with principal and interest payable monthly. The second finance lease agreement commenced on December 3, 2021 with the effective interest rate of 3.70% per annum, due through November, 2026, with principal and interest payable monthly. The obligation under the finance lease is as follows:

 

  

As of

December 31, 2023

  

As of

December 31, 2022

 
Finance leases  $38,817   $58,768 
Less: interest expense   (1,813)   (3,792)
Net present value of finance leases   37,004    54,976 
           
Current portion   21,039    16,515 
Non-current portion   15,965    38,461 
Total  $37,004   $54,976 

 

As of December 31, 2023, the maturities of the finance leases for each of the years are as follows:

 

      
2024   16,570 
2025   12,655 
2026   7,779 
Total  $37,004 

 

F-16

 

 

DSWISS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

12. INCOME TAXES

 

For the year ended December 31, 2023 and year ended December 31, 2022, the local (United States) and foreign components of (loss)/profit before income taxes were comprised of the following:

 

  

For the year ended

December 31, 2023

  

For the year ended

December 31, 2022

 
         
Tax jurisdictions from:          
- Local  $(51,974)  $(43,174)
- Foreign, representing          
Seychelles   (3,207)   (11,643)
Hong Kong   (3,703)   (3,951)
Malaysia   10,006    56,347 
Loss before income tax  $(48,878)  $(2,421)

 

The provision for income taxes consisted of the following:

 

  

For the year ended

December 31, 2023

  

For the year ended

December 31, 2022

 
         
Current:          
- Local  $-   $- 
- Foreign   (657)   (516)
           
Deferred:          
- Local   -    - 
- Foreign   -    - 
           
Income tax expense  $(657)  $(516)

 

The following table sets forth the significant components of the aggregate deferred tax assets of the Company for the year ended December 31, 2023 and 2022.

 

  

For the year ended

December 31, 2023

  

For the year ended

December 31, 2022

 
Deferred tax assets:          
Net operating loss carry forwards          
-United States of America  $(110,066)  $(99,152)
-Seychelles   -    - 
-Hong Kong   (104,743)   (104,132)
-Malaysia   (31,143)   (36,884)
-PRC  $-   $- 
    (245,952)   (240,168)
Less: valuation allowance  $245,952   $240,168 
Deferred tax assets  $-   $- 

 

The effective tax rate in the periods presented is the result of the mix of income earned in various tax jurisdictions that apply a broad range of income tax rates. The Company and its subsidiary that operate in various countries: United States, Seychelles, Hong Kong, Malaysia, PRC that are subject to taxes in the jurisdictions in which they operate, as follows:

 

United States of America

 

The Company is registered in the State of Nevada and is subject to the tax laws of the United States of America. As of 31 December, 2023, the operations in the United States of America incurred $524,125 of cumulative net operating losses which can be carried forward to offset future taxable income, at the tax rate of 21%. The net operating loss carry forwards begin to expire in 2038, if unutilized. The Company has provided for a full valuation allowance of $110,066 against the deferred tax assets on the expected future tax benefits from the net operating loss carry forwards as the management believes it is more likely than not that these assets will not be realized in the future.

 

Seychelles

 

Under the current laws of the Seychelles, DSwiss Holding Limited is registered as an international business company which governs by the International Business Companies Act of Seychelles and there is no income tax charged in Seychelles.

 

Hong Kong

 

DSwiss (HK) Limited is subject to Hong Kong Profits Tax, which is charged at the statutory income tax rate of 16.5% on its assessable income. As of December 31, 2023, the operations in the Hong Kong incurred $634,806 of cumulative net operating losses which can be carried forward to offset future taxable income, at the tax rate of 16.5%. The Company has provided for a full valuation allowance of $104,743 against the deferred tax assets on the expected future tax benefits from the net operating loss carry forwards as the management believes it is more likely than not that these assets will not be realized in the future.

 

F-17

 

 

DSWISS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

Malaysia

 

DSwiss Sdn Bhd and DSwiss Biotech Sdn Bhd are subject to Malaysia Corporate Tax, which is charged at the statutory income tax rate range from 15% to 24% on its assessable income. As of December 31, 2023, the operations in the Malaysia incurred $207,619 of cumulative net operating losses which can be carried forward to offset future taxable income, at the tax rate of 15%. The Company has provided for a full valuation allowance of $31,143 against the deferred tax assets on the expected future tax benefits from the net operating loss carry forwards as the management believes it is more likely than not that these assets will not be realized in the future.

 

13. CONCENTRATIONS OF RISKS

 

(a) Major customers

 

For the year ended December 31, 2023 and 2022, the customers who accounted for 10% or more of the Company’s revenues and its accounts receivable balance at year-end are presented as follows:

 

   For the year ended December 31 
   2023   2022   2023   2022   2023   2022 
   Revenues   Percentage of Revenues   Accounts Receivable, Trade 
Customer A  $-   $501,470    -%   26%  $-   $- 
Customer B  $263,195   $386,232    18%   20%  $35,247   $- 
Customer C  $230,525   $221,638    16%   12%  $-   $- 
Customer D  $182,786   $-    12%   12%  $-   $- 
Customer E  $494,182   $-    33%   12%  $-   $- 
   $1,170,688   $1,109,340    79%   58%  $35,247   $- 

 

(b) Major vendors

 

For the year ended December 31, 2023 and 2022, the vendors who accounted for 10% or more of the Company’s purchases and its accounts payable balance at year-end are presented as follows:

 

   For the year ended December 31 
   2023   2022   2023   2022   2023   2022 
   Purchases   Percentage of Purchases   Account Payable, Trade 
Vendor A  $163,262   $477,099    49%   23%  $5,984   $1,626 
Vendor B  $548,438   $331,538    15%   15%  $64,194   $- 
Vendor C  $164,854   $221,743    14%   33%  $22,008   $16,759 
   $876,554   $1,030,380    78%   71%  $92,186   $18,385 

 

(c) Credit risk

 

Financial instruments that are potentially subject to credit risk consist principally of accounts receivable. The Company believes the concentration of credit risk in its trade receivables is substantially mitigated by its ongoing credit evaluation process and relatively short collection terms. The Company does not generally require collateral from customers. The Company evaluates the need for an allowance for doubtful accounts based upon factors surrounding the credit risk of specific customers, historical trends and other information.

 

(d) Exchange rate risk

 

The Company cannot guarantee that the current exchange rate will remain steady; therefore, there is a possibility that the Company could post the same amount of profit for two comparable periods and because of the fluctuating exchange rate actually post higher or lower profit depending on exchange rate of MYR, HK$ and RMB converted to US$ on that date. The exchange rate could fluctuate depending on changes in political and economic environments without notice.

 

F-18

 

 

DSWISS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

14. LEASE RIGHT-OF-USE ASSET AND LEASE LIABILITIES

 

The Company officially adopted ASC 842 for the period on and after January 1, 2019 as permitted by ASU 2016-02. ASC 842 originally required all entities to use a “modified retrospective” transition approach that is intended to maximize comparability and be less complex than a full retrospective approach. On July 30, 2018, the FASB issued ASU 2018-11 to provide entities with relief from the costs of implementing certain aspects of the new leasing standard, ASU 2016-02 of which permits entities may elect not to recast the comparative periods presented when transitioning to ASC 842. As permitted by ASU 2018-11, the Company elect not to recast comparative periods, thusly.

 

As of January 1, 2022, the Company recognized approximately US$386,451, lease liability as well as right-of-use asset for all leases (with the exception of short-term leases) at the commencement date. Lease liabilities are measured at present value of the sum of remaining rental payments as of January 1, 2022, with discounted rate of 5.40% adopted from Malayan Banking Berhad’s base lending rate as a reference for discount rate.

 

As of December 31, 2023, the tenancy agreement had expired, a new and fresh tenancy agreement for renewal term has yet to be executed. The lease on premises had continued on a month- to-month basis which is terminable by the end of each month.

 

A single lease cost is recognized over the lease term on a generally straight-line basis. All cash payments of operating lease cost are classified within operating activities in the statement of cash flows.

 

The initial recognition of operating lease right and lease liability as follow:

 

As of December 31, 2023, operating lease right of use asset as follow:

 

   Year ended December 31, 
   2023   2022 
As of January 1,  $44,548   $92,606 
Accumulated amortization   (43,099)   (42,310)
Effect of translation exchange   (1,449)   (5,748)
Balance as of December 31  $-   $44,548 

 

As of December 31, 2023, operating lease liability as follow:

 

As of January 1,  $44,548 
Less: gross repayment   (44,171)
Add: imputed interest   1,072 
Effect of translation exchange   (1,449)
Balance as of December 31, 2023  $- 
Less: lease liability current portion   - 
Lease liability non-current portion  $- 

 

For the year ended December 31, 2023 and 2022, the amortization of the operating lease right of use asset are $43,099 and $42,310 respectively.

 

    Year ended December 31,  
    2023     2022  
             
Cash paid for amounts included in the measurement of lease liabilities:             -  
Operating cash flow from operating lease   $ 42,862     $ 42,212  
Right-of-use assets obtained in exchange for operating lease liabilities     -       44,548  
Remaining lease term for operating lease (years)     -       1  
Weighted average discount rate for operating lease     5.40 %     5.40 %

 

For the year ended December 31, 2023 and 2022, lease expenses were $43,099 and $42,310 respectively.

 

F-19

 

 

DSWISS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

15. RELATED PARTY TRANSACTIONS

 

For the years ended December 31, 2023 and December 31, 2022, the Company has the following transactions with related party:

 

  

For the year ended

December 31, 2023

(Audited)

  

For the year ended

December 31, 2022

(Audited)

 
Professional Fees:          
- Related party A  $13,001   $12,226 
           
Sales          
- Related party B  $-   $386,232 
- Related party C   48,366    24,261 

 

The related party A is a wholly owned subsidiary of a 7.33% shareholder of the Company.

 

The related party B’s director and shareholder is the founder of the Company. Founder of the Company resigned as director of company B on October 02, 2022 and is no longer a shareholder of company B.

 

The related party C’s director is the founder of the Company.

 

The related party transaction is generally transacted in an arm-length basis at the current market value in the normal course of business.

 

16. SEGMENTED INFORMATION

 

ASC 280, “Segment Reporting” establishes standards for reporting information about operating segments on a basis consistent with the Company’s internal organization structure as well as information about services categories, business segments and major customers in financial statements. In accordance with the “Segment Reporting” Topic of the ASC, the Company’s chief operating decision maker has been identified as the Chief Executive Officer and President, who reviews operating results to make decisions about allocating resources and assessing performance for the entire Company. Existing guidance, which is based on a management approach to segment reporting, establishes requirements to report selected segment information quarterly and to report annually entity-wide disclosures about products and services, major customers, and the countries in which the entity holds material assets and reports revenue. All material operating units qualify for aggregation under “Segment Reporting” due to their similar customer base and similarities in economic characteristics; nature of products and services; and procurement, manufacturing and distribution processes.

 

The Company had no inter-segment sales for the periods presented. Summarized financial information concerning the Company’s reportable segments is shown as below:

 

By Geography*:

 

   Nevada*   Seychelles*   Hong Kong*   Malaysia*   Total* 
   For the year ended December 31, 2023 
   Nevada   Seychelles   Hong Kong   Malaysia   Total 
                     
Revenue  $-   $-   $-   $1,470,071   $1,470,071 
Cost of revenue   -    -    -    (1,110,846)   (1,110,846)
Depreciation and amortization   -    -    -    (64,933)   (64,933)
Net (loss)/profit before taxation   (51,974)   (3,207)   (3,703)   10,006    (48,878)
                          
Total assets  $19,729   $22,720   $24,545   $300,499   $367,493 

 

   Nevada*   Seychelles*   Hong Kong*   Malaysia*   Total* 
   For the year ended December 31, 2022 
   Nevada   Seychelles   Hong Kong   Malaysia   Total 
                     
Revenue  $-   $-   $-   $1,849,047   $1,849,047 
Cost of revenue   -    -    -    (1,404,054)   (1,404,054)
Depreciation and amortization   -    -    -    (72,441)   (72,441)
Net (loss) / profit before taxation   (43,174)   (11,643)   (3,951)   56,347    (2,421)
                          
Total assets  $27,294   $7,056   $14,264   $333,310   $381,924 

 

*Revenues and costs are attributed to countries based on the location of customers.

 

17. SUBSEQUENT EVENTS

 

In accordance with ASC Topic 855, “Subsequent Events”, which establishes general standards of accounting for and disclosure of events that occur after the balance sheet date but before financial statements are issued, the Company has evaluated all events or transactions that occurred after December 31, 2023 up through the date the Company issued the audited consolidated financial statements.

 

F-20

 

 EX-31.1 2 ex31-1.htm

 

EXHIBIT 31.1

 

CERTIFICATION

 

I, LEONG MING CHIA, certify that:

 

1. I have reviewed this annual report on Form 10-K of DSwiss, Inc. (the “Company”) for the year ended December 31, 2023;

 

2. Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
     
  b. Designed such internal control over financial reporting, or caused such internal control to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles.
     
  c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
     
  d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
     
  b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: March 29, 2024 By: /s/ Leong Ming Chia
    LEONG MING CHIA
   

Chief Executive Officer,

President, Director, Secretary, Treasurer

    (Principal Executive Officer)

 

 

 

 EX-32.1 3 ex32-1.htm

 

EXHIBIT 32.1

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Annual Report of DSwiss, Inc. (the “Company”) on Form 10-K for the year ended December 31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), The undersigned hereby certifies, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge and belief:

 

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

 

Date: March 29, 2024 By: /s/ Leong Ming Chia
    LEONG MING CHIA
    Chief Executive Officer, President, Director
    (Principal Executive Officer)

 

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement has been provided to the Company and will be retained by the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

 

 

 

 GRAPHIC 4 form10-k_001.jpg begin 644 form10-k_001.jpg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�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end GRAPHIC 5 form10-k_002.jpg begin 644 form10-k_002.jpg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end GRAPHIC 6 form10-k_003.jpg begin 644 form10-k_003.jpg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end GRAPHIC 7 form10-k_004.jpg begin 644 form10-k_004.jpg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end GRAPHIC 8 form10-k_005.jpg begin 644 form10-k_005.jpg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end GRAPHIC 9 form10-k_006.jpg begin 644 form10-k_006.jpg M_]C_X 02D9)1@ ! 0$ 8 !@ #_VP!# @&!@<&!0@'!P<)"0@*#!0-# L+ M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$! M 0$! 0 $" P0%!@<("0H+_\0 M1$ @$"! 0#! <%! 0 0)W $" M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P#="U/$O--" M\U-&,5]"V>98MPIQ5I5XJ"*K*]*YY,T2$Q28J3%(12N%B/%(14F*0BG*=Y$G]P_E6SH&EF]N067Y17=+HUH% ,8_ M*N:KB%!V.NCA95%<\L\B3^X?RI&1E^\I%>J_V-:?\\Q^58/B+0XU@,D*8QZ5 M$,5&3L:3PA F I0*0&G UDS=(7%*!0#2 MU+-$A0*7% I14MFB08IC'%/)J&1L"D:)$$S<5FSMR:MSO6?(VG*,5)MH"UOLST#0M.6SM%)'S$5L55T^X2XM49?2K>*\2;;DVSZ.FDHI( M2HKB%9H60C.14M(Q"J2:A%L\SUS3C9W;$#Y2:R0*Z7Q1>I-<>6N.*YP5[--M MP5SP:R2FTA,5U7ACPK'J]K)=7;R1PYVQ;."V.I^E8>F:=+J>HPVD75S\S?W5 M[FO7K:VBM+:*WA7;%&H51[5S8JLX+ECN=N"H*;YI;(YP>!-+'_+>Y_[Z'^%3 M)X)TU>DUS_WT/\*Z0 D\#-."-_=/Y5YSK5.YZRH4_P"4YRZ\*P064DEI)*TR M#<%8C!]16#%-Q7HBJW]T_E7#^([ Z=J'G(,03Y8?[+=Q5TJCD^61-6FHJ\1B MR^]/$HK*6?WIXG]ZV<28R-02TX2^]9@G]ZD27<<5#B;)F@):<):J@BG$C%9M M&R+!EJO))[U"TN#BHFDS2L6-E;-56&:F8TS&:921%MI=M2A:<$I-E)$06E"U M+MI=E2V4D=%MHVU-MHVUT7.>Q$!BIXS3-M.7BADV+:'-2XJO&:L UDQB$4F* M?332!C"*:13R:::HAC"*::>33&/%4B&0R' JA.W6KNH0TW'0P[G.SV1I)&L4:QH,*H MP!56[U.QL1FZNHHO]]@*P_%'B"Z@N8=&TA0^I7'?M&OJ:JVO@.Q2%[G5I)-0 MO"I9FE;Y0?85XC9[INV_B#2;M]D&H6[L>P<5H@Y&0<@UY_X=\,:1X@T1YKBT M2*83.BO#\I !XJ2"[U+P7J4-GJ$[76D3MMBG;[T1[ T ,\:Z/Y$XOX5^23A\ M=C7']#FO9KVUBU&Q>!\,DB\&O(]0LI+"]EMI!@H>/<5ZV$J\T>5[H\#'T.2? M.MF=%X8U3:P@=N*[,,",Y%>203/;R!T."*UE\1W:J!NZ45L.Y2O$>'Q:A'ED M>BY'K65K>H+:6C8/S$5R'_"27G]ZJ5YJ4][_ *PG%1#"M2NS6IC8N-HE6>1I MIF=CG)I@%*!3@*[CSEJ>A^"]&^Q6!O9EQ/<#Y<_PIV_/K6#XY^)$WA[4X;#2 M4M+E]F^=W.X*<\+P>O>MK0-2EU?PU=Z>&_TV*!HT.<%@00I_I7B-YH5YI6JP MZ1?6,@O9=N0#DDMTVXX->'7YO:/F/I,.H^R7+L;/B;QQJ_B31+/SV6V"SR!E MMBRA\!2,\]LFN3^UW7_/UG\ M/2LP?#+Q=_T"O_(J_P"-8G2CF1=W7_/U(/AK;1W.6V@W=_K,NB6MC(U]'N4#.#E>N[/ %>X>&;.;P=X#AAU#9 M]ICW,44Y&YCPN:%>^A3M;4Y1Q)#*T4@*NA*L#V-*'--EEDN)WFE;=([%F/O0 M!7I,X8HE#FKD'"YJD%JU W8UE(Z(EH-3@U, IP%9,V1'*.]15)(%J&RT1A*=MJ0)3PE2V6B$+3MM2A*=LJ&RT= 5I-M3E:0K6_,<]B MN5HQ4I6FE:JY-@4XJ97J#%+F@1.7IIDJ$M3"U%B6R6XVQ[C2E*5M!1C%[FLEO&!SBJTZKO '2@:M;M\LH*/Z&DWQ3C,4JD^ MF:Y'4FGJ=*I19I:3I<5U<>8R#8G)R.]='+%A?E X%H^1=&W=QM?H?>NI MP6!]ZYZE23>IO3I1BM#S_P &VS:AKVM:O,-TGGF%">RBNNN$802\?P'^502 $B,LI]".16-J.G7?AG5_[5TJ)I;.=\7-LO8G^(5J>*=5CL/"] MS<-P\L>V-3U+'M5HS8WP9>O?>%;*60Y<)L)^G%9_C71_M%L+^%?WD?#X[BM/ MPA8/IWA>R@D&)-FYA[GFJGC'5Q9V'V2,CS9N#["NB@Y>T7*;$45 M(L;/T7-6(].N91E8Z]OF2W/FU!O9%2G"IULKAI?+$3;\9QBF-&T;%74JPZ@T M73%RM;H8!3P*%%. I,TB7-)U"32]2BNX\D*<.O\ >7N*]6C^S7:PW:)')E=T MTO2_EJK@ZR@^66QW5 M**P1XOTG^_+_ -^Z?[*?8]55:?]<:!DY/)K:C M3:?-(SJU$U:(*M2*M"K4@6MVR(H0+4B<'(I0M/"UFV;(D$OM3O,)'2F!:>%K M)FR$"YIX2G*M2!:ALT0P)BGA*>%IX6H;+1&$IP2I0E."U#9HB,)2A*F"4X)4 MW*1NE::5JP5II6M.8P*Y6F%:L%*85JTR2 K3"*L%:85JTR65R*814Y6F%:I, MAD!%1D58(J,BK3,F5R*C(J/[ MN!^%:#A).""3[51:WD;.V-B!Z"DW?<:TV*DSF1BS?RGH.=SE[OXA:*JXM?.NY3]V. M.,G)JA9:1JGBC5(M3UN+[/90G=!:>I]6KL8[&TA.Z*UA0^JH!4]6C-L@N)H[ M2V>5R%1%S7E&JWS:EJ,ES(3@GY1Z"NH\:ZN>-/A;WDQ_*N)YKU<)2Y5S/J>' MCJZE+D6R+]N$4 DBM>VN$48!%AW>AV4 M>H:@&)P%'+#L*UM3\'Z?>9'=/;3M,C5QF9QN<_TK>BM)IB ?E' MO7CSJ.,[IGT%.G&=.THWN<6/ EB/^7B6LO7?"B:;9"YMG>0*?G#=A7I,]DT0 MRZU2EA6>%XI!E'&"*N&*G>][HSG@Z=FDK,\> IX%7]6TYM,U"2!A\N3Z M0L 56PX+3U6D5T M/ R3]*<)4!YR/PJ7B:7\Q2H5.PX+3PM()8_7]*9/>16K1B0-^\&5QWK.6*HQ MWDBXT*CT42<)3@M/C&Y PZ$9J4)6G-%Y)8R^!GAL4R5X7 MA1T4(&(Q\^:/:).PO9-JY585&PJRR5$RFME(P<65V%1D8JP5J)EYK12,9(6+ M:&R0*U[21=O %89!%.2>2/H:SJ*Z*IRLS5FTJROG?>OERGHRUSDFA7_FLD<# M.O.&'0BM9+UE*NK?,.H-6O[?*+A1CMQ7,JDX;'4Z4)K4XJ:%XI"DBE74X(/: MHB*ZE["+5S+.TFV7CFJ-QX>^.M4YK*"&%MD,8#>W6ICB*?\@Y8:K_.SRJYFDN9WFE.YW.2:AVUUNJZ M)!/.IMR(F/WN.*R+_1)++:?,5T/<=J]*G7A))(\>KAJL6VUM>;ZQKUSIWBV>19&98IK,PR>*\5MO<^CBDMCT&W\1V5ZUK$95-Q.F MXJIR%/<&M5XA+!L4 =Z\A;PMXABD#16K(PZ%7Q76: /$)UN*74T*6Z1%,!N# MZ$^]-7!I,?XQTM7L!.V!)&?E/K[5PJ6TS(7$;%1U(%>C:K?)>3M!P\2<'/>J MR"VA08VCVKMIXIPCRV//JX.-2?->QQ@TR]$"S&W?RVZ'%:'_ C>H)9BY,8Q M_=!YKJ&O@T1C4?=Y!'2K6G7#31XDP%!ZU,L7/L:0P4%U.'M]+N)MP$; KU!% M=-I7A:*22*:5R53EU[,:Z2%H78J%4GUQS5I%5%PH %A3Y#@-@<;:R8=%TI^$C!_P!US71?$S(U?3L?\M#L.>PK*M+%;:0N MK$Y&*\I)79[\9/V<=2-=!L.R2#Z.:C_LVV>6&$;PJ[N0QSU]:UA5>*,"^8\\ M#C\:4DAQG+N,71+?M)./^VAIESIT<-M,!)*QP,;GSCFM=14%RF70=F(!K.<5 M8J,Y7W,JWA$ARTC@*I& W&<=ZO0Z5(8U(O9QD>M06T0:.Y/3$YK=A7" >U8) M)[FDY-;&?_9T\0W"_FXIRV$[N^R\=5W8 QFM.1-T9%):*2A)ZDYJ905[$^T= MBF-.O .+TX]UJ"[MKA9[?SK@R#.%XQBMMT9HF"\-VJE(C1R1"<%B3\OM7/4A M$<:CN;$"?N4_W14X2EA7]TF/2I0E?1Q?N(\.7QLUBM-*U.5IA6MKF%B K3"M M6"M,*T[BL5RM,*!WSGFKC0-Z=:1[9C%& M2-N210ZBNK,I0T9E7MND]L\;OL4CEO2LNTTLQS"47?F0CY@!R":Z6YT2&YB> M.6Y8HZ[6 (%5H=#M=+LY4@F;: 2%+9Q6.ZE.S(YQQ6SK14D[]#'V3::,@K4;IR>*U+F M-[B8%80@"@84<&HI-/FW'CMFMXUXM7N82HO:QE,E1./:M6>Q:*U$K9#;L8[5 M1*UM&HI+0YITG%ZE5(VE<*!5]=&5@"6.:N:?;JJ[R!FKO1Q64VF]#6G=+4H1 MZ5Y,9,;-FJGVA@'BF1BHX^HKH5DQ5"\\L-N(&W/(K%/NC5NY'ILZ(P6*-5'< MX[5NM)$8F(89QTK'MQ;+!E?E)/ %#W/E.06#+6(V]A5>ZU,. M@QC'O5*]N 1E /7-8LUP5@[U MDM,=_7-26TX68%\[?:NE*R.=ZFO9,MHQ(X'IFK:ZHI)4UD_:(Y9 !QVS4US: M&.,2QN#Q2:4GJ";BM-C?TC656Y-NS81ONDGH:W&NX_\ GJO_ 'U7F$,S13%R M1GWJ^US'+&I9OK@TIX>ST'2Q2:U.\-W$>LR?]]5FZWJRV=@WE.&E?Y5VGI7) MB*"6W8I.1(.E9\LF M:R$=E.)- MH%=)H=F\VV^ND&[_ )9@_P ZY:BY+RF=<)*6D6;-C;^1""W^L8<^U6LU%FEW M5YC=SL/-_B4"X.E*143045%<#]Y%]:G3FH+E"98R&(YZ5G/8< M=RI:#]W=_P#71\I^E%HO[H4]E M)C.#@XZT68/E#/K2D_>,^A8"U4O5_>VW^_5[A5R>@JI[+N[VL<.]K?;25BF(^AJ&6UO98W M_P!&E)*\<&NXOM1>UN!$L2L",Y)IEEJ4ET)MT2J47(P>M/GZ7-U-VYK&1IW] MMM%;P1$01QPC=YD?4^E37UOKHMY#'=I@J0P"9)^E:6EZC+>M()(U3;TVGK1> M7&IKU@]*9P8GWI%FQFQ^[)J_6(K%&#"K7]HL!C; M74U?8YEH:D:R2$K&A8@9XK.U"TO96VI;.0*W]/5HK4,ZXDDY/M[5,06)XS6/ M-9E\NARGV;45C"BU?(JI>07ZQ&66VD5%'S'L*[0BF.BNC(PRK#!![BA-=A.+ MZ,\WD?/.[)K"3:=[ M&\/>5KG'/$RL0RD'T(J[%HM_+&'2W8J>0:[*VLDU"8F6!&4]21S700VT:8 ' MR@8 IRQ=EHA0P%W=L\XA\,ZLZEDMF&/4XICZ'JHRCP/@=J]6!50!VJN9(;C> ML95RIPV.QK'ZW*^J.GZE%*R;/,(_#^H,X46Y'UK<7PW;6]E_I183D=<\5USV MX'W<@U2U"S:ZLV ;#CE:F>(E+9V+IX:$-U,6\"Q@8P.?K4P->?6JRJ.[.VG2C!61)F@4T&G"L#8\Y^(HSK&F# M'5QFJT<:(K.;T''J?]]53NKNX21!;P+,A'+;NE<^<2( 2<'BM)-/MK#$L;2< M<8+$@UC*;E&\6:*"B]32MYIW:F=8RV7"D^IK$D:&:=20057CG M%,-Y$CN&F'!Z,<\8J(U%;5C]FV]#9D-N02S1Y]2167]E$+*YU)OO=, ;O:L6 MYD!"N@8J,DMU!&:N+J%N\D*C;!$>J*2.U9 M-]JMS'=NEO+;+$JC!?.=WI4=S?10E2R.!M/\-8%[J,$ES<,@)R5YV].**LTE M9,K#X?GE[RT.HTR_N#;-+?S0$8RIB!QBKUMJ%I>)NMKB.4=]K9Q7,VEPO]B# M"2']TW;ZUY5<7]Q:2!K6:6%CG)4XK>,?HXK34]&\8DCQ!:.6LK%8[F)SZ*X-<]/J6/K7 0PRQS ID<@_*>G- M=]*K*G"*M(C;7PM M3;7KB2W52/W2!L8W?SSZU>U&/6/%E[I$]ITNI!=O9S_N]JE3C@\MU'OC M-7_'/@M?%-Q87_G2HD",DRH1G8><@'C.>M:>@W6C0>$Y3X86.YBMXFVPQ'YG M<#H<]R:1FT9OB?XCV&@74]G]GGDN(_N$ ;)#CL?0''/Y5YO!\3/%MP\5K#>6 MZR2285WC7J3T)/ '/Z53CMKC7-8BTIM*%KJDC?.7!);/NG8NO<@(QQG )K@?A[J\EU?Z\KL3BZ)&>U5_%O MCT: ;RS$8-UP(<'L1U->>^"_&S^']2N'N4$D-TVZ0CJ#ZTN4KF/H7[1QUI1* MIZUD:-J2:EIEO=.T8:89 4UIJ@+ 46'<9>0^6^\?=:H!6M+&)(RAK**E&*D< MBN.:LSH0X4\5@:S*/.OB$/^)U9$DYQ\@_VJS[$W6\^?G;CBM'X@G.N:6/ M]L5&G2LUNSO3_=Q)5J./_C[;Z5*M11_\?C?2E(<2\M1S_?C_ -ZI%J.?[\?^ M]6A:Z(2.U0.3+LW +M.15M!FBXBR(^/XA6=2+:(3U-.U7]T MOT%6@M,M4Q&!["K02O8I_ C@EN3D5!<+^[Z=ZME:8PQR:UG&\6B8NSN9<)6& MU>/5T7(MCT*>KYGN0")FM MP2C[?4#WK18P@*<]QCG-,CNE%H$()XQTI[S0*HQMR".E7248JZ9-24I/5$$U MS;Q2KYNWE3@D=*Q[T+<74CVZ%DR,E%SVJ]J+_:&C6)2QP<_+THTQFAAEC=64 M[\]*N<5-;E4INF[I#DDC&E;Z;Y"T+1719FVA#]XUTTI22=S.E%2EVF58E4AT(ZUSMM<;)"2N1[5TVC20_V+<1-(JN0WRD\]*YTVGER?(_!7O7 M5'F=G$:Y$Y1F;&MZSI^J:2$MU,<@=<1MZ =:9X2UQ=%OXED.+:Y;RY?8]F_" MN9Y!"GMFK"E6BA#C(W'@BM*3O=$UJ48P78^BS(L=HC.NY" "/4&N/\!>&K?2 M;K5M15#'+<7#I%%VBB#':/J>OTQ57P7XCDUG2VLIY"9[,["#_$G\)_I78Z:# M^\X/:MXM]3R*E-1N4#X6MSXSE\2--)YSP)$L8X"XZG/N.,?6KVM6=]?:7+!I MMW'9WC8"7#IOV#/.!ZXK0P?2AW6*-G?KBL%9\]A6MJK#4WED>0J#PN.P["L9].$49<7#9^E=,/=1Q55S,N6 MD1NI0B_B:T_[&7_GI4?AD126)<' />LS6;>!H5+J-^>*K:"\-A>8("QR?>J)RYHE4H8&58SPGN:[Q8HF#$ @DC@-/^&YNM^I:_,US=N"S(K<#V-8G@OPEIGB$:K%=0L##,51T M;[HKV2=;:&"1Y"J(%.XG@"O/OAFVFK?:S#'-&9)+@LB@_>'J*6H]"E#H>L^" MM2AN(5DU'28F+;5;YH\]\5Z-I6N6NK1Q369+HYP3_=/H:N201K"^%&,=*I:3 M906L8>&%8R[EFVC&:ELI)&_69>,IG^7J.M7;B80PENYZ5D;LDD]37/-]#6*) M :<*C!IP-8%GGOCY@=?TT9Z,"?:F1NK=&!^AI?'XSK=E'WE7;GTJCIU@;,G, MA?CJ:S6[/027LT:B]*KQ.&OF7!SCTJPM0Q_\?C?2E((E]:BN' DC!]:E6HY_ MO1_[U9SV'' M*I)\NIC)ZZ&K;@;1]!5D)Q56%@JC) XJ<2IC[XKTX25CDDM2T144V0G'K4W: MHY?N?C71/X60MS/E^5\D<$50R%W ]SZUJ2E-P.S( Z53+1$L/(!YKRJE.[W. MR$VC(-YM@*%#GG%0/>^7)$X ZC=4EPAYQQS5"51YD>X;E#C*CO7G*I.*<%U/ M05.+]YFD-9B28'&05(Z]#5:+6T2\N78?*2,<^U0W:R6:/S M94^S!@V#@*3MINZGL73H0FKM&U)KJBS].E\0H8XC@%MRDC/0= MZH">'^S3&-/*G9@/L[^M93(2!STZ^]:RJSC;4TIX:G.]ULS0U75OM-Q#M"F, M*V[)[]JBTS6H].29-@8,P8$-5%+8RZA"!'YIPW[O&1(%Z5QMUUM/4LB6\L46YA:2'>2NZ M-L''X5T?@_Q#'"/\ A);//R[- MV3^%=D;+5'EUO?33Z?H>H_;;K_GXE_[Z-1S7LQ3;+6U1V;/E;C@5T!\66@!)0K@=R!F MO)Y6?#;G91DXY/-*EHS:>ETQR6?;LSR/>I7?BF*X=F9XT .%RW:LV M3Q4BGY)H-JGDYS@5QTSM$?N Y[D9J]X>M[74KN:VN04#+]X86I]H[V17L$H\ MQZUX4\6VNK6KPB=7FB/0#J*Z+[>H'4GZ"O*='BT7P]J*W!NF5@Y4C?G*_A7I M1N+&>*.:VGC,;+G.ZD[A&S*6OV(U^!;:2ZGAM\Y=(^"_MFL"T\":7979GMGN M89$8&-T?!%=K9?9)%;>Z$@]=U6)8[79B-H\GU85)6B*RWK+&JE2Q ZD]:M6$ MY<2Y "@9K,PIF$6].OK4VJW8M+)HH60NRX)!J6[*Y=NA;N[CSI<#[J\"H0:B M0G:/I3P:Y&[FB1(#3P:B!IP-(9Y_X\Y\1:9Z9%12W"VZJ6!.3@8J;QNR_P!O M6C,A;8NRA<5$KEJS6B)Y=0\E 3$W7'2GFZ6:2-0K#G/-6#&CCY@#5> MZ=8I8^.^Y+MD)^4&E^=1\PQ^%-6\V':%Z< M4Z2838)0@_6D^6VCU%J:^^@G>,#K3*=&?FKT4VW9G-8B="'R>E5)@(75T[]: MT''7?55T4J%7F0]*SG%="XMF3)8^>2J3)GKC/(K,FMHTD#?;( R-GDUNB."U MF\QAM?!#'M68;"RNG)2-E *D@U M131[N%W99H\/C=6K;6*6B%4=CSFG>7A6!+$,<]>E=2P5.23FM?4P^N5(.T'I MZ&'E5(=,BN03#?1.(^6P>GUK5GT2WGG:5W?).<"GV^F0 M6JS(A8B5=IK)83FE[T=/4Z5C.2'NRU]#%MQ;V=XMS'J5KE00?F[&KL\%SJC_ M &B&:"2-@!D-GI57_A#;$*R^=-\PQSBM?3=/BTNR6UA9F123ENM:TL+=YQ[:1J./^/9OP:H7TV^7_ETF'TYKL3<) MZTPW2#O6BI">(..==5CA$:PS;%.0"N<5K>%("MW//>PL <(FZ,XR?7TK:-RN MWK70Z2LRZ+,S6JM#.W^M9\8QTJIQ:@U2[G#-/,YE1N489!K##0T;9&)D[ MJQ5N;5%=B#M7L :SI+620D(DASZ UZIX9T-+B%KJ^MXRA&U$=.OJ<5T*:-I@ MZ6$!^D8K>*:.64DSP5M(O9/NP2?4\5-'X>U CY0!]6KW1M-TM.ME;9] @-07 M%A9RV\D4=K%$64@.%&5/K5:F39XN/"]X?OS*OMUJ2+1!:2;WOT4_2IM3>_M[ MV:UNI&$D;%2!P/K6?R:JS"Y-<6%BP^:]=V]56HC;P @)=704#[H; H">M*?2 MIY46I,FMLK\D4MT6/I(:SKK7M0CN6CAGF"I\O))K=TK"[CCYJOM9V[>> ME+FY=BT[[F+H1NM8\V26YE5XB!PY%7[Z8Z+&)VN)996(P&5I]FEL)))(4&R4IN(ZUI M:#/'IHW+&B/,/FBD.0?<9K.4FA.A&UT6_'(?G3H]3V,66 ;CWS42GYE*FUT-D:A<#_ER?\Q5> MYO&F?:T#(0.YJ :RY'^J_6FB^W2F0Q DUE.=^HXT[=">&7 QM8Y/)]*V+*_8 MQ*/L\AQQD5BQ78^;,0.ZM&TU#RU"B/BL8RL]QSC=;&_%=%EQY$@R.XJ_9R[% MQY;'Z5EVVH[@ 8ZT[>Z51PF*Z(R\SBG&W0T5GX_U;_E2%^FU6!]Q4:W8(^[2 MF<.. 0:TE+S,.7R+:H"^?*^P*.!ZUT4D$9Z@&J$UO"O\ "M9.G+FYC=35K#'O[0=914#:E9#_ );" MHIEB&1^[Q5-O)&?FCK3VE;R$J-'S+C:K8CK,HJO)KNFQ\M=1BJDGV?J?*/X5 M"1:G@I!_WS1SUO(KV-'S'3^+M-BSLWR'V&!67=>-7((MX53W;FM Q6?]V#_O MFFD68X'D_P#?(HO6?4I4Z"Z?BH#%Q.Q3^Z!@54@O(Q\A8^U=HZ6; M@B(Y_P!D52>RT\G/EQ_7%5&-2]S5U*25DK',M>(#C)J-KQ#W/Y5T,]I9D?*B M53:QMLYV+^5=4**WMY$F<_,2 M>@_B-5C$HS@'\J[+PEI:6]B;UL&6?@?[*CM1/#4Z<;HYUBZDY:G0HT-O$D4* M'8@P-QKF?%GB:ZTF2PT_3K9;G5-1D,=O$[;44#JS>PKI2M*?49/-O(3OACE(4%3[=#GWKTX8(! M!!!Y!%(9Q7CK1?/@75(4^>(;9L=U['\*X(1U[A)$DT3Q2*&1P58'N#7DVKZ9 M_9>JSV@8,J'*G/\ ">1GWIW$96VF[.:LE*-E26@LW\J49Z'BMM.@]*Q0E:-E M-D"-OPJ)%HMF,&HY)%M@)7.%7J?2K('%17-JES"T<@RIZUB]3:+,I+2ZGO$^ MS2;7QYPVM@D9[4:G=RSW$7GPCSH<_O0,$C'0U#=VMY;WLE:HN M?[5A"7=H8[L<>8!@,*Q:.N+ZF&DO^BVUN?NF0R-[U;U=C.L2J!A4R#W%22:> M$2"1>G*CWIEVA655X.$P:AHWBU?0QPK$Y)))[FI$0@U=6PD*JM<] )$P60@5MV3,70X.,]:UI[G+41T"6J YR/H:7[(W!4C-+',C=&!J42IG M&X9KMY8G!=CMK#'[H'UH<*&_U1IX)%.#&GRD7-&DI^*,5ZARC*0T\@48H&5W M&1UK/N%X/-:;@8JG*%P?ES4MHI&%<1]>:H/$#U/Y5N2H-V6C)JN;>/'W,?6E MS(U1AO'SP?TIAA;=@M^0K;>WC88""HU@09R!GUQ1SH=F8Q0\GG J-@RC@]?: MMUK='R !^50M;A#P 3CIBG[5(.5LQ\/C@_@149\WD8/Y5NK; K\RCIZ5"\./ MN@8^E4JT>Q#@S!9&ST./I49C;=R.*U[J%TC#JRY[C%4CY@P2$(]*Z85$T<\X MM,IM&1T&?PI%B8M@KG\*O\LOW.?I4UO$6;D5NIHYY)E..U9OX0?PJQ]C/419 M_"MJ.%0HXYJ98\#I1[0S:.?-H<B1?2N-G:CQ.YU1O$^D:IH&CV%U/<:AJC3&1XBJ01_+\ MS$]#QTKUNV@^S6L,&[=Y<:IGUP,46FGP6'VC[.&'VB=IY-S$Y=L9/MT'%6,4 MAE'4[Z/3-/ENI.=H^5?[S=A7E4\DES/)/,Q:21BS$^M=)XLU/[=?_98FS!;G M!Q_$_<_TKG]E("OLHV5/LHV4F4B$)3UR&4@ $>E2!*Z+2O!UYJ5@EV)HX5@/?O4^*W(? MY$^?MD!'T-7!X,NL:Z#273NP.2>]9-'3!W9J3:8TM@KPK MN.,\3 M&\\5(LDN<[SS4,+,TDB0#M3_ "1C*8W9K/5Y<8WG%2+)+_?/YUF[!9F@0PG7 M:F4'7WK3CP$.W(K!220'[YJ[;S/W*.:;9:2:1>CG\:F6Y;N%-5 :?6FIBTCI:*2BO6.$4TTD4A-1.W%2- M".]4Y6&3S^M$A)SC]:H2,Y)! V_6H9HB1B">N/QJ%S[Y-1GS/[H_ U$0Y.,8 MS[U-BKDC_+T)IF>>F:0HPC@-3L%R5CA23C\*C[ @<4AR/O ?2E'3 M 'TIV"XH&[(.X>XJ#[N0%;'KFIF)"]:A8]ANS[4U$ER*=PBGJI(JF8U63A"2..U6-V4@/OSM]^E1W=OD'B MLB6'#5)12V'KWHV58V>U+L]J *VRDV5:V4GETAEC1=*;5=3CMQD1_>D;T45Z MF%CMX0!MCBC7')P% K)\,:3_ &;IH>1<7$^&?V'850\='.GZ=#*Q6SFOXDNN M< IGH3Z4TALZ6&XAN8]\$T)=.\V(7L:_/'Q) M[KZ_A64U=7-(.S.0V9[4TPJW50?PJSMI=M<[1U)E(VL1_@7\JLVFCP2Y9TXJ M>.+?(!6S%$(XPH%)1N4YM&4-$LO[E5;[18ECWP<$=JZ/8*&C#*010X(%4:.$ M,#(<$4X1^U=%/;A)2,#%1B%?[H_*N9P.A5#%6/VJ14]JV1#'_<'Y4\6\7]P5 M#@/VACJGM5B,8K2%M%_<%/6VB'\(J>0/:$$#$8K2A>HHX(A_#5I(XQVJXJQE M*29*KU(&I@113L+Z5H9G48%!HI":]0\\8U5I?K4LC53E?F_6LN8UL0>6!T)_.HPHW<%JF*.3QCZYIP20=2/RHN!7 M,1/(?%1&*3MDCW-6F7GG'YTH&.@I\UA6*9AGSTR/K2B*7D%L"KA)'^%-+CKM MI\S"R*31OD#^=-*."_XBMH29A-(F@'/(JZJY%4HMP/;%78R#5\QG8<5([4>6,7[4Z(F&:.4*&*,&VGH<5/Y=+Y= 'HUIU%U:6]];/;74*30R##(XR#7,^%[_ .SW!LI#^[E.4)[-Z?C7 M7XIH9QFL:=9Z=;P^']$MTM[G5GVR.F2RPC[[$GGIP/K0/[3O=6O]*TC4/[,L MM(A2- L*N9'QGG/0<=JW;/1GBUZ^U>ZF66:95B@55($,0[<]R>2:I7_AR^.J MW5_H^IK9/>QB.Y22+S V. R^C8-,"UX7U:76_#UM?3HJS$M'(%Z%E."1^57- M5NTL]/D9@&9QL53W)HT?2H-%TF#3[!Q+&#WK-VU/#*T72DM!O4 MT0M-D8(A)JO]K;TIDLQE&.E#:!(K2$R.2:394@6G!:Q:-4R()3@M2;:=MJ;# MN, IX%+MI0*5AW%'%2 TP"GBE85QX8T_?40IU CK-U-9^*@\T4QI?>O2N<%A M97JF\C;N1Q4COFH"WZ4[%)@^U9E"8]!BD.[OB@J,\\4 MN !3 80>V*;C'>G-CWI@ /7/YU0KBX [TA9O:E"@\U KB'(^\?R%)@$ MYS@4XDD\TQ@,?XTQ$,R MAJ'''-.7 Z5IVEV5*%I=M38JY%LI0M2;:7; M4V'YHHI &*3-%%,0UNE(***!AM%-/W1113#H)4;= M:**9!&>E,(%%%4B6(:;115$CE)%+N-%%,0;C1N-%% #"Q]:C:BBF(80*3 HH MI &!1@444 &T48%%% !@4N!112*# H %%%(8N!2X%%%(I"[11@445)2)1]VG L8%%%2RA<4N***3*%Q2XHHJ1BXH'6BBD,=BC%%%(8N*7%%%( P*6BBD,__]D! end GRAPHIC 10 form10-k_007.jpg begin 644 form10-k_007.jpg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end GRAPHIC 11 form10-k_008.jpg begin 644 form10-k_008.jpg M_]C_X 02D9)1@ ! 0$ 8 !@ #_VP!# @&!@<&!0@'!P<)"0@*#!0-# L+ M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$! M 0$! 0 $" P0%!@<("0H+_\0 M1$ @$"! 0#! <%! 0 0)W $" M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P#W#K2BBDH M7-!Z4@YI<4 (.*=1BEQ0 B\"BBEH :1BDIU-QS0 AI!WIQ% % #:*7- H 2B M@T4 )1BD-*.E "TE&>** $I0.*2C- !11FD)H ,T&DZTM !T%+24#K0 M!XQ M1[T4 .I*!CIZ4M "9^6G"@4#B@!*6CO2B@!:6DI: %HI*6@ I110* %I:2E% M P/-)10*!"BE[TF:7- "&DI30* "DH/6@&@!:*** (,THI@'YTHR!0 \<&@] M*;SDDT\T (O-./2FCK3J $%*:!10 4E+0: &T4O0XH]Z &D48Q3J3% #.]': MEQ1WH ;BDI:#TH 2C-&*2@ -%%% "4&CK10 44E** "@9HI10 &E%)2CK0 Z MB@44 H/6EH[4 '>E%)3J "BBEH *6BB@ I124M "THI*6@!.]+@T44 !%+2 MCTI,8H 0T4-10 AZT4M)0 HHI** (>X]N:3'-/Q@4T'F@!5.?SIQIJGC(%&[ M< 10 X4M-V]\TN,4 +FC(I*,"@!M-'%*?K24 (>O6ES@XI/PI M.HH 7FD- .:"* &GC^=(#QBE(ZCI[TA'3L: $+8I >>:<::: %-%-)HS0 M) M^-)FDS0 ZCK3:-W/'XT /Z49I.U H <*=3 3CFC/2@"2BF@TN: '44F:7/% M"XHI!UI: %H&:,T YH 6EIO.*7F@!:7O3><4HYH =1110,6@444"'4$TW=10 M A.:***!BTE+24""BBB@8PG/%-QS3J0=:!"<# I0HX]J#S2B@!:,BBB@!./P MI*=10 AI/PI:DH- $9!/:F$8J4TTT 1?44G&:>::0#0 G'I2TA44O H 0FC'.:#2'J, M]/2@!V1244 +WI:04M "TE%!H 3/-+VI *=0 E% M+BB@ I":*#0,;12@44"&#ZT#@4HQ2@!P-+BD%.H 2EH MI* '4VEI* "BBCM0 44F>:* (\$TM/ H(H :#FBBDR: %/2DHS3210 N:44S M-*#0 ZBBD/2@!:*;FEW"@!ZC# MKU&>E)M+<:3>Q=+4A8UG'6=/_P"?N/\ .FG6M/\ ^?N/\Z7/'N5R2[&COH$F M*RSK>G@_\?:4PZ[IPZW2"ESQ[A[.?8V1)09*QO[?TWI]K2D_X2#3L?\ 'P#^ M!H]I'N'LY]C9WT;JQ3XBTWMO6E]<"&#S"Q&S!TY MK=&MFFG.:!SR:4FK,PSR*6F@\T[- "TN*;FE% #J6FYQ2YH <#FEIN:6@!U* M*;VI5ZT .QD4@Z4ZB@ HHHH 44M(*=0 444N.* 9I12@9<::N!O5 M#:I.<9YKMX"LYC!'+'&:HZ[J$^DWB0VB0*C1ACF,9)R?\*YL3%.-VSHP\FI- M)'([,8RO.?2FL!DX'3]:VE\37IXFBMY5[J8\5EW]W]LN/-6". 8QLC''UKSF MHVT9Z,7*]FBLWHIXY MQ2]OPIK'YL4P&$$ #VII3&.U*3Q^%-R<@4 1N 3].E:_AEO^)R@[[#S60W(/ M2M/PT?\ B>1>FQJUI_&C.I\#.]!H+=*8#2GUKUCQB3/-+^-,/8THH ?2YIN* M,<=>: '9S2Y'>DP*7C'- #\TH-1]!S^=/% #J7-)24 2@TM,4TI- "YYI:8# MS3Z %%**;2B@!U+FDHH 6BD- H <*6D!I: %HI,TM PI :"*!F@0M%)DT4 + M129I:!BBBBB@1R[2FHB[,< $GVIC-[TD#XG%!=BY;7<-G)$+J00@-D,_ -+X MCTZ?5&BO+';-&J;2%/)YK%\8/_HEJ?\ II_2NMT)LZ I']W^E1."G'E80FX2 MYD>>2*8V*L,,IY%1&I[@YN9?]\_SJ COUKQI*S:/:B[I,;W-+QD'VI>U(O09 M&*0Q!]*7'\J3IV/6EYP/\* %[\BDYI3R328'4>E !0.H[]J0&D)P:8$3MA3_ M #I-V6(/YU/86RWM_%;2,5$K8)'TKJ#X0M,_-/./IBMH4I35XF,ZT(.TCC@V M1U^E1E\''<&NP?PC: X%U<<^PJN_A2USSE0MNW((QG)P<]A3\YKT3S22G+48ZT\=1S2 D'-+SBFBG9Y H 4# MBE S@T9I5(H "*<*2E H @S6G$Q]:9F.F37J[PQSQ-'*@=&X*L,@UP'B/1O[*N \>3;2?;7H. M/O+8].A74O=>YB%O>D4D4QB>WI3 V&S^E<9UDV>0/>EWY.<_G4#2=QSCM2&0 M 9((S3 L;^1Q0&SP:@\P9SFA6)[\TP)1WH;(Q\I_*D1V#+L(W>N*>U[/:7MS M:0R!HHF !903D@$_SJE'0ARL0QNT,\<@#95@J.+%:V9TX4$YJO?1CRLKPPJ2&4,@.: MBN7#+@5VG"94=TZ/@FK)E+D8JI+'\U6;5 6&X@#WH TH8_+LI93][;@51"9I MOBNXDL_#9,!.YY%7@9XKAH;_ %1QA#,V?1"?Z5C.MR.UC>G1YU>YZ (S3PAS M7!M>:Q&,O]H4>K1D?TIG]JW_ "?M)K-XE=C3ZLWU/0-I'/:D'6N'\+:A>WWB MZ\2:[D>"*,HD7 4<#)/J<_SKN%_"MX34U='/.#@[#\4JKWI ::LR'BJDAR:!CHY-K5HP2@XK)3EJOPCI0(UX'S5'Q# M9K?:-^*A,N#U[4R27@U M5>7WKQ#W"T9L9YI!-QUJB9>O/- D(XS5)$MF@)1DYIZR8YS_ /6K-,WOD_6G M"XIV%S&K'(-R]N145T2$DH >!7+#Q+J#'Y!&!^)KLV!M-1UF;[P$!? _P!V MO.;<@@<5R8BI*-K,[,/",KW1MP^(]1CY.UN..HQ[UE$LS,[G+-DDGUJ0=.E! MQ@\=JXY3E+=G7&$8[(E\#$'Q3J1ZD.X_E7H+#&/SKSWP,/\ BJM2Q_STDKT- MN37?0^$X,1\0+T-/ %,''%/4\5T'.+2YI*4B@ -*#2**0=*6@ I:2EH !110: % M%+2"EH&(:,TM-H$*#ZT&DI>U "44M% &-)TJHYYJS(>*J.>:!BQGYJOPGI6= M&?FJ]$>E C2A/2IIS_H\G^X?Y56A/(J>8_N'_P!T_P J&"/"9I,,>>]5VD]* M;<2?OG!Q]X_SJNS5XMCV[D^^F&;!Z_A4)DJ)I!5I&;9.9N>M-\_!ZU49ZC,F M*=A7-.SN#]OM\'^,5LSL/[>U,Y_Y:K_Z M6]-U'Y/VA/+;![8QQFN=U[P\-)N(_L0GFM_+W M/(1D*<^HK8\*2,]NI9R?J:Z/6N?#U]_UP;^595::G'4UI5'&6AYDAR!BE?&T MU!$W&:D8Y'2O*/4'^ GSXFU;K_KY!^@KT5NM>;^ 01XJU<'J+A_Y"O1^IKTZ M'PGFU_B0H/M3P>::!3MO(-;G.+FESFDQD8IP'% "+]:<.&IN*<>,F@!: #2G MI6!XGN+JVAMWMI7C.XY*F@#H!U%**Y_1;Z:[L$S=.;@'#*_>NK10+?Y@"VWD MX[T 5AQ3L\4VE% !VH'6E%+0 "EI*,T .I*6B@ _G2T@[TZ@ [T444 ':FTZ MFF@ %**0=:=0 4444 8,AXJHYYJS(?EJHYYH&$?WJOQ&LX.$!=CA5!)/H!6= M_P )QX8@($VMVB9Z;FQ0(Z^$X(JQ*W[E_P#=/\JP-)\3:+J]U]GT[48+F;9O MV1G)V^M;)_KKQ /]A<_P Z\N-.4MD>K*I&.[.5:48ZU$THSUKK%\!^8=HO96/L MB_XU97X874H^26<_@O\ C6OL)]C+VT.YPK2^]1F3/>O0A\(=1D(VW)7_ 'MO M^-,R*8\\ ''-#IRBKL%4B]$9]@Y&IVW//F"NCFHGOO7_ - 6N4LGQ?VYSTD%=1(W_$[U ^K)_P"@+6;V-$6<]*W_ K)EKM/ M8&NC_D:*3]]!5^!EKQ!J5OHVGSW]T6\J(9(49)/H*Q M-!\26_B*S-S;PRPJ&*@28YQUQCZBI/B@J_\ "%W9) .YBG_:&PG]"*]!['!?6QZ9!/MD'-4_&&L6>FBVEO)U02+M51RW'<@=!5#5]1 M.F64MP@!=>$!_O'I7GWV"[UK5]U]BUYQX&<'Q?JW/6 M5O\ T%:]'KU*'PGF5_B'K3\5R]Q?S1W,NV1A\Q -1QZI18XO-W/( M6))8 =>G?\ZU/B)_(.!5SPC%%I%U:QV-M;P;X55V2)0 MS# ZG&36L*BGL9SIN&YZ1R*4#/6K31I]FW[1NXY%08Y-:&8&LG7RJ:>&(!.[ MC(K5-1\S?TI/8J.Y#H;&6[&<*,_PC%=R5Q;'!/3UKA?#W$P)K MO(COAQ[4T*6Y5Q2T'@D$'-.N; MJ;8X;8S[%Z[1V&:QK5XT8\TC>C0E6=HFI\#WSXLE'O2>;-$ES)#Y<'.,DGE3[X%>RSG]V_T-7"2G'F1G4@X2Y6>&:*P7QC: MD]KD_P S7J]U(IC/4<5Y'I9QXOM/^OP#_P >KUBZ'R'Z5CA]F:XC=&?;.BSY M+5U5A.?&U_^)UI(_P"G9C_X]6=7X36E\1YW:-_IL _VQ75R,&UJ^([M'T_ZYK7' M6;XO8/\ ?%=4'W:K=$=_+_\ 0%KAD=T2]G(!%:_AM]NLJ#_$C"L<#M6EH1VZ MU;]LDC'X5$-)HN?PL7XHV;3^#&F,A5!=*FU1R<@\_I7*?"N%9OM-@\LHB5_/ M7:!RV-N/I@_I7>?$A-W@65 ,M]LC.!U^ZU<7\*5,&JW33HR#RL+N!'.16]2I M)1EJD6XTZ%D,D_P [ M,Y8GBN7:YP,@FNY^)#;=&LR?^>_]#7FAD([UQ8A)3LCLH-N%V;'P]F+^+[[/ M\4LG_H*UZKU->1?#?_D<)O=YC_XZ*]=85VT/A..O\1QURQ^T2^S'^=0*W[P$ M]!Z5),VZ5SW+$_K4#3PV5O+2.)0"RNHSCCN14R:K;>--0N(K=#:FUB5 MCZG+]F8W\B-AU^SX52/3'6HEC/8S=./Q;DNBJB4F>U MV?C%+ZS)32K]%4 NSJ,+^1K;BD2XB6:([D<9!KYHC^(GB&Q:06]R8B_RLA3( M(^E?0OA1I)O"FGRR/ND>(,2!C.?:NW"U*TW^]2^1R5J<8KW34?!?WQKL>YE#9LV]%3:X-=E:O\HKDM)'(K MJ+;H*HS)[A0'##O6'K\TD5G%Y4A3=* <=QZ5NW'*+]:X/QQXGL=-^SVSRC>L MH,O_ $S&.,U$[\NA^@V0IIEH%6, ;9S_ (5TGQ#X\.PGTNDK-NRPN!G_ )YBO SBHXJ* M/;RN-U)G%:C_ &C!-:AEMX$A8-\C%F)R"#G'6OHJ4DP9]4_I7@&NDM.#V!%> M^2M_H_\ P#^E=>6SV.N U>E6WB;3-47 M;:R2.?NXV'.<5Y3>\7<__71OYUT/@;_6D^DI_P#016D:CA>Q$Z:G:YV+726I M,DT4Z+ZF(U>M/&&CQ@*T[ CL4-&M-G3F';%>=R1 2GIUK3ZQ(Q]@CUN#Q=I< MA^2;=7$_$'1;WQ?J]C+I\):.* H2&'4MFLK3QM<5V>BRXN%YQQ43KR>C+A14 M7='EEUX&U721]JN_+C2+YBI8$G'TJ2$C^TKGL#LQ_P!\BO2/&ZE]*N,?\\R: M\RM3F_G]@G\JQO>YNE:QKH,Y-:&F2);W\-Q*V(XSN<^@[U0BP5JS)&QL9BIP MVWCZU%[.Y=KJQS?CKQ%?ZUK!MA";6W0#R\-\V <]1[UF^';R_@NXK2.'[9]N ME$0#N2ZD,/NY. 3CO39H;N?4(U=H6?R@I9MW-%M;RPQ6MUO1/W^4:,GW/RBN8TUL-BND@/RUT1,)G+?$Q\:': M'_IX_P#937F!^- M3Z7(_P#037EHF7N:X,1\9V8?X#I/ABO_ !5K MG_KL?T%>O/@!C[5Y'\,2#XJ;'=)C_*O6Y3\C_0UUT/@.6O\ &<3]XL>^:YKQ MX2GAM0"=CW"JP]>"?Y@5TB'J:YWX@#_BFH?3[4O/_ 6KB@O>1V2V.<^&0WW6 MNNJA7%NA)!R2;8Z\/&\-['F&HPW(E\VZI\K [_=KWR?[J?6O$O&\5UK_B5S':D_ M9\PH5M-^X ]SN&:RJSY5=*YO1@IR:;L0?#.,0O*K$ F2/&>I.>E>W]:\C\(: M!JVF:A!.-(N%F4\,UJ%C(/!R2_!'J!7K6\9Q13FYJ[5A5::@[)W'44W>/6EW MCUK4Q'4'I2;Q1N% #LY%.J(-SQ3]PH =13=P]:7*<'% #Z*;N%% '+02+);H0>PS[4UNM4(["2(YAU!5/N,YJR$N>,SV MS>^"*19S/Q%'_%-18_Y^HZRKU7WY[;!6M\0&,/AI7N)8]@N$'[L$G)X%.LM# M,]O&=0NBC%0?+1?F ]#7B9GAZN(E&--'K8"O3HP;FS@-:7Y<]S7MFIWT=CI[ M2ORPC^5!U8XZ"N>;P5H=ZH#_ &DG@Y$N/Z5OR:1!(V7:9VZ;MU=N P\Z$&I[ MG+C<1"M).)X#<>%_$<\TDIEV[V+;<],G-=/X2T_4M'TB\-RP,QN$*/U(' -> MGR:%"3\DTBYZ9YK(UG2)[>T:.-U>5B"BDX# $9KK]FCF534U;NUMYK;:Y8@C MIFN>7<=#I%DF M"B,/JU=+I6D0^8&WD8':N474H.!YR?@:ZK1M3MU 9I!T]1D_A1[.'8.>7LE=+U2+HS?D*SJ4U+8TIU&MSG87!&,C%:ML4<%K[/+;/''2N=XQS4,FGC^R+)4YD$X!%8HZJ^CIOG,I9LH7! [8_&LQ_B%XK3Y;K0_F'4BW<9K MUJ5Y1;\V>?5:C*QZYI[X<9KI+>3*UX%%\2_$*']WH8S_ -3 L84*>YJY?Z>F_?;1;U/\!X(^E)TDY^&)=41 \EHL"=E:4,3^5:))*R,9-MZE>^LY--O7MI"'*X(8=P M>AKE?B"P'A56+?*MRI//;!KO;[PY<:K?27QSJ'40E@#V8=#7L_A,[_">G-C_ )9U\[6FJO(MR% PT3#'?I7N MW@UYIO!VF21W 53%P".G->]AJ;A"S/.Q-13EH=%>C-E. /X#7#JA\[I76.MY M@@749!XY6L,:+?"=B+BU,><@8;(KH.=;&EIBXQ700#I6+9VMQ"!DQ'Z&MB!G M Y"_A3))IQE4'O7FQ&-REP M*?Q2X%62,P*7 ]*>![4;1Z4 ,P/2E ]J=Q10 F/:DVBG48H 88QZZ4EQ M%Y4]M.Z;@VTID9!R/UK.U:]FM"7>QNY<\YAB+$?A7HQ;VII/? I#4CR./Q9) M ?ET?6WQ_=M&J_;>.YP(Q>NG_$NU!!_ MTTM'7^8K0U>UFU.*)(E6)5!R77).?Y5L[C[4A;/I3$<1+X2ED^_%9R'U9&'\ MC5,^"YMY86>GYZ\H_P#C7H6:3/M0%SSYO"EVV-UEIYP.T1_QJW9^'#:N)5TJ MW$RG*NBXQ7;;J3KZ_G0(YC;J,4RRO:RS%>0N0 *D;5M0[Z2Q_&NC)'HWYTSY M3Q@T#N<\-3O/^@2_X5%=ZE>264\2Z3/NDC91@'@D8]*Z;Y<]#2Y!_A_.I:?< MI278^;H]%\=6L[[-#O3\QP5CW"M2VL_B)*RJ-%G4 @Y:#;_.O?04'./TJ19$ MS@=:R="F]7%%^WJ+:1Y_X'\.ZY93W]]K21QS7.-L88$CG))Q75R:?*W39^5: MVX>E&X#L*VBE%61DY.3NS!?3+D:)XD6Z>:#0FE1SD MKYR CZ'-:VF+XC@ !T"^0^T\>/\ T*O2"%[+2_*.QIB;N<[9W?B#@'3'C'K+ M.@Q^6:T=1@U'4;#[/)<11*V"Z[=V:T@1Z&EW#TI-75@3L[GGNL?#VXU:V$46 MIPVC YWPP $_7%MU\11GW:W.?_ $*O:/E_NTGR^E1&G&+NBG.3W/*- M.^"SVTA:3Q Q!&#L@P?U->F:1H\.CZ3;Z?"[/'"NT,_4^YJZ,5(,5H3<@:V4 MCG-1'3XSW;\#5SBDR>U BJ--A_O2?@QJ1-/C7I),/^!FIP3ZT\?6@"N;)3_R MWN!])*Y_4_ MAJLDK3ZAJ064[GC6X^0GZ8KJ#BBIE",E:2N5&U1!_8T;^>AHC",-(JP2G*;O)W)L_2@5$']J M7?S5$DN?>BH\GTIU "[J M3(I-OJ* .QH 7)[44O'I10!3S[T E<\]:#UHH -S4N>.12&F"@!Y()!Q2%A MGI312'K0 NXBF&/ODT44 ((QV)_.G!/?]::*=VH =MXY-(0<<&FGI10 [/TI M< ^E5I/ZU(.E $N![4A'TJ(]:=0!(,4X$=JC'2E'>@"0-[4N5[BHQTI>] #\ MBD/XU'V-':@!23GJ::<>](O2@T +CG-&<=Z:>E,/6@"3?1N'K2=J!0 [@T8& M:;VH]* ) /04_'^*.0.*::* '@GN10?]ZF'[M'8 M4 2;<]#2;#313NU "E6J,[MP/-/I5ZF@!06([TX;J!TI: %Y!ZTX'V%-[4P? D?H EW GRAPHIC 12 form10-k_009.jpg begin 644 form10-k_009.jpg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form10-k_010.jpg begin 644 form10-k_010.jpg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
XML 23 R2.htm IDEA: XBRL DOCUMENT v3.24.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2023
Dec. 31, 2022
CURRENT ASSETS    
Cash and cash equivalents $ 249,110 $ 214,269
Accounts receivable 36,148 17,492
Other receivables, prepaid expenses, and deposit 24,532 21,749
Tax recoverable 299 745
Inventories 6,872 7,483
Total current assets 316,961 261,738
NON-CURRENT ASSETS    
Property and equipment, net 48,105 72,179
Intangible assets, net 2,427 3,459
Operating lease right-of-use assets, net 44,548
Total non-current assets 50,532 120,186
TOTAL ASSETS [1] 367,493 381,924
CURRENT LIABILITIES    
Accounts payable 99,360 29,539
Other payables and accrued liabilities 174,714 154,710
Finance lease liability 21,039 16,515
Operating lease liability 44,548
Total current liabilities 295,113 245,312
NON-CURRENT LIABILITY    
Finance lease liability 15,965 38,461
Total non-current liability 15,965 38,461
TOTAL LIABILITIES 311,078 283,773
STOCKHOLDERS’ EQUITY    
Preferred stock, $0.0001 par value, 200,000,000 shares authorized, None issued and outstanding
Common stock, $0.0001 par value, 600,000,000 shares authorized, 206,904,585 shares and 206,904,585 shares issued and outstanding as of December 31, 2023 and 2022 respectively 20,690 20,690
Additional paid-in capital 1,395,426 1,395,426
Accumulated other comprehensive income/(loss) 50,452 (5,846)
Accumulated deficit (1,410,153) (1,324,002)
TOTAL DSWISS, INC. STOCKHOLDERS’ EQUITY 56,415 86,268
NON-CONTROLLING INTEREST 11,883
TOTAL STOCKHOLDERS’ EQUITY 56,415 98,151
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 367,493 $ 381,924
[1] Revenues and costs are attributed to countries based on the location of customers.
XML 24 R3.htm IDEA: XBRL DOCUMENT v3.24.1
Consolidated Balance Sheets (Parenthetical) - $ / shares
Dec. 31, 2023
Dec. 31, 2022
Statement of Financial Position [Abstract]    
Preferred stock, par value $ 0.0001 $ 0.0001
Preferred stock, shares authorized 200,000,000 200,000,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Common stock, par value $ 0.0001 $ 0.0001
Common stock, shares authorized 600,000,000 600,000,000
Common stock, shares issued 206,904,585 206,904,585
Common stock, shares outstanding 206,904,585 206,904,585
XML 25 R4.htm IDEA: XBRL DOCUMENT v3.24.1
Consolidated Statements of Operations and Comprehensive Income - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Income Statement [Abstract]    
REVENUE [1] $ 1,470,071 $ 1,849,047
COST OF REVENUE [1] (1,110,846) (1,404,054)
GROSS PROFIT 359,225 444,993
OTHER INCOME 6,904 4,823
SELLING, GENERAL AND ADMINISTRATIVE EXPENSES (367,647) (402,412)
OPERATING EXPENSES (1,342) (1,303)
FINANCE COST (2,919) (6,212)
LEASE EXPENSES (43,099) (42,310)
LOSS BEFORE INCOME TAX [1] (48,878) (2,421)
INCOME TAXES PROVISION (657) (516)
NET LOSS (49,535) (2,937)
Non-Controlling Interests (11,354)
Other comprehensive income:    
- Foreign currency translation adjustment 56,298 27,139
COMPREHENSIVE INCOME $ 6,763 $ 12,848
Net loss per share - basic $ (0.0002) $ (0.0001)
Net loss per share - diluted $ (0.0002) $ (0.0001)
Weighted average number of common shares outstanding - basic 206,904,585 206,904,585
Weighted average number of common shares outstanding - diluted 206,904,585 206,904,585
[1] Revenues and costs are attributed to countries based on the location of customers.
XML 26 R5.htm IDEA: XBRL DOCUMENT v3.24.1
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
AOCI Attributable to Parent [Member]
Retained Earnings [Member]
Noncontrolling Interest [Member]
Total
Balance at Dec. 31, 2021 $ 20,690 $ 1,395,426 $ (32,985) $ (1,309,711) $ 589 $ 74,009
Balance, shares at Dec. 31, 2021 206,904,585          
Foreign currency translation adjustment 27,139 (60) 27,079
Net gain (loss) (14,291) 11,354 (2,937)
Balance at Dec. 31, 2022 $ 20,690 1,395,426 (5,846) (1,324,002) 11,883 98,151
Balance, shares at Dec. 31, 2022 206,904,585          
Foreign currency translation adjustment 56,298 56,298
Net gain (loss) (49,535) (49,535)
Changes in ownership interests in an associate (36,616) (11,883) (48,499)
Balance at Dec. 31, 2023 $ 20,690 $ 1,395,426 $ 50,452 $ (1,410,153) $ 56,415
Balance, shares at Dec. 31, 2023 206,904,585          
XML 27 R6.htm IDEA: XBRL DOCUMENT v3.24.1
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
CASH FLOWS FROM OPERATING ACTIVITIES:    
Loss before tax [1] $ (48,878) $ (2,421)
Adjustments to reconcile net loss to net cash generated from operating activities:    
Depreciation and amortization 64,933 72,441
Amortization for intangible assets 1,030 1,029
Changes in operating assets and liabilities:    
Accounts receivable 26,440 (15,551)
Accounts payable 25,180 14,702
Inventories 329 8,707
Other payables and accrued liabilities 22,967 (42,440)
Other receivables, prepaid expenses, and deposit (3,606) 28,995
Reduction in lease liability (42,862) (42,212)
Cash generated from operating activities 45,533 23,250
Taxation paid (238) (822)
Net cash generated from operating activities 45,295 22,428
CASH FLOWS FROM INVESTING ACTIVITIES:    
Purchase of property and equipment (373) (14,376)
Disposal of property and equipment 1
Net cash used in investing activities (372) (14,376)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Repayment to directors (38,284)
Repayment of finance lease (15,890) (15,671)
Net cash used in financing activities (15,890) (53,955)
Effect of exchange rate changes on cash and cash equivalents 5,808 25,626
Net change in cash and cash equivalents 34,841 (20,277)
Cash and cash equivalents, beginning of year 214,269 234,546
CASH AND CASH EQUIVALENTS, END OF YEAR 249,110 214,269
SUPPLEMENTAL CASH FLOWS INFORMATION    
Income taxes paid 238 141
Interest paid $ 406 $ 421
[1] Revenues and costs are attributed to countries based on the location of customers.
XML 28 R7.htm IDEA: XBRL DOCUMENT v3.24.1
ORGANIZATION AND BUSINESS BACKGROUND
 12 Months Ended
Dec. 31, 2023
Accounting Policies [Abstract]  
ORGANIZATION AND BUSINESS BACKGROUND

1. ORGANIZATION AND BUSINESS BACKGROUND

 

DSwiss, Inc., a Nevada corporation (“the Company”) was incorporated under the laws of the State of Nevada on May 28, 2015.

 

DSwiss, Inc. operates through its wholly owned subsidiary, DSwiss Holding Limited, a Company organized under the laws of Seychelles.

 

The principal activity of the Company and its subsidiaries is to supply high-quality health and beauty products, including beverages to assist in weight management, anti-aging creams, and products designed to improve the overall health system in our body.

 

We have historically conducted our business through DSwiss Sdn Bhd, a private limited liability company, incorporated in Malaysia. DSwiss Holding Limited, incorporated in Seychelles, is an investment holding company with 100% equity interest in DSwiss (HK) Limited, a company incorporated in Hong Kong, which subsequent hold 100% equity interest in DSwiss Sdn. Bhd. On August 31, 2015, DSwiss, Inc. was restructured to be the holding company parent to, and succeed to the operations of, DSwiss Holding Limited. The former unit holder of DSwiss Holding Limited became the unit holder of DSwiss, Inc. and DSwiss Holding Limited became a wholly-owned subsidiary of DSwiss, Inc. This transaction was accounted for as a transaction among entities under common control and the assets, liabilities, revenues and expenses of DSwiss Holding Limited were carried over to and combined with DSwiss, Inc. at historical cost, and as if the transfer occurred at the beginning of the period. Prior periods have been retrospectively adjusted for comparative purposes.

 

We have invested in DSwiss Biotech Sdn Bhd, a Company incorporated in Malaysia, and owned 40% equity interest. On January 18, 2023, DSwiss (HK) Limited acquired 150,000 shares, representing 60% equity interest in DSwiss Biotech Sdn. Bhd., from the other party with consideration of RM 1. After such acquisition, DSwiss Biotech Sdn. Bhd. became a wholly owned subsidiary of DSwiss (HK) Limited.

 

The Company, through its subsidiaries, mainly supplies high quality beauty products. Details of the Company’s subsidiaries:

 

  Company name  

Place and date of

incorporation

   Particulars of issued capital   Principal activities  

Proportional of ownership

interest and

voting power

held

1. DSwiss Holding Limited  

Seychelles,

May 28, 2015

   1 share of ordinary share of US$1 each   Investment holding   100%
                   
2. DSwiss (HK) Limited  

Hong Kong,

May 28, 2015

   1 share of ordinary share of HK$1 each   Supply of beauty products   100%
                   
3. DSwiss Sdn Bhd  

Malaysia,

March 10, 2011

   2 shares of ordinary share of RM 1 each   Supply of beauty products   100%
                   
4. DSwiss Biotech Sdn Bhd  

Malaysia,

March 17, 2016

   250,000 shares of ordinary share of RM 1 each   Supply of biotech products   100%

 

 

DSWISS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

Business Overview

 

One of the leading one-stop ODM/OEM manufacturing companies, DSwiss is a premier biotech nutraceutical firm that offers premium healthcare, skincare, and personal care products. At DSwiss, we procure excellent and precise formulation using the finest natural ingredients, developing effective solutions with alluring favours in a variety of forms. DSwiss addresses a distinct demand in the market for a manufacturer who could ensure the quality of the ingredient sources and offer efficient one-stop service from raw material, product development, manufacturing and packaging.

 

Since our founding, we have experienced tremendous growth in Malaysia. We offer exceptional lifestyle solutions to consumers all over the world thanks to our over 10 years of continuous innovation and work in the health and beauty business. Our company’s Chief Executive Officer, Vincent Leong has led it with a strong hand, and as a result, our products are now consumed around the world, such as Malaysia, Singapore, Indonesia, Hong Kong, Australia, Taiwan, Macau, and China. With the help of our distributors, we have so far extended throughout Asia, and we are adamant about extending our geographic reach into untapped markets.

 

With a team of professionals at the helm, DSwiss is assured of providing the best products and attending client’s needs from consultations to products. To fulfil customer needs, we carry out research and development based on our philosophy of “creating beauty, health, and the ecosystem”. Our cutting-edge research and development team has always been exploring new product lines and integrating the most recent science and technology, which will enable us to produce more evidence-based, high-value added formulations and products and maintain our competitive position in the market.

 

With our extensive years of expertise in the OEM and ODM services industry, we offer comprehensive solutions to our customers. In addition to business consultancy, DSwiss offers useful guidance on current market trends as we all as marketing solutions and support to assist our clients’ business endeavours. Versatility and reliability are evidently the driving principles behind DSwiss, who manufactures products using high-grade ingredients and materials at every stage of research, development, and production.

 

As advocates of natural and high-quality active ingredients, we actively seek for and select the best ingredients, as we are dedicated to adhering to policies under rigorous quality control and assurance criteria, thereby maximizing the safety and efficacy of our products. We dedicate ourselves to maintaining the highest standard in our products in order to provide assurance and a continual commitment to producing high-quality products in accordance with the strict specifications and guidelines specified out by Ministry of Health (“MOH”) Malaysia. Each step of production process has quality control built in and implemented. We guarantee the highest quality product using precise production techniques and specialised equipment, promising ongoing improvements and enhancements based on customer feedback. DSwiss takes pride in offering the best results in customisable solutions for health supplements and beauty product manufacturing.

 
XML 29 R8.htm IDEA: XBRL DOCUMENT v3.24.1
GOING CONCERN UNCERTAINTIES
 12 Months Ended
Dec. 31, 2023
Going Concern Uncertainties  
GOING CONCERN UNCERTAINTIES

2. GOING CONCERN UNCERTAINTIES

 

The accompanying financial statements have been prepared using the going concern basis of accounting, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business.

 

As of December 31, 2023, the Company suffered an accumulated deficit of $1,410,153. The continuation of the Company as a going concern through December 31, 2023 is dependent upon improving the profitability and the continuing financial support from its major stockholders. Management believes the existing major shareholders or external financing will provide the additional cash to meet the Company’s obligations as they become due.

 

There is no assurance that the Company will able to maintain profitable in the future, which raise substantial doubt about the Company’s ability to continue as a going concern. These financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result in the Company not being able to continue as a going concern.

 
XML 30 R9.htm IDEA: XBRL DOCUMENT v3.24.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
 12 Months Ended
Dec. 31, 2023
Accounting Policies [Abstract]  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

The accompanying consolidated financial statements reflect the application of certain significant accounting policies as described in this note and elsewhere in the accompanying consolidated financial statements and notes.

 

Basis of presentation

 

These accompanying consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“US GAAP”).

 

Basis of consolidation

 

The condensed consolidated financial statements include the accounts of the Company and its subsidiaries in which the Company is the primary beneficiary. All inter-company accounts and transactions have been eliminated upon consolidation.

 

 

DSWISS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

Use of estimates

 

In preparing these consolidated financial statements, management makes estimates and assumptions that affect the reported amounts of assets and liabilities in the balance sheets, and revenues and expenses during the periods reported. Actual results may differ from these estimates.

 

Cash and cash equivalents

 

Cash and cash equivalents are carried at cost and represent cash on hand, time deposits placed with banks or other financial institutions and all highly liquid investments with an original maturity of six months or less as of the purchase date of such investments.

 

Property and equipment

 

Property and equipment are stated at cost less accumulated depreciation and impairment. Depreciation of plant, equipment and software are calculated on the straight-line method over their estimated useful lives or lease terms generally as follows:

 

Classification  Estimated useful lives
Computer and software  5 years
Furniture and Fittings  5 years
Office equipment  10 years
Motor vehicle  5 years

 

Intangible assets

 

Intangible assets are stated at cost less accumulated amortization. Intangible assets represented the registration costs of trademarks in Malaysia and Hong Kong which are amortized on a straight-line basis over a useful life of ten years.

 

The Company follows ASC Topic 350 in accounting for intangible assets, which requires impairment losses to be recorded when indicators of impairment are present and the undiscounted cash flows estimated to be generated by the assets are less than the assets’ carrying amounts. There were no impairment losses recorded on intangible assets for the year ended December 31, 2023.

 

 

DSWISS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

Leases

 

The company determines if an arrangement is a lease at inception. Operating leases are included in operating in operating lease right-of-use (“ROU”) as assets, operating lease non-current liabilities, and operating lease current liabilities in our consolidated balance sheet. Finance leases are property and equipment, other current liabilities, and other non-current liabilities in the consolidated balance sheet.

 

ROU assets represent the right to use an asset for the lease term and lease liability represent the obligation to make lease payment arising from the lease. Operating lease ROU assets and liabilities are recognized at the commencement date based on the present value of lease payments over lease term. As most of the leases doesn’t provide an implicit rate. The company generally use the incremental borrowing rate on the estimated rate of interest for collateralized borrowing over a similar term of the lease payments at commencement date. The operating ROU asset also includes any lease payments made and exclude lease incentives. Lease expense for lease payment is recognized on a straight -line basis over lease term. The Company adopted Public Bank Berhad’s base rate lending rate as a reference for discount rate.

 

Leases that transfer substantially all the rewards and risks of ownership to the lessee, other than legal title, are accounted for as finance leases. Substantially all of the risks or benefits of ownership are deemed to have been transferred if any one of the four criteria is met: (i) transfer of ownership to the lessee at the end of the lease term, (ii) the lease containing a bargain purchase option, (iii) the lease term exceeding 75% of the estimated economic life of the leased asset, (iv) the present value of the minimum lease payments exceeding 90% of the fair value. At the inception of a finance lease, the Company as the lessee records an asset and an obligation at an amount equal to the present value of the minimum lease payments. The leased asset is amortized over the shorter of the lease term or its estimated useful life if title does not transfer to the Company, while the leased asset is depreciated in accordance with the Company’s depreciation policy if the title is to eventually transfer to the Company. The periodic rent payments made during the lease term are allocated between a reduction in the obligation and interest element using the effective interest method in accordance with the provisions of ASC Topic 835-30, “Imputation of Interest”.

 

Inventories

 

Inventories consisting of products available for sell, are stated at the lower of cost or market value. Cost of inventory is determined using the first-in, first-out (FIFO) method. Inventory reserve is recorded to write down the cost of inventory to the estimated market value due to slow-moving merchandise and damaged goods, which is dependent upon factors such as historical and forecasted consumer demand, and promotional environment. The Company takes ownership, risks and rewards of the products purchased. Write downs are recorded in cost of revenues in the Condensed Consolidated Statements of Operations and Comprehensive Income.

 

Revenue recognition

 

The Company follows the guidance of Accounting Standards Codification (ASC) 606, Revenue from Contracts. ASC 606 creates a five-step model that requires entities to exercise judgment when considering the terms of contracts, which includes (1) identifying the contracts or agreements with a customer, (2) identifying our performance obligations in the contract or agreement, (3) determining the transaction price, (4) allocating the transaction price to the separate performance obligations, and (5) recognizing revenue as each performance obligation is satisfied. The Company only applies the five-step model to contracts when it is probable that the Company will collect the consideration it is entitled to in exchange for the services it transfers to its clients.

 

Revenue from trading of retail goods is recognized when title and risk of loss are transferred and there are no continuing obligations to the customer. Title and the risks and rewards of ownership transfer to and accepted by the customer when the products are collected by the customer at the Company’s office. Revenue is recorded net of sales discounts, returns, allowances, and other adjustments that are based upon management’s best estimates and historical experience and are provided for in the same period as the related revenues are recorded.

 

The Company mainly derives its revenue from the sale of healthy food products. Generally, the Company recognizes revenue when OEM, Home brand and medical consumables products are sold and accepted by the customers and there are no continuing obligations to the customer.

 

 

DSWISS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

Cost of revenue

 

Cost of revenue includes the purchase cost of retail goods for re-sale to customers and packing materials (such as boxes). It excludes purchasing and receiving costs, inspection costs, warehousing costs, internal transfer costs and other costs of distribution network in cost of revenues.

 

Shipping and handling fees

 

Shipping and handling fees, if billed to customers, are included in revenue. Shipping and handling fees associated with inbound and outbound freight are expensed as incurred and included in selling and distribution expenses.

 

Selling and distribution expenses

 

Selling and distribution expenses are primarily comprised of travelling and accommodation, transportation fees such as petrol, toll and parking and shipping and handling fees.

 

Income taxes

 

The provision of income taxes is determined in accordance with the provisions of ASC Topic 740, “Income Taxes” (“ASC 740”). Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted income tax rates expected to apply to taxable income in the periods in which those temporary differences are expected to be recovered or settled. Any effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.

 

ASC 740 prescribes a comprehensive model for how companies should recognize, measure, present, and disclose in their financial statements uncertain tax positions taken or expected to be taken on a tax return. Under ASC 740, tax positions must initially be recognized in the financial statements when it is more likely than not the position will be sustained upon examination by the tax authorities. Such tax positions must initially and subsequently be measured as the largest amount of tax benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the tax authority assuming full knowledge of the position and relevant facts.

 

The Company conducts much of its businesses activities in Hong Kong and is subject to tax in this jurisdiction. As a result of its business activities, the Company will file separate tax returns that are subject to examination by the foreign tax authorities.

 

Net profit per share

 

The Company calculates net profit per share in accordance with ASC Topic 260 “Earnings per share”. Basic profit per share is computed by dividing the net profit by the weighted average number of common shares outstanding during the period. Diluted profit per share is computed similar to basic profit per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common stock equivalents had been issued and if the additional common shares were dilutive.

 

 

DSWISS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

Foreign currencies translation

 

Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency using the applicable exchange rates at the balance sheet dates. The resulting exchange differences are recorded in the Condensed Consolidated Statements of Operations and Comprehensive Income

 

The reporting currency of the Company is United States Dollars (“US$”) and the accompanying financial statements have been expressed in US$. In addition, the Company’s subsidiaries and VIEs in Malaysia, Hong Kong and China maintains their books and record in their local currency, Ringgits Malaysia (“MYR”), Hong Kong Dollars (“HK$”) and Chinese Renminbi (“RMB”) respectively, which is functional currency as being the primary currency of the economic environment in which the entity operates.

 

In general, for consolidation purposes, assets and liabilities of its subsidiaries whose functional currency is not US$ are translated into US$, in accordance with ASC Topic 830-30, “Translation of Financial Statement”, using the exchange rate on the balance sheet date. Revenues and expenses are translated at average rates prevailing during the period. The gains and losses resulting from translation of financial statements of foreign subsidiary are recorded as a separate component of accumulated other comprehensive income within the statements of stockholders’ equity.

 

Translation of amounts from MYR into US$1, HK$ into US$1 and RMB into US$1 has been made at the following exchange rates for the respective periods:

 

   As of and for the year ended
December 31,		 
   2023   2022 
         
Year-end MYR : US$1 exchange rate   4.59    4.42 
Year-average MYR : US$1 exchange rate   4.56    4.41 
Year-end HK$ : US$1 exchange rate   7.81    7.81 
Year-average HK$ : US$1 exchange rate   7.83    7.83 
Year-end RMB : US$1 exchange rate   7.10    6.92 
Year-average RMB : US$1 exchange rate   7.08    6.75 

 

Related parties

 

Parties, which can be a corporation or individual, are considered to be related if the Company has the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operating decisions. Companies are also considered to be related if they are subject to common control or common significant influence.

 

Fair value of financial instruments:

 

The carrying value of the Company’s financial instruments: cash and cash equivalents, subscription receivables, prepayment and deposits, accounts payable, and other payables and accrued liabilities approximate at their fair values because of the short-term nature of these financial instruments.

 

 

DSWISS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

The Company also follows the guidance of the ASC Topic 820-10, “Fair Value Measurements and Disclosures” (“ASC 820-10”), with respect to financial assets and liabilities that are measured at fair value. ASC 820-10 establishes a three-tier fair value hierarchy that prioritizes the inputs used in measuring fair value as follows:

 

  Level 1: Observable inputs such as quoted prices in active markets;
   
  Level 2: Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and
   
  Level 3: Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.

 

Fair value estimates are made at a specific point in time based on relevant market information about the financial instrument. These estimates are subjective in nature and involve uncertainties and matters of significant judgment and, therefore, cannot be determined with precision. Changes in assumptions could significantly affect the estimates.

 

Recently Adopted Accounting Standards

 

In June 2016, the FASB issued Accounting Standards Update No. 2016-13, Financial Instruments – Credit Losses (Topics 326): Measurement of Credit Losses on Financial Instruments, which introduced the expected credit losses methodology for the measurement of credit losses on financial assets measured at amortized cost basis, replacing the previous incurred loss methodology. In November 2019, the FASB issued ASU 2019-10 highlighted the adoption timeline. For smaller reporting entities, Topic 326 is effective for annual periods beginning after December 15, 2022, including interim period within those fiscal years, of which is effective for the Company on January 1, 2023 as the Company is qualified as a smaller reporting company. The adoption of this standard did not have a material impact on the Company’s consolidated financial statements.

 

Credit loss rate is determined by historical collection based on aging schedule, adjusted for current conditions using reasonable and supportable forecast. Based on the aging categorization and the adjusted loss per category, an allowance for credit losses is calculated by multiplying the adjusted loss rate with the amortized cost in the respective age category.

 

 

DSWISS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 
XML 31 R10.htm IDEA: XBRL DOCUMENT v3.24.1
VIE STRUCTURE AND ARRANGEMENTS
 12 Months Ended
Dec. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
VIE STRUCTURE AND ARRANGEMENTS

4. VIE STRUCTURE AND ARRANGEMENTS

 

On June 27, 2016, DSwiss (HK) Limited (“DSHK”) entered into a Management Services Agreement (the “Management Services Agreement I”) which entitles DSHK to substantially entitled to all of the economic benefits of DSwiss Biotech Sdn Bhd (“DSBT”) in consideration of services provided by DSHK to DSBT. Pursuant to the Management Services Agreement I, DSHK has the exclusive right to provide to DSBT management, financial and other services related to the operation of DSBT’s business, and DSBT is required to take all commercially reasonable efforts to permit and facilitate the provision of the services provided by DSHK. As compensation for providing the services, DSHK is entitled to receive a fee from DSBT, upon demand, equal to 100% of the annual net profits of DSBT during the term of the Management Services Agreement I. DSHK may also request, on ad hoc basis, quarterly payments of the aggregate fee, which payments will be credited against DSBT’s future payment obligations.

 

The Management Services Agreement I also provides DSHK, or its designee, with a right of first refusal to acquire all or any portion of the equity of DSBT upon any proposal by the sole shareholder of DSBT to transfer such equity. In addition, at the sole discretion of DSHK, DSBT is obligated to transfer to DSHK, or its designee, any part or all of the business, personnel, assets and operations of DSBT which may be lawfully conducted, employed, owned or operated by DSHK, including:

 

(a) business opportunities presented to, or available to DSBT may be pursued and contracted for in the name of DSHK rather than DSBT, and at its discretion, DSHK may employ the resources of DSBT to secure such opportunities;

 

(b) any tangible or intangible property of DSBT, any contractual rights, any personnel, and any other items or things of value held by DSBT may be transferred to DSHK at book value;

 

(c) real property, personal or intangible property, personnel, services, equipment, supplies and any other items useful for the conduct of the business may be obtained by DSHK by acquisition, lease, license or otherwise, and made available to DSBT on terms to be determined by agreement between DSHK and DSBT;

 

(d) contracts entered into in the name of DSBT may be transferred to DSHK, or the work under such contracts may be subcontracted, in whole or in part, to DSHK, on terms to be determined by agreement between DSHK and DSBT; and

 

(e) any changes to, or any expansion or contraction of, the business may be carried out in the exercise of the sole discretion of DSHK, and in the name of and at the expense of, DSHK; provided, however, that none of the foregoing may cause or have the effect of terminating (without being substantially replaced under the name of DSHK) or adversely affecting any license, permit or regulatory status of DSBT.

 

In addition, DSHK entered into certain agreements with Jervey Choon, (the “DSBT shareholder”), including

 

(i) a Call Option Agreement allowing DSHK to acquire the shares of DSBT as permitted by Malaysia laws;
   
(ii) a Shareholders’ Voting Rights Proxy Agreement that provides DSHK with the voting rights of the DSBT; and
   
(ii) an Equity Pledge Agreement that pledges the shares in DSBT.

 

This VIE structure provides DSHK, a wholly-owned subsidiary of DSwiss Holding Limited, which is the wholly-owned subsidiary of DSwiss Inc, with control over the operations and benefits of DSBT without having a direct equity ownership in DSBT.

 

On January 18, 2023, DSwiss (HK) Limited acquired 150,000 shares, representing 60% equity interest in DSwiss Biotech Sdn. Bhd., from the other party with consideration of RM 1. After such acquisition, DSwiss Biotech Sdn. Bhd. became a wholly owned subsidiary of DSwiss (HK) Limited.

 

 

DSWISS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 
XML 32 R11.htm IDEA: XBRL DOCUMENT v3.24.1
STOCKHOLDERS’ EQUITY
 12 Months Ended
Dec. 31, 2023
Equity [Abstract]  
STOCKHOLDERS’ EQUITY

5. STOCKHOLDERS’ EQUITY

 

As of December 31, 2023 and 2022, the Company had a total of 206,904,585 and 206,904,585 of its common stock issued and outstanding. There are no shares of preferred stock issued and outstanding.

 
XML 33 R12.htm IDEA: XBRL DOCUMENT v3.24.1
PROPERTY AND EQUIPMENT
 12 Months Ended
Dec. 31, 2023
Property, Plant and Equipment [Abstract]  
PROPERTY AND EQUIPMENT

6. PROPERTY AND EQUIPMENT

 

  

As of

December 31, 2023

  

As of

December 31, 2022

 
Computer and software  $102,064   $105,535 
Furniture and fittings   6,144    6,144 
Office equipment   21,525    21,152 
Motor vehicle   135,868    135,868 
Total property and equipment   265,601   $268,699 
Accumulated depreciation   (205,600)   (187,236)
Effect of translation exchange   (11,896)   (9,284)
Property and equipment, net  $48,105   $72,179 

 

Depreciation expense for the year ended December 31, 2023 and December 31, 2022 were $21,833 and $30,131, respectively.

 
XML 34 R13.htm IDEA: XBRL DOCUMENT v3.24.1
INTANGIBLE ASSETS
 12 Months Ended
Dec. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
INTANGIBLE ASSETS

7. INTANGIBLE ASSETS

 

  

As of

December 31, 2023

  

As of

December 31, 2022

 
Trademarks  $12,077   $12,077 
Amortization   (9,194)   (8,164)
Effect of translation exchange   (456)   (454)
Intangible assets, net  $2,427   $3,459 

 

Amortization for the year ended December 31, 2023 and December 31, 2022 were $1,030 and $1,029, respectively.

 
XML 35 R14.htm IDEA: XBRL DOCUMENT v3.24.1
OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS
 12 Months Ended
Dec. 31, 2023
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]  
OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS

8. OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS

 

  

As of

December 31, 2023

  

As of

December 31, 2022

 
Other receivables  $5,460   $- 
Prepaid expenses   1,932    2,080 
Deposits   17,140    19,669 
Total other receivables, prepaid expenses and deposits  $24,532   $21,749 

 
XML 36 R15.htm IDEA: XBRL DOCUMENT v3.24.1
INVENTORIES
 12 Months Ended
Dec. 31, 2023
Inventory Disclosure [Abstract]  
INVENTORIES

9. INVENTORIES

 

  

As of

December 31, 2023

  

As of

December 31, 2022

 
Finished goods, at cost  $6,872   $7,483 
Total inventories  $6,872   $7,483 

 

 

DSWISS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 
XML 37 R16.htm IDEA: XBRL DOCUMENT v3.24.1
OTHER PAYABLES AND ACCRUED LIABILITIES
 12 Months Ended
Dec. 31, 2023
Payables and Accruals [Abstract]  
OTHER PAYABLES AND ACCRUED LIABILITIES

10. OTHER PAYABLES AND ACCRUED LIABILITIES

 

  

As of

December 31, 2023

  

As of

December 31, 2022

 
Other payables  $114,964   $100,385 
Accrued audit fees   30,207    20,266 
Accrued other expenses   15,222    16,683 
Accrued professional fees   14,321    17,376 
Total payables and accrued liabilities  $174,714   $154,710 

 
XML 38 R17.htm IDEA: XBRL DOCUMENT v3.24.1
FINANCE LEASE LIABILITIES
 12 Months Ended
Dec. 31, 2023
Finance Lease Liabilities  
FINANCE LEASE LIABILITIES

11. FINANCE LEASE LIABILITIES

 

The Company purchased motor vehicles with finance lease. The first finance lease agreement commenced on July 31, 2018 with the effective interest rate of 3.62% per annum, due through June, 2025, with principal and interest payable monthly. The second finance lease agreement commenced on December 3, 2021 with the effective interest rate of 3.70% per annum, due through November, 2026, with principal and interest payable monthly. The obligation under the finance lease is as follows:

 

  

As of

December 31, 2023

  

As of

December 31, 2022

 
Finance leases  $38,817   $58,768 
Less: interest expense   (1,813)   (3,792)
Net present value of finance leases   37,004    54,976 
           
Current portion   21,039    16,515 
Non-current portion   15,965    38,461 
Total  $37,004   $54,976 

 

As of December 31, 2023, the maturities of the finance leases for each of the years are as follows:

 

      
2024   16,570 
2025   12,655 
2026   7,779 
Total  $37,004 

 

 

DSWISS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 
XML 39 R18.htm IDEA: XBRL DOCUMENT v3.24.1
INCOME TAXES
 12 Months Ended
Dec. 31, 2023
Income Tax Disclosure [Abstract]  
INCOME TAXES

12. INCOME TAXES

 

For the year ended December 31, 2023 and year ended December 31, 2022, the local (United States) and foreign components of (loss)/profit before income taxes were comprised of the following:

 

  

For the year ended

December 31, 2023

  

For the year ended

December 31, 2022

 
         
Tax jurisdictions from:          
- Local  $(51,974)  $(43,174)
- Foreign, representing          
Seychelles   (3,207)   (11,643)
Hong Kong   (3,703)   (3,951)
Malaysia   10,006    56,347 
Loss before income tax  $(48,878)  $(2,421)

 

The provision for income taxes consisted of the following:

 

  

For the year ended

December 31, 2023

  

For the year ended

December 31, 2022

 
         
Current:          
- Local  $-   $- 
- Foreign   (657)   (516)
           
Deferred:          
- Local   -    - 
- Foreign   -    - 
           
Income tax expense  $(657)  $(516)

 

The following table sets forth the significant components of the aggregate deferred tax assets of the Company for the year ended December 31, 2023 and 2022.

 

  

For the year ended

December 31, 2023

  

For the year ended

December 31, 2022

 
Deferred tax assets:          
Net operating loss carry forwards          
-United States of America  $(110,066)  $(99,152)
-Seychelles   -    - 
-Hong Kong   (104,743)   (104,132)
-Malaysia   (31,143)   (36,884)
-PRC  $-   $- 
    (245,952)   (240,168)
Less: valuation allowance  $245,952   $240,168 
Deferred tax assets  $-   $- 

 

The effective tax rate in the periods presented is the result of the mix of income earned in various tax jurisdictions that apply a broad range of income tax rates. The Company and its subsidiary that operate in various countries: United States, Seychelles, Hong Kong, Malaysia, PRC that are subject to taxes in the jurisdictions in which they operate, as follows:

 

United States of America

 

The Company is registered in the State of Nevada and is subject to the tax laws of the United States of America. As of 31 December, 2023, the operations in the United States of America incurred $524,125 of cumulative net operating losses which can be carried forward to offset future taxable income, at the tax rate of 21%. The net operating loss carry forwards begin to expire in 2038, if unutilized. The Company has provided for a full valuation allowance of $110,066 against the deferred tax assets on the expected future tax benefits from the net operating loss carry forwards as the management believes it is more likely than not that these assets will not be realized in the future.

 

Seychelles

 

Under the current laws of the Seychelles, DSwiss Holding Limited is registered as an international business company which governs by the International Business Companies Act of Seychelles and there is no income tax charged in Seychelles.

 

Hong Kong

 

DSwiss (HK) Limited is subject to Hong Kong Profits Tax, which is charged at the statutory income tax rate of 16.5% on its assessable income. As of December 31, 2023, the operations in the Hong Kong incurred $634,806 of cumulative net operating losses which can be carried forward to offset future taxable income, at the tax rate of 16.5%. The Company has provided for a full valuation allowance of $104,743 against the deferred tax assets on the expected future tax benefits from the net operating loss carry forwards as the management believes it is more likely than not that these assets will not be realized in the future.

 

 

DSWISS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

Malaysia

 

DSwiss Sdn Bhd and DSwiss Biotech Sdn Bhd are subject to Malaysia Corporate Tax, which is charged at the statutory income tax rate range from 15% to 24% on its assessable income. As of December 31, 2023, the operations in the Malaysia incurred $207,619 of cumulative net operating losses which can be carried forward to offset future taxable income, at the tax rate of 15%. The Company has provided for a full valuation allowance of $31,143 against the deferred tax assets on the expected future tax benefits from the net operating loss carry forwards as the management believes it is more likely than not that these assets will not be realized in the future.

 
XML 40 R19.htm IDEA: XBRL DOCUMENT v3.24.1
CONCENTRATIONS OF RISKS
 12 Months Ended
Dec. 31, 2023
Risks and Uncertainties [Abstract]  
CONCENTRATIONS OF RISKS

13. CONCENTRATIONS OF RISKS

 

(a) Major customers

 

For the year ended December 31, 2023 and 2022, the customers who accounted for 10% or more of the Company’s revenues and its accounts receivable balance at year-end are presented as follows:

 

   For the year ended December 31 
   2023   2022   2023   2022   2023   2022 
   Revenues   Percentage of Revenues   Accounts Receivable, Trade 
Customer A  $-   $501,470    -%   26%  $-   $- 
Customer B  $263,195   $386,232    18%   20%  $35,247   $- 
Customer C  $230,525   $221,638    16%   12%  $-   $- 
Customer D  $182,786   $-    12%   12%  $-   $- 
Customer E  $494,182   $-    33%   12%  $-   $- 
   $1,170,688   $1,109,340    79%   58%  $35,247   $- 

 

(b) Major vendors

 

For the year ended December 31, 2023 and 2022, the vendors who accounted for 10% or more of the Company’s purchases and its accounts payable balance at year-end are presented as follows:

 

   For the year ended December 31 
   2023   2022   2023   2022   2023   2022 
   Purchases   Percentage of Purchases   Account Payable, Trade 
Vendor A  $163,262   $477,099    49%   23%  $5,984   $1,626 
Vendor B  $548,438   $331,538    15%   15%  $64,194   $- 
Vendor C  $164,854   $221,743    14%   33%  $22,008   $16,759 
   $876,554   $1,030,380    78%   71%  $92,186   $18,385 

 

(c) Credit risk

 

Financial instruments that are potentially subject to credit risk consist principally of accounts receivable. The Company believes the concentration of credit risk in its trade receivables is substantially mitigated by its ongoing credit evaluation process and relatively short collection terms. The Company does not generally require collateral from customers. The Company evaluates the need for an allowance for doubtful accounts based upon factors surrounding the credit risk of specific customers, historical trends and other information.

 

(d) Exchange rate risk

 

The Company cannot guarantee that the current exchange rate will remain steady; therefore, there is a possibility that the Company could post the same amount of profit for two comparable periods and because of the fluctuating exchange rate actually post higher or lower profit depending on exchange rate of MYR, HK$ and RMB converted to US$ on that date. The exchange rate could fluctuate depending on changes in political and economic environments without notice.

 

 

DSWISS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 
XML 41 R20.htm IDEA: XBRL DOCUMENT v3.24.1
LEASE RIGHT-OF-USE ASSET AND LEASE LIABILITIES
 12 Months Ended
Dec. 31, 2023
Leases [Abstract]  
LEASE RIGHT-OF-USE ASSET AND LEASE LIABILITIES

14. LEASE RIGHT-OF-USE ASSET AND LEASE LIABILITIES

 

The Company officially adopted ASC 842 for the period on and after January 1, 2019 as permitted by ASU 2016-02. ASC 842 originally required all entities to use a “modified retrospective” transition approach that is intended to maximize comparability and be less complex than a full retrospective approach. On July 30, 2018, the FASB issued ASU 2018-11 to provide entities with relief from the costs of implementing certain aspects of the new leasing standard, ASU 2016-02 of which permits entities may elect not to recast the comparative periods presented when transitioning to ASC 842. As permitted by ASU 2018-11, the Company elect not to recast comparative periods, thusly.

 

As of January 1, 2022, the Company recognized approximately US$386,451, lease liability as well as right-of-use asset for all leases (with the exception of short-term leases) at the commencement date. Lease liabilities are measured at present value of the sum of remaining rental payments as of January 1, 2022, with discounted rate of 5.40% adopted from Malayan Banking Berhad’s base lending rate as a reference for discount rate.

 

As of December 31, 2023, the tenancy agreement had expired, a new and fresh tenancy agreement for renewal term has yet to be executed. The lease on premises had continued on a month- to-month basis which is terminable by the end of each month.

 

A single lease cost is recognized over the lease term on a generally straight-line basis. All cash payments of operating lease cost are classified within operating activities in the statement of cash flows.

 

The initial recognition of operating lease right and lease liability as follow:

 

As of December 31, 2023, operating lease right of use asset as follow:

 

   Year ended December 31, 
   2023   2022 
As of January 1,  $44,548   $92,606 
Accumulated amortization   (43,099)   (42,310)
Effect of translation exchange   (1,449)   (5,748)
Balance as of December 31  $-   $44,548 

 

As of December 31, 2023, operating lease liability as follow:

 

As of January 1,  $44,548 
Less: gross repayment   (44,171)
Add: imputed interest   1,072 
Effect of translation exchange   (1,449)
Balance as of December 31, 2023  $- 
Less: lease liability current portion   - 
Lease liability non-current portion  $- 

 

For the year ended December 31, 2023 and 2022, the amortization of the operating lease right of use asset are $43,099 and $42,310 respectively.

 

    Year ended December 31,  
    2023     2022  
             
Cash paid for amounts included in the measurement of lease liabilities:             -  
Operating cash flow from operating lease   $ 42,862     $ 42,212  
Right-of-use assets obtained in exchange for operating lease liabilities     -       44,548  
Remaining lease term for operating lease (years)     -       1  
Weighted average discount rate for operating lease     5.40 %     5.40 %

 

For the year ended December 31, 2023 and 2022, lease expenses were $43,099 and $42,310 respectively.

 

 

DSWISS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 
XML 42 R21.htm IDEA: XBRL DOCUMENT v3.24.1
RELATED PARTY TRANSACTIONS
 12 Months Ended
Dec. 31, 2023
Related Party Transactions [Abstract]  
RELATED PARTY TRANSACTIONS

15. RELATED PARTY TRANSACTIONS

 

For the years ended December 31, 2023 and December 31, 2022, the Company has the following transactions with related party:

 

  

For the year ended

December 31, 2023

(Audited)

  

For the year ended

December 31, 2022

(Audited)

 
Professional Fees:          
- Related party A  $13,001   $12,226 
           
Sales          
- Related party B  $-   $386,232 
- Related party C   48,366    24,261 

 

The related party A is a wholly owned subsidiary of a 7.33% shareholder of the Company.

 

The related party B’s director and shareholder is the founder of the Company. Founder of the Company resigned as director of company B on October 02, 2022 and is no longer a shareholder of company B.

 

The related party C’s director is the founder of the Company.

 

The related party transaction is generally transacted in an arm-length basis at the current market value in the normal course of business.

 
XML 43 R22.htm IDEA: XBRL DOCUMENT v3.24.1
SEGMENTED INFORMATION
 12 Months Ended
Dec. 31, 2023
Segment Reporting [Abstract]  
SEGMENTED INFORMATION

16. SEGMENTED INFORMATION

 

ASC 280, “Segment Reporting” establishes standards for reporting information about operating segments on a basis consistent with the Company’s internal organization structure as well as information about services categories, business segments and major customers in financial statements. In accordance with the “Segment Reporting” Topic of the ASC, the Company’s chief operating decision maker has been identified as the Chief Executive Officer and President, who reviews operating results to make decisions about allocating resources and assessing performance for the entire Company. Existing guidance, which is based on a management approach to segment reporting, establishes requirements to report selected segment information quarterly and to report annually entity-wide disclosures about products and services, major customers, and the countries in which the entity holds material assets and reports revenue. All material operating units qualify for aggregation under “Segment Reporting” due to their similar customer base and similarities in economic characteristics; nature of products and services; and procurement, manufacturing and distribution processes.

 

The Company had no inter-segment sales for the periods presented. Summarized financial information concerning the Company’s reportable segments is shown as below:

 

By Geography*:

 

   Nevada*   Seychelles*   Hong Kong*   Malaysia*   Total* 
   For the year ended December 31, 2023 
   Nevada   Seychelles   Hong Kong   Malaysia   Total 
                     
Revenue  $-   $-   $-   $1,470,071   $1,470,071 
Cost of revenue   -    -    -    (1,110,846)   (1,110,846)
Depreciation and amortization   -    -    -    (64,933)   (64,933)
Net (loss)/profit before taxation   (51,974)   (3,207)   (3,703)   10,006    (48,878)
                          
Total assets  $19,729   $22,720   $24,545   $300,499   $367,493 

 

   Nevada*   Seychelles*   Hong Kong*   Malaysia*   Total* 
   For the year ended December 31, 2022 
   Nevada   Seychelles   Hong Kong   Malaysia   Total 
                     
Revenue  $-   $-   $-   $1,849,047   $1,849,047 
Cost of revenue   -    -    -    (1,404,054)   (1,404,054)
Depreciation and amortization   -    -    -    (72,441)   (72,441)
Net (loss) / profit before taxation   (43,174)   (11,643)   (3,951)   56,347    (2,421)
                          
Total assets  $27,294   $7,056   $14,264   $333,310   $381,924 

 

*Revenues and costs are attributed to countries based on the location of customers.

 
XML 44 R23.htm IDEA: XBRL DOCUMENT v3.24.1
SUBSEQUENT EVENTS
 12 Months Ended
Dec. 31, 2023
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS

17. SUBSEQUENT EVENTS

 

In accordance with ASC Topic 855, “Subsequent Events”, which establishes general standards of accounting for and disclosure of events that occur after the balance sheet date but before financial statements are issued, the Company has evaluated all events or transactions that occurred after December 31, 2023 up through the date the Company issued the audited consolidated financial statements.
XML 45 R24.htm IDEA: XBRL DOCUMENT v3.24.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
 12 Months Ended
Dec. 31, 2023
Accounting Policies [Abstract]  
Basis of presentation

Basis of presentation

 

These accompanying consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“US GAAP”).

 
Basis of consolidation

Basis of consolidation

 

The condensed consolidated financial statements include the accounts of the Company and its subsidiaries in which the Company is the primary beneficiary. All inter-company accounts and transactions have been eliminated upon consolidation.

 

 

DSWISS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 
Use of estimates

Use of estimates

 

In preparing these consolidated financial statements, management makes estimates and assumptions that affect the reported amounts of assets and liabilities in the balance sheets, and revenues and expenses during the periods reported. Actual results may differ from these estimates.

 
Cash and cash equivalents

Cash and cash equivalents

 

Cash and cash equivalents are carried at cost and represent cash on hand, time deposits placed with banks or other financial institutions and all highly liquid investments with an original maturity of six months or less as of the purchase date of such investments.

 
Property and equipment

Property and equipment

 

Property and equipment are stated at cost less accumulated depreciation and impairment. Depreciation of plant, equipment and software are calculated on the straight-line method over their estimated useful lives or lease terms generally as follows:

 

Classification  Estimated useful lives
Computer and software  5 years
Furniture and Fittings  5 years
Office equipment  10 years
Motor vehicle  5 years

 
Intangible assets

Intangible assets

 

Intangible assets are stated at cost less accumulated amortization. Intangible assets represented the registration costs of trademarks in Malaysia and Hong Kong which are amortized on a straight-line basis over a useful life of ten years.

 

The Company follows ASC Topic 350 in accounting for intangible assets, which requires impairment losses to be recorded when indicators of impairment are present and the undiscounted cash flows estimated to be generated by the assets are less than the assets’ carrying amounts. There were no impairment losses recorded on intangible assets for the year ended December 31, 2023.

 

 

DSWISS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 
Leases

Leases

 

The company determines if an arrangement is a lease at inception. Operating leases are included in operating in operating lease right-of-use (“ROU”) as assets, operating lease non-current liabilities, and operating lease current liabilities in our consolidated balance sheet. Finance leases are property and equipment, other current liabilities, and other non-current liabilities in the consolidated balance sheet.

 

ROU assets represent the right to use an asset for the lease term and lease liability represent the obligation to make lease payment arising from the lease. Operating lease ROU assets and liabilities are recognized at the commencement date based on the present value of lease payments over lease term. As most of the leases doesn’t provide an implicit rate. The company generally use the incremental borrowing rate on the estimated rate of interest for collateralized borrowing over a similar term of the lease payments at commencement date. The operating ROU asset also includes any lease payments made and exclude lease incentives. Lease expense for lease payment is recognized on a straight -line basis over lease term. The Company adopted Public Bank Berhad’s base rate lending rate as a reference for discount rate.

 

Leases that transfer substantially all the rewards and risks of ownership to the lessee, other than legal title, are accounted for as finance leases. Substantially all of the risks or benefits of ownership are deemed to have been transferred if any one of the four criteria is met: (i) transfer of ownership to the lessee at the end of the lease term, (ii) the lease containing a bargain purchase option, (iii) the lease term exceeding 75% of the estimated economic life of the leased asset, (iv) the present value of the minimum lease payments exceeding 90% of the fair value. At the inception of a finance lease, the Company as the lessee records an asset and an obligation at an amount equal to the present value of the minimum lease payments. The leased asset is amortized over the shorter of the lease term or its estimated useful life if title does not transfer to the Company, while the leased asset is depreciated in accordance with the Company’s depreciation policy if the title is to eventually transfer to the Company. The periodic rent payments made during the lease term are allocated between a reduction in the obligation and interest element using the effective interest method in accordance with the provisions of ASC Topic 835-30, “Imputation of Interest”.

 
Inventories

Inventories

 

Inventories consisting of products available for sell, are stated at the lower of cost or market value. Cost of inventory is determined using the first-in, first-out (FIFO) method. Inventory reserve is recorded to write down the cost of inventory to the estimated market value due to slow-moving merchandise and damaged goods, which is dependent upon factors such as historical and forecasted consumer demand, and promotional environment. The Company takes ownership, risks and rewards of the products purchased. Write downs are recorded in cost of revenues in the Condensed Consolidated Statements of Operations and Comprehensive Income.

 
Revenue recognition

Revenue recognition

 

The Company follows the guidance of Accounting Standards Codification (ASC) 606, Revenue from Contracts. ASC 606 creates a five-step model that requires entities to exercise judgment when considering the terms of contracts, which includes (1) identifying the contracts or agreements with a customer, (2) identifying our performance obligations in the contract or agreement, (3) determining the transaction price, (4) allocating the transaction price to the separate performance obligations, and (5) recognizing revenue as each performance obligation is satisfied. The Company only applies the five-step model to contracts when it is probable that the Company will collect the consideration it is entitled to in exchange for the services it transfers to its clients.

 

Revenue from trading of retail goods is recognized when title and risk of loss are transferred and there are no continuing obligations to the customer. Title and the risks and rewards of ownership transfer to and accepted by the customer when the products are collected by the customer at the Company’s office. Revenue is recorded net of sales discounts, returns, allowances, and other adjustments that are based upon management’s best estimates and historical experience and are provided for in the same period as the related revenues are recorded.

 

The Company mainly derives its revenue from the sale of healthy food products. Generally, the Company recognizes revenue when OEM, Home brand and medical consumables products are sold and accepted by the customers and there are no continuing obligations to the customer.

 

 

DSWISS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 
Cost of revenue

Cost of revenue

 

Cost of revenue includes the purchase cost of retail goods for re-sale to customers and packing materials (such as boxes). It excludes purchasing and receiving costs, inspection costs, warehousing costs, internal transfer costs and other costs of distribution network in cost of revenues.

 
Shipping and handling fees

Shipping and handling fees

 

Shipping and handling fees, if billed to customers, are included in revenue. Shipping and handling fees associated with inbound and outbound freight are expensed as incurred and included in selling and distribution expenses.

 
Selling and distribution expenses

Selling and distribution expenses

 

Selling and distribution expenses are primarily comprised of travelling and accommodation, transportation fees such as petrol, toll and parking and shipping and handling fees.

 
Income taxes

Income taxes

 

The provision of income taxes is determined in accordance with the provisions of ASC Topic 740, “Income Taxes” (“ASC 740”). Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted income tax rates expected to apply to taxable income in the periods in which those temporary differences are expected to be recovered or settled. Any effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.

 

ASC 740 prescribes a comprehensive model for how companies should recognize, measure, present, and disclose in their financial statements uncertain tax positions taken or expected to be taken on a tax return. Under ASC 740, tax positions must initially be recognized in the financial statements when it is more likely than not the position will be sustained upon examination by the tax authorities. Such tax positions must initially and subsequently be measured as the largest amount of tax benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the tax authority assuming full knowledge of the position and relevant facts.

 

The Company conducts much of its businesses activities in Hong Kong and is subject to tax in this jurisdiction. As a result of its business activities, the Company will file separate tax returns that are subject to examination by the foreign tax authorities.

 
Net profit per share

Net profit per share

 

The Company calculates net profit per share in accordance with ASC Topic 260 “Earnings per share”. Basic profit per share is computed by dividing the net profit by the weighted average number of common shares outstanding during the period. Diluted profit per share is computed similar to basic profit per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common stock equivalents had been issued and if the additional common shares were dilutive.

 

 

DSWISS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 
Foreign currencies translation

Foreign currencies translation

 

Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency using the applicable exchange rates at the balance sheet dates. The resulting exchange differences are recorded in the Condensed Consolidated Statements of Operations and Comprehensive Income

 

The reporting currency of the Company is United States Dollars (“US$”) and the accompanying financial statements have been expressed in US$. In addition, the Company’s subsidiaries and VIEs in Malaysia, Hong Kong and China maintains their books and record in their local currency, Ringgits Malaysia (“MYR”), Hong Kong Dollars (“HK$”) and Chinese Renminbi (“RMB”) respectively, which is functional currency as being the primary currency of the economic environment in which the entity operates.

 

In general, for consolidation purposes, assets and liabilities of its subsidiaries whose functional currency is not US$ are translated into US$, in accordance with ASC Topic 830-30, “Translation of Financial Statement”, using the exchange rate on the balance sheet date. Revenues and expenses are translated at average rates prevailing during the period. The gains and losses resulting from translation of financial statements of foreign subsidiary are recorded as a separate component of accumulated other comprehensive income within the statements of stockholders’ equity.

 

Translation of amounts from MYR into US$1, HK$ into US$1 and RMB into US$1 has been made at the following exchange rates for the respective periods:

 

   As of and for the year ended
December 31,		 
   2023   2022 
         
Year-end MYR : US$1 exchange rate   4.59    4.42 
Year-average MYR : US$1 exchange rate   4.56    4.41 
Year-end HK$ : US$1 exchange rate   7.81    7.81 
Year-average HK$ : US$1 exchange rate   7.83    7.83 
Year-end RMB : US$1 exchange rate   7.10    6.92 
Year-average RMB : US$1 exchange rate   7.08    6.75 

 
Related parties

Related parties

 

Parties, which can be a corporation or individual, are considered to be related if the Company has the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operating decisions. Companies are also considered to be related if they are subject to common control or common significant influence.

 
Fair value of financial instruments:

Fair value of financial instruments:

 

The carrying value of the Company’s financial instruments: cash and cash equivalents, subscription receivables, prepayment and deposits, accounts payable, and other payables and accrued liabilities approximate at their fair values because of the short-term nature of these financial instruments.

 

 

DSWISS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

The Company also follows the guidance of the ASC Topic 820-10, “Fair Value Measurements and Disclosures” (“ASC 820-10”), with respect to financial assets and liabilities that are measured at fair value. ASC 820-10 establishes a three-tier fair value hierarchy that prioritizes the inputs used in measuring fair value as follows:

 

  Level 1: Observable inputs such as quoted prices in active markets;
   
  Level 2: Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and
   
  Level 3: Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.

 

Fair value estimates are made at a specific point in time based on relevant market information about the financial instrument. These estimates are subjective in nature and involve uncertainties and matters of significant judgment and, therefore, cannot be determined with precision. Changes in assumptions could significantly affect the estimates.

 
Recently Adopted Accounting Standards

Recently Adopted Accounting Standards

 

In June 2016, the FASB issued Accounting Standards Update No. 2016-13, Financial Instruments – Credit Losses (Topics 326): Measurement of Credit Losses on Financial Instruments, which introduced the expected credit losses methodology for the measurement of credit losses on financial assets measured at amortized cost basis, replacing the previous incurred loss methodology. In November 2019, the FASB issued ASU 2019-10 highlighted the adoption timeline. For smaller reporting entities, Topic 326 is effective for annual periods beginning after December 15, 2022, including interim period within those fiscal years, of which is effective for the Company on January 1, 2023 as the Company is qualified as a smaller reporting company. The adoption of this standard did not have a material impact on the Company’s consolidated financial statements.

 

Credit loss rate is determined by historical collection based on aging schedule, adjusted for current conditions using reasonable and supportable forecast. Based on the aging categorization and the adjusted loss per category, an allowance for credit losses is calculated by multiplying the adjusted loss rate with the amortized cost in the respective age category.
XML 46 R25.htm IDEA: XBRL DOCUMENT v3.24.1
ORGANIZATION AND BUSINESS BACKGROUND (Tables)
 12 Months Ended
Dec. 31, 2023
Accounting Policies [Abstract]  
SCHEDULE OF VARIABLE INTEREST ENTITY

The Company, through its subsidiaries, mainly supplies high quality beauty products. Details of the Company’s subsidiaries:

 

  Company name  

Place and date of

incorporation

   Particulars of issued capital   Principal activities  

Proportional of ownership

interest and

voting power

held

1. DSwiss Holding Limited  

Seychelles,

May 28, 2015

   1 share of ordinary share of US$1 each   Investment holding   100%
                   
2. DSwiss (HK) Limited  

Hong Kong,

May 28, 2015

   1 share of ordinary share of HK$1 each   Supply of beauty products   100%
                   
3. DSwiss Sdn Bhd  

Malaysia,

March 10, 2011

   2 shares of ordinary share of RM 1 each   Supply of beauty products   100%
                   
4. DSwiss Biotech Sdn Bhd  

Malaysia,

March 17, 2016

   250,000 shares of ordinary share of RM 1 each   Supply of biotech products   100%
XML 47 R26.htm IDEA: XBRL DOCUMENT v3.24.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
 12 Months Ended
Dec. 31, 2023
Accounting Policies [Abstract]  
SCHEDULE OF PROPERTY AND EQUIPMENT USEFUL LIFE

Property and equipment are stated at cost less accumulated depreciation and impairment. Depreciation of plant, equipment and software are calculated on the straight-line method over their estimated useful lives or lease terms generally as follows:

 

Classification  Estimated useful lives
Computer and software  5 years
Furniture and Fittings  5 years
Office equipment  10 years
Motor vehicle  5 years
SCHEDULE OF FOREIGN CURRENCIES TRANSLATION

Translation of amounts from MYR into US$1, HK$ into US$1 and RMB into US$1 has been made at the following exchange rates for the respective periods:

 

   As of and for the year ended
December 31,		 
   2023   2022 
         
Year-end MYR : US$1 exchange rate   4.59    4.42 
Year-average MYR : US$1 exchange rate   4.56    4.41 
Year-end HK$ : US$1 exchange rate   7.81    7.81 
Year-average HK$ : US$1 exchange rate   7.83    7.83 
Year-end RMB : US$1 exchange rate   7.10    6.92 
Year-average RMB : US$1 exchange rate   7.08    6.75 
XML 48 R27.htm IDEA: XBRL DOCUMENT v3.24.1
PROPERTY AND EQUIPMENT (Tables)
 12 Months Ended
Dec. 31, 2023
Property, Plant and Equipment [Abstract]  
SCHEDULE OF PLANT AND EQUIPMENT

  

As of

December 31, 2023

  

As of

December 31, 2022

 
Computer and software  $102,064   $105,535 
Furniture and fittings   6,144    6,144 
Office equipment   21,525    21,152 
Motor vehicle   135,868    135,868 
Total property and equipment   265,601   $268,699 
Accumulated depreciation   (205,600)   (187,236)
Effect of translation exchange   (11,896)   (9,284)
Property and equipment, net  $48,105   $72,179 
XML 49 R28.htm IDEA: XBRL DOCUMENT v3.24.1
INTANGIBLE ASSETS (Tables)
 12 Months Ended
Dec. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
SCHEDULE OF INTANGIBLE ASSETS

  

As of

December 31, 2023

  

As of

December 31, 2022

 
Trademarks  $12,077   $12,077 
Amortization   (9,194)   (8,164)
Effect of translation exchange   (456)   (454)
Intangible assets, net  $2,427   $3,459 
XML 50 R29.htm IDEA: XBRL DOCUMENT v3.24.1
OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS (Tables)
 12 Months Ended
Dec. 31, 2023
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]  
SCHEDULE OF OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS

  

As of

December 31, 2023

  

As of

December 31, 2022

 
Other receivables  $5,460   $- 
Prepaid expenses   1,932    2,080 
Deposits   17,140    19,669 
Total other receivables, prepaid expenses and deposits  $24,532   $21,749 
XML 51 R30.htm IDEA: XBRL DOCUMENT v3.24.1
INVENTORIES (Tables)
 12 Months Ended
Dec. 31, 2023
Inventory Disclosure [Abstract]  
SCHEDULE OF INVENTORIES

  

As of

December 31, 2023

  

As of

December 31, 2022

 
Finished goods, at cost  $6,872   $7,483 
Total inventories  $6,872   $7,483 
XML 52 R31.htm IDEA: XBRL DOCUMENT v3.24.1
OTHER PAYABLES AND ACCRUED LIABILITIES (Tables)
 12 Months Ended
Dec. 31, 2023
Payables and Accruals [Abstract]  
SCHEDULE OF OTHER PAYABLE AND ACCRUED LIABILITIES

  

As of

December 31, 2023

  

As of

December 31, 2022

 
Other payables  $114,964   $100,385 
Accrued audit fees   30,207    20,266 
Accrued other expenses   15,222    16,683 
Accrued professional fees   14,321    17,376 
Total payables and accrued liabilities  $174,714   $154,710 
XML 53 R32.htm IDEA: XBRL DOCUMENT v3.24.1
FINANCE LEASE LIABILITIES (Tables)
 12 Months Ended
Dec. 31, 2023
Finance Lease Liabilities  
SCHEDULE OF OBLIGATION UNDER FINANCE LEASE

  

As of

December 31, 2023

  

As of

December 31, 2022

 
Finance leases  $38,817   $58,768 
Less: interest expense   (1,813)   (3,792)
Net present value of finance leases   37,004    54,976 
           
Current portion   21,039    16,515 
Non-current portion   15,965    38,461 
Total  $37,004   $54,976 
SCHEDULE OF MATURITIES OF FINANCE LEASE

As of December 31, 2023, the maturities of the finance leases for each of the years are as follows:

 

      
2024   16,570 
2025   12,655 
2026   7,779 
Total  $37,004 
XML 54 R33.htm IDEA: XBRL DOCUMENT v3.24.1
INCOME TAXES (Tables)
 12 Months Ended
Dec. 31, 2023
Income Tax Disclosure [Abstract]  
SCHEDULE OF COMPONENTS OF INCOME LOSS BEFORE INCOME TAXES

For the year ended December 31, 2023 and year ended December 31, 2022, the local (United States) and foreign components of (loss)/profit before income taxes were comprised of the following:

 

  

For the year ended

December 31, 2023

  

For the year ended

December 31, 2022

 
         
Tax jurisdictions from:          
- Local  $(51,974)  $(43,174)
- Foreign, representing          
Seychelles   (3,207)   (11,643)
Hong Kong   (3,703)   (3,951)
Malaysia   10,006    56,347 
Loss before income tax  $(48,878)  $(2,421)
SCHEDULE OF PROVISION FOR INCOME TAXES

The provision for income taxes consisted of the following:

 

  

For the year ended

December 31, 2023

  

For the year ended

December 31, 2022

 
         
Current:          
- Local  $-   $- 
- Foreign   (657)   (516)
           
Deferred:          
- Local   -    - 
- Foreign   -    - 
           
Income tax expense  $(657)  $(516)
SCHEDULE OF DEFERRED INCOME TAX ASSETS

The following table sets forth the significant components of the aggregate deferred tax assets of the Company for the year ended December 31, 2023 and 2022.

 

  

For the year ended

December 31, 2023

  

For the year ended

December 31, 2022

 
Deferred tax assets:          
Net operating loss carry forwards          
-United States of America  $(110,066)  $(99,152)
-Seychelles   -    - 
-Hong Kong   (104,743)   (104,132)
-Malaysia   (31,143)   (36,884)
-PRC  $-   $- 
    (245,952)   (240,168)
Less: valuation allowance  $245,952   $240,168 
Deferred tax assets  $-   $- 
XML 55 R34.htm IDEA: XBRL DOCUMENT v3.24.1
CONCENTRATIONS OF RISKS (Tables)
 12 Months Ended
Dec. 31, 2023
Risks and Uncertainties [Abstract]  
SCHEDULE OF CONCENTRATION OF RISK

(a) Major customers

 

For the year ended December 31, 2023 and 2022, the customers who accounted for 10% or more of the Company’s revenues and its accounts receivable balance at year-end are presented as follows:

 

   For the year ended December 31 
   2023   2022   2023   2022   2023   2022 
   Revenues   Percentage of Revenues   Accounts Receivable, Trade 
Customer A  $-   $501,470    -%   26%  $-   $- 
Customer B  $263,195   $386,232    18%   20%  $35,247   $- 
Customer C  $230,525   $221,638    16%   12%  $-   $- 
Customer D  $182,786   $-    12%   12%  $-   $- 
Customer E  $494,182   $-    33%   12%  $-   $- 
   $1,170,688   $1,109,340    79%   58%  $35,247   $- 

 

(b) Major vendors

 

For the year ended December 31, 2023 and 2022, the vendors who accounted for 10% or more of the Company’s purchases and its accounts payable balance at year-end are presented as follows:

 

   For the year ended December 31 
   2023   2022   2023   2022   2023   2022 
   Purchases   Percentage of Purchases   Account Payable, Trade 
Vendor A  $163,262   $477,099    49%   23%  $5,984   $1,626 
Vendor B  $548,438   $331,538    15%   15%  $64,194   $- 
Vendor C  $164,854   $221,743    14%   33%  $22,008   $16,759 
   $876,554   $1,030,380    78%   71%  $92,186   $18,385 
XML 56 R35.htm IDEA: XBRL DOCUMENT v3.24.1
LEASE RIGHT-OF-USE ASSET AND LEASE LIABILITIES (Tables)
 12 Months Ended
Dec. 31, 2023
Leases [Abstract]  
SCHEDULE OF OPERATION LEASE RIGHT OF USE ASSETS

As of December 31, 2023, operating lease right of use asset as follow:

 

   Year ended December 31, 
   2023   2022 
As of January 1,  $44,548   $92,606 
Accumulated amortization   (43,099)   (42,310)
Effect of translation exchange   (1,449)   (5,748)
Balance as of December 31  $-   $44,548 
SCHEDULE OF OPERATING LEASE LIABILITY

As of December 31, 2023, operating lease liability as follow:

 

As of January 1,  $44,548 
Less: gross repayment   (44,171)
Add: imputed interest   1,072 
Effect of translation exchange   (1,449)
Balance as of December 31, 2023  $- 
Less: lease liability current portion   - 
Lease liability non-current portion  $- 
SCHEDULE OF OPERATING LEASE OTHER INFORMATION

 

    Year ended December 31,  
    2023     2022  
             
Cash paid for amounts included in the measurement of lease liabilities:             -  
Operating cash flow from operating lease   $ 42,862     $ 42,212  
Right-of-use assets obtained in exchange for operating lease liabilities     -       44,548  
Remaining lease term for operating lease (years)     -       1  
Weighted average discount rate for operating lease     5.40 %     5.40 %
XML 57 R36.htm IDEA: XBRL DOCUMENT v3.24.1
RELATED PARTY TRANSACTIONS (Tables)
 12 Months Ended
Dec. 31, 2023
Related Party Transactions [Abstract]  
SCHEDULE OF RELATED PARTY TRANSACTION

For the years ended December 31, 2023 and December 31, 2022, the Company has the following transactions with related party:

 

  

For the year ended

December 31, 2023

(Audited)

  

For the year ended

December 31, 2022

(Audited)

 
Professional Fees:          
- Related party A  $13,001   $12,226 
           
Sales          
- Related party B  $-   $386,232 
- Related party C   48,366    24,261 
XML 58 R37.htm IDEA: XBRL DOCUMENT v3.24.1
SEGMENTED INFORMATION (Tables)
 12 Months Ended
Dec. 31, 2023
Segment Reporting [Abstract]  
SCHEDULE OF REPORTING SEGMENTS

The Company had no inter-segment sales for the periods presented. Summarized financial information concerning the Company’s reportable segments is shown as below:

 

By Geography*:

 

   Nevada*   Seychelles*   Hong Kong*   Malaysia*   Total* 
   For the year ended December 31, 2023 
   Nevada   Seychelles   Hong Kong   Malaysia   Total 
                     
Revenue  $-   $-   $-   $1,470,071   $1,470,071 
Cost of revenue   -    -    -    (1,110,846)   (1,110,846)
Depreciation and amortization   -    -    -    (64,933)   (64,933)
Net (loss)/profit before taxation   (51,974)   (3,207)   (3,703)   10,006    (48,878)
                          
Total assets  $19,729   $22,720   $24,545   $300,499   $367,493 

 

   Nevada*   Seychelles*   Hong Kong*   Malaysia*   Total* 
   For the year ended December 31, 2022 
   Nevada   Seychelles   Hong Kong   Malaysia   Total 
                     
Revenue  $-   $-   $-   $1,849,047   $1,849,047 
Cost of revenue   -    -    -    (1,404,054)   (1,404,054)
Depreciation and amortization   -    -    -    (72,441)   (72,441)
Net (loss) / profit before taxation   (43,174)   (11,643)   (3,951)   56,347    (2,421)
                          
Total assets  $27,294   $7,056   $14,264   $333,310   $381,924 

 

*Revenues and costs are attributed to countries based on the location of customers.
XML 59 R38.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF VARIABLE INTEREST ENTITY (Details)
 12 Months Ended
Dec. 31, 2023
DSwiss Holding Limited [Member]  
Company name DSwiss Holding Limited
Place of incorporation Seychelles
Date of incorporation May 28, 2015
Particulars of issued capital 1 share of ordinary share of US$1 each
Principal activities Investment holding
Proportional of ownership interest and voting power held 100.00%
DSwiss (HK) Limited [Member]  
Company name DSwiss (HK) Limited
Place of incorporation Hong Kong
Date of incorporation May 28, 2015
Particulars of issued capital 1 share of ordinary share of HK$1 each
Principal activities Supply of beauty products
Proportional of ownership interest and voting power held 100.00%
DSwiss Sdn Bhd [Member]  
Company name DSwiss Sdn Bhd
Place of incorporation Malaysia
Date of incorporation Mar. 10, 2011
Particulars of issued capital 2 shares of ordinary share of RM 1 each
Principal activities Supply of beauty products
Proportional of ownership interest and voting power held 100.00%
DSwiss Biotech Sdn Bhd [Member]  
Company name DSwiss Biotech Sdn Bhd
Place of incorporation Malaysia
Date of incorporation Mar. 17, 2016
Particulars of issued capital 250,000 shares of ordinary share of RM 1 each
Principal activities Supply of biotech products
Proportional of ownership interest and voting power held 100.00%
XML 60 R39.htm IDEA: XBRL DOCUMENT v3.24.1
ORGANIZATION AND BUSINESS BACKGROUND (Details Narrative) - RM / shares
Jan. 18, 2023
Dec. 31, 2023
DSwiss (HK) Limited [Member]    
Consideration price per share RM 1  
DSwiss Holding Limited [Member] | HONG KONG    
Equity ownership interest rate percentage   100.00%
DSwiss Sdn Bhd [Member] | MALAYSIA    
Equity ownership interest rate percentage   100.00%
DSwiss Biotech [Member] | HONG KONG    
Equity ownership interest rate percentage 60.00%  
Stock issued during period, shares, new issues 150,000  
DSwiss Biotech [Member] | MALAYSIA    
Equity ownership interest rate percentage   40.00%
XML 61 R40.htm IDEA: XBRL DOCUMENT v3.24.1
GOING CONCERN UNCERTAINTIES (Details Narrative) - USD ($)
Dec. 31, 2023
Dec. 31, 2022
Going Concern Uncertainties    
Accumulated deficit $ 1,410,153 $ 1,324,002
XML 62 R41.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF PROPERTY AND EQUIPMENT USEFUL LIFE (Details)
Dec. 31, 2023
Computer and Software [Member]  
Property, Plant and Equipment [Line Items]  
Property and equipment, estimated useful lives 5 years
Furniture and Fixtures [Member]  
Property, Plant and Equipment [Line Items]  
Property and equipment, estimated useful lives 5 years
Office Equipment [Member]  
Property, Plant and Equipment [Line Items]  
Property and equipment, estimated useful lives 10 years
Motor Vehicles [Member]  
Property, Plant and Equipment [Line Items]  
Property and equipment, estimated useful lives 5 years
XML 63 R42.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF FOREIGN CURRENCIES TRANSLATION (Details)
Dec. 31, 2023
Dec. 31, 2022
Year-end MYR [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Foreign currency exchange rate, translation 4.59 4.42
Year-average MYR [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Foreign currency exchange rate, translation 4.56 4.41
Year-end HK [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Foreign currency exchange rate, translation 7.81 7.81
Year-average HK [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Foreign currency exchange rate, translation 7.83 7.83
Year-end RMB [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Foreign currency exchange rate, translation 7.10 6.92
Year-average RMB [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Foreign currency exchange rate, translation 7.08 6.75
XML 64 R43.htm IDEA: XBRL DOCUMENT v3.24.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)
 12 Months Ended
Dec. 31, 2023
USD ($)
Accounting Policies [Abstract]  
Intangible asset, useful life 10 years
Impairment loss $ 0
Finance lease, description Substantially all of the risks or benefits of ownership are deemed to have been transferred if any one of the four criteria is met: (i) transfer of ownership to the lessee at the end of the lease term, (ii) the lease containing a bargain purchase option, (iii) the lease term exceeding 75% of the estimated economic life of the leased asset, (iv) the present value of the minimum lease payments exceeding 90% of the fair value.
Largest amount of tax benefit, description greater than 50%
XML 65 R44.htm IDEA: XBRL DOCUMENT v3.24.1
VIE STRUCTURE AND ARRANGEMENTS (Details Narrative) - RM / shares
Jan. 18, 2023
Jun. 27, 2016
DSwiss (HK) Limited [Member]    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Number of shares, acquired 150,000  
Equity ownership interest rate percentage 60.00%  
Consideration price per share RM 1  
Management Services Agreement I [Member] | DSwiss (HK) Limited [Member]    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Percentage of annual net profit to be received as fee   100.00%
XML 66 R45.htm IDEA: XBRL DOCUMENT v3.24.1
STOCKHOLDERS’ EQUITY (Details Narrative) - shares
Dec. 31, 2023
Dec. 31, 2022
Equity [Abstract]    
Common stock shares issued 206,904,585 206,904,585
Common stock shares outstanding 206,904,585 206,904,585
Preferred stock shares issued 0 0
Preferred stock shares outstanding 0 0
XML 67 R46.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF PLANT AND EQUIPMENT (Details) - USD ($)
Dec. 31, 2023
Dec. 31, 2022
Property, Plant and Equipment [Line Items]    
Total property and equipment $ 265,601 $ 268,699
Accumulated depreciation (205,600) (187,236)
Effect of translation exchange (11,896) (9,284)
Property and equipment, net 48,105 72,179
Computer and Software [Member]    
Property, Plant and Equipment [Line Items]    
Total property and equipment 102,064 105,535
Furniture and Fixtures [Member]    
Property, Plant and Equipment [Line Items]    
Total property and equipment 6,144 6,144
Office Equipment [Member]    
Property, Plant and Equipment [Line Items]    
Total property and equipment 21,525 21,152
Motor Vehicles [Member]    
Property, Plant and Equipment [Line Items]    
Total property and equipment $ 135,868 $ 135,868
XML 68 R47.htm IDEA: XBRL DOCUMENT v3.24.1
PROPERTY AND EQUIPMENT (Details Narrative) - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Property, Plant and Equipment [Abstract]    
Depreciation expense $ 21,833 $ 30,131
XML 69 R48.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF INTANGIBLE ASSETS (Details) - USD ($)
Dec. 31, 2023
Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]    
Trademarks $ 12,077 $ 12,077
Amortization (9,194) (8,164)
Effect of translation exchange (456) (454)
Intangible assets, net $ 2,427 $ 3,459
XML 70 R49.htm IDEA: XBRL DOCUMENT v3.24.1
INTANGIBLE ASSETS (Details Narrative) - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]    
Amortization of intangible assets $ 1,030 $ 1,029
XML 71 R50.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS (Details) - USD ($)
Dec. 31, 2023
Dec. 31, 2022
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]    
Other receivables $ 5,460
Prepaid expenses 1,932 2,080
Deposits 17,140 19,669
Total other receivables, prepaid expenses and deposits $ 24,532 $ 21,749
XML 72 R51.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF INVENTORIES (Details) - USD ($)
Dec. 31, 2023
Dec. 31, 2022
Inventory Disclosure [Abstract]    
Finished goods, at cost $ 6,872 $ 7,483
Total inventories $ 6,872 $ 7,483
XML 73 R52.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF OTHER PAYABLE AND ACCRUED LIABILITIES (Details) - USD ($)
Dec. 31, 2023
Dec. 31, 2022
Payables and Accruals [Abstract]    
Other payables $ 114,964 $ 100,385
Accrued audit fees 30,207 20,266
Accrued other expenses 15,222 16,683
Accrued professional fees 14,321 17,376
Total payables and accrued liabilities $ 174,714 $ 154,710
XML 74 R53.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF OBLIGATION UNDER FINANCE LEASE (Details) - USD ($)
Dec. 31, 2023
Dec. 31, 2022
Finance Lease Liabilities    
Finance leases $ 38,817 $ 58,768
Less: interest expense (1,813) (3,792)
Total 37,004 54,976
Current portion 21,039 16,515
Non-current portion $ 15,965 $ 38,461
XML 75 R54.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF MATURITIES OF FINANCE LEASE (Details) - USD ($)
Dec. 31, 2023
Dec. 31, 2022
Finance Lease Liabilities    
2024 $ 16,570  
2025 12,655  
2026 7,779  
Total $ 37,004 $ 54,976
XML 76 R55.htm IDEA: XBRL DOCUMENT v3.24.1
FINANCE LEASE LIABILITIES (Details Narrative)
 12 Months Ended
Dec. 31, 2023
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]  
Finance lease, description Substantially all of the risks or benefits of ownership are deemed to have been transferred if any one of the four criteria is met: (i) transfer of ownership to the lessee at the end of the lease term, (ii) the lease containing a bargain purchase option, (iii) the lease term exceeding 75% of the estimated economic life of the leased asset, (iv) the present value of the minimum lease payments exceeding 90% of the fair value.
First Finance Lease Agreement [Member]  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]  
Finance lease, description The first finance lease agreement commenced on July 31, 2018 with the effective interest rate of 3.62% per annum, due through June, 2025, with principal and interest payable monthly.
Second Finance Lease Agreement [Member]  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]  
Finance lease, description The second finance lease agreement commenced on December 3, 2021 with the effective interest rate of 3.70% per annum, due through November, 2026, with principal and interest payable monthly.
XML 77 R56.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF COMPONENTS OF INCOME LOSS BEFORE INCOME TAXES (Details) - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Loss before income tax [1] $ (48,878) $ (2,421)
UNITED STATES    
Loss before income tax (51,974) (43,174)
SEYCHELLES    
Loss before income tax [1] (3,207) (11,643)
HONG KONG    
Loss before income tax [1] (3,703) (3,951)
MALAYSIA    
Loss before income tax [1] $ 10,006 $ 56,347
[1] Revenues and costs are attributed to countries based on the location of customers.
XML 78 R57.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF PROVISION FOR INCOME TAXES (Details) - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Current:    
- Local
- Foreign (657) (516)
Deferred:    
- Local
- Foreign
Income tax expense $ (657) $ (516)
XML 79 R58.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF DEFERRED INCOME TAX ASSETS (Details) - USD ($)
Dec. 31, 2023
Dec. 31, 2022
Operating Loss Carryforwards [Line Items]    
Net operating loss carry forwards $ (245,952) $ (240,168)
Less: valuation allowance 245,952 240,168
Deferred tax assets
United States of America [Member]    
Operating Loss Carryforwards [Line Items]    
Net operating loss carry forwards (110,066) (99,152)
Seychelles [Member]    
Operating Loss Carryforwards [Line Items]    
Net operating loss carry forwards
Hong Kong [Member]    
Operating Loss Carryforwards [Line Items]    
Net operating loss carry forwards (104,743) (104,132)
Malaysia [Member]    
Operating Loss Carryforwards [Line Items]    
Net operating loss carry forwards (31,143) (36,884)
People's Republic of China (PRC) [Member]    
Operating Loss Carryforwards [Line Items]    
Net operating loss carry forwards
XML 80 R59.htm IDEA: XBRL DOCUMENT v3.24.1
INCOME TAXES (Details Narrative)
 12 Months Ended
Dec. 31, 2023
USD ($)
United States of America [Member]  
Operating Loss Carryforwards [Line Items]  
Cumulative net operating losses $ 524,125
Income tax rate 21.00%
Net operating loss carryforwards expiration The net operating loss carry forwards begin to expire in 2038, if unutilized.
Valuation allowance $ 110,066
Hong Kong [Member] | DSwiss (HK) Limited [Member]  
Operating Loss Carryforwards [Line Items]  
Cumulative net operating losses $ 634,806
Income tax rate 16.50%
Valuation allowance $ 104,743
Statutory income tax, rate 16.50%
Malaysia [Member] | DSwiss Sdn Bhd and DSwiss Biotech Sdn Bhd [Member]  
Operating Loss Carryforwards [Line Items]  
Cumulative net operating losses $ 207,619
Income tax rate 15.00%
Valuation allowance $ 31,143
Malaysia [Member] | DSwiss Sdn Bhd and DSwiss Biotech Sdn Bhd [Member] | Minimum [Member]  
Operating Loss Carryforwards [Line Items]  
Statutory income tax, rate 15.00%
Malaysia [Member] | DSwiss Sdn Bhd and DSwiss Biotech Sdn Bhd [Member] | Maximum [Member]  
Operating Loss Carryforwards [Line Items]  
Statutory income tax, rate 24.00%
XML 81 R60.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF CONCENTRATION OF RISK (Details) - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Concentration Risk [Line Items]    
Revenues [1] $ 1,470,071 $ 1,849,047
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Customer A [Member]    
Concentration Risk [Line Items]    
Revenues $ 501,470
Concentration risk, percentage 26.00%
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Customer B [Member]    
Concentration Risk [Line Items]    
Revenues $ 263,195 $ 386,232
Concentration risk, percentage 18.00% 20.00%
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Customer C [Member]    
Concentration Risk [Line Items]    
Revenues $ 230,525 $ 221,638
Concentration risk, percentage 16.00% 12.00%
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Customer D [Member]    
Concentration Risk [Line Items]    
Revenues $ 182,786
Concentration risk, percentage 12.00% 12.00%
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Customer E [Member]    
Concentration Risk [Line Items]    
Revenues $ 494,182
Concentration risk, percentage 33.00% 12.00%
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Customers [Member]    
Concentration Risk [Line Items]    
Revenues $ 1,170,688 $ 1,109,340
Concentration risk, percentage 79.00% 58.00%
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Customer A [Member]    
Concentration Risk [Line Items]    
Accounts receivable, trade
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Customer B [Member]    
Concentration Risk [Line Items]    
Accounts receivable, trade 35,247
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Customer C [Member]    
Concentration Risk [Line Items]    
Accounts receivable, trade
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Customer D [Member]    
Concentration Risk [Line Items]    
Accounts receivable, trade
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Customer E [Member]    
Concentration Risk [Line Items]    
Accounts receivable, trade
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Customers [Member]    
Concentration Risk [Line Items]    
Accounts receivable, trade $ 35,247
Cost of Goods and Service Benchmark [Member] | Supplier Concentration Risk [Member] | Vendor A [Member]    
Concentration Risk [Line Items]    
Concentration risk, percentage 49.00% 23.00%
Purchase $ 163,262 $ 477,099
Cost of Goods and Service Benchmark [Member] | Supplier Concentration Risk [Member] | Vendor B [Member]    
Concentration Risk [Line Items]    
Concentration risk, percentage 15.00% 15.00%
Purchase $ 548,438 $ 331,538
Cost of Goods and Service Benchmark [Member] | Supplier Concentration Risk [Member] | Vendor C [Member]    
Concentration Risk [Line Items]    
Concentration risk, percentage 14.00% 33.00%
Purchase $ 164,854 $ 221,743
Cost of Goods and Service Benchmark [Member] | Supplier Concentration Risk [Member] | Vendors [Member]    
Concentration Risk [Line Items]    
Concentration risk, percentage 78.00% 71.00%
Purchase $ 876,554 $ 1,030,380
Accounts Payable [Member] | Supplier Concentration Risk [Member] | Vendor A [Member]    
Concentration Risk [Line Items]    
Accounts payable, trade 5,984 1,626
Accounts Payable [Member] | Supplier Concentration Risk [Member] | Vendor B [Member]    
Concentration Risk [Line Items]    
Accounts payable, trade 64,194
Accounts Payable [Member] | Supplier Concentration Risk [Member] | Vendor C [Member]    
Concentration Risk [Line Items]    
Accounts payable, trade 22,008 16,759
Accounts Payable [Member] | Supplier Concentration Risk [Member] | Vendors [Member]    
Concentration Risk [Line Items]    
Accounts payable, trade $ 92,186 $ 18,385
[1] Revenues and costs are attributed to countries based on the location of customers.
XML 82 R61.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF OPERATION LEASE RIGHT OF USE ASSETS (Details) - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Leases [Abstract]    
Operating lease right of use asset, beginning $ 44,548 $ 92,606
Accumulated amortization (43,099) (42,310)
Effect of translation exchange (1,449) (5,748)
Operating lease right of use asset, ending $ 44,548
XML 83 R62.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF OPERATING LEASE LIABILITY (Details) - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Leases [Abstract]    
Operating lease liability, beginning $ 44,548  
Less: gross repayment (44,171)  
Add: imputed interest 1,072  
Effect of translation exchange (1,449)  
Operating lease liability, ending  
Less: lease liability current portion $ (44,548)
Lease liability non-current portion  
XML 84 R63.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF OPERATING LEASE OTHER INFORMATION (Details) - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Leases [Abstract]    
Operating cash flow from operating lease $ 42,862 $ 42,212
Right-of-use assets obtained in exchange for operating lease liabilities $ 44,548
Remaining lease term for operating lease (years)   1 year
Weighted average discount rate for operating lease 5.40% 5.40%
XML 85 R64.htm IDEA: XBRL DOCUMENT v3.24.1
LEASE RIGHT-OF-USE ASSET AND LEASE LIABILITIES (Details Narrative) - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Jan. 01, 2022
Dec. 31, 2021
Lease asset- right of use $ 44,548   $ 92,606
Discount rate of lease payment 5.40% 5.40%    
Operating lease right of use asset, amortization $ 43,099 $ 42,310    
Lease expenses 43,099 42,310    
Accounting Standards Update 2016-02 [Member]        
Lease asset- right of use     $ 386,451  
Discount rate of lease payment     5.40%  
Operating lease right of use asset, amortization $ 43,099 $ 42,310    
XML 86 R65.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF RELATED PARTY TRANSACTION (Details) - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Related Party A [Member]    
Related Party Transaction [Line Items]    
Professional Fees $ 13,001 $ 12,226
Related Party B [Member]    
Related Party Transaction [Line Items]    
Sales 386,232
Related Party C [Member]    
Related Party Transaction [Line Items]    
Sales $ 48,366 $ 24,261
XML 87 R66.htm IDEA: XBRL DOCUMENT v3.24.1
RELATED PARTY TRANSACTIONS (Details Narrative)
Dec. 31, 2023
Related Party A [Member]  
Ownership percentage 7.33%
XML 88 R67.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF REPORTING SEGMENTS (Details) - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Revenues from External Customers and Long-Lived Assets [Line Items]    
Revenue [1] $ 1,470,071 $ 1,849,047
Cost of revenue [1] (1,110,846) (1,404,054)
Depreciation and amortization [1] (64,933) (72,441)
Net (loss) / profit before taxation [1] (48,878) (2,421)
Total assets [1] 367,493 381,924
NV [Member]    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Revenue [1]
Cost of revenue [1]
Depreciation and amortization [1]
Net (loss) / profit before taxation [1] (51,974) (43,174)
Total assets [1] 19,729 27,294
SEYCHELLES    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Revenue [1]
Cost of revenue [1]
Depreciation and amortization [1]
Net (loss) / profit before taxation [1] (3,207) (11,643)
Total assets [1] 22,720 7,056
HONG KONG    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Revenue [1]
Cost of revenue [1]
Depreciation and amortization [1]
Net (loss) / profit before taxation [1] (3,703) (3,951)
Total assets [1] 24,545 14,264
MALAYSIA    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Revenue [1] 1,470,071 1,849,047
Cost of revenue [1] (1,110,846) (1,404,054)
Depreciation and amortization [1] (64,933) (72,441)
Net (loss) / profit before taxation [1] 10,006 56,347
Total assets [1] $ 300,499 $ 333,310
[1] Revenues and costs are attributed to countries based on the location of customers.
EXCEL 89 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 90 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 91 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 93 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1 html 150 240 1 true 60 0 false 7 false false R1.htm 00000001 - Document - Cover Sheet http://dswissbeauty.com/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - Consolidated Balance Sheets Sheet http://dswissbeauty.com/role/BalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://dswissbeauty.com/role/BalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Consolidated Statements of Operations and Comprehensive Income Sheet http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome Consolidated Statements of Operations and Comprehensive Income Statements 4 false false R5.htm 00000005 - Statement - Consolidated Statements of Changes in Stockholders' Equity Sheet http://dswissbeauty.com/role/StatementsOfChangesInStockholdersEquity Consolidated Statements of Changes in Stockholders' Equity Statements 5 false false R6.htm 00000006 - Statement - Consolidated Statements of Cash Flows Sheet http://dswissbeauty.com/role/StatementsOfCashFlows Consolidated Statements of Cash Flows Statements 6 false false R7.htm 00000007 - Disclosure - ORGANIZATION AND BUSINESS BACKGROUND Sheet http://dswissbeauty.com/role/OrganizationAndBusinessBackground ORGANIZATION AND BUSINESS BACKGROUND Notes 7 false false R8.htm 00000008 - Disclosure - GOING CONCERN UNCERTAINTIES Sheet http://dswissbeauty.com/role/GoingConcernUncertainties GOING CONCERN UNCERTAINTIES Notes 8 false false R9.htm 00000009 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://dswissbeauty.com/role/SummaryOfSignificantAccountingPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 9 false false R10.htm 00000010 - Disclosure - VIE STRUCTURE AND ARRANGEMENTS Sheet http://dswissbeauty.com/role/VieStructureAndArrangements VIE STRUCTURE AND ARRANGEMENTS Notes 10 false false R11.htm 00000011 - Disclosure - STOCKHOLDERS??? EQUITY Sheet http://dswissbeauty.com/role/StockholdersEquity STOCKHOLDERS??? EQUITY Notes 11 false false R12.htm 00000012 - Disclosure - PROPERTY AND EQUIPMENT Sheet http://dswissbeauty.com/role/PropertyAndEquipment PROPERTY AND EQUIPMENT Notes 12 false false R13.htm 00000013 - Disclosure - INTANGIBLE ASSETS Sheet http://dswissbeauty.com/role/IntangibleAssets INTANGIBLE ASSETS Notes 13 false false R14.htm 00000014 - Disclosure - OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS Sheet http://dswissbeauty.com/role/OtherReceivablesPrepaidExpensesAndDeposits OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS Notes 14 false false R15.htm 00000015 - Disclosure - INVENTORIES Sheet http://dswissbeauty.com/role/Inventories INVENTORIES Notes 15 false false R16.htm 00000016 - Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES Sheet http://dswissbeauty.com/role/OtherPayablesAndAccruedLiabilities OTHER PAYABLES AND ACCRUED LIABILITIES Notes 16 false false R17.htm 00000017 - Disclosure - FINANCE LEASE LIABILITIES Sheet http://dswissbeauty.com/role/FinanceLeaseLiabilities FINANCE LEASE LIABILITIES Notes 17 false false R18.htm 00000018 - Disclosure - INCOME TAXES Sheet http://dswissbeauty.com/role/IncomeTaxes INCOME TAXES Notes 18 false false R19.htm 00000019 - Disclosure - CONCENTRATIONS OF RISKS Sheet http://dswissbeauty.com/role/ConcentrationsOfRisks CONCENTRATIONS OF RISKS Notes 19 false false R20.htm 00000020 - Disclosure - LEASE RIGHT-OF-USE ASSET AND LEASE LIABILITIES Sheet http://dswissbeauty.com/role/LeaseRight-of-useAssetAndLeaseLiabilities LEASE RIGHT-OF-USE ASSET AND LEASE LIABILITIES Notes 20 false false R21.htm 00000021 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://dswissbeauty.com/role/RelatedPartyTransactions RELATED PARTY TRANSACTIONS Notes 21 false false R22.htm 00000022 - Disclosure - SEGMENTED INFORMATION Sheet http://dswissbeauty.com/role/SegmentedInformation SEGMENTED INFORMATION Notes 22 false false R23.htm 00000023 - Disclosure - SUBSEQUENT EVENTS Sheet http://dswissbeauty.com/role/SubsequentEvents SUBSEQUENT EVENTS Notes 23 false false R24.htm 00000024 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 24 false false R25.htm 00000025 - Disclosure - ORGANIZATION AND BUSINESS BACKGROUND (Tables) Sheet http://dswissbeauty.com/role/OrganizationAndBusinessBackgroundTables ORGANIZATION AND BUSINESS BACKGROUND (Tables) Tables http://dswissbeauty.com/role/OrganizationAndBusinessBackground 25 false false R26.htm 00000026 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesTables SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Tables http://dswissbeauty.com/role/SummaryOfSignificantAccountingPolicies 26 false false R27.htm 00000027 - Disclosure - PROPERTY AND EQUIPMENT (Tables) Sheet http://dswissbeauty.com/role/PropertyAndEquipmentTables PROPERTY AND EQUIPMENT (Tables) Tables http://dswissbeauty.com/role/PropertyAndEquipment 27 false false R28.htm 00000028 - Disclosure - INTANGIBLE ASSETS (Tables) Sheet http://dswissbeauty.com/role/IntangibleAssetsTables INTANGIBLE ASSETS (Tables) Tables http://dswissbeauty.com/role/IntangibleAssets 28 false false R29.htm 00000029 - Disclosure - OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS (Tables) Sheet http://dswissbeauty.com/role/OtherReceivablesPrepaidExpensesAndDepositsTables OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS (Tables) Tables http://dswissbeauty.com/role/OtherReceivablesPrepaidExpensesAndDeposits 29 false false R30.htm 00000030 - Disclosure - INVENTORIES (Tables) Sheet http://dswissbeauty.com/role/InventoriesTables INVENTORIES (Tables) Tables http://dswissbeauty.com/role/Inventories 30 false false R31.htm 00000031 - Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES (Tables) Sheet http://dswissbeauty.com/role/OtherPayablesAndAccruedLiabilitiesTables OTHER PAYABLES AND ACCRUED LIABILITIES (Tables) Tables http://dswissbeauty.com/role/OtherPayablesAndAccruedLiabilities 31 false false R32.htm 00000032 - Disclosure - FINANCE LEASE LIABILITIES (Tables) Sheet http://dswissbeauty.com/role/FinanceLeaseLiabilitiesTables FINANCE LEASE LIABILITIES (Tables) Tables http://dswissbeauty.com/role/FinanceLeaseLiabilities 32 false false R33.htm 00000033 - Disclosure - INCOME TAXES (Tables) Sheet http://dswissbeauty.com/role/IncomeTaxesTables INCOME TAXES (Tables) Tables http://dswissbeauty.com/role/IncomeTaxes 33 false false R34.htm 00000034 - Disclosure - CONCENTRATIONS OF RISKS (Tables) Sheet http://dswissbeauty.com/role/ConcentrationsOfRisksTables CONCENTRATIONS OF RISKS (Tables) Tables http://dswissbeauty.com/role/ConcentrationsOfRisks 34 false false R35.htm 00000035 - Disclosure - LEASE RIGHT-OF-USE ASSET AND LEASE LIABILITIES (Tables) Sheet http://dswissbeauty.com/role/LeaseRight-of-useAssetAndLeaseLiabilitiesTables LEASE RIGHT-OF-USE ASSET AND LEASE LIABILITIES (Tables) Tables http://dswissbeauty.com/role/LeaseRight-of-useAssetAndLeaseLiabilities 35 false false R36.htm 00000036 - Disclosure - RELATED PARTY TRANSACTIONS (Tables) Sheet http://dswissbeauty.com/role/RelatedPartyTransactionsTables RELATED PARTY TRANSACTIONS (Tables) Tables http://dswissbeauty.com/role/RelatedPartyTransactions 36 false false R37.htm 00000037 - Disclosure - SEGMENTED INFORMATION (Tables) Sheet http://dswissbeauty.com/role/SegmentedInformationTables SEGMENTED INFORMATION (Tables) Tables http://dswissbeauty.com/role/SegmentedInformation 37 false false R38.htm 00000038 - Disclosure - SCHEDULE OF VARIABLE INTEREST ENTITY (Details) Sheet http://dswissbeauty.com/role/ScheduleOfVariableInterestEntityDetails SCHEDULE OF VARIABLE INTEREST ENTITY (Details) Details 38 false false R39.htm 00000039 - Disclosure - ORGANIZATION AND BUSINESS BACKGROUND (Details Narrative) Sheet http://dswissbeauty.com/role/OrganizationAndBusinessBackgroundDetailsNarrative ORGANIZATION AND BUSINESS BACKGROUND (Details Narrative) Details http://dswissbeauty.com/role/OrganizationAndBusinessBackgroundTables 39 false false R40.htm 00000040 - Disclosure - GOING CONCERN UNCERTAINTIES (Details Narrative) Sheet http://dswissbeauty.com/role/GoingConcernUncertaintiesDetailsNarrative GOING CONCERN UNCERTAINTIES (Details Narrative) Details http://dswissbeauty.com/role/GoingConcernUncertainties 40 false false R41.htm 00000041 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT USEFUL LIFE (Details) Sheet http://dswissbeauty.com/role/ScheduleOfPropertyAndEquipmentUsefulLifeDetails SCHEDULE OF PROPERTY AND EQUIPMENT USEFUL LIFE (Details) Details 41 false false R42.htm 00000042 - Disclosure - SCHEDULE OF FOREIGN CURRENCIES TRANSLATION (Details) Sheet http://dswissbeauty.com/role/ScheduleOfForeignCurrenciesTranslationDetails SCHEDULE OF FOREIGN CURRENCIES TRANSLATION (Details) Details 42 false false R43.htm 00000043 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Sheet http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Details http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesTables 43 false false R44.htm 00000044 - Disclosure - VIE STRUCTURE AND ARRANGEMENTS (Details Narrative) Sheet http://dswissbeauty.com/role/VieStructureAndArrangementsDetailsNarrative VIE STRUCTURE AND ARRANGEMENTS (Details Narrative) Details http://dswissbeauty.com/role/VieStructureAndArrangements 44 false false R45.htm 00000045 - Disclosure - STOCKHOLDERS??? EQUITY (Details Narrative) Sheet http://dswissbeauty.com/role/StockholdersEquityDetailsNarrative STOCKHOLDERS??? EQUITY (Details Narrative) Details http://dswissbeauty.com/role/StockholdersEquity 45 false false R46.htm 00000046 - Disclosure - SCHEDULE OF PLANT AND EQUIPMENT (Details) Sheet http://dswissbeauty.com/role/ScheduleOfPlantAndEquipmentDetails SCHEDULE OF PLANT AND EQUIPMENT (Details) Details 46 false false R47.htm 00000047 - Disclosure - PROPERTY AND EQUIPMENT (Details Narrative) Sheet http://dswissbeauty.com/role/PropertyAndEquipmentDetailsNarrative PROPERTY AND EQUIPMENT (Details Narrative) Details http://dswissbeauty.com/role/PropertyAndEquipmentTables 47 false false R48.htm 00000048 - Disclosure - SCHEDULE OF INTANGIBLE ASSETS (Details) Sheet http://dswissbeauty.com/role/ScheduleOfIntangibleAssetsDetails SCHEDULE OF INTANGIBLE ASSETS (Details) Details 48 false false R49.htm 00000049 - Disclosure - INTANGIBLE ASSETS (Details Narrative) Sheet http://dswissbeauty.com/role/IntangibleAssetsDetailsNarrative INTANGIBLE ASSETS (Details Narrative) Details http://dswissbeauty.com/role/IntangibleAssetsTables 49 false false R50.htm 00000050 - Disclosure - SCHEDULE OF OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS (Details) Sheet http://dswissbeauty.com/role/ScheduleOfOtherReceivablesPrepaidExpensesAndDepositsDetails SCHEDULE OF OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS (Details) Details 50 false false R51.htm 00000051 - Disclosure - SCHEDULE OF INVENTORIES (Details) Sheet http://dswissbeauty.com/role/ScheduleOfInventoriesDetails SCHEDULE OF INVENTORIES (Details) Details 51 false false R52.htm 00000052 - Disclosure - SCHEDULE OF OTHER PAYABLE AND ACCRUED LIABILITIES (Details) Sheet http://dswissbeauty.com/role/ScheduleOfOtherPayableAndAccruedLiabilitiesDetails SCHEDULE OF OTHER PAYABLE AND ACCRUED LIABILITIES (Details) Details 52 false false R53.htm 00000053 - Disclosure - SCHEDULE OF OBLIGATION UNDER FINANCE LEASE (Details) Sheet http://dswissbeauty.com/role/ScheduleOfObligationUnderFinanceLeaseDetails SCHEDULE OF OBLIGATION UNDER FINANCE LEASE (Details) Details 53 false false R54.htm 00000054 - Disclosure - SCHEDULE OF MATURITIES OF FINANCE LEASE (Details) Sheet http://dswissbeauty.com/role/ScheduleOfMaturitiesOfFinanceLeaseDetails SCHEDULE OF MATURITIES OF FINANCE LEASE (Details) Details 54 false false R55.htm 00000055 - Disclosure - FINANCE LEASE LIABILITIES (Details Narrative) Sheet http://dswissbeauty.com/role/FinanceLeaseLiabilitiesDetailsNarrative FINANCE LEASE LIABILITIES (Details Narrative) Details http://dswissbeauty.com/role/FinanceLeaseLiabilitiesTables 55 false false R56.htm 00000056 - Disclosure - SCHEDULE OF COMPONENTS OF INCOME LOSS BEFORE INCOME TAXES (Details) Sheet http://dswissbeauty.com/role/ScheduleOfComponentsOfIncomeLossBeforeIncomeTaxesDetails SCHEDULE OF COMPONENTS OF INCOME LOSS BEFORE INCOME TAXES (Details) Details 56 false false R57.htm 00000057 - Disclosure - SCHEDULE OF PROVISION FOR INCOME TAXES (Details) Sheet http://dswissbeauty.com/role/ScheduleOfProvisionForIncomeTaxesDetails SCHEDULE OF PROVISION FOR INCOME TAXES (Details) Details 57 false false R58.htm 00000058 - Disclosure - SCHEDULE OF DEFERRED INCOME TAX ASSETS (Details) Sheet http://dswissbeauty.com/role/ScheduleOfDeferredIncomeTaxAssetsDetails SCHEDULE OF DEFERRED INCOME TAX ASSETS (Details) Details 58 false false R59.htm 00000059 - Disclosure - INCOME TAXES (Details Narrative) Sheet http://dswissbeauty.com/role/IncomeTaxesDetailsNarrative INCOME TAXES (Details Narrative) Details http://dswissbeauty.com/role/IncomeTaxesTables 59 false false R60.htm 00000060 - Disclosure - SCHEDULE OF CONCENTRATION OF RISK (Details) Sheet http://dswissbeauty.com/role/ScheduleOfConcentrationOfRiskDetails SCHEDULE OF CONCENTRATION OF RISK (Details) Details 60 false false R61.htm 00000061 - Disclosure - SCHEDULE OF OPERATION LEASE RIGHT OF USE ASSETS (Details) Sheet http://dswissbeauty.com/role/ScheduleOfOperationLeaseRightOfUseAssetsDetails SCHEDULE OF OPERATION LEASE RIGHT OF USE ASSETS (Details) Details 61 false false R62.htm 00000062 - Disclosure - SCHEDULE OF OPERATING LEASE LIABILITY (Details) Sheet http://dswissbeauty.com/role/ScheduleOfOperatingLeaseLiabilityDetails SCHEDULE OF OPERATING LEASE LIABILITY (Details) Details 62 false false R63.htm 00000063 - Disclosure - SCHEDULE OF OPERATING LEASE OTHER INFORMATION (Details) Sheet http://dswissbeauty.com/role/ScheduleOfOperatingLeaseOtherInformationDetails SCHEDULE OF OPERATING LEASE OTHER INFORMATION (Details) Details 63 false false R64.htm 00000064 - Disclosure - LEASE RIGHT-OF-USE ASSET AND LEASE LIABILITIES (Details Narrative) Sheet http://dswissbeauty.com/role/LeaseRight-of-useAssetAndLeaseLiabilitiesDetailsNarrative LEASE RIGHT-OF-USE ASSET AND LEASE LIABILITIES (Details Narrative) Details http://dswissbeauty.com/role/LeaseRight-of-useAssetAndLeaseLiabilitiesTables 64 false false R65.htm 00000065 - Disclosure - SCHEDULE OF RELATED PARTY TRANSACTION (Details) Sheet http://dswissbeauty.com/role/ScheduleOfRelatedPartyTransactionDetails SCHEDULE OF RELATED PARTY TRANSACTION (Details) Details 65 false false R66.htm 00000066 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative) Sheet http://dswissbeauty.com/role/RelatedPartyTransactionsDetailsNarrative RELATED PARTY TRANSACTIONS (Details Narrative) Details http://dswissbeauty.com/role/RelatedPartyTransactionsTables 66 false false R67.htm 00000067 - Disclosure - SCHEDULE OF REPORTING SEGMENTS (Details) Sheet http://dswissbeauty.com/role/ScheduleOfReportingSegmentsDetails SCHEDULE OF REPORTING SEGMENTS (Details) Details 67 false false All Reports Book All Reports dqws-20231231.xsd dqws-20231231_cal.xml dqws-20231231_def.xml dqws-20231231_lab.xml dqws-20231231_pre.xml form10-k.htm audit_001.jpg form10-k_001.jpg form10-k_002.jpg form10-k_003.jpg form10-k_004.jpg form10-k_005.jpg form10-k_006.jpg form10-k_007.jpg form10-k_008.jpg form10-k_009.jpg form10-k_010.jpg form10-k_011.jpg http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 true true JSON 95 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "form10-k.htm": { "nsprefix": "DQWS", "nsuri": "http://dswissbeauty.com/20231231", "dts": { "schema": { "local": [ "dqws-20231231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "calculationLink": { "local": [ "dqws-20231231_cal.xml" ] }, "definitionLink": { "local": [ "dqws-20231231_def.xml" ] }, "labelLink": { "local": [ "dqws-20231231_lab.xml" ] }, "presentationLink": { "local": [ "dqws-20231231_pre.xml" ] }, "inline": { "local": [ "form10-k.htm" ] } }, "keyStandard": 220, "keyCustom": 20, "axisStandard": 15, "axisCustom": 0, "memberStandard": 20, "memberCustom": 36, "hidden": { "total": 87, "http://fasb.org/us-gaap/2023": 78, "http://dswissbeauty.com/20231231": 5, "http://xbrl.sec.gov/dei/2023": 4 }, "contextCount": 150, "entityCount": 1, "segmentCount": 60, "elementCount": 405, "unitCount": 7, "baseTaxonomies": { "http://fasb.org/us-gaap/2023": 562, "http://xbrl.sec.gov/dei/2023": 41 }, "report": { "R1": { "role": "http://dswissbeauty.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R2": { "role": "http://dswissbeauty.com/role/BalanceSheets", "longName": "00000002 - Statement - Consolidated Balance Sheets", "shortName": "Consolidated Balance Sheets", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R3": { "role": "http://dswissbeauty.com/role/BalanceSheetsParenthetical", "longName": "00000003 - Statement - Consolidated Balance Sheets (Parenthetical)", "shortName": "Consolidated Balance Sheets (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R4": { "role": "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome", "longName": "00000004 - Statement - Consolidated Statements of Operations and Comprehensive Income", "shortName": "Consolidated Statements of Operations and Comprehensive Income", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:GrossProfit", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R5": { "role": "http://dswissbeauty.com/role/StatementsOfChangesInStockholdersEquity", "longName": "00000005 - Statement - Consolidated Statements of Changes in Stockholders' Equity", "shortName": "Consolidated Statements of Changes in Stockholders' Equity", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "AsOf2021-12-31_us-gaap_CommonStockMember", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2021-12-31_us-gaap_CommonStockMember", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R6": { "role": "http://dswissbeauty.com/role/StatementsOfCashFlows", "longName": "00000006 - Statement - Consolidated Statements of Cash Flows", "shortName": "Consolidated Statements of Cash Flows", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:DepreciationAndAmortization", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R7": { "role": "http://dswissbeauty.com/role/OrganizationAndBusinessBackground", "longName": "00000007 - Disclosure - ORGANIZATION AND BUSINESS BACKGROUND", "shortName": "ORGANIZATION AND BUSINESS BACKGROUND", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "7", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R8": { "role": "http://dswissbeauty.com/role/GoingConcernUncertainties", "longName": "00000008 - Disclosure - GOING CONCERN UNCERTAINTIES", "shortName": "GOING CONCERN UNCERTAINTIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "8", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "DQWS:GoingConcernUncertaintiesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "DQWS:GoingConcernUncertaintiesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R9": { "role": "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPolicies", "longName": "00000009 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R10": { "role": "http://dswissbeauty.com/role/VieStructureAndArrangements", "longName": "00000010 - Disclosure - VIE STRUCTURE AND ARRANGEMENTS", "shortName": "VIE STRUCTURE AND ARRANGEMENTS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:VariableInterestEntityDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:VariableInterestEntityDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R11": { "role": "http://dswissbeauty.com/role/StockholdersEquity", "longName": "00000011 - Disclosure - STOCKHOLDERS\u2019 EQUITY", "shortName": "STOCKHOLDERS\u2019 EQUITY", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R12": { "role": "http://dswissbeauty.com/role/PropertyAndEquipment", "longName": "00000012 - Disclosure - PROPERTY AND EQUIPMENT", "shortName": "PROPERTY AND EQUIPMENT", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R13": { "role": "http://dswissbeauty.com/role/IntangibleAssets", "longName": "00000013 - Disclosure - INTANGIBLE ASSETS", "shortName": "INTANGIBLE ASSETS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R14": { "role": "http://dswissbeauty.com/role/OtherReceivablesPrepaidExpensesAndDeposits", "longName": "00000014 - Disclosure - OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS", "shortName": "OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:OtherCurrentAssetsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:OtherCurrentAssetsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R15": { "role": "http://dswissbeauty.com/role/Inventories", "longName": "00000015 - Disclosure - INVENTORIES", "shortName": "INVENTORIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:InventoryDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:InventoryDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R16": { "role": "http://dswissbeauty.com/role/OtherPayablesAndAccruedLiabilities", "longName": "00000016 - Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES", "shortName": "OTHER PAYABLES AND ACCRUED LIABILITIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R17": { "role": "http://dswissbeauty.com/role/FinanceLeaseLiabilities", "longName": "00000017 - Disclosure - FINANCE LEASE LIABILITIES", "shortName": "FINANCE LEASE LIABILITIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:LesseeFinanceLeasesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:LesseeFinanceLeasesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R18": { "role": "http://dswissbeauty.com/role/IncomeTaxes", "longName": "00000018 - Disclosure - INCOME TAXES", "shortName": "INCOME TAXES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R19": { "role": "http://dswissbeauty.com/role/ConcentrationsOfRisks", "longName": "00000019 - Disclosure - CONCENTRATIONS OF RISKS", "shortName": "CONCENTRATIONS OF RISKS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "19", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R20": { "role": "http://dswissbeauty.com/role/LeaseRight-of-useAssetAndLeaseLiabilities", "longName": "00000020 - Disclosure - LEASE RIGHT-OF-USE ASSET AND LEASE LIABILITIES", "shortName": "LEASE RIGHT-OF-USE ASSET AND LEASE LIABILITIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "20", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:LeasesOfLesseeDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:LeasesOfLesseeDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R21": { "role": "http://dswissbeauty.com/role/RelatedPartyTransactions", "longName": "00000021 - Disclosure - RELATED PARTY TRANSACTIONS", "shortName": "RELATED PARTY TRANSACTIONS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "21", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R22": { "role": "http://dswissbeauty.com/role/SegmentedInformation", "longName": "00000022 - Disclosure - SEGMENTED INFORMATION", "shortName": "SEGMENTED INFORMATION", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "22", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R23": { "role": "http://dswissbeauty.com/role/SubsequentEvents", "longName": "00000023 - Disclosure - SUBSEQUENT EVENTS", "shortName": "SUBSEQUENT EVENTS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "23", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R24": { "role": "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesPolicies", "longName": "00000024 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "24", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R25": { "role": "http://dswissbeauty.com/role/OrganizationAndBusinessBackgroundTables", "longName": "00000025 - Disclosure - ORGANIZATION AND BUSINESS BACKGROUND (Tables)", "shortName": "ORGANIZATION AND BUSINESS BACKGROUND (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "25", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfVariableInterestEntitiesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfVariableInterestEntitiesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R26": { "role": "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesTables", "longName": "00000026 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "26", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "DQWS:SummaryOfPropertyAndEquipmentUsefulLifeTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "DQWS:SummaryOfPropertyAndEquipmentUsefulLifeTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R27": { "role": "http://dswissbeauty.com/role/PropertyAndEquipmentTables", "longName": "00000027 - Disclosure - PROPERTY AND EQUIPMENT (Tables)", "shortName": "PROPERTY AND EQUIPMENT (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "27", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R28": { "role": "http://dswissbeauty.com/role/IntangibleAssetsTables", "longName": "00000028 - Disclosure - INTANGIBLE ASSETS (Tables)", "shortName": "INTANGIBLE ASSETS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "28", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R29": { "role": "http://dswissbeauty.com/role/OtherReceivablesPrepaidExpensesAndDepositsTables", "longName": "00000029 - Disclosure - OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS (Tables)", "shortName": "OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "29", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:OtherCurrentAssetsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:OtherCurrentAssetsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R30": { "role": "http://dswissbeauty.com/role/InventoriesTables", "longName": "00000030 - Disclosure - INVENTORIES (Tables)", "shortName": "INVENTORIES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "30", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R31": { "role": "http://dswissbeauty.com/role/OtherPayablesAndAccruedLiabilitiesTables", "longName": "00000031 - Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES (Tables)", "shortName": "OTHER PAYABLES AND ACCRUED LIABILITIES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "31", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R32": { "role": "http://dswissbeauty.com/role/FinanceLeaseLiabilitiesTables", "longName": "00000032 - Disclosure - FINANCE LEASE LIABILITIES (Tables)", "shortName": "FINANCE LEASE LIABILITIES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "32", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "DQWS:ScheduleOfObligationUnderFinanceLeaseTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:LesseeFinanceLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "DQWS:ScheduleOfObligationUnderFinanceLeaseTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:LesseeFinanceLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R33": { "role": "http://dswissbeauty.com/role/IncomeTaxesTables", "longName": "00000033 - Disclosure - INCOME TAXES (Tables)", "shortName": "INCOME TAXES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "33", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R34": { "role": "http://dswissbeauty.com/role/ConcentrationsOfRisksTables", "longName": "00000034 - Disclosure - CONCENTRATIONS OF RISKS (Tables)", "shortName": "CONCENTRATIONS OF RISKS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "34", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:ConcentrationRiskDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:ConcentrationRiskDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R35": { "role": "http://dswissbeauty.com/role/LeaseRight-of-useAssetAndLeaseLiabilitiesTables", "longName": "00000035 - Disclosure - LEASE RIGHT-OF-USE ASSET AND LEASE LIABILITIES (Tables)", "shortName": "LEASE RIGHT-OF-USE ASSET AND LEASE LIABILITIES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "35", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:OperatingLeasesOfLesseeDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:LeasesOfLesseeDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:OperatingLeasesOfLesseeDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:LeasesOfLesseeDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R36": { "role": "http://dswissbeauty.com/role/RelatedPartyTransactionsTables", "longName": "00000036 - Disclosure - RELATED PARTY TRANSACTIONS (Tables)", "shortName": "RELATED PARTY TRANSACTIONS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "36", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R37": { "role": "http://dswissbeauty.com/role/SegmentedInformationTables", "longName": "00000037 - Disclosure - SEGMENTED INFORMATION (Tables)", "shortName": "SEGMENTED INFORMATION (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "37", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R38": { "role": "http://dswissbeauty.com/role/ScheduleOfVariableInterestEntityDetails", "longName": "00000038 - Disclosure - SCHEDULE OF VARIABLE INTEREST ENTITY (Details)", "shortName": "SCHEDULE OF VARIABLE INTEREST ENTITY (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "38", "firstAnchor": { "contextRef": "From2023-01-012023-12-31_custom_DSwissHoldingLimitedMember", "name": "us-gaap:VariableInterestEntityTypeOfEntity", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:ScheduleOfVariableInterestEntitiesTextBlock", "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-012023-12-31_custom_DSwissHoldingLimitedMember", "name": "us-gaap:VariableInterestEntityTypeOfEntity", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:ScheduleOfVariableInterestEntitiesTextBlock", "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R39": { "role": "http://dswissbeauty.com/role/OrganizationAndBusinessBackgroundDetailsNarrative", "longName": "00000039 - Disclosure - ORGANIZATION AND BUSINESS BACKGROUND (Details Narrative)", "shortName": "ORGANIZATION AND BUSINESS BACKGROUND (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "39", "firstAnchor": { "contextRef": "AsOf2023-01-18_custom_DSwissHKLimitedMember", "name": "us-gaap:SharesIssuedPricePerShare", "unitRef": "MYRPShare", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "span", "p", "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31_custom_DSwissHoldingLimitedMember_country_HK", "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R40": { "role": "http://dswissbeauty.com/role/GoingConcernUncertaintiesDetailsNarrative", "longName": "00000040 - Disclosure - GOING CONCERN UNCERTAINTIES (Details Narrative)", "shortName": "GOING CONCERN UNCERTAINTIES (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "40", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:RetainedEarningsAccumulatedDeficit", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": null }, "R41": { "role": "http://dswissbeauty.com/role/ScheduleOfPropertyAndEquipmentUsefulLifeDetails", "longName": "00000041 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT USEFUL LIFE (Details)", "shortName": "SCHEDULE OF PROPERTY AND EQUIPMENT USEFUL LIFE (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "41", "firstAnchor": { "contextRef": "AsOf2023-12-31_custom_ComputerAndSoftwareMember", "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "td", "tr", "table", "DQWS:SummaryOfPropertyAndEquipmentUsefulLifeTableTextBlock", "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31_custom_ComputerAndSoftwareMember", "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "td", "tr", "table", "DQWS:SummaryOfPropertyAndEquipmentUsefulLifeTableTextBlock", "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R42": { "role": "http://dswissbeauty.com/role/ScheduleOfForeignCurrenciesTranslationDetails", "longName": "00000042 - Disclosure - SCHEDULE OF FOREIGN CURRENCIES TRANSLATION (Details)", "shortName": "SCHEDULE OF FOREIGN CURRENCIES TRANSLATION (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "42", "firstAnchor": { "contextRef": "AsOf2023-12-31_custom_YearEndMYRMember", "name": "us-gaap:ForeignCurrencyExchangeRateTranslation1", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfIntercompanyForeignCurrencyBalancesTextBlock", "us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31_custom_YearEndMYRMember", "name": "us-gaap:ForeignCurrencyExchangeRateTranslation1", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfIntercompanyForeignCurrencyBalancesTextBlock", "us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R43": { "role": "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative", "longName": "00000043 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "43", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "p", "us-gaap:IntangibleAssetsFiniteLivedPolicy", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "p", "us-gaap:IntangibleAssetsFiniteLivedPolicy", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R44": { "role": "http://dswissbeauty.com/role/VieStructureAndArrangementsDetailsNarrative", "longName": "00000044 - Disclosure - VIE STRUCTURE AND ARRANGEMENTS (Details Narrative)", "shortName": "VIE STRUCTURE AND ARRANGEMENTS (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "44", "firstAnchor": { "contextRef": "From2023-01-182023-01-18_custom_DSwissHKLimitedMember", "name": "us-gaap:StockIssuedDuringPeriodSharesAcquisitions", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "us-gaap:VariableInterestEntityDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-182023-01-18_custom_DSwissHKLimitedMember", "name": "us-gaap:StockIssuedDuringPeriodSharesAcquisitions", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "us-gaap:VariableInterestEntityDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R45": { "role": "http://dswissbeauty.com/role/StockholdersEquityDetailsNarrative", "longName": "00000045 - Disclosure - STOCKHOLDERS\u2019 EQUITY (Details Narrative)", "shortName": "STOCKHOLDERS\u2019 EQUITY (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "45", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:CommonStockSharesIssued", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": null }, "R46": { "role": "http://dswissbeauty.com/role/ScheduleOfPlantAndEquipmentDetails", "longName": "00000046 - Disclosure - SCHEDULE OF PLANT AND EQUIPMENT (Details)", "shortName": "SCHEDULE OF PLANT AND EQUIPMENT (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "46", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:PropertyPlantAndEquipmentGross", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:PropertyPlantAndEquipmentGross", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R47": { "role": "http://dswissbeauty.com/role/PropertyAndEquipmentDetailsNarrative", "longName": "00000047 - Disclosure - PROPERTY AND EQUIPMENT (Details Narrative)", "shortName": "PROPERTY AND EQUIPMENT (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "47", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:Depreciation", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:Depreciation", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R48": { "role": "http://dswissbeauty.com/role/ScheduleOfIntangibleAssetsDetails", "longName": "00000048 - Disclosure - SCHEDULE OF INTANGIBLE ASSETS (Details)", "shortName": "SCHEDULE OF INTANGIBLE ASSETS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "48", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:FiniteLivedTrademarksGross", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:FiniteLivedTrademarksGross", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R49": { "role": "http://dswissbeauty.com/role/IntangibleAssetsDetailsNarrative", "longName": "00000049 - Disclosure - INTANGIBLE ASSETS (Details Narrative)", "shortName": "INTANGIBLE ASSETS (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "49", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:AmortizationOfIntangibleAssets", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": null }, "R50": { "role": "http://dswissbeauty.com/role/ScheduleOfOtherReceivablesPrepaidExpensesAndDepositsDetails", "longName": "00000050 - Disclosure - SCHEDULE OF OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS (Details)", "shortName": "SCHEDULE OF OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "50", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:OtherReceivables", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "us-gaap:OtherCurrentAssetsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:OtherReceivables", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "us-gaap:OtherCurrentAssetsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R51": { "role": "http://dswissbeauty.com/role/ScheduleOfInventoriesDetails", "longName": "00000051 - Disclosure - SCHEDULE OF INVENTORIES (Details)", "shortName": "SCHEDULE OF INVENTORIES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "51", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:InventoryFinishedGoods", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:InventoryFinishedGoods", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R52": { "role": "http://dswissbeauty.com/role/ScheduleOfOtherPayableAndAccruedLiabilitiesDetails", "longName": "00000052 - Disclosure - SCHEDULE OF OTHER PAYABLE AND ACCRUED LIABILITIES (Details)", "shortName": "SCHEDULE OF OTHER PAYABLE AND ACCRUED LIABILITIES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "52", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:AccountsPayableOtherCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:AccountsPayableOtherCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R53": { "role": "http://dswissbeauty.com/role/ScheduleOfObligationUnderFinanceLeaseDetails", "longName": "00000053 - Disclosure - SCHEDULE OF OBLIGATION UNDER FINANCE LEASE (Details)", "shortName": "SCHEDULE OF OBLIGATION UNDER FINANCE LEASE (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "53", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:FinanceLeaseLiabilityPaymentsDue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "DQWS:ScheduleOfObligationUnderFinanceLeaseTableTextBlock", "us-gaap:LesseeFinanceLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:FinanceLeaseLiabilityPaymentsDue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "DQWS:ScheduleOfObligationUnderFinanceLeaseTableTextBlock", "us-gaap:LesseeFinanceLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R54": { "role": "http://dswissbeauty.com/role/ScheduleOfMaturitiesOfFinanceLeaseDetails", "longName": "00000054 - Disclosure - SCHEDULE OF MATURITIES OF FINANCE LEASE (Details)", "shortName": "SCHEDULE OF MATURITIES OF FINANCE LEASE (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "54", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock", "us-gaap:LesseeFinanceLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock", "us-gaap:LesseeFinanceLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R55": { "role": "http://dswissbeauty.com/role/FinanceLeaseLiabilitiesDetailsNarrative", "longName": "00000055 - Disclosure - FINANCE LEASE LIABILITIES (Details Narrative)", "shortName": "FINANCE LEASE LIABILITIES (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "55", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:LesseeFinanceLeaseDescription", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "p", "us-gaap:LesseeLeasesPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-012023-12-31_custom_FirstFinanceLeaseAgreementMember", "name": "us-gaap:LesseeFinanceLeaseDescription", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "p", "us-gaap:LesseeFinanceLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R56": { "role": "http://dswissbeauty.com/role/ScheduleOfComponentsOfIncomeLossBeforeIncomeTaxesDetails", "longName": "00000056 - Disclosure - SCHEDULE OF COMPONENTS OF INCOME LOSS BEFORE INCOME TAXES (Details)", "shortName": "SCHEDULE OF COMPONENTS OF INCOME LOSS BEFORE INCOME TAXES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "56", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-012023-12-31_country_US", "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R57": { "role": "http://dswissbeauty.com/role/ScheduleOfProvisionForIncomeTaxesDetails", "longName": "00000057 - Disclosure - SCHEDULE OF PROVISION FOR INCOME TAXES (Details)", "shortName": "SCHEDULE OF PROVISION FOR INCOME TAXES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "57", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:CurrentForeignTaxExpenseBenefit", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:CurrentForeignTaxExpenseBenefit", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R58": { "role": "http://dswissbeauty.com/role/ScheduleOfDeferredIncomeTaxAssetsDetails", "longName": "00000058 - Disclosure - SCHEDULE OF DEFERRED INCOME TAX ASSETS (Details)", "shortName": "SCHEDULE OF DEFERRED INCOME TAX ASSETS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "58", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R59": { "role": "http://dswissbeauty.com/role/IncomeTaxesDetailsNarrative", "longName": "00000059 - Disclosure - INCOME TAXES (Details Narrative)", "shortName": "INCOME TAXES (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "59", "firstAnchor": { "contextRef": "AsOf2023-12-31_custom_UnitedStatesOfAmericaMember", "name": "us-gaap:OperatingLossCarryforwards", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31_custom_UnitedStatesOfAmericaMember", "name": "us-gaap:OperatingLossCarryforwards", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R60": { "role": "http://dswissbeauty.com/role/ScheduleOfConcentrationOfRiskDetails", "longName": "00000060 - Disclosure - SCHEDULE OF CONCENTRATION OF RISK (Details)", "shortName": "SCHEDULE OF CONCENTRATION OF RISK (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "60", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2022-01-012022-12-31_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerAMember", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "us-gaap:ConcentrationRiskDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R61": { "role": "http://dswissbeauty.com/role/ScheduleOfOperationLeaseRightOfUseAssetsDetails", "longName": "00000061 - Disclosure - SCHEDULE OF OPERATION LEASE RIGHT OF USE ASSETS (Details)", "shortName": "SCHEDULE OF OPERATION LEASE RIGHT OF USE ASSETS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "61", "firstAnchor": { "contextRef": "AsOf2022-12-31", "name": "us-gaap:OperatingLeaseRightOfUseAsset", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "DQWS:EffectOfTranslationExchangeOperatingLeaseRightOfUseAsset", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:OperatingLeasesOfLesseeDisclosureTextBlock", "us-gaap:LeasesOfLesseeDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R62": { "role": "http://dswissbeauty.com/role/ScheduleOfOperatingLeaseLiabilityDetails", "longName": "00000062 - Disclosure - SCHEDULE OF OPERATING LEASE LIABILITY (Details)", "shortName": "SCHEDULE OF OPERATING LEASE LIABILITY (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "62", "firstAnchor": { "contextRef": "AsOf2022-12-31", "name": "us-gaap:OperatingLeaseLiability", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "DQWS:ScheduleOfOperatingLeaseLiabilityDisclosureTextBlock", "us-gaap:LeasesOfLesseeDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2022-12-31", "name": "us-gaap:OperatingLeaseLiability", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "DQWS:ScheduleOfOperatingLeaseLiabilityDisclosureTextBlock", "us-gaap:LeasesOfLesseeDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R63": { "role": "http://dswissbeauty.com/role/ScheduleOfOperatingLeaseOtherInformationDetails", "longName": "00000063 - Disclosure - SCHEDULE OF OPERATING LEASE OTHER INFORMATION (Details)", "shortName": "SCHEDULE OF OPERATING LEASE OTHER INFORMATION (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "63", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ProceedsFromLeasePayments", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "DQWS:ScheduleOfOperatingLeaseOtherInformationTableTextBlock", "us-gaap:LeasesOfLesseeDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ProceedsFromLeasePayments", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "DQWS:ScheduleOfOperatingLeaseOtherInformationTableTextBlock", "us-gaap:LeasesOfLesseeDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R64": { "role": "http://dswissbeauty.com/role/LeaseRight-of-useAssetAndLeaseLiabilitiesDetailsNarrative", "longName": "00000064 - Disclosure - LEASE RIGHT-OF-USE ASSET AND LEASE LIABILITIES (Details Narrative)", "shortName": "LEASE RIGHT-OF-USE ASSET AND LEASE LIABILITIES (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "64", "firstAnchor": { "contextRef": "AsOf2022-12-31", "name": "us-gaap:OperatingLeaseRightOfUseAsset", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:PaymentsForRent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:LeasesOfLesseeDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R65": { "role": "http://dswissbeauty.com/role/ScheduleOfRelatedPartyTransactionDetails", "longName": "00000065 - Disclosure - SCHEDULE OF RELATED PARTY TRANSACTION (Details)", "shortName": "SCHEDULE OF RELATED PARTY TRANSACTION (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "65", "firstAnchor": { "contextRef": "From2023-01-012023-12-31_custom_RelatedPartyAMember", "name": "us-gaap:ProfessionalFees", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-012023-12-31_custom_RelatedPartyAMember", "name": "us-gaap:ProfessionalFees", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R66": { "role": "http://dswissbeauty.com/role/RelatedPartyTransactionsDetailsNarrative", "longName": "00000066 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)", "shortName": "RELATED PARTY TRANSACTIONS (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "66", "firstAnchor": { "contextRef": "AsOf2023-12-31_custom_RelatedPartyAMember", "name": "us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31_custom_RelatedPartyAMember", "name": "us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R67": { "role": "http://dswissbeauty.com/role/ScheduleOfReportingSegmentsDetails", "longName": "00000067 - Disclosure - SCHEDULE OF REPORTING SEGMENTS (Details)", "shortName": "SCHEDULE OF REPORTING SEGMENTS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "67", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:DepreciationDepletionAndAmortization", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } } }, "tag": { "us-gaap_AccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountingPoliciesAbstract", "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AccountingStandardsUpdate201602Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountingStandardsUpdate201602Member", "presentation": [ "http://dswissbeauty.com/role/LeaseRight-of-useAssetAndLeaseLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Accounting Standards Update 2016-02 [Member]", "documentation": "Accounting Standards Update 2016-02 Leases (Topic 842)." } } }, "auth_ref": [ "r402" ] }, "us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "presentation": [ "http://dswissbeauty.com/role/OtherPayablesAndAccruedLiabilities" ], "lang": { "en-us": { "role": { "label": "OTHER PAYABLES AND ACCRUED LIABILITIES", "documentation": "The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period." } } }, "auth_ref": [] }, "us-gaap_AccountsPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableCurrent", "crdr": "credit", "calculation": { "http://dswissbeauty.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://dswissbeauty.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accounts payable", "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r19", "r595" ] }, "us-gaap_AccountsPayableMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableMember", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfConcentrationOfRiskDetails" ], "lang": { "en-us": { "role": { "label": "Accounts Payable [Member]", "documentation": "Obligations incurred and payable to vendors for goods and services received." } } }, "auth_ref": [ "r16" ] }, "us-gaap_AccountsPayableOtherCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableOtherCurrent", "crdr": "credit", "calculation": { "http://dswissbeauty.com/role/ScheduleOfOtherPayableAndAccruedLiabilitiesDetails": { "parentTag": "us-gaap_OtherAccountsPayableAndAccruedLiabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://dswissbeauty.com/role/ScheduleOfOtherPayableAndAccruedLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Other payables", "documentation": "Amount of obligations incurred classified as other, payable within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r19" ] }, "us-gaap_AccountsPayableTradeCurrentAndNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableTradeCurrentAndNoncurrent", "crdr": "credit", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfConcentrationOfRiskDetails" ], "lang": { "en-us": { "role": { "label": "Accounts payable, trade", "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business." } } }, "auth_ref": [ "r77" ] }, "us-gaap_AccountsReceivableMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsReceivableMember", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfConcentrationOfRiskDetails" ], "lang": { "en-us": { "role": { "label": "Accounts Receivable [Member]", "documentation": "Due from customers or clients for goods or services that have been delivered or sold." } } }, "auth_ref": [ "r566" ] }, "us-gaap_AccountsReceivableNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsReceivableNet", "crdr": "debit", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfConcentrationOfRiskDetails" ], "lang": { "en-us": { "role": { "label": "Accounts receivable, trade", "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business." } } }, "auth_ref": [ "r510", "r565", "r600", "r671" ] }, "us-gaap_AccountsReceivableNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsReceivableNetCurrent", "crdr": "debit", "calculation": { "http://dswissbeauty.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://dswissbeauty.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accounts receivable", "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current." } } }, "auth_ref": [ "r234", "r235" ] }, "DQWS_AccruedAuditFeesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://dswissbeauty.com/20231231", "localname": "AccruedAuditFeesCurrent", "crdr": "credit", "calculation": { "http://dswissbeauty.com/role/ScheduleOfOtherPayableAndAccruedLiabilitiesDetails": { "parentTag": "us-gaap_OtherAccountsPayableAndAccruedLiabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://dswissbeauty.com/role/ScheduleOfOtherPayableAndAccruedLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Accrued audit fees", "documentation": "Accrued audit fees current." } } }, "auth_ref": [] }, "us-gaap_AccruedProfessionalFeesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedProfessionalFeesCurrent", "crdr": "credit", "calculation": { "http://dswissbeauty.com/role/ScheduleOfOtherPayableAndAccruedLiabilitiesDetails": { "parentTag": "us-gaap_OtherAccountsPayableAndAccruedLiabilities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://dswissbeauty.com/role/ScheduleOfOtherPayableAndAccruedLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Accrued professional fees", "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r21" ] }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://dswissbeauty.com/role/ScheduleOfPlantAndEquipmentDetails": { "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://dswissbeauty.com/role/ScheduleOfPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Accumulated depreciation", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services." } } }, "auth_ref": [ "r52", "r153", "r457" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "crdr": "credit", "calculation": { "http://dswissbeauty.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://dswissbeauty.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accumulated other comprehensive income/(loss)", "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source." } } }, "auth_ref": [ "r25", "r26", "r93", "r157", "r452", "r472", "r476" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeMember", "presentation": [ "http://dswissbeauty.com/role/StatementsOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "AOCI Attributable to Parent [Member]", "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r2", "r13", "r26", "r365", "r368", "r425", "r467", "r468", "r637", "r638", "r639", "r643", "r644", "r645" ] }, "us-gaap_AdditionalPaidInCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapital", "crdr": "credit", "calculation": { "http://dswissbeauty.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://dswissbeauty.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Additional paid-in capital", "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock." } } }, "auth_ref": [ "r85", "r595", "r675" ] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://dswissbeauty.com/role/StatementsOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Additional Paid-in Capital [Member]", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r327", "r328", "r329", "r487", "r643", "r644", "r645", "r657", "r678" ] }, "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsForNewAccountingPronouncementsAxis", "presentation": [ "http://dswissbeauty.com/role/LeaseRight-of-useAssetAndLeaseLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Accounting Standards Update [Axis]", "documentation": "Information by amendment to accounting standards." } } }, "auth_ref": [ "r142", "r143", "r144", "r145", "r146", "r186", "r187", "r188", "r189", "r198", "r236", "r237", "r242", "r243", "r244", "r245", "r246", "r247", "r248", "r249", "r250", "r251", "r259", "r327", "r328", "r329", "r342", "r343", "r344", "r345", "r352", "r353", "r354", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r382", "r383", "r384", "r385", "r387", "r388", "r389", "r390", "r400", "r401", "r403", "r404", "r405", "r406", "r421", "r422", "r423", "r424", "r425", "r442", "r443", "r444", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r473", "r474", "r475", "r476" ] }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://dswissbeauty.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net loss to net cash generated from operating activities:" } } }, "auth_ref": [] }, "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "us-gaap_AmortizationOfIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AmortizationOfIntangibleAssets", "crdr": "debit", "calculation": { "http://dswissbeauty.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://dswissbeauty.com/role/IntangibleAssetsDetailsNarrative", "http://dswissbeauty.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Amortization for intangible assets", "verboseLabel": "Amortization of intangible assets", "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method." } } }, "auth_ref": [ "r7", "r47", "r50" ] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AnnualInformationForm", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r622" ] }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ArrangementsAndNonarrangementTransactionsMember", "presentation": [ "http://dswissbeauty.com/role/FinanceLeaseLiabilitiesDetailsNarrative", "http://dswissbeauty.com/role/VieStructureAndArrangementsDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r355" ] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Assets", "crdr": "debit", "calculation": { "http://dswissbeauty.com/role/BalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://dswissbeauty.com/role/BalanceSheets", "http://dswissbeauty.com/role/ScheduleOfReportingSegmentsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "TOTAL ASSETS", "label": "Total assets", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r120", "r155", "r181", "r212", "r220", "r225", "r241", "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r356", "r358", "r386", "r449", "r515", "r595", "r607", "r649", "r650", "r663" ] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsAbstract", "presentation": [ "http://dswissbeauty.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "ASSETS" } } }, "auth_ref": [] }, "us-gaap_AssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrent", "crdr": "debit", "calculation": { "http://dswissbeauty.com/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://dswissbeauty.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total current assets", "label": "Assets, Current", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r148", "r161", "r181", "r241", "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r356", "r358", "r386", "r595", "r649", "r650", "r663" ] }, "us-gaap_AssetsCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrentAbstract", "presentation": [ "http://dswissbeauty.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "CURRENT ASSETS" } } }, "auth_ref": [] }, "us-gaap_AssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsNoncurrent", "crdr": "debit", "calculation": { "http://dswissbeauty.com/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://dswissbeauty.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total non-current assets", "label": "Assets, Noncurrent", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer." } } }, "auth_ref": [ "r181", "r241", "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r356", "r358", "r386", "r649", "r650", "r663" ] }, "us-gaap_AssetsNoncurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsNoncurrentAbstract", "presentation": [ "http://dswissbeauty.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "NON-CURRENT ASSETS" } } }, "auth_ref": [] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r622" ] }, "dei_AuditorFirmId": { "xbrltype": "nonemptySequenceNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorFirmId", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Auditor Firm ID", "documentation": "PCAOB issued Audit Firm Identifier" } } }, "auth_ref": [ "r619", "r621", "r622" ] }, "dei_AuditorLocation": { "xbrltype": "internationalNameItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorLocation", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Auditor Location" } } }, "auth_ref": [ "r619", "r621", "r622" ] }, "dei_AuditorName": { "xbrltype": "internationalNameItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorName", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Auditor Name" } } }, "auth_ref": [ "r619", "r621", "r622" ] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AwardTypeAxis", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfForeignCurrenciesTranslationDetails" ], "lang": { "en-us": { "role": { "label": "Award Type [Axis]", "documentation": "Information by type of award under share-based payment arrangement." } } }, "auth_ref": [ "r301", "r302", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r323", "r324", "r325", "r326" ] }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BasisOfAccountingPolicyPolicyTextBlock", "presentation": [ "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Basis of presentation", "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)." } } }, "auth_ref": [] }, "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock", "presentation": [ "http://dswissbeauty.com/role/OrganizationAndBusinessBackground" ], "lang": { "en-us": { "role": { "label": "ORGANIZATION AND BUSINESS BACKGROUND", "documentation": "The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)." } } }, "auth_ref": [ "r78", "r105", "r106" ] }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://dswissbeauty.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://dswissbeauty.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Cash and cash equivalents", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r28", "r151", "r580" ] }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsPolicyTextBlock", "presentation": [ "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "verboseLabel": "Cash and cash equivalents", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value." } } }, "auth_ref": [ "r29" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "crdr": "debit", "presentation": [ "http://dswissbeauty.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "periodStartLabel": "Cash and cash equivalents, beginning of year", "periodEndLabel": "CASH AND CASH EQUIVALENTS, END OF YEAR", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r28", "r102", "r178" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://dswissbeauty.com/role/StatementsOfCashFlows": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://dswissbeauty.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net change in cash and cash equivalents", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r1", "r102" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems", "presentation": [ "http://dswissbeauty.com/role/FinanceLeaseLiabilitiesDetailsNarrative", "http://dswissbeauty.com/role/VieStructureAndArrangementsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r355" ] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockMember", "presentation": [ "http://dswissbeauty.com/role/StatementsOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Common Stock [Member]", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r597", "r598", "r599", "r601", "r602", "r603", "r604", "r643", "r644", "r657", "r674", "r678" ] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://dswissbeauty.com/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common stock, par value", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r84" ] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://dswissbeauty.com/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common stock, shares authorized", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r84", "r501" ] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesIssued", "presentation": [ "http://dswissbeauty.com/role/BalanceSheetsParenthetical", "http://dswissbeauty.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Common stock, shares issued", "verboseLabel": "Common stock shares issued", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r84" ] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://dswissbeauty.com/role/BalanceSheetsParenthetical", "http://dswissbeauty.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Common stock, shares outstanding", "verboseLabel": "Common stock shares outstanding", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r14", "r84", "r501", "r521", "r678", "r679" ] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://dswissbeauty.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://dswissbeauty.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Common stock, $0.0001 par value, 600,000,000 shares authorized, 206,904,585 shares and 206,904,585 shares issued and outstanding as of December 31, 2023 and 2022 respectively", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r84", "r451", "r595" ] }, "us-gaap_ComprehensiveIncomeNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNetOfTax", "crdr": "credit", "calculation": { "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome" ], "lang": { "en-us": { "role": { "totalLabel": "COMPREHENSIVE INCOME", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r27", "r163", "r165", "r171", "r445", "r461" ] }, "DQWS_ComputerAndSoftwareMember": { "xbrltype": "domainItemType", "nsuri": "http://dswissbeauty.com/20231231", "localname": "ComputerAndSoftwareMember", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfPlantAndEquipmentDetails", "http://dswissbeauty.com/role/ScheduleOfPropertyAndEquipmentUsefulLifeDetails" ], "lang": { "en-us": { "role": { "label": "Computer and Software [Member]", "documentation": "Computer and Software [Member]" } } }, "auth_ref": [] }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskBenchmarkDomain", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfConcentrationOfRiskDetails" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage." } } }, "auth_ref": [ "r34", "r36", "r71", "r72", "r233", "r566" ] }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskByBenchmarkAxis", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfConcentrationOfRiskDetails" ], "lang": { "en-us": { "role": { "label": "Concentration Risk Benchmark [Axis]", "documentation": "Information by benchmark of concentration risk." } } }, "auth_ref": [ "r34", "r36", "r71", "r72", "r233", "r477", "r566" ] }, "us-gaap_ConcentrationRiskByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskByTypeAxis", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfConcentrationOfRiskDetails" ], "lang": { "en-us": { "role": { "label": "Concentration Risk Type [Axis]", "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender." } } }, "auth_ref": [ "r34", "r36", "r71", "r72", "r233", "r566", "r630" ] }, "us-gaap_ConcentrationRiskDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskDisclosureTextBlock", "presentation": [ "http://dswissbeauty.com/role/ConcentrationsOfRisks" ], "lang": { "en-us": { "role": { "label": "CONCENTRATIONS OF RISKS", "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date." } } }, "auth_ref": [ "r106" ] }, "us-gaap_ConcentrationRiskLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskLineItems", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfConcentrationOfRiskDetails" ], "lang": { "en-us": { "role": { "label": "Concentration Risk [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r566" ] }, "us-gaap_ConcentrationRiskPercentage1": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskPercentage1", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfConcentrationOfRiskDetails" ], "lang": { "en-us": { "role": { "label": "Concentration risk, percentage", "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division." } } }, "auth_ref": [ "r34", "r36", "r71", "r72", "r233" ] }, "us-gaap_ConcentrationRiskTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskTable", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfConcentrationOfRiskDetails" ], "lang": { "en-us": { "role": { "label": "Concentration Risk [Table]", "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark." } } }, "auth_ref": [ "r33", "r34", "r36", "r37", "r71", "r119", "r566" ] }, "us-gaap_ConcentrationRiskTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskTypeDomain", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfConcentrationOfRiskDetails" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration." } } }, "auth_ref": [ "r34", "r36", "r71", "r72", "r233", "r566" ] }, "us-gaap_ConsolidationPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConsolidationPolicyTextBlock", "presentation": [ "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Basis of consolidation", "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary." } } }, "auth_ref": [ "r60", "r583" ] }, "us-gaap_CostOfGoodsAndServicesSold": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostOfGoodsAndServicesSold", "crdr": "debit", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfConcentrationOfRiskDetails" ], "lang": { "en-us": { "role": { "label": "Purchase", "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities." } } }, "auth_ref": [ "r98", "r440" ] }, "us-gaap_CostOfGoodsTotalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostOfGoodsTotalMember", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfConcentrationOfRiskDetails" ], "lang": { "en-us": { "role": { "label": "Cost of Goods and Service Benchmark [Member]", "documentation": "Cost of product sold and service rendered, when it serves as benchmark in concentration of risk calculation." } } }, "auth_ref": [ "r629" ] }, "us-gaap_CostOfRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostOfRevenue", "crdr": "debit", "calculation": { "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome": { "parentTag": "us-gaap_GrossProfit", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://dswissbeauty.com/role/ScheduleOfReportingSegmentsDetails", "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome" ], "lang": { "en-us": { "role": { "negatedLabel": "COST OF REVENUE", "negatedTerseLabel": "Cost of revenue", "label": "Cost of Revenue", "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period." } } }, "auth_ref": [ "r99", "r181", "r241", "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r386", "r649" ] }, "us-gaap_CostOfSalesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostOfSalesPolicyTextBlock", "presentation": [ "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Cost of revenue", "documentation": "Disclosure of accounting policy for cost of product sold and service rendered." } } }, "auth_ref": [ "r632" ] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CountryRegion", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "us-gaap_CurrentForeignTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CurrentForeignTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://dswissbeauty.com/role/ScheduleOfProvisionForIncomeTaxesDetails": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://dswissbeauty.com/role/ScheduleOfProvisionForIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "- Foreign", "label": "Current Foreign Tax Expense (Benefit)", "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations." } } }, "auth_ref": [ "r631", "r642" ] }, "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfProvisionForIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Current:" } } }, "auth_ref": [] }, "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CurrentStateAndLocalTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://dswissbeauty.com/role/ScheduleOfProvisionForIncomeTaxesDetails": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://dswissbeauty.com/role/ScheduleOfProvisionForIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "- Local", "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction." } } }, "auth_ref": [ "r631", "r642", "r656" ] }, "DQWS_CustomerAMember": { "xbrltype": "domainItemType", "nsuri": "http://dswissbeauty.com/20231231", "localname": "CustomerAMember", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfConcentrationOfRiskDetails" ], "lang": { "en-us": { "role": { "label": "Customer A [Member]", "documentation": "Customer A [Member]" } } }, "auth_ref": [] }, "DQWS_CustomerBMember": { "xbrltype": "domainItemType", "nsuri": "http://dswissbeauty.com/20231231", "localname": "CustomerBMember", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfConcentrationOfRiskDetails" ], "lang": { "en-us": { "role": { "label": "Customer B [Member]", "documentation": "Customer B [Member]" } } }, "auth_ref": [] }, "DQWS_CustomerCMember": { "xbrltype": "domainItemType", "nsuri": "http://dswissbeauty.com/20231231", "localname": "CustomerCMember", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfConcentrationOfRiskDetails" ], "lang": { "en-us": { "role": { "label": "Customer C [Member]", "documentation": "Customer C [Member]" } } }, "auth_ref": [] }, "us-gaap_CustomerConcentrationRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CustomerConcentrationRiskMember", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfConcentrationOfRiskDetails" ], "lang": { "en-us": { "role": { "label": "Customer Concentration Risk [Member]", "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer." } } }, "auth_ref": [ "r35", "r233" ] }, "DQWS_CustomerDMember": { "xbrltype": "domainItemType", "nsuri": "http://dswissbeauty.com/20231231", "localname": "CustomerDMember", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfConcentrationOfRiskDetails" ], "lang": { "en-us": { "role": { "label": "Customer D [Member]", "documentation": "Customer D [Member]" } } }, "auth_ref": [] }, "DQWS_CustomerEMember": { "xbrltype": "domainItemType", "nsuri": "http://dswissbeauty.com/20231231", "localname": "CustomerEMember", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfConcentrationOfRiskDetails" ], "lang": { "en-us": { "role": { "label": "Customer E [Member]", "documentation": "Customer E [Member]" } } }, "auth_ref": [] }, "DQWS_CustomersMember": { "xbrltype": "domainItemType", "nsuri": "http://dswissbeauty.com/20231231", "localname": "CustomersMember", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfConcentrationOfRiskDetails" ], "lang": { "en-us": { "role": { "label": "Customers [Member]", "documentation": "Customers [Member]" } } }, "auth_ref": [] }, "DQWS_DSwissBiotechMember": { "xbrltype": "domainItemType", "nsuri": "http://dswissbeauty.com/20231231", "localname": "DSwissBiotechMember", "presentation": [ "http://dswissbeauty.com/role/OrganizationAndBusinessBackgroundDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "DSwiss Biotech [Member]", "documentation": "D Swiss Biotech [Member]" } } }, "auth_ref": [] }, "DQWS_DSwissBiotechSdnBhdMember": { "xbrltype": "domainItemType", "nsuri": "http://dswissbeauty.com/20231231", "localname": "DSwissBiotechSdnBhdMember", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfVariableInterestEntityDetails" ], "lang": { "en-us": { "role": { "label": "DSwiss Biotech Sdn Bhd [Member]", "documentation": "DSwiss Biotech Sdn Bhd [Member]" } } }, "auth_ref": [] }, "DQWS_DSwissHKLimitedMember": { "xbrltype": "domainItemType", "nsuri": "http://dswissbeauty.com/20231231", "localname": "DSwissHKLimitedMember", "presentation": [ "http://dswissbeauty.com/role/IncomeTaxesDetailsNarrative", "http://dswissbeauty.com/role/OrganizationAndBusinessBackgroundDetailsNarrative", "http://dswissbeauty.com/role/ScheduleOfVariableInterestEntityDetails", "http://dswissbeauty.com/role/VieStructureAndArrangementsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "DSwiss (HK) Limited [Member]", "documentation": "D Swiss HK Limited [Member]" } } }, "auth_ref": [] }, "DQWS_DSwissHoldingLimitedMember": { "xbrltype": "domainItemType", "nsuri": "http://dswissbeauty.com/20231231", "localname": "DSwissHoldingLimitedMember", "presentation": [ "http://dswissbeauty.com/role/OrganizationAndBusinessBackgroundDetailsNarrative", "http://dswissbeauty.com/role/ScheduleOfVariableInterestEntityDetails" ], "lang": { "en-us": { "role": { "label": "DSwiss Holding Limited [Member]", "documentation": "D Swiss Holding Limited [Member]" } } }, "auth_ref": [] }, "DQWS_DSwissSdnBhdMember": { "xbrltype": "domainItemType", "nsuri": "http://dswissbeauty.com/20231231", "localname": "DSwissSdnBhdMember", "presentation": [ "http://dswissbeauty.com/role/OrganizationAndBusinessBackgroundDetailsNarrative", "http://dswissbeauty.com/role/ScheduleOfVariableInterestEntityDetails" ], "lang": { "en-us": { "role": { "label": "DSwiss Sdn Bhd [Member]", "documentation": "D Swiss Sdn Bhd [Member]" } } }, "auth_ref": [] }, "DQWS_DSwissSdnBhdandDSwissBiotechSdnBhdMember": { "xbrltype": "domainItemType", "nsuri": "http://dswissbeauty.com/20231231", "localname": "DSwissSdnBhdandDSwissBiotechSdnBhdMember", "presentation": [ "http://dswissbeauty.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "DSwiss Sdn Bhd and DSwiss Biotech Sdn Bhd [Member]", "documentation": "DSwiss Sdn Bhd and DSwiss Biotech Sdn Bhd [Member]" } } }, "auth_ref": [] }, "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "presentation": [ "http://dswissbeauty.com/role/OtherReceivablesPrepaidExpensesAndDepositsTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS", "documentation": "Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs." } } }, "auth_ref": [] }, "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredForeignIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://dswissbeauty.com/role/ScheduleOfProvisionForIncomeTaxesDetails": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://dswissbeauty.com/role/ScheduleOfProvisionForIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "- Foreign", "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations." } } }, "auth_ref": [ "r116", "r642", "r655" ] }, "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfProvisionForIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Deferred:" } } }, "auth_ref": [] }, "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://dswissbeauty.com/role/ScheduleOfProvisionForIncomeTaxesDetails": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://dswissbeauty.com/role/ScheduleOfProvisionForIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "- Local", "label": "Deferred State and Local Income Tax Expense (Benefit)", "documentation": "Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction." } } }, "auth_ref": [ "r642", "r655", "r656" ] }, "us-gaap_DeferredTaxAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsNet", "crdr": "debit", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfDeferredIncomeTaxAssetsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Deferred tax assets", "label": "Deferred Tax Assets, Net of Valuation Allowance", "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards." } } }, "auth_ref": [ "r653" ] }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsOperatingLossCarryforwards", "crdr": "debit", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfDeferredIncomeTaxAssetsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Net operating loss carry forwards", "label": "Deferred Tax Assets, Operating Loss Carryforwards", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards." } } }, "auth_ref": [ "r57", "r654" ] }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsValuationAllowance", "crdr": "credit", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfDeferredIncomeTaxAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Less: valuation allowance", "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized." } } }, "auth_ref": [ "r338" ] }, "us-gaap_DepositsAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DepositsAssets", "crdr": "debit", "calculation": { "http://dswissbeauty.com/role/ScheduleOfOtherReceivablesPrepaidExpensesAndDepositsDetails": { "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://dswissbeauty.com/role/ScheduleOfOtherReceivablesPrepaidExpensesAndDepositsDetails" ], "lang": { "en-us": { "role": { "label": "Deposits", "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment in the future." } } }, "auth_ref": [ "r633" ] }, "us-gaap_Depreciation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Depreciation", "crdr": "debit", "presentation": [ "http://dswissbeauty.com/role/PropertyAndEquipmentDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Depreciation expense", "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation." } } }, "auth_ref": [ "r7", "r51" ] }, "us-gaap_DepreciationAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DepreciationAndAmortization", "crdr": "debit", "calculation": { "http://dswissbeauty.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://dswissbeauty.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Depreciation and amortization", "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production." } } }, "auth_ref": [ "r7", "r51" ] }, "us-gaap_DepreciationDepletionAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DepreciationDepletionAndAmortization", "crdr": "debit", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfReportingSegmentsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Depreciation and amortization", "label": "Depreciation, Depletion and Amortization", "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets." } } }, "auth_ref": [ "r7", "r215" ] }, "DQWS_DisclosureFinanceLeaseLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://dswissbeauty.com/20231231", "localname": "DisclosureFinanceLeaseLiabilitiesAbstract", "lang": { "en-us": { "role": { "label": "Finance Lease Liabilities", "verboseLabel": "Schedule Of Obligation Under Finance Lease", "terseLabel": "Schedule Of Maturities Of Finance Lease" } } }, "auth_ref": [] }, "DQWS_DisclosureGoingConcernUncertaintiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://dswissbeauty.com/20231231", "localname": "DisclosureGoingConcernUncertaintiesAbstract", "lang": { "en-us": { "role": { "label": "Going Concern Uncertainties" } } }, "auth_ref": [] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAccountingStandard", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r621" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r619", "r621", "r622" ] }, "dei_DocumentFinStmtErrorCorrectionFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFinStmtErrorCorrectionFlag", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Financial Statement Error Correction [Flag]", "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction." } } }, "auth_ref": [ "r619", "r621", "r622", "r624" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodStartDate", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r620" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r608" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r621" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyReport", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r621" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r623" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r611" ] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareBasic", "presentation": [ "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Net loss per share - basic", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r172", "r190", "r191", "r192", "r193", "r194", "r199", "r201", "r203", "r204", "r205", "r206", "r381", "r382", "r446", "r462", "r586" ] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareDiluted", "presentation": [ "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Net loss per share - diluted", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r172", "r190", "r191", "r192", "r193", "r194", "r201", "r203", "r204", "r205", "r206", "r381", "r382", "r446", "r462", "r586" ] }, "us-gaap_EarningsPerSharePolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerSharePolicyTextBlock", "presentation": [ "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Net profit per share", "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements." } } }, "auth_ref": [ "r31", "r32" ] }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "crdr": "debit", "calculation": { "http://dswissbeauty.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://dswissbeauty.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Effect of exchange rate changes on cash and cash equivalents", "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r659" ] }, "DQWS_EffectOfTranslationExchange": { "xbrltype": "monetaryItemType", "nsuri": "http://dswissbeauty.com/20231231", "localname": "EffectOfTranslationExchange", "crdr": "credit", "calculation": { "http://dswissbeauty.com/role/ScheduleOfPlantAndEquipmentDetails": { "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://dswissbeauty.com/role/ScheduleOfPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Effect of translation exchange", "documentation": "Effect of translation exchange.", "label": "EffectOfTranslationExchange" } } }, "auth_ref": [] }, "DQWS_EffectOfTranslationExchangeOfOperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://dswissbeauty.com/20231231", "localname": "EffectOfTranslationExchangeOfOperatingLeaseLiability", "crdr": "debit", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfOperatingLeaseLiabilityDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Effect of translation exchange", "documentation": "Effect of translation exchange of operating lease liability.", "label": "EffectOfTranslationExchangeOfOperatingLeaseLiability" } } }, "auth_ref": [] }, "DQWS_EffectOfTranslationExchangeOperatingLeaseRightOfUseAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://dswissbeauty.com/20231231", "localname": "EffectOfTranslationExchangeOperatingLeaseRightOfUseAsset", "crdr": "debit", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfOperationLeaseRightOfUseAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Effect of translation exchange", "documentation": "Effect of translation exchange of operating lease right of use asset." } } }, "auth_ref": [] }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateContinuingOperations", "presentation": [ "http://dswissbeauty.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Income tax rate", "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r334" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "presentation": [ "http://dswissbeauty.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Statutory income tax, rate", "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss)." } } }, "auth_ref": [ "r182", "r334", "r348" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r614" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r610" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityDomain", "presentation": [ "http://dswissbeauty.com/role/IncomeTaxesDetailsNarrative", "http://dswissbeauty.com/role/ScheduleOfVariableInterestEntityDetails", "http://dswissbeauty.com/role/VieStructureAndArrangementsDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r610" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r628" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r610" ] }, "dei_EntityIncorporationDateOfIncorporation": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationDateOfIncorporation", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfVariableInterestEntityDetails" ], "lang": { "en-us": { "role": { "label": "Date of incorporation", "documentation": "Date when an entity was incorporated" } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r625" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPrimarySicNumber", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r622" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r610" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r610" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r610" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r610" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r626" ] }, "us-gaap_EquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityAbstract", "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityComponentDomain", "presentation": [ "http://dswissbeauty.com/role/StatementsOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r14", "r144", "r167", "r168", "r169", "r183", "r184", "r185", "r187", "r195", "r197", "r207", "r245", "r251", "r286", "r327", "r328", "r329", "r344", "r345", "r363", "r365", "r366", "r367", "r368", "r370", "r380", "r392", "r393", "r394", "r395", "r396", "r397", "r425", "r467", "r468", "r469", "r487", "r545" ] }, "srt_EquityMethodInvesteeNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "EquityMethodInvesteeNameDomain", "presentation": [ "http://dswissbeauty.com/role/OrganizationAndBusinessBackgroundDetailsNarrative" ], "auth_ref": [ "r238", "r239", "r240" ] }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityMethodInvestmentOwnershipPercentage", "presentation": [ "http://dswissbeauty.com/role/OrganizationAndBusinessBackgroundDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Equity ownership interest rate percentage", "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting." } } }, "auth_ref": [ "r238" ] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Extension", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueOfFinancialInstrumentsPolicy", "presentation": [ "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Fair value of financial instruments:", "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments." } } }, "auth_ref": [ "r9", "r15" ] }, "DQWS_FinanceExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://dswissbeauty.com/20231231", "localname": "FinanceExpenses", "crdr": "debit", "calculation": { "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome" ], "lang": { "en-us": { "role": { "negatedLabel": "FINANCE COST", "documentation": "Finance expenses.", "label": "FinanceExpenses" } } }, "auth_ref": [] }, "us-gaap_FinanceLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseLiability", "crdr": "credit", "calculation": { "http://dswissbeauty.com/role/ScheduleOfMaturitiesOfFinanceLeaseDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://dswissbeauty.com/role/ScheduleOfMaturitiesOfFinanceLeaseDetails", "http://dswissbeauty.com/role/ScheduleOfObligationUnderFinanceLeaseDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total", "label": "Finance Lease, Liability", "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease." } } }, "auth_ref": [ "r409", "r418" ] }, "us-gaap_FinanceLeaseLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseLiabilityCurrent", "crdr": "credit", "calculation": { "http://dswissbeauty.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://dswissbeauty.com/role/BalanceSheets", "http://dswissbeauty.com/role/ScheduleOfObligationUnderFinanceLeaseDetails" ], "lang": { "en-us": { "role": { "label": "Finance lease liability", "verboseLabel": "Current portion", "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current." } } }, "auth_ref": [ "r409" ] }, "us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseLiabilityMaturityTableTextBlock", "presentation": [ "http://dswissbeauty.com/role/FinanceLeaseLiabilitiesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF MATURITIES OF FINANCE LEASE", "documentation": "Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position." } } }, "auth_ref": [ "r661" ] }, "us-gaap_FinanceLeaseLiabilityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseLiabilityNoncurrent", "crdr": "credit", "calculation": { "http://dswissbeauty.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://dswissbeauty.com/role/BalanceSheets", "http://dswissbeauty.com/role/ScheduleOfObligationUnderFinanceLeaseDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Finance lease liability", "label": "Non-current portion", "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent." } } }, "auth_ref": [ "r409" ] }, "us-gaap_FinanceLeaseLiabilityPaymentsDue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseLiabilityPaymentsDue", "crdr": "credit", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfObligationUnderFinanceLeaseDetails" ], "lang": { "en-us": { "role": { "label": "Finance leases", "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease." } } }, "auth_ref": [ "r418" ] }, "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths", "crdr": "credit", "calculation": { "http://dswissbeauty.com/role/ScheduleOfMaturitiesOfFinanceLeaseDetails": { "parentTag": "us-gaap_FinanceLeaseLiability", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://dswissbeauty.com/role/ScheduleOfMaturitiesOfFinanceLeaseDetails" ], "lang": { "en-us": { "role": { "label": "2024", "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r418" ] }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseLiabilityPaymentsDueYearThree", "crdr": "credit", "calculation": { "http://dswissbeauty.com/role/ScheduleOfMaturitiesOfFinanceLeaseDetails": { "parentTag": "us-gaap_FinanceLeaseLiability", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://dswissbeauty.com/role/ScheduleOfMaturitiesOfFinanceLeaseDetails" ], "lang": { "en-us": { "role": { "label": "2026", "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r418" ] }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo", "crdr": "credit", "calculation": { "http://dswissbeauty.com/role/ScheduleOfMaturitiesOfFinanceLeaseDetails": { "parentTag": "us-gaap_FinanceLeaseLiability", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://dswissbeauty.com/role/ScheduleOfMaturitiesOfFinanceLeaseDetails" ], "lang": { "en-us": { "role": { "label": "2025", "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r418" ] }, "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount", "crdr": "credit", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfObligationUnderFinanceLeaseDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Less: interest expense", "label": "Finance Lease, Liability, Undiscounted Excess Amount", "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease." } } }, "auth_ref": [ "r418" ] }, "us-gaap_FinanceLeasePrincipalPayments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeasePrincipalPayments", "crdr": "credit", "calculation": { "http://dswissbeauty.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://dswissbeauty.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Repayment of finance lease", "label": "Finance Lease, Principal Payments", "documentation": "Amount of cash outflow for principal payment on finance lease." } } }, "auth_ref": [ "r410", "r414" ] }, "us-gaap_FiniteLivedIntangibleAssetUsefulLife": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetUsefulLife", "presentation": [ "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Intangible asset, useful life", "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "crdr": "credit", "calculation": { "http://dswissbeauty.com/role/ScheduleOfIntangibleAssetsDetails": { "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://dswissbeauty.com/role/ScheduleOfIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Amortization", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r154", "r258" ] }, "us-gaap_FiniteLivedTrademarksGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedTrademarksGross", "crdr": "debit", "calculation": { "http://dswissbeauty.com/role/ScheduleOfIntangibleAssetsDetails": { "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://dswissbeauty.com/role/ScheduleOfIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Trademarks", "documentation": "Gross carrying amount before accumulated amortization as of the balance sheet date for the rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style for a specified period of time." } } }, "auth_ref": [ "r108" ] }, "DQWS_FirstFinanceLeaseAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://dswissbeauty.com/20231231", "localname": "FirstFinanceLeaseAgreementMember", "presentation": [ "http://dswissbeauty.com/role/FinanceLeaseLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "First Finance Lease Agreement [Member]", "documentation": "First Finance Lease Agreement [Member]" } } }, "auth_ref": [] }, "us-gaap_ForeignCurrencyExchangeRateTranslation1": { "xbrltype": "pureItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignCurrencyExchangeRateTranslation1", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfForeignCurrenciesTranslationDetails" ], "lang": { "en-us": { "role": { "label": "Foreign currency exchange rate, translation", "documentation": "Foreign exchange rate used to translate amounts denominated in functional currency to reporting currency." } } }, "auth_ref": [ "r398", "r399" ] }, "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock", "presentation": [ "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Foreign currencies translation", "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy." } } }, "auth_ref": [ "r391" ] }, "us-gaap_FurnitureAndFixturesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FurnitureAndFixturesMember", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfPlantAndEquipmentDetails", "http://dswissbeauty.com/role/ScheduleOfPropertyAndEquipmentUsefulLifeDetails" ], "lang": { "en-us": { "role": { "label": "Furniture and Fixtures [Member]", "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases." } } }, "auth_ref": [] }, "DQWS_GoingConcernUncertaintiesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://dswissbeauty.com/20231231", "localname": "GoingConcernUncertaintiesTextBlock", "presentation": [ "http://dswissbeauty.com/role/GoingConcernUncertainties" ], "lang": { "en-us": { "role": { "label": "GOING CONCERN UNCERTAINTIES", "documentation": "Going Concern Uncertainties [Text Block]" } } }, "auth_ref": [] }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_GrossProfit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GrossProfit", "crdr": "credit", "calculation": { "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome" ], "lang": { "en-us": { "role": { "totalLabel": "GROSS PROFIT", "label": "Gross Profit", "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity." } } }, "auth_ref": [ "r97", "r181", "r212", "r219", "r224", "r227", "r241", "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r386", "r588", "r649" ] }, "country_HK": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "HK", "presentation": [ "http://dswissbeauty.com/role/OrganizationAndBusinessBackgroundDetailsNarrative", "http://dswissbeauty.com/role/ScheduleOfComponentsOfIncomeLossBeforeIncomeTaxesDetails", "http://dswissbeauty.com/role/ScheduleOfReportingSegmentsDetails" ], "lang": { "en-us": { "role": { "label": "HONG KONG" } } }, "auth_ref": [] }, "DQWS_HongKongMember": { "xbrltype": "domainItemType", "nsuri": "http://dswissbeauty.com/20231231", "localname": "HongKongMember", "presentation": [ "http://dswissbeauty.com/role/IncomeTaxesDetailsNarrative", "http://dswissbeauty.com/role/ScheduleOfDeferredIncomeTaxAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Hong Kong [Member]", "documentation": "Hong Kong [Member]" } } }, "auth_ref": [] }, "us-gaap_ImpairmentOfIntangibleAssetsFinitelived": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ImpairmentOfIntangibleAssetsFinitelived", "crdr": "debit", "presentation": [ "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Impairment loss", "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value." } } }, "auth_ref": [ "r640", "r647" ] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "crdr": "credit", "calculation": { "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 1.0 }, "http://dswissbeauty.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://dswissbeauty.com/role/ScheduleOfComponentsOfIncomeLossBeforeIncomeTaxesDetails", "http://dswissbeauty.com/role/ScheduleOfReportingSegmentsDetails", "http://dswissbeauty.com/role/StatementsOfCashFlows", "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome" ], "lang": { "en-us": { "role": { "totalLabel": "LOSS BEFORE INCOME TAX", "label": "Loss before tax", "verboseLabel": "Loss before income tax", "terseLabel": "Net (loss) / profit before taxation", "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r0", "r95", "r123", "r212", "r219", "r224", "r227", "r447", "r459", "r588" ] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxAuthorityNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxAuthorityNameAxis", "presentation": [ "http://dswissbeauty.com/role/IncomeTaxesDetailsNarrative", "http://dswissbeauty.com/role/ScheduleOfDeferredIncomeTaxAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Income Tax Authority, Name [Axis]", "documentation": "Information by name of taxing authority." } } }, "auth_ref": [ "r11" ] }, "us-gaap_IncomeTaxAuthorityNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxAuthorityNameDomain", "presentation": [ "http://dswissbeauty.com/role/IncomeTaxesDetailsNarrative", "http://dswissbeauty.com/role/ScheduleOfDeferredIncomeTaxAssetsDetails" ], "lang": { "en-us": { "role": { "documentation": "Named agency, division or body that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes." } } }, "auth_ref": [] }, "us-gaap_IncomeTaxDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureTextBlock", "presentation": [ "http://dswissbeauty.com/role/IncomeTaxes" ], "lang": { "en-us": { "role": { "label": "INCOME TAXES", "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information." } } }, "auth_ref": [ "r182", "r330", "r335", "r336", "r340", "r346", "r349", "r350", "r351", "r482" ] }, "us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxExaminationLikelihoodOfUnfavorableSettlement", "presentation": [ "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Largest amount of tax benefit, description", "documentation": "Description of the likelihood that an uncertainty in income taxes will not be sustained as a result of the examination by the taxing authority." } } }, "auth_ref": [ "r53", "r115" ] }, "us-gaap_IncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome": { "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0, "order": 2.0 }, "http://dswissbeauty.com/role/ScheduleOfProvisionForIncomeTaxesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://dswissbeauty.com/role/ScheduleOfProvisionForIncomeTaxesDetails", "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome" ], "lang": { "en-us": { "role": { "negatedLabel": "INCOME TAXES PROVISION", "negatedTotalLabel": "Income tax expense", "label": "Income Tax Expense (Benefit)", "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r131", "r140", "r196", "r197", "r216", "r333", "r347", "r463" ] }, "us-gaap_IncomeTaxPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxPolicyTextBlock", "presentation": [ "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Income taxes", "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements." } } }, "auth_ref": [ "r166", "r331", "r332", "r336", "r337", "r339", "r341", "r479" ] }, "us-gaap_IncomeTaxesPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxesPaidNet", "crdr": "credit", "presentation": [ "http://dswissbeauty.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Income taxes paid", "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes." } } }, "auth_ref": [ "r30" ] }, "us-gaap_IncomeTaxesReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxesReceivable", "crdr": "debit", "calculation": { "http://dswissbeauty.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://dswissbeauty.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Tax recoverable", "documentation": "Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes." } } }, "auth_ref": [ "r76", "r634" ] }, "us-gaap_IncreaseDecreaseInAccountsPayableTrade": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsPayableTrade", "crdr": "debit", "calculation": { "http://dswissbeauty.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://dswissbeauty.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Accounts payable", "label": "Increase (Decrease) in Accounts Payable, Trade", "documentation": "Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services." } } }, "auth_ref": [ "r6" ] }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsReceivable", "crdr": "credit", "calculation": { "http://dswissbeauty.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://dswissbeauty.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Accounts receivable", "label": "Increase (Decrease) in Accounts Receivable", "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services." } } }, "auth_ref": [ "r6" ] }, "us-gaap_IncreaseDecreaseInInventories": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInInventories", "crdr": "credit", "calculation": { "http://dswissbeauty.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://dswissbeauty.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Inventories", "label": "Increase (Decrease) in Inventories", "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities." } } }, "auth_ref": [ "r6" ] }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "presentation": [ "http://dswissbeauty.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Changes in operating assets and liabilities:" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities", "crdr": "debit", "calculation": { "http://dswissbeauty.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://dswissbeauty.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Other payables and accrued liabilities", "label": "Increase (Decrease) in Other Accounts Payable and Accrued Liabilities", "documentation": "The increase (decrease) during the reporting period in other obligations or expenses incurred but not yet paid." } } }, "auth_ref": [ "r6" ] }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "crdr": "credit", "calculation": { "http://dswissbeauty.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": -1.0, "order": 8.0 } }, "presentation": [ "http://dswissbeauty.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Other receivables, prepaid expenses, and deposit", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other." } } }, "auth_ref": [ "r6" ] }, "DQWS_IncreaseDecreaseInReductionInLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://dswissbeauty.com/20231231", "localname": "IncreaseDecreaseInReductionInLeaseLiability", "crdr": "debit", "calculation": { "http://dswissbeauty.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://dswissbeauty.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Reduction in lease liability", "documentation": "Increase decrease in reduction in lease liability." } } }, "auth_ref": [] }, "us-gaap_IntangibleAssetsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IntangibleAssetsDisclosureTextBlock", "presentation": [ "http://dswissbeauty.com/role/IntangibleAssets" ], "lang": { "en-us": { "role": { "label": "INTANGIBLE ASSETS", "documentation": "The entire disclosure for all or part of the information related to intangible assets." } } }, "auth_ref": [ "r257" ] }, "DQWS_IntangibleAssetsEffectOfTranslationExchange": { "xbrltype": "monetaryItemType", "nsuri": "http://dswissbeauty.com/20231231", "localname": "IntangibleAssetsEffectOfTranslationExchange", "crdr": "credit", "calculation": { "http://dswissbeauty.com/role/ScheduleOfIntangibleAssetsDetails": { "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://dswissbeauty.com/role/ScheduleOfIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Effect of translation exchange", "documentation": "Intangible assets, Effect of translation exchange.", "label": "IntangibleAssetsEffectOfTranslationExchange" } } }, "auth_ref": [] }, "us-gaap_IntangibleAssetsFiniteLivedPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IntangibleAssetsFiniteLivedPolicy", "presentation": [ "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Intangible assets", "documentation": "Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets." } } }, "auth_ref": [ "r49", "r437", "r438", "r439", "r441", "r584" ] }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IntangibleAssetsNetExcludingGoodwill", "crdr": "debit", "calculation": { "http://dswissbeauty.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0, "order": 2.0 }, "http://dswissbeauty.com/role/ScheduleOfIntangibleAssetsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://dswissbeauty.com/role/BalanceSheets", "http://dswissbeauty.com/role/ScheduleOfIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Intangible assets, net", "totalLabel": "Intangible assets, net", "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges." } } }, "auth_ref": [ "r46", "r48" ] }, "us-gaap_InterestPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestPaidNet", "crdr": "credit", "presentation": [ "http://dswissbeauty.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Interest paid", "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount." } } }, "auth_ref": [ "r174", "r176", "r177" ] }, "us-gaap_InventoryDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Inventory Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_InventoryDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryDisclosureTextBlock", "presentation": [ "http://dswissbeauty.com/role/Inventories" ], "lang": { "en-us": { "role": { "label": "INVENTORIES", "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory." } } }, "auth_ref": [ "r252" ] }, "us-gaap_InventoryFinishedGoods": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryFinishedGoods", "crdr": "debit", "calculation": { "http://dswissbeauty.com/role/ScheduleOfInventoriesDetails": { "parentTag": "us-gaap_InventoryNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://dswissbeauty.com/role/ScheduleOfInventoriesDetails" ], "lang": { "en-us": { "role": { "label": "Finished goods, at cost", "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer." } } }, "auth_ref": [ "r635" ] }, "us-gaap_InventoryNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryNet", "crdr": "debit", "calculation": { "http://dswissbeauty.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 5.0 }, "http://dswissbeauty.com/role/ScheduleOfInventoriesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://dswissbeauty.com/role/BalanceSheets", "http://dswissbeauty.com/role/ScheduleOfInventoriesDetails" ], "lang": { "en-us": { "role": { "label": "Inventories", "totalLabel": "Total inventories", "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer." } } }, "auth_ref": [ "r159", "r581", "r595" ] }, "us-gaap_InventoryPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryPolicyTextBlock", "presentation": [ "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "verboseLabel": "Inventories", "label": "Inventory, Policy [Policy Text Block]", "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost." } } }, "auth_ref": [ "r132", "r150", "r158", "r252", "r253", "r254", "r436", "r585" ] }, "us-gaap_LeasesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeasesAbstract", "lang": { "en-us": { "role": { "label": "Leases [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LeasesOfLesseeDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeasesOfLesseeDisclosureTextBlock", "presentation": [ "http://dswissbeauty.com/role/LeaseRight-of-useAssetAndLeaseLiabilities" ], "lang": { "en-us": { "role": { "label": "LEASE RIGHT-OF-USE ASSET AND LEASE LIABILITIES", "documentation": "The entire disclosure for lessee entity's leasing arrangements including, but not limited to, all of the following: (a.) The basis on which contingent rental payments are determined, (b.) The existence and terms of renewal or purchase options and escalation clauses, (c.) Restrictions imposed by lease agreements, such as those concerning dividends, additional debt, and further leasing." } } }, "auth_ref": [ "r126" ] }, "dei_LegalEntityAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LegalEntityAxis", "presentation": [ "http://dswissbeauty.com/role/IncomeTaxesDetailsNarrative", "http://dswissbeauty.com/role/ScheduleOfVariableInterestEntityDetails", "http://dswissbeauty.com/role/VieStructureAndArrangementsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Legal Entity [Axis]", "documentation": "The set of legal entities associated with a report." } } }, "auth_ref": [] }, "us-gaap_LesseeFinanceLeaseDescription": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeFinanceLeaseDescription", "presentation": [ "http://dswissbeauty.com/role/FinanceLeaseLiabilitiesDetailsNarrative", "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Finance lease, description", "documentation": "Description of lessee's finance lease." } } }, "auth_ref": [ "r413" ] }, "us-gaap_LesseeFinanceLeasesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeFinanceLeasesTextBlock", "presentation": [ "http://dswissbeauty.com/role/FinanceLeaseLiabilities" ], "lang": { "en-us": { "role": { "label": "FINANCE LEASE LIABILITIES", "documentation": "The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability." } } }, "auth_ref": [ "r407" ] }, "us-gaap_LesseeLeasesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeLeasesPolicyTextBlock", "presentation": [ "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Leases", "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee." } } }, "auth_ref": [ "r412" ] }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "crdr": "credit", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfOperatingLeaseLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "Add: imputed interest", "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease." } } }, "auth_ref": [ "r418" ] }, "us-gaap_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://dswissbeauty.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://dswissbeauty.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "TOTAL LIABILITIES", "label": "Liabilities", "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future." } } }, "auth_ref": [ "r20", "r181", "r241", "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r357", "r358", "r359", "r386", "r500", "r587", "r607", "r649", "r663", "r664" ] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://dswissbeauty.com/role/BalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://dswissbeauty.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "TOTAL LIABILITIES AND STOCKHOLDERS\u2019 EQUITY", "label": "Liabilities and Equity", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r89", "r122", "r455", "r595", "r641", "r646", "r658" ] }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquityAbstract", "presentation": [ "http://dswissbeauty.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrent", "crdr": "credit", "calculation": { "http://dswissbeauty.com/role/BalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://dswissbeauty.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total current liabilities", "label": "Liabilities, Current", "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer." } } }, "auth_ref": [ "r22", "r149", "r181", "r241", "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r357", "r358", "r359", "r386", "r595", "r649", "r663", "r664" ] }, "us-gaap_LiabilitiesCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrentAbstract", "presentation": [ "http://dswissbeauty.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "CURRENT LIABILITIES" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesNoncurrent", "crdr": "credit", "calculation": { "http://dswissbeauty.com/role/BalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://dswissbeauty.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total non-current liability", "label": "Liabilities, Noncurrent", "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer." } } }, "auth_ref": [ "r17", "r79", "r80", "r81", "r82", "r181", "r241", "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r357", "r358", "r359", "r386", "r649", "r663", "r664" ] }, "us-gaap_LiabilitiesNoncurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesNoncurrentAbstract", "presentation": [ "http://dswissbeauty.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "NON-CURRENT LIABILITY" } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "country_MY": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "MY", "presentation": [ "http://dswissbeauty.com/role/OrganizationAndBusinessBackgroundDetailsNarrative", "http://dswissbeauty.com/role/ScheduleOfComponentsOfIncomeLossBeforeIncomeTaxesDetails", "http://dswissbeauty.com/role/ScheduleOfReportingSegmentsDetails" ], "lang": { "en-us": { "role": { "label": "MALAYSIA" } } }, "auth_ref": [] }, "srt_MajorCustomersAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MajorCustomersAxis", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfConcentrationOfRiskDetails" ], "lang": { "en-us": { "role": { "label": "Customer [Axis]" } } }, "auth_ref": [ "r233", "r592", "r652", "r672", "r673" ] }, "DQWS_MalaysiaMember": { "xbrltype": "domainItemType", "nsuri": "http://dswissbeauty.com/20231231", "localname": "MalaysiaMember", "presentation": [ "http://dswissbeauty.com/role/IncomeTaxesDetailsNarrative", "http://dswissbeauty.com/role/ScheduleOfDeferredIncomeTaxAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Malaysia [Member]", "documentation": "Malaysia [Member]" } } }, "auth_ref": [] }, "DQWS_ManagementServicesAgreementIMember": { "xbrltype": "domainItemType", "nsuri": "http://dswissbeauty.com/20231231", "localname": "ManagementServicesAgreementIMember", "presentation": [ "http://dswissbeauty.com/role/VieStructureAndArrangementsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Management Services Agreement I [Member]", "documentation": "Management Services Agreement I [Member]" } } }, "auth_ref": [] }, "srt_MaximumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MaximumMember", "presentation": [ "http://dswissbeauty.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]" } } }, "auth_ref": [ "r260", "r261", "r262", "r263", "r298", "r435", "r464", "r492", "r493", "r552", "r554", "r556", "r557", "r559", "r576", "r577", "r589", "r590", "r593", "r596", "r651", "r665", "r666", "r667", "r668", "r669", "r670" ] }, "srt_MinimumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MinimumMember", "presentation": [ "http://dswissbeauty.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]" } } }, "auth_ref": [ "r260", "r261", "r262", "r263", "r298", "r435", "r464", "r492", "r493", "r552", "r554", "r556", "r557", "r559", "r576", "r577", "r589", "r590", "r593", "r596", "r651", "r665", "r666", "r667", "r668", "r669", "r670" ] }, "us-gaap_MinorityInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MinorityInterest", "crdr": "credit", "calculation": { "http://dswissbeauty.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://dswissbeauty.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "NON-CONTROLLING INTEREST", "documentation": "Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity." } } }, "auth_ref": [ "r24", "r121", "r181", "r241", "r264", "r266", "r267", "r268", "r271", "r272", "r386", "r454", "r503" ] }, "us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MinorityInterestOwnershipPercentageByNoncontrollingOwners", "presentation": [ "http://dswissbeauty.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Ownership percentage", "documentation": "The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity." } } }, "auth_ref": [] }, "us-gaap_MinorityInterestOwnershipPercentageByParent": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MinorityInterestOwnershipPercentageByParent", "presentation": [ "http://dswissbeauty.com/role/VieStructureAndArrangementsDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Equity ownership interest rate percentage", "label": "Subsidiary, Ownership Percentage, Parent", "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage." } } }, "auth_ref": [] }, "DQWS_MotorVehiclesMember": { "xbrltype": "domainItemType", "nsuri": "http://dswissbeauty.com/20231231", "localname": "MotorVehiclesMember", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfPlantAndEquipmentDetails", "http://dswissbeauty.com/role/ScheduleOfPropertyAndEquipmentUsefulLifeDetails" ], "lang": { "en-us": { "role": { "label": "Motor Vehicles [Member]", "documentation": "Motor Vehicles [Member]" } } }, "auth_ref": [] }, "DQWS_NVMember": { "xbrltype": "domainItemType", "nsuri": "http://dswissbeauty.com/20231231", "localname": "NVMember", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfReportingSegmentsDetails" ], "lang": { "en-us": { "role": { "label": "NV [Member]", "documentation": "NV [Member]" } } }, "auth_ref": [] }, "srt_NameOfMajorCustomerDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "NameOfMajorCustomerDomain", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfConcentrationOfRiskDetails" ], "auth_ref": [ "r233", "r592", "r652", "r672", "r673" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://dswissbeauty.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://dswissbeauty.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in financing activities", "label": "Net Cash Provided by (Used in) Financing Activities", "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit." } } }, "auth_ref": [ "r175" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "presentation": [ "http://dswissbeauty.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "CASH FLOWS FROM FINANCING ACTIVITIES:" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://dswissbeauty.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://dswissbeauty.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in investing activities", "label": "Net Cash Provided by (Used in) Investing Activities", "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets." } } }, "auth_ref": [ "r175" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "presentation": [ "http://dswissbeauty.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "CASH FLOWS FROM INVESTING ACTIVITIES:" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://dswissbeauty.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://dswissbeauty.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash generated from operating activities", "label": "Net Cash Provided by (Used in) Operating Activities", "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r102", "r103", "r104" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://dswissbeauty.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "CASH FLOWS FROM OPERATING ACTIVITIES:" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "calculation": { "http://dswissbeauty.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://dswissbeauty.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Cash generated from operating activities", "label": "Net Cash Provided by (Used in) Operating Activities, Continuing Operations", "documentation": "Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r102", "r103", "r104" ] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLoss", "crdr": "credit", "calculation": { "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://dswissbeauty.com/role/StatementsOfChangesInStockholdersEquity", "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome" ], "lang": { "en-us": { "role": { "totalLabel": "NET LOSS", "label": "Net gain (loss)", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r96", "r104", "r124", "r147", "r162", "r164", "r169", "r181", "r186", "r190", "r191", "r192", "r193", "r196", "r197", "r202", "r212", "r219", "r224", "r227", "r241", "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r382", "r386", "r460", "r523", "r543", "r544", "r588", "r605", "r649" ] }, "DQWS_NetIncomeLossAttributableToMinorityInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://dswissbeauty.com/20231231", "localname": "NetIncomeLossAttributableToMinorityInterest", "crdr": "debit", "calculation": { "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome" ], "lang": { "en-us": { "role": { "negatedLabel": "Non-Controlling Interests", "documentation": "Net income loss attributable to minority interest.", "label": "NetIncomeLossAttributableToMinorityInterest" } } }, "auth_ref": [] }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "presentation": [ "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Recently Adopted Accounting Standards", "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact." } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "DQWS_NoncontrollingInterestChangesInOwnershipInterestsInAssociate": { "xbrltype": "monetaryItemType", "nsuri": "http://dswissbeauty.com/20231231", "localname": "NoncontrollingInterestChangesInOwnershipInterestsInAssociate", "crdr": "credit", "presentation": [ "http://dswissbeauty.com/role/StatementsOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Changes in ownership interests in an associate", "documentation": "Noncontrolling interest changes in ownership interests in associate." } } }, "auth_ref": [] }, "us-gaap_NoncontrollingInterestMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NoncontrollingInterestMember", "presentation": [ "http://dswissbeauty.com/role/StatementsOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Noncontrolling Interest [Member]", "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest." } } }, "auth_ref": [ "r58", "r286", "r643", "r644", "r645", "r678" ] }, "us-gaap_OfficeEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OfficeEquipmentMember", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfPlantAndEquipmentDetails", "http://dswissbeauty.com/role/ScheduleOfPropertyAndEquipmentUsefulLifeDetails" ], "lang": { "en-us": { "role": { "label": "Office Equipment [Member]", "documentation": "Tangible personal property used in an office setting. Examples include, but are not limited to, computers, copiers and fax machine." } } }, "auth_ref": [] }, "us-gaap_OperatingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingIncomeLoss", "crdr": "credit", "calculation": { "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "OPERATING EXPENSES", "documentation": "The net result for the period of deducting operating expenses from operating revenues." } } }, "auth_ref": [ "r212", "r219", "r224", "r227", "r588" ] }, "us-gaap_OperatingLeaseExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseExpense", "crdr": "debit", "calculation": { "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome" ], "lang": { "en-us": { "role": { "negatedLabel": "LEASE EXPENSES", "label": "Operating Lease, Expense", "documentation": "Amount of operating lease expense. Excludes sublease income." } } }, "auth_ref": [ "r660" ] }, "us-gaap_OperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiability", "crdr": "credit", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfOperatingLeaseLiabilityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Operating lease liability, beginning", "periodEndLabel": "Operating lease liability, ending", "label": "Operating Lease, Liability", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease." } } }, "auth_ref": [ "r409" ] }, "us-gaap_OperatingLeaseLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilityCurrent", "crdr": "credit", "calculation": { "http://dswissbeauty.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://dswissbeauty.com/role/BalanceSheets", "http://dswissbeauty.com/role/ScheduleOfOperatingLeaseLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "Operating lease liability", "negatedLabel": "Less: lease liability current portion", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current." } } }, "auth_ref": [ "r409" ] }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilityNoncurrent", "crdr": "credit", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfOperatingLeaseLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "Lease liability non-current portion", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent." } } }, "auth_ref": [ "r409" ] }, "us-gaap_OperatingLeasePayments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeasePayments", "crdr": "credit", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfOperatingLeaseLiabilityDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Less: gross repayment", "label": "Operating Lease, Payments", "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use." } } }, "auth_ref": [ "r411", "r414" ] }, "us-gaap_OperatingLeaseRightOfUseAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseRightOfUseAsset", "crdr": "debit", "calculation": { "http://dswissbeauty.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://dswissbeauty.com/role/BalanceSheets", "http://dswissbeauty.com/role/LeaseRight-of-useAssetAndLeaseLiabilitiesDetailsNarrative", "http://dswissbeauty.com/role/ScheduleOfOperationLeaseRightOfUseAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Operating lease right-of-use assets, net", "periodStartLabel": "Operating lease right of use asset, beginning", "periodEndLabel": "Operating lease right of use asset, ending", "verboseLabel": "Lease asset- right of use", "documentation": "Amount of lessee's right to use underlying asset under operating lease." } } }, "auth_ref": [ "r408" ] }, "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense", "crdr": "debit", "presentation": [ "http://dswissbeauty.com/role/LeaseRight-of-useAssetAndLeaseLiabilitiesDetailsNarrative", "http://dswissbeauty.com/role/ScheduleOfOperationLeaseRightOfUseAssetsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Accumulated amortization", "label": "Operating lease right of use asset, amortization", "documentation": "Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease." } } }, "auth_ref": [ "r640" ] }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "presentation": [ "http://dswissbeauty.com/role/LeaseRight-of-useAssetAndLeaseLiabilitiesDetailsNarrative", "http://dswissbeauty.com/role/ScheduleOfOperatingLeaseOtherInformationDetails" ], "lang": { "en-us": { "role": { "label": "Weighted average discount rate for operating lease", "verboseLabel": "Discount rate of lease payment", "documentation": "Weighted average discount rate for operating lease calculated at point in time." } } }, "auth_ref": [ "r417", "r594" ] }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfOperatingLeaseOtherInformationDetails" ], "lang": { "en-us": { "role": { "label": "Remaining lease term for operating lease (years)", "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r416", "r594" ] }, "us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeasesOfLesseeDisclosureTextBlock", "presentation": [ "http://dswissbeauty.com/role/LeaseRight-of-useAssetAndLeaseLiabilitiesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF OPERATION LEASE RIGHT OF USE ASSETS", "documentation": "Tabular disclosure for lessee's operating leases. Includes, but is not limited to, description of lessee's operating lease, existence and terms of renewal or purchase options and escalation clauses, restrictions imposed by lease, such as those concerning dividends, additional debt, and further leasing, rent holidays, rent concessions, or leasehold improvement incentives and unusual provisions or conditions." } } }, "auth_ref": [ "r125", "r127", "r128", "r129", "r130" ] }, "us-gaap_OperatingLossCarryforwards": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLossCarryforwards", "crdr": "debit", "presentation": [ "http://dswissbeauty.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Cumulative net operating losses", "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws." } } }, "auth_ref": [ "r56" ] }, "us-gaap_OperatingLossCarryforwardsLimitationsOnUse": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLossCarryforwardsLimitationsOnUse", "presentation": [ "http://dswissbeauty.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Net operating loss carryforwards expiration", "documentation": "A description of the limitations on the use of all operating loss carryforwards available to reduce future taxable income." } } }, "auth_ref": [] }, "us-gaap_OperatingLossCarryforwardsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLossCarryforwardsLineItems", "presentation": [ "http://dswissbeauty.com/role/IncomeTaxesDetailsNarrative", "http://dswissbeauty.com/role/ScheduleOfDeferredIncomeTaxAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Operating Loss Carryforwards [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_OperatingLossCarryforwardsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLossCarryforwardsTable", "presentation": [ "http://dswissbeauty.com/role/IncomeTaxesDetailsNarrative", "http://dswissbeauty.com/role/ScheduleOfDeferredIncomeTaxAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Operating Loss Carryforwards [Table]", "documentation": "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization." } } }, "auth_ref": [ "r55" ] }, "us-gaap_OperatingLossCarryforwardsValuationAllowance": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLossCarryforwardsValuationAllowance", "crdr": "credit", "presentation": [ "http://dswissbeauty.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Valuation allowance", "documentation": "The portion of the valuation allowance pertaining to the deferred tax asset representing potential future taxable deductions from net operating loss carryforwards for which it is more likely than not that a tax benefit will not be realized." } } }, "auth_ref": [ "r54" ] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OtherAccountsPayableAndAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAccountsPayableAndAccruedLiabilities", "crdr": "credit", "calculation": { "http://dswissbeauty.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 2.0 }, "http://dswissbeauty.com/role/ScheduleOfOtherPayableAndAccruedLiabilitiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://dswissbeauty.com/role/BalanceSheets", "http://dswissbeauty.com/role/ScheduleOfOtherPayableAndAccruedLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Other payables and accrued liabilities", "totalLabel": "Total payables and accrued liabilities", "documentation": "Amount of liabilities incurred and payable to vendors for goods and services received classified as other, and expenses incurred but not yet paid, payable within one year or the operating cycle, if longer." } } }, "auth_ref": [] }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://dswissbeauty.com/role/ScheduleOfOtherPayableAndAccruedLiabilitiesDetails": { "parentTag": "us-gaap_OtherAccountsPayableAndAccruedLiabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://dswissbeauty.com/role/ScheduleOfOtherPayableAndAccruedLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Accrued other expenses", "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r21" ] }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent", "crdr": "credit", "presentation": [ "http://dswissbeauty.com/role/StatementsOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Foreign currency translation adjustment", "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity." } } }, "auth_ref": [ "r4", "r12", "r118" ] }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "crdr": "credit", "calculation": { "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "- Foreign currency translation adjustment", "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature." } } }, "auth_ref": [ "r3" ] }, "us-gaap_OtherComprehensiveIncomeLossTaxAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossTaxAbstract", "presentation": [ "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Other comprehensive income:" } } }, "auth_ref": [] }, "us-gaap_OtherCurrentAssetsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherCurrentAssetsTextBlock", "presentation": [ "http://dswissbeauty.com/role/OtherReceivablesPrepaidExpensesAndDeposits" ], "lang": { "en-us": { "role": { "label": "OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS", "documentation": "The entire disclosure for other current assets." } } }, "auth_ref": [] }, "us-gaap_OtherNonoperatingIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNonoperatingIncome", "crdr": "credit", "calculation": { "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "OTHER INCOME", "documentation": "Amount of income related to nonoperating activities, classified as other." } } }, "auth_ref": [ "r173" ] }, "us-gaap_OtherReceivables": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherReceivables", "crdr": "debit", "calculation": { "http://dswissbeauty.com/role/ScheduleOfOtherReceivablesPrepaidExpensesAndDepositsDetails": { "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://dswissbeauty.com/role/ScheduleOfOtherReceivablesPrepaidExpensesAndDepositsDetails" ], "lang": { "en-us": { "role": { "label": "Other receivables", "documentation": "Amount due from parties in nontrade transactions, classified as other." } } }, "auth_ref": [ "r156", "r509" ] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r621" ] }, "srt_OwnershipAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "OwnershipAxis", "presentation": [ "http://dswissbeauty.com/role/OrganizationAndBusinessBackgroundDetailsNarrative", "http://dswissbeauty.com/role/RelatedPartyTransactionsDetailsNarrative", "http://dswissbeauty.com/role/VieStructureAndArrangementsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Ownership [Axis]" } } }, "auth_ref": [] }, "srt_OwnershipDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "OwnershipDomain", "presentation": [ "http://dswissbeauty.com/role/OrganizationAndBusinessBackgroundDetailsNarrative", "http://dswissbeauty.com/role/RelatedPartyTransactionsDetailsNarrative", "http://dswissbeauty.com/role/VieStructureAndArrangementsDetailsNarrative" ], "auth_ref": [] }, "DQWS_ParticularsOfIssuedCapital": { "xbrltype": "stringItemType", "nsuri": "http://dswissbeauty.com/20231231", "localname": "ParticularsOfIssuedCapital", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfVariableInterestEntityDetails" ], "lang": { "en-us": { "role": { "label": "Particulars of issued capital", "documentation": "Particulars of Issued Capital." } } }, "auth_ref": [] }, "us-gaap_PayablesAndAccrualsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PayablesAndAccrualsAbstract", "lang": { "en-us": { "role": { "label": "Payables and Accruals [Abstract]" } } }, "auth_ref": [] }, "us-gaap_PaymentsForRent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsForRent", "crdr": "credit", "presentation": [ "http://dswissbeauty.com/role/LeaseRight-of-useAssetAndLeaseLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Lease expenses", "documentation": "Cash payments to lessor's for use of assets under operating leases." } } }, "auth_ref": [ "r5" ] }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://dswissbeauty.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://dswissbeauty.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Purchase of property and equipment", "label": "Payments to Acquire Property, Plant, and Equipment", "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets." } } }, "auth_ref": [ "r101" ] }, "DQWS_PeoplesRepublicOfChinaPRCMember": { "xbrltype": "domainItemType", "nsuri": "http://dswissbeauty.com/20231231", "localname": "PeoplesRepublicOfChinaPRCMember", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfDeferredIncomeTaxAssetsDetails" ], "lang": { "en-us": { "role": { "label": "People's Republic of China (PRC) [Member]", "documentation": "People's Republic of China (PRC) [Member]" } } }, "auth_ref": [] }, "DQWS_PercentageOfAnnualNetProfitToBeReceivedAsFee": { "xbrltype": "percentItemType", "nsuri": "http://dswissbeauty.com/20231231", "localname": "PercentageOfAnnualNetProfitToBeReceivedAsFee", "presentation": [ "http://dswissbeauty.com/role/VieStructureAndArrangementsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Percentage of annual net profit to be received as fee", "documentation": "Percentage of annual net profit to be received as fee." } } }, "auth_ref": [] }, "DQWS_PlaceOfIncorporation": { "xbrltype": "stringItemType", "nsuri": "http://dswissbeauty.com/20231231", "localname": "PlaceOfIncorporation", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfVariableInterestEntityDetails" ], "lang": { "en-us": { "role": { "label": "Place of incorporation", "documentation": "Place of incorporation." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r615" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r616" ] }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockParOrStatedValuePerShare", "presentation": [ "http://dswissbeauty.com/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Preferred stock, par value", "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer." } } }, "auth_ref": [ "r83", "r274" ] }, "us-gaap_PreferredStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesAuthorized", "presentation": [ "http://dswissbeauty.com/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Preferred stock, shares authorized", "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r83", "r501" ] }, "us-gaap_PreferredStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesIssued", "presentation": [ "http://dswissbeauty.com/role/BalanceSheetsParenthetical", "http://dswissbeauty.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Preferred stock, shares issued", "verboseLabel": "Preferred stock shares issued", "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt." } } }, "auth_ref": [ "r83", "r274" ] }, "us-gaap_PreferredStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesOutstanding", "presentation": [ "http://dswissbeauty.com/role/BalanceSheetsParenthetical", "http://dswissbeauty.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Preferred stock, shares outstanding", "verboseLabel": "Preferred stock shares outstanding", "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased." } } }, "auth_ref": [ "r83", "r501", "r521", "r678", "r679" ] }, "us-gaap_PreferredStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockValue", "crdr": "credit", "calculation": { "http://dswissbeauty.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://dswissbeauty.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Preferred stock, $0.0001 par value, 200,000,000 shares authorized, None issued and outstanding", "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r83", "r450", "r595" ] }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrepaidExpenseAndOtherAssetsCurrent", "crdr": "debit", "calculation": { "http://dswissbeauty.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 3.0 }, "http://dswissbeauty.com/role/ScheduleOfOtherReceivablesPrepaidExpensesAndDepositsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://dswissbeauty.com/role/BalanceSheets", "http://dswissbeauty.com/role/ScheduleOfOtherReceivablesPrepaidExpensesAndDepositsDetails" ], "lang": { "en-us": { "role": { "label": "Other receivables, prepaid expenses, and deposit", "totalLabel": "Total other receivables, prepaid expenses and deposits", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r636" ] }, "us-gaap_PrepaidExpenseCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrepaidExpenseCurrent", "crdr": "debit", "calculation": { "http://dswissbeauty.com/role/ScheduleOfOtherReceivablesPrepaidExpensesAndDepositsDetails": { "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://dswissbeauty.com/role/ScheduleOfOtherReceivablesPrepaidExpensesAndDepositsDetails" ], "lang": { "en-us": { "role": { "label": "Prepaid expenses", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r160", "r255", "r256", "r582" ] }, "DQWS_ProceedsFromDisposalOfPropertyAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://dswissbeauty.com/20231231", "localname": "ProceedsFromDisposalOfPropertyAndEquipment", "crdr": "debit", "calculation": { "http://dswissbeauty.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://dswissbeauty.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Disposal of property and equipment", "documentation": "Proceeds from disposal of property and equipment." } } }, "auth_ref": [] }, "us-gaap_ProceedsFromLeasePayments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromLeasePayments", "crdr": "debit", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfOperatingLeaseOtherInformationDetails" ], "lang": { "en-us": { "role": { "label": "Operating cash flow from operating lease", "documentation": "Amount of cash inflow from lease payment, classified as operating activity." } } }, "auth_ref": [ "r419", "r420" ] }, "us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromRepaymentsOfRelatedPartyDebt", "crdr": "debit", "calculation": { "http://dswissbeauty.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://dswissbeauty.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Repayment to directors", "documentation": "Amount of cash inflow (outflow) from long-term debt by a related party. Related parties, include, but are not limited to, affiliates, owners or officers and their immediate families, and pension trusts." } } }, "auth_ref": [] }, "us-gaap_ProfessionalFees": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProfessionalFees", "crdr": "debit", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfRelatedPartyTransactionDetails" ], "lang": { "en-us": { "role": { "label": "Professional Fees", "documentation": "A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer." } } }, "auth_ref": [ "r605", "r676", "r677" ] }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentAbstract", "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Abstract]" } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentByTypeAxis", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfPlantAndEquipmentDetails", "http://dswissbeauty.com/role/ScheduleOfPropertyAndEquipmentUsefulLifeDetails" ], "lang": { "en-us": { "role": { "label": "Long-Lived Tangible Asset [Axis]", "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale." } } }, "auth_ref": [ "r8" ] }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "presentation": [ "http://dswissbeauty.com/role/PropertyAndEquipment" ], "lang": { "en-us": { "role": { "label": "PROPERTY AND EQUIPMENT", "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections." } } }, "auth_ref": [ "r109", "r135", "r138", "r139" ] }, "us-gaap_PropertyPlantAndEquipmentGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentGross", "crdr": "debit", "calculation": { "http://dswissbeauty.com/role/ScheduleOfPlantAndEquipmentDetails": { "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://dswissbeauty.com/role/ScheduleOfPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Total property and equipment", "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r110", "r152", "r458" ] }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentLineItems", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfPlantAndEquipmentDetails", "http://dswissbeauty.com/role/ScheduleOfPropertyAndEquipmentUsefulLifeDetails" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentNet", "crdr": "debit", "calculation": { "http://dswissbeauty.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0, "order": 1.0 }, "http://dswissbeauty.com/role/ScheduleOfPlantAndEquipmentDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://dswissbeauty.com/role/BalanceSheets", "http://dswissbeauty.com/role/ScheduleOfPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Property and equipment, net", "totalLabel": "Property and equipment, net", "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r8", "r448", "r458", "r595" ] }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "presentation": [ "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Property and equipment", "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections." } } }, "auth_ref": [ "r8", "r135", "r138", "r456" ] }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentTextBlock", "presentation": [ "http://dswissbeauty.com/role/PropertyAndEquipmentTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF PLANT AND EQUIPMENT", "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation." } } }, "auth_ref": [ "r8" ] }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentTypeDomain", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfPlantAndEquipmentDetails", "http://dswissbeauty.com/role/ScheduleOfPropertyAndEquipmentUsefulLifeDetails" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "auth_ref": [ "r110" ] }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentUsefulLife", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfPropertyAndEquipmentUsefulLifeDetails" ], "lang": { "en-us": { "role": { "label": "Property and equipment, estimated useful lives", "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment." } } }, "auth_ref": [] }, "srt_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeAxis", "presentation": [ "http://dswissbeauty.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "auth_ref": [ "r260", "r261", "r262", "r263", "r297", "r298", "r323", "r324", "r325", "r434", "r435", "r464", "r492", "r493", "r552", "r554", "r556", "r557", "r559", "r576", "r577", "r589", "r590", "r593", "r596", "r599", "r648", "r651", "r666", "r667", "r668", "r669", "r670" ] }, "srt_RangeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeMember", "presentation": [ "http://dswissbeauty.com/role/IncomeTaxesDetailsNarrative" ], "auth_ref": [ "r260", "r261", "r262", "r263", "r297", "r298", "r323", "r324", "r325", "r434", "r435", "r464", "r492", "r493", "r552", "r554", "r556", "r557", "r559", "r576", "r577", "r589", "r590", "r593", "r596", "r599", "r648", "r651", "r666", "r667", "r668", "r669", "r670" ] }, "DQWS_RelatedPartiesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://dswissbeauty.com/20231231", "localname": "RelatedPartiesPolicyTextBlock", "presentation": [ "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Related parties", "documentation": "Related Parties [Policy Text Block]" } } }, "auth_ref": [] }, "DQWS_RelatedPartyAMember": { "xbrltype": "domainItemType", "nsuri": "http://dswissbeauty.com/20231231", "localname": "RelatedPartyAMember", "presentation": [ "http://dswissbeauty.com/role/RelatedPartyTransactionsDetailsNarrative", "http://dswissbeauty.com/role/ScheduleOfRelatedPartyTransactionDetails" ], "lang": { "en-us": { "role": { "label": "Related Party A [Member]", "documentation": "Related Party A [Member]" } } }, "auth_ref": [] }, "DQWS_RelatedPartyBMember": { "xbrltype": "domainItemType", "nsuri": "http://dswissbeauty.com/20231231", "localname": "RelatedPartyBMember", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfRelatedPartyTransactionDetails" ], "lang": { "en-us": { "role": { "label": "Related Party B [Member]", "documentation": "Related Party B [Member]" } } }, "auth_ref": [] }, "DQWS_RelatedPartyCMember": { "xbrltype": "domainItemType", "nsuri": "http://dswissbeauty.com/20231231", "localname": "RelatedPartyCMember", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfRelatedPartyTransactionDetails" ], "lang": { "en-us": { "role": { "label": "Related Party C [Member]", "documentation": "Related Party C [Member]" } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionAxis", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfRelatedPartyTransactionDetails" ], "lang": { "en-us": { "role": { "label": "Related Party Transaction [Axis]", "documentation": "Information by type of related party transaction." } } }, "auth_ref": [ "r429", "r430", "r662" ] }, "us-gaap_RelatedPartyTransactionDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionDomain", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfRelatedPartyTransactionDetails" ], "lang": { "en-us": { "role": { "documentation": "Transaction between related party." } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionLineItems", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfRelatedPartyTransactionDetails" ], "lang": { "en-us": { "role": { "label": "Related Party Transaction [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r526", "r527", "r530" ] }, "us-gaap_RelatedPartyTransactionsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsAbstract", "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsDisclosureTextBlock", "presentation": [ "http://dswissbeauty.com/role/RelatedPartyTransactions" ], "lang": { "en-us": { "role": { "label": "RELATED PARTY TRANSACTIONS", "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates." } } }, "auth_ref": [ "r426", "r427", "r428", "r430", "r431", "r483", "r484", "r485", "r528", "r529", "r530", "r549", "r551" ] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://dswissbeauty.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://dswissbeauty.com/role/BalanceSheets", "http://dswissbeauty.com/role/GoingConcernUncertaintiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Accumulated deficit", "negatedLabel": "Accumulated deficit", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r86", "r112", "r453", "r471", "r476", "r481", "r502", "r595" ] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsMember", "presentation": [ "http://dswissbeauty.com/role/StatementsOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Retained Earnings [Member]", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r144", "r183", "r184", "r185", "r187", "r195", "r197", "r245", "r251", "r327", "r328", "r329", "r344", "r345", "r363", "r366", "r367", "r370", "r380", "r467", "r469", "r487", "r678" ] }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "crdr": "credit", "calculation": { "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome": { "parentTag": "us-gaap_GrossProfit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://dswissbeauty.com/role/ScheduleOfConcentrationOfRiskDetails", "http://dswissbeauty.com/role/ScheduleOfReportingSegmentsDetails", "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "REVENUE", "verboseLabel": "Revenues", "terseLabel": "Revenue", "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise." } } }, "auth_ref": [ "r213", "r214", "r218", "r222", "r223", "r229", "r231", "r233", "r295", "r296", "r440" ] }, "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerPolicyTextBlock", "presentation": [ "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Revenue recognition", "documentation": "Disclosure of accounting policy for revenue from contract with customer." } } }, "auth_ref": [ "r141", "r287", "r288", "r289", "r290", "r291", "r292", "r293", "r294", "r578" ] }, "us-gaap_Revenues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Revenues", "crdr": "credit", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfRelatedPartyTransactionDetails" ], "lang": { "en-us": { "role": { "label": "Sales", "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)." } } }, "auth_ref": [ "r170", "r181", "r213", "r214", "r218", "r222", "r223", "r229", "r231", "r233", "r241", "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r386", "r447", "r649" ] }, "us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenuesFromExternalCustomersAndLongLivedAssetsLineItems", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfReportingSegmentsDetails" ], "lang": { "en-us": { "role": { "label": "Revenues from External Customers and Long-Lived Assets [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability", "crdr": "debit", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfOperatingLeaseOtherInformationDetails" ], "lang": { "en-us": { "role": { "label": "Right-of-use assets obtained in exchange for operating lease liabilities", "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability." } } }, "auth_ref": [ "r415", "r594" ] }, "us-gaap_RisksAndUncertaintiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RisksAndUncertaintiesAbstract", "lang": { "en-us": { "role": { "label": "Risks and Uncertainties [Abstract]" } } }, "auth_ref": [] }, "country_SC": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "SC", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfComponentsOfIncomeLossBeforeIncomeTaxesDetails", "http://dswissbeauty.com/role/ScheduleOfReportingSegmentsDetails" ], "lang": { "en-us": { "role": { "label": "SEYCHELLES" } } }, "auth_ref": [] }, "us-gaap_SalesRevenueNetMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SalesRevenueNetMember", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfConcentrationOfRiskDetails" ], "lang": { "en-us": { "role": { "label": "Revenue Benchmark [Member]", "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation." } } }, "auth_ref": [ "r233", "r629" ] }, "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "presentation": [ "http://dswissbeauty.com/role/OtherPayablesAndAccruedLiabilitiesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF OTHER PAYABLE AND ACCRUED LIABILITIES", "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable", "presentation": [ "http://dswissbeauty.com/role/FinanceLeaseLiabilitiesDetailsNarrative", "http://dswissbeauty.com/role/VieStructureAndArrangementsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]", "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r355" ] }, "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "presentation": [ "http://dswissbeauty.com/role/IncomeTaxesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF PROVISION FOR INCOME TAXES", "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years." } } }, "auth_ref": [ "r114" ] }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "presentation": [ "http://dswissbeauty.com/role/IncomeTaxesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF DEFERRED INCOME TAX ASSETS", "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets." } } }, "auth_ref": [ "r113" ] }, "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "presentation": [ "http://dswissbeauty.com/role/OrganizationAndBusinessBackgroundDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Investment, Name [Axis]" } } }, "auth_ref": [ "r238", "r239", "r240" ] }, "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "presentation": [ "http://dswissbeauty.com/role/IncomeTaxesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF COMPONENTS OF INCOME LOSS BEFORE INCOME TAXES", "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions." } } }, "auth_ref": [ "r642" ] }, "us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "presentation": [ "http://dswissbeauty.com/role/IntangibleAssetsTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF INTANGIBLE ASSETS", "documentation": "Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class." } } }, "auth_ref": [ "r45" ] }, "us-gaap_ScheduleOfIntercompanyForeignCurrencyBalancesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfIntercompanyForeignCurrencyBalancesTextBlock", "presentation": [ "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF FOREIGN CURRENCIES TRANSLATION", "documentation": "Tabular disclosure of long-term intercompany foreign balances, including related intercompany entity, underlying foreign currencies and amounts of intercompany foreign currency transactions that are of a long-term investment nature (that is settlement is not planned or anticipated in the foreseeable future), as of the balance sheet date." } } }, "auth_ref": [ "r73" ] }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfInventoryCurrentTableTextBlock", "presentation": [ "http://dswissbeauty.com/role/InventoriesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF INVENTORIES", "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process." } } }, "auth_ref": [ "r18", "r90", "r91", "r92" ] }, "DQWS_ScheduleOfObligationUnderFinanceLeaseTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://dswissbeauty.com/20231231", "localname": "ScheduleOfObligationUnderFinanceLeaseTableTextBlock", "presentation": [ "http://dswissbeauty.com/role/FinanceLeaseLiabilitiesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF OBLIGATION UNDER FINANCE LEASE", "documentation": "Schedule of Obligation Under Finance Lease [Table Tex tBlock]" } } }, "auth_ref": [] }, "DQWS_ScheduleOfOperatingLeaseLiabilityDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://dswissbeauty.com/20231231", "localname": "ScheduleOfOperatingLeaseLiabilityDisclosureTextBlock", "presentation": [ "http://dswissbeauty.com/role/LeaseRight-of-useAssetAndLeaseLiabilitiesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF OPERATING LEASE LIABILITY", "documentation": "Schedule Of Operating Lease Liability Disclosure [Text Block]" } } }, "auth_ref": [] }, "DQWS_ScheduleOfOperatingLeaseOtherInformationTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://dswissbeauty.com/20231231", "localname": "ScheduleOfOperatingLeaseOtherInformationTableTextBlock", "presentation": [ "http://dswissbeauty.com/role/LeaseRight-of-useAssetAndLeaseLiabilitiesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF OPERATING LEASE OTHER INFORMATION", "documentation": "Schedule of Operating Lease Other Information [Table Text Block]" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfPlantAndEquipmentDetails", "http://dswissbeauty.com/role/ScheduleOfPropertyAndEquipmentUsefulLifeDetails" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Table]", "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation." } } }, "auth_ref": [ "r8" ] }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfRelatedPartyTransactionDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Related Party Transactions, by Related Party [Table]", "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates." } } }, "auth_ref": [ "r74", "r75", "r526", "r527", "r530" ] }, "us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfRelatedPartyTransactionsTableTextBlock", "presentation": [ "http://dswissbeauty.com/role/RelatedPartyTransactionsTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF RELATED PARTY TRANSACTION", "documentation": "Tabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfReportingSegmentsDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]", "documentation": "Schedule of material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries." } } }, "auth_ref": [ "r44", "r94" ] }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "presentation": [ "http://dswissbeauty.com/role/SegmentedInformationTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF REPORTING SEGMENTS", "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss." } } }, "auth_ref": [ "r41", "r42", "r43", "r45" ] }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfForeignCurrenciesTranslationDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]", "documentation": "Disclosure of information about share-based payment arrangement." } } }, "auth_ref": [ "r299", "r300", "r301", "r302", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r323", "r324", "r325", "r326" ] }, "us-gaap_ScheduleOfVariableInterestEntitiesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfVariableInterestEntitiesTextBlock", "presentation": [ "http://dswissbeauty.com/role/OrganizationAndBusinessBackgroundTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF VARIABLE INTEREST ENTITY", "documentation": "Tabular disclosure of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide." } } }, "auth_ref": [ "r62", "r63", "r65", "r67", "r69" ] }, "us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "presentation": [ "http://dswissbeauty.com/role/ConcentrationsOfRisksTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF CONCENTRATION OF RISK", "documentation": "Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark." } } }, "auth_ref": [ "r33", "r34", "r36", "r37", "r71", "r119" ] }, "DQWS_SecondFinanceLeaseAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://dswissbeauty.com/20231231", "localname": "SecondFinanceLeaseAgreementMember", "presentation": [ "http://dswissbeauty.com/role/FinanceLeaseLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Second Finance Lease Agreement [Member]", "documentation": "Second Finance Lease Agreement [Member]" } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r609" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r613" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r612" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityReportingObligation", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r617" ] }, "srt_SegmentGeographicalDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "SegmentGeographicalDomain", "presentation": [ "http://dswissbeauty.com/role/OrganizationAndBusinessBackgroundDetailsNarrative", "http://dswissbeauty.com/role/ScheduleOfComponentsOfIncomeLossBeforeIncomeTaxesDetails", "http://dswissbeauty.com/role/ScheduleOfReportingSegmentsDetails" ], "auth_ref": [ "r231", "r232", "r489", "r490", "r491", "r553", "r555", "r558", "r560", "r567", "r568", "r569", "r570", "r571", "r572", "r573", "r574", "r575", "r579", "r591", "r599", "r652", "r672" ] }, "us-gaap_SegmentReportingAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingAbstract", "lang": { "en-us": { "role": { "label": "Segment Reporting [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SegmentReportingDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingDisclosureTextBlock", "presentation": [ "http://dswissbeauty.com/role/SegmentedInformation" ], "lang": { "en-us": { "role": { "label": "SEGMENTED INFORMATION", "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments." } } }, "auth_ref": [ "r208", "r209", "r210", "r211", "r212", "r217", "r221", "r225", "r226", "r227", "r228", "r229", "r230", "r233" ] }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SellingGeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome" ], "lang": { "en-us": { "role": { "negatedLabel": "SELLING, GENERAL AND ADMINISTRATIVE EXPENSES", "label": "Selling, General and Administrative Expense", "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc." } } }, "auth_ref": [ "r100" ] }, "us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SellingGeneralAndAdministrativeExpensesPolicyTextBlock", "presentation": [ "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Selling and distribution expenses", "documentation": "Disclosure of accounting policy for inclusion of significant items in the selling, general and administrative (or similar) expense report caption." } } }, "auth_ref": [ "r10" ] }, "DQWS_SeychellesMember": { "xbrltype": "domainItemType", "nsuri": "http://dswissbeauty.com/20231231", "localname": "SeychellesMember", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfDeferredIncomeTaxAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Seychelles [Member]", "documentation": "Seychelles [Member]" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfForeignCurrenciesTranslationDetails" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r299", "r300", "r301", "r302", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r323", "r324", "r325", "r326" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfForeignCurrenciesTranslationDetails" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement." } } }, "auth_ref": [ "r301", "r302", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r323", "r324", "r325", "r326" ] }, "us-gaap_SharesIssuedPricePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharesIssuedPricePerShare", "presentation": [ "http://dswissbeauty.com/role/OrganizationAndBusinessBackgroundDetailsNarrative", "http://dswissbeauty.com/role/VieStructureAndArrangementsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Consideration price per share", "documentation": "Per share or per unit amount of equity securities issued." } } }, "auth_ref": [] }, "us-gaap_SharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharesOutstanding", "presentation": [ "http://dswissbeauty.com/role/StatementsOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "periodStartLabel": "Balance, shares", "periodEndLabel": "Balance, shares", "label": "Shares, Outstanding", "documentation": "Number of shares issued which are neither cancelled nor held in the treasury." } } }, "auth_ref": [] }, "us-gaap_ShippingAndHandlingCostPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShippingAndHandlingCostPolicyTextBlock", "presentation": [ "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Shipping and handling fees", "documentation": "Disclosure of accounting policy for the classification of shipping and handling costs, including whether the costs are included in cost of sales or included in other income statement accounts. If shipping and handling fees are significant and are not included in cost of sales, disclosure includes both the amounts of such costs and the line item on the income statement which includes such costs." } } }, "auth_ref": [] }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SignificantAccountingPoliciesTextBlock", "presentation": [ "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPolicies" ], "lang": { "en-us": { "role": { "label": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "documentation": "The entire disclosure for all significant accounting policies of the reporting entity." } } }, "auth_ref": [ "r105", "r179" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r618" ] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://dswissbeauty.com/role/StatementsOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r14", "r23", "r144", "r167", "r168", "r169", "r183", "r184", "r185", "r187", "r195", "r197", "r207", "r245", "r251", "r286", "r327", "r328", "r329", "r344", "r345", "r363", "r365", "r366", "r367", "r368", "r370", "r380", "r392", "r393", "r394", "r395", "r396", "r397", "r425", "r467", "r468", "r469", "r487", "r545" ] }, "srt_StatementGeographicalAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "StatementGeographicalAxis", "presentation": [ "http://dswissbeauty.com/role/OrganizationAndBusinessBackgroundDetailsNarrative", "http://dswissbeauty.com/role/ScheduleOfComponentsOfIncomeLossBeforeIncomeTaxesDetails", "http://dswissbeauty.com/role/ScheduleOfReportingSegmentsDetails" ], "lang": { "en-us": { "role": { "label": "Geographical [Axis]" } } }, "auth_ref": [ "r231", "r232", "r489", "r490", "r491", "r553", "r555", "r558", "r560", "r564", "r567", "r568", "r569", "r570", "r571", "r572", "r573", "r574", "r575", "r579", "r591", "r599", "r652", "r672" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementLineItems", "presentation": [ "http://dswissbeauty.com/role/LeaseRight-of-useAssetAndLeaseLiabilitiesDetailsNarrative", "http://dswissbeauty.com/role/OrganizationAndBusinessBackgroundDetailsNarrative", "http://dswissbeauty.com/role/RelatedPartyTransactionsDetailsNarrative", "http://dswissbeauty.com/role/ScheduleOfComponentsOfIncomeLossBeforeIncomeTaxesDetails", "http://dswissbeauty.com/role/ScheduleOfVariableInterestEntityDetails", "http://dswissbeauty.com/role/StatementsOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r183", "r184", "r185", "r207", "r440", "r478", "r488", "r494", "r495", "r496", "r497", "r498", "r499", "r501", "r504", "r505", "r506", "r507", "r508", "r511", "r512", "r513", "r514", "r516", "r517", "r518", "r519", "r520", "r522", "r524", "r525", "r531", "r532", "r533", "r534", "r535", "r536", "r537", "r538", "r539", "r540", "r541", "r542", "r545", "r600" ] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfStockholdersEquityAbstract", "auth_ref": [] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementTable", "presentation": [ "http://dswissbeauty.com/role/LeaseRight-of-useAssetAndLeaseLiabilitiesDetailsNarrative", "http://dswissbeauty.com/role/OrganizationAndBusinessBackgroundDetailsNarrative", "http://dswissbeauty.com/role/RelatedPartyTransactionsDetailsNarrative", "http://dswissbeauty.com/role/ScheduleOfComponentsOfIncomeLossBeforeIncomeTaxesDetails", "http://dswissbeauty.com/role/ScheduleOfVariableInterestEntityDetails", "http://dswissbeauty.com/role/StatementsOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Statement [Table]", "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed." } } }, "auth_ref": [ "r183", "r184", "r185", "r207", "r440", "r478", "r488", "r494", "r495", "r496", "r497", "r498", "r499", "r501", "r504", "r505", "r506", "r507", "r508", "r511", "r512", "r513", "r514", "r516", "r517", "r518", "r519", "r520", "r522", "r524", "r525", "r531", "r532", "r533", "r534", "r535", "r536", "r537", "r538", "r539", "r540", "r541", "r542", "r545", "r600" ] }, "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesAcquisitions", "presentation": [ "http://dswissbeauty.com/role/VieStructureAndArrangementsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of shares, acquired", "documentation": "Number of shares of stock issued during the period pursuant to acquisitions." } } }, "auth_ref": [ "r83", "r84", "r112" ] }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesNewIssues", "presentation": [ "http://dswissbeauty.com/role/OrganizationAndBusinessBackgroundDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Stock issued during period, shares, new issues", "documentation": "Number of new stock issued during the period." } } }, "auth_ref": [ "r14", "r83", "r84", "r112", "r480", "r545", "r561" ] }, "us-gaap_StockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquity", "crdr": "credit", "calculation": { "http://dswissbeauty.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://dswissbeauty.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "TOTAL DSWISS, INC. STOCKHOLDERS\u2019 EQUITY", "label": "Equity, Attributable to Parent", "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest." } } }, "auth_ref": [ "r84", "r87", "r88", "r107", "r503", "r521", "r546", "r547", "r595", "r607", "r641", "r646", "r658", "r678" ] }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "crdr": "credit", "calculation": { "http://dswissbeauty.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://dswissbeauty.com/role/BalanceSheets", "http://dswissbeauty.com/role/StatementsOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "totalLabel": "TOTAL STOCKHOLDERS\u2019 EQUITY", "periodStartLabel": "Balance", "periodEndLabel": "Balance", "label": "Equity, Including Portion Attributable to Noncontrolling Interest", "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity." } } }, "auth_ref": [ "r58", "r59", "r70", "r144", "r145", "r168", "r183", "r184", "r185", "r187", "r195", "r245", "r251", "r286", "r327", "r328", "r329", "r344", "r345", "r363", "r365", "r366", "r367", "r368", "r370", "r380", "r392", "r393", "r397", "r425", "r468", "r469", "r486", "r503", "r521", "r546", "r547", "r562", "r606", "r641", "r646", "r658", "r678" ] }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract", "presentation": [ "http://dswissbeauty.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "STOCKHOLDERS\u2019 EQUITY" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityNoteDisclosureTextBlock", "presentation": [ "http://dswissbeauty.com/role/StockholdersEquity" ], "lang": { "en-us": { "role": { "verboseLabel": "STOCKHOLDERS\u2019 EQUITY", "label": "Equity [Text Block]", "documentation": "The entire disclosure for equity." } } }, "auth_ref": [ "r111", "r180", "r273", "r275", "r276", "r277", "r278", "r279", "r280", "r281", "r282", "r283", "r284", "r285", "r286", "r371", "r548", "r550", "r563" ] }, "us-gaap_SubsequentEventsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventsAbstract", "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SubsequentEventsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventsTextBlock", "presentation": [ "http://dswissbeauty.com/role/SubsequentEvents" ], "lang": { "en-us": { "role": { "label": "SUBSEQUENT EVENTS", "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business." } } }, "auth_ref": [ "r432", "r433" ] }, "DQWS_SummaryOfPropertyAndEquipmentUsefulLifeTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://dswissbeauty.com/20231231", "localname": "SummaryOfPropertyAndEquipmentUsefulLifeTableTextBlock", "presentation": [ "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF PROPERTY AND EQUIPMENT USEFUL LIFE", "documentation": "Summary of Property and Equipment Useful Life [Table Text Block]" } } }, "auth_ref": [] }, "us-gaap_SupplementalCashFlowInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplementalCashFlowInformationAbstract", "presentation": [ "http://dswissbeauty.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "SUPPLEMENTAL CASH FLOWS INFORMATION" } } }, "auth_ref": [] }, "us-gaap_SupplierConcentrationRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplierConcentrationRiskMember", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfConcentrationOfRiskDetails" ], "lang": { "en-us": { "role": { "label": "Supplier Concentration Risk [Member]", "documentation": "Reflects the percentage that purchases in the period from one or more significant suppliers is to cost of goods or services, as defined by the entity, such as total cost of sales or services, product line cost of sales or services, segment cost of sales or services. Risk is the materially adverse effects of loss of a material supplier or a supplier of critically needed goods or services." } } }, "auth_ref": [ "r35" ] }, "DQWS_TaxationPaid": { "xbrltype": "monetaryItemType", "nsuri": "http://dswissbeauty.com/20231231", "localname": "TaxationPaid", "crdr": "credit", "calculation": { "http://dswissbeauty.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://dswissbeauty.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Taxation paid", "documentation": "Taxation paid.", "label": "TaxationPaid" } } }, "auth_ref": [] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "us-gaap_TypeOfAdoptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TypeOfAdoptionMember", "presentation": [ "http://dswissbeauty.com/role/LeaseRight-of-useAssetAndLeaseLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Amendment to accounting standards." } } }, "auth_ref": [ "r142", "r143", "r144", "r145", "r146", "r186", "r187", "r188", "r189", "r198", "r236", "r237", "r242", "r243", "r244", "r245", "r246", "r247", "r248", "r249", "r250", "r251", "r259", "r327", "r328", "r329", "r342", "r343", "r344", "r345", "r352", "r353", "r354", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r382", "r383", "r384", "r385", "r387", "r388", "r389", "r390", "r400", "r401", "r403", "r404", "r405", "r406", "r421", "r422", "r423", "r424", "r425", "r442", "r443", "r444", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r473", "r474", "r475", "r476" ] }, "us-gaap_TypeOfArrangementAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TypeOfArrangementAxis", "presentation": [ "http://dswissbeauty.com/role/FinanceLeaseLiabilitiesDetailsNarrative", "http://dswissbeauty.com/role/VieStructureAndArrangementsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]", "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r355" ] }, "country_US": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "US", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfComponentsOfIncomeLossBeforeIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "UNITED STATES" } } }, "auth_ref": [] }, "DQWS_UnitedStatesOfAmericaMember": { "xbrltype": "domainItemType", "nsuri": "http://dswissbeauty.com/20231231", "localname": "UnitedStatesOfAmericaMember", "presentation": [ "http://dswissbeauty.com/role/IncomeTaxesDetailsNarrative", "http://dswissbeauty.com/role/ScheduleOfDeferredIncomeTaxAssetsDetails" ], "lang": { "en-us": { "role": { "label": "United States of America [Member]", "documentation": "United States of America [Member]" } } }, "auth_ref": [] }, "us-gaap_UseOfEstimates": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UseOfEstimates", "presentation": [ "http://dswissbeauty.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Use of estimates", "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles." } } }, "auth_ref": [ "r38", "r39", "r40", "r133", "r134", "r136", "r137" ] }, "us-gaap_VariableInterestEntityDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VariableInterestEntityDisclosureTextBlock", "presentation": [ "http://dswissbeauty.com/role/VieStructureAndArrangements" ], "lang": { "en-us": { "role": { "label": "VIE STRUCTURE AND ARRANGEMENTS", "documentation": "The entire disclosure for a variable interest entity (VIE), including but not limited to, judgments and assumptions in determining whether to consolidate and in identifying the primary beneficiary, gain (loss) recognized on the initial consolidation of the VIE, terms of arrangements, amounts and classification of the VIE's assets and liabilities, and the entity's maximum exposure to loss." } } }, "auth_ref": [ "r117" ] }, "us-gaap_VariableInterestEntityOwnershipPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VariableInterestEntityOwnershipPercentage", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfVariableInterestEntityDetails" ], "lang": { "en-us": { "role": { "label": "Proportional of ownership interest and voting power held", "documentation": "Percentage of the Variable Interest Entity's (VIE) voting interest owned by (or beneficial interest in) the reporting entity (directly or indirectly)." } } }, "auth_ref": [ "r66" ] }, "us-gaap_VariableInterestEntityTypeOfEntity": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VariableInterestEntityTypeOfEntity", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfVariableInterestEntityDetails" ], "lang": { "en-us": { "role": { "label": "Company name", "documentation": "Structure or legal form of Variable Interest Entity (VIE). In general, a VIE is a corporation, partnership, trust, or any other legal structure used for business purposes that either (a) does not have equity investors with voting rights or (b) has equity investors that do not provide sufficient financial resources for the entity to support its activities." } } }, "auth_ref": [ "r66" ] }, "us-gaap_VariableInterestEntityVIEActivitiesOfVIE": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VariableInterestEntityVIEActivitiesOfVIE", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfVariableInterestEntityDetails" ], "lang": { "en-us": { "role": { "label": "Principal activities", "documentation": "Description of the transactions or business conducted by the Variable Interest Entity (VIE), including how the VIE is financed." } } }, "auth_ref": [ "r61", "r64", "r66", "r68" ] }, "DQWS_VendorAMember": { "xbrltype": "domainItemType", "nsuri": "http://dswissbeauty.com/20231231", "localname": "VendorAMember", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfConcentrationOfRiskDetails" ], "lang": { "en-us": { "role": { "label": "Vendor A [Member]", "documentation": "Vendor A [Member]" } } }, "auth_ref": [] }, "DQWS_VendorBMember": { "xbrltype": "domainItemType", "nsuri": "http://dswissbeauty.com/20231231", "localname": "VendorBMember", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfConcentrationOfRiskDetails" ], "lang": { "en-us": { "role": { "label": "Vendor B [Member]", "documentation": "Vendor B [Member]" } } }, "auth_ref": [] }, "DQWS_VendorCMember": { "xbrltype": "domainItemType", "nsuri": "http://dswissbeauty.com/20231231", "localname": "VendorCMember", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfConcentrationOfRiskDetails" ], "lang": { "en-us": { "role": { "label": "Vendor C [Member]", "documentation": "Vendor C [Member]" } } }, "auth_ref": [] }, "DQWS_VendorsMember": { "xbrltype": "domainItemType", "nsuri": "http://dswissbeauty.com/20231231", "localname": "VendorsMember", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfConcentrationOfRiskDetails" ], "lang": { "en-us": { "role": { "label": "Vendors [Member]", "documentation": "Vendors [Member]" } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "presentation": [ "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Weighted average number of common shares outstanding - diluted", "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period." } } }, "auth_ref": [ "r200", "r205" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "presentation": [ "http://dswissbeauty.com/role/StatementsOfOperationsAndComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Weighted average number of common shares outstanding - basic", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period." } } }, "auth_ref": [ "r199", "r205" ] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://dswissbeauty.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r627" ] }, "DQWS_YearAverageHKMember": { "xbrltype": "domainItemType", "nsuri": "http://dswissbeauty.com/20231231", "localname": "YearAverageHKMember", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfForeignCurrenciesTranslationDetails" ], "lang": { "en-us": { "role": { "label": "Year-average HK [Member]", "documentation": "Year-average HK [Member]" } } }, "auth_ref": [] }, "DQWS_YearAverageMYRMember": { "xbrltype": "domainItemType", "nsuri": "http://dswissbeauty.com/20231231", "localname": "YearAverageMYRMember", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfForeignCurrenciesTranslationDetails" ], "lang": { "en-us": { "role": { "label": "Year-average MYR [Member]", "documentation": "Year-average MYR [Member]" } } }, "auth_ref": [] }, "DQWS_YearAverageRMBMember": { "xbrltype": "domainItemType", "nsuri": "http://dswissbeauty.com/20231231", "localname": "YearAverageRMBMember", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfForeignCurrenciesTranslationDetails" ], "lang": { "en-us": { "role": { "label": "Year-average RMB [Member]", "documentation": "Year-average RMB [Member]" } } }, "auth_ref": [] }, "DQWS_YearEndHKMember": { "xbrltype": "domainItemType", "nsuri": "http://dswissbeauty.com/20231231", "localname": "YearEndHKMember", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfForeignCurrenciesTranslationDetails" ], "lang": { "en-us": { "role": { "label": "Year-end HK [Member]", "documentation": "Year-end HK [Member]" } } }, "auth_ref": [] }, "DQWS_YearEndMYRMember": { "xbrltype": "domainItemType", "nsuri": "http://dswissbeauty.com/20231231", "localname": "YearEndMYRMember", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfForeignCurrenciesTranslationDetails" ], "lang": { "en-us": { "role": { "label": "Year-end MYR [Member]", "documentation": "Year-end MYR [Member]" } } }, "auth_ref": [] }, "DQWS_YearEndRMBMember": { "xbrltype": "domainItemType", "nsuri": "http://dswissbeauty.com/20231231", "localname": "YearEndRMBMember", "presentation": [ "http://dswissbeauty.com/role/ScheduleOfForeignCurrenciesTranslationDetails" ], "lang": { "en-us": { "role": { "label": "Year-end RMB [Member]", "documentation": "Year-end RMB [Member]" } } }, "auth_ref": [] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "SubTopic": "20", "Topic": "940", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-20" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(g)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "825", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-1" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "SubTopic": "35", "Topic": "720", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483406/720-35-50-1" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(3)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c),(3)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "60", "Paragraph": "1", "SubTopic": "10", "Topic": "820", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482053/820-10-60-1" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(19)", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19-26)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.20)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.21)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29-31)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.31)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-5" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-1" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-16" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-20" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-21" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "30", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "41", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-1" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-2" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "((a)(1),(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "50", "Paragraph": "15", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-3" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-3" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-8" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-15" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-16" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "16", "Subparagraph": "(c,d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-16" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-4" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-4" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "5A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-5A" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "5A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-5A" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-6" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-6" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-9" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4I", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4I" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-20" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "830", "SubTopic": "30", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r74": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "850", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r75": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "850", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r76": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.10)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r77": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.15(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r78": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//205/tableOfContent" }, "r79": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 201.5-02(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r80": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 201.5-02(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r81": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 201.5-02(26))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r82": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r83": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r84": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r85": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r86": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r87": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r88": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r89": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r90": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r91": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r92": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r93": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11" }, "r94": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r95": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r96": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r97": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.1,2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r98": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r99": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r100": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r101": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r102": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r103": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r104": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r105": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "235", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//235/tableOfContent" }, "r106": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "275", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//275/tableOfContent" }, "r107": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 4.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2" }, "r108": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r109": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//360/tableOfContent" }, "r110": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r111": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//505/tableOfContent" }, "r112": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r113": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r114": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Paragraph": "9", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r115": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "15", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482669/740-10-15-2" }, "r116": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r117": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//810/tableOfContent" }, "r118": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19" }, "r119": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21" }, "r120": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r121": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r122": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r123": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r124": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r125": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-4" }, "r126": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "840", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//840/tableOfContent" }, "r127": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "840", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481440/840-10-50-2" }, "r128": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "840", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "40", "Subparagraph": "(Note 3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481418/840-10-55-40" }, "r129": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "840", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481501/840-20-50-1" }, "r130": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "840", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481501/840-20-50-2" }, "r131": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2" }, "r132": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "270", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482989/270-10-45-6" }, "r133": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r134": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r135": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-1" }, "r136": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11" }, "r137": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12" }, "r138": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-6" }, "r139": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-7" }, "r140": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h))", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r141": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Topic": "606", "Publisher": "FASB", "URI": "https://asc.fasb.org//606/tableOfContent" }, "r142": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r143": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r144": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r145": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r146": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r147": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7" }, "r148": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r149": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5" }, "r150": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1" }, "r151": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r152": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r153": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r154": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r155": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r156": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(3)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r157": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r158": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r159": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r160": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r161": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r162": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r163": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r164": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r165": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r166": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-1" }, "r167": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r168": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r169": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r170": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r171": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(7)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-1" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(e)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 11.M.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480530/250-10-S99-5" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//280/tableOfContent" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-15" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21" }, "r212": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r213": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-26" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "34", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-34" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481925/310-20-65-2" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481925/310-20-65-2" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//330/tableOfContent" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-1" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-4" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "340", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482955/340-10-05-5" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "340", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483032/340-10-45-1" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//350-30/tableOfContent" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147477123/405-50-65-1" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-17" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-19" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1D", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-1D" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-3" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//740/tableOfContent" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-25" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-28" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-19" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-20" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 11.C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "270", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479845/805-20-65-3" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479845/805-20-65-3" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479845/805-20-65-3" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "808", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r373": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r374": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r375": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r376": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r377": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r378": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r379": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r380": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r381": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r382": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r383": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-2" }, "r384": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482477/820-10-65-13" }, "r385": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482477/820-10-65-13" }, "r386": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r387": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6" }, "r388": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6" }, "r389": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6" }, "r390": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6" }, "r391": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//830/tableOfContent" }, "r392": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17" }, "r393": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r394": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r395": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r396": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r397": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1" }, "r398": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-2" }, "r399": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479424/830-30-S99-1" }, "r400": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "832", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483482/832-10-65-1" }, "r401": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "832", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483482/832-10-65-1" }, "r402": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-1" }, "r403": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5" }, "r404": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5" }, "r405": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5" }, "r406": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5" }, "r407": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//842-20/tableOfContent" }, "r408": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1" }, "r409": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1" }, "r410": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-5" }, "r411": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-5" }, "r412": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-1" }, "r413": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3" }, "r414": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r415": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r416": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r417": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r418": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6" }, "r419": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479016/842-30-45-5" }, "r420": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479016/842-30-45-7" }, "r421": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r422": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r423": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r424": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r425": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r426": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//850/tableOfContent" }, "r427": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r428": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r429": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r430": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r431": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-6" }, "r432": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//855/tableOfContent" }, "r433": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2" }, "r434": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r435": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "910", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6" }, "r436": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "912", "SubTopic": "330", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482105/912-330-50-1" }, "r437": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "920", "SubTopic": "350", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483256/920-350-50-1" }, "r438": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "920", "SubTopic": "350", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483256/920-350-50-1" }, "r439": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "920", "SubTopic": "350", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483256/920-350-50-4" }, "r440": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1" }, "r441": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483154/926-20-50-5" }, "r442": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483194/926-20-65-2" }, "r443": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483194/926-20-65-2" }, "r444": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483194/926-20-65-2" }, "r445": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(26))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r446": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r447": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1" }, "r448": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1" }, "r449": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r450": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r451": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r452": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r453": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r454": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r455": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r456": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r457": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r458": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r459": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r460": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r461": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r462": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r463": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r464": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A" }, "r465": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r466": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r467": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r468": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r469": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r470": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r471": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r472": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r473": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r474": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r475": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r476": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r477": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "825", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B" }, "r478": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r479": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(h)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r480": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r481": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11" }, "r482": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13" }, "r483": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-2" }, "r484": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-5" }, "r485": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-6" }, "r486": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3" }, "r487": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r488": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4" }, "r489": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r490": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-2" }, "r491": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r492": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r493": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r494": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r495": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r496": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r497": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r498": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r499": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r500": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r501": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r502": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r503": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r504": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r505": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r506": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r507": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r508": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r509": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(5)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r510": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(5)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r511": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r512": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r513": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r514": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r515": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r516": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r517": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r518": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r519": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r520": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r521": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r522": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r523": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7" }, "r524": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r525": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r526": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r527": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r528": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r529": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r530": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r531": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r532": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r533": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r534": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r535": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r536": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r537": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r538": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r539": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r540": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r541": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r542": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r543": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r544": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r545": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r546": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r547": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r548": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r549": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r550": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r551": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r552": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r553": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r554": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r555": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r556": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r557": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r558": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r559": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r560": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r561": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r562": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-3" }, "r563": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6" }, "r564": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "948", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479851/948-310-S99-1" }, "r565": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481058/954-310-45-1" }, "r566": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481027/954-310-50-2" }, "r567": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r568": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r569": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r570": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r571": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r572": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r573": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r574": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column I))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r575": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r576": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "976", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1" }, "r577": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "978", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1" }, "r578": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r579": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(b)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r580": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r581": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r582": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r583": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r584": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r585": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r586": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52" }, "r587": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r588": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r589": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A" }, "r590": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r591": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r592": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r593": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8" }, "r594": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "53", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479589/842-20-55-53" }, "r595": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10" }, "r596": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F" }, "r597": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r598": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r599": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1" }, "r600": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r601": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r602": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r603": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r604": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r605": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10" }, "r606": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11" }, "r607": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12" }, "r608": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r609": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r610": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r611": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r612": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r613": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r614": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r615": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r616": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r617": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r618": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r619": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r620": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r621": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r622": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r623": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r624": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w" }, "r625": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r626": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r627": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r628": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" }, "r629": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r630": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "SubTopic": "825", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B" }, "r631": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r632": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Topic": "705", "Publisher": "FASB", "URI": "https://asc.fasb.org//705/tableOfContent" }, "r633": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r634": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(3)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r635": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r636": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r637": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r638": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r639": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r640": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r641": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r642": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r643": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r644": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r645": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r646": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r647": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-3" }, "r648": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10" }, "r649": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r650": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r651": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r652": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r653": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r654": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-6" }, "r655": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r656": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r657": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r658": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r659": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "830", "SubTopic": "230", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r660": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-4" }, "r661": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6" }, "r662": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r663": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r664": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r665": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r666": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r667": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r668": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r669": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r670": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r671": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r672": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B" }, "r673": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r674": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r675": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r676": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(k)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r677": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r678": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r679": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" } } } ZIP 96 0001493152-24-011843-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-24-011843-xbrl.zip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®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form10-k_htm.xml IDEA: XBRL DOCUMENT 0001652561 2023-01-01 2023-12-31 0001652561 2023-06-30 0001652561 2023-12-31 0001652561 2022-12-31 0001652561 2022-01-01 2022-12-31 0001652561 us-gaap:CommonStockMember 2021-12-31 0001652561 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001652561 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001652561 us-gaap:RetainedEarningsMember 2021-12-31 0001652561 us-gaap:NoncontrollingInterestMember 2021-12-31 0001652561 2021-12-31 0001652561 us-gaap:CommonStockMember 2022-12-31 0001652561 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001652561 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001652561 us-gaap:RetainedEarningsMember 2022-12-31 0001652561 us-gaap:NoncontrollingInterestMember 2022-12-31 0001652561 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001652561 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001652561 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-12-31 0001652561 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001652561 us-gaap:NoncontrollingInterestMember 2022-01-01 2022-12-31 0001652561 us-gaap:CommonStockMember 2023-01-01 2023-12-31 0001652561 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-12-31 0001652561 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-12-31 0001652561 us-gaap:RetainedEarningsMember 2023-01-01 2023-12-31 0001652561 us-gaap:NoncontrollingInterestMember 2023-01-01 2023-12-31 0001652561 us-gaap:CommonStockMember 2023-12-31 0001652561 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001652561 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001652561 us-gaap:RetainedEarningsMember 2023-12-31 0001652561 us-gaap:NoncontrollingInterestMember 2023-12-31 0001652561 DQWS:DSwissHoldingLimitedMember country:HK 2023-12-31 0001652561 DQWS:DSwissSdnBhdMember country:MY 2023-12-31 0001652561 DQWS:DSwissBiotechMember country:MY 2023-12-31 0001652561 DQWS:DSwissBiotechMember country:HK 2023-01-17 2023-01-18 0001652561 DQWS:DSwissBiotechMember country:HK 2023-01-18 0001652561 DQWS:DSwissHKLimitedMember 2023-01-18 0001652561 DQWS:DSwissHoldingLimitedMember 2023-01-01 2023-12-31 0001652561 DQWS:DSwissHKLimitedMember 2023-01-01 2023-12-31 0001652561 DQWS:DSwissSdnBhdMember 2023-01-01 2023-12-31 0001652561 DQWS:DSwissBiotechSdnBhdMember 2023-01-01 2023-12-31 0001652561 DQWS:ComputerAndSoftwareMember 2023-12-31 0001652561 us-gaap:FurnitureAndFixturesMember 2023-12-31 0001652561 us-gaap:OfficeEquipmentMember 2023-12-31 0001652561 DQWS:MotorVehiclesMember 2023-12-31 0001652561 DQWS:YearEndMYRMember 2023-12-31 0001652561 DQWS:YearEndMYRMember 2022-12-31 0001652561 DQWS:YearAverageMYRMember 2023-12-31 0001652561 DQWS:YearAverageMYRMember 2022-12-31 0001652561 DQWS:YearEndHKMember 2023-12-31 0001652561 DQWS:YearEndHKMember 2022-12-31 0001652561 DQWS:YearAverageHKMember 2023-12-31 0001652561 DQWS:YearAverageHKMember 2022-12-31 0001652561 DQWS:YearEndRMBMember 2023-12-31 0001652561 DQWS:YearEndRMBMember 2022-12-31 0001652561 DQWS:YearAverageRMBMember 2023-12-31 0001652561 DQWS:YearAverageRMBMember 2022-12-31 0001652561 DQWS:ManagementServicesAgreementIMember DQWS:DSwissHKLimitedMember 2016-06-26 2016-06-27 0001652561 DQWS:DSwissHKLimitedMember 2023-01-18 2023-01-18 0001652561 DQWS:ComputerAndSoftwareMember 2022-12-31 0001652561 us-gaap:FurnitureAndFixturesMember 2022-12-31 0001652561 us-gaap:OfficeEquipmentMember 2022-12-31 0001652561 DQWS:MotorVehiclesMember 2022-12-31 0001652561 DQWS:FirstFinanceLeaseAgreementMember 2023-01-01 2023-12-31 0001652561 DQWS:SecondFinanceLeaseAgreementMember 2023-01-01 2023-12-31 0001652561 country:US 2023-01-01 2023-12-31 0001652561 country:US 2022-01-01 2022-12-31 0001652561 country:SC 2023-01-01 2023-12-31 0001652561 country:SC 2022-01-01 2022-12-31 0001652561 country:HK 2023-01-01 2023-12-31 0001652561 country:HK 2022-01-01 2022-12-31 0001652561 country:MY 2023-01-01 2023-12-31 0001652561 country:MY 2022-01-01 2022-12-31 0001652561 DQWS:UnitedStatesOfAmericaMember 2023-12-31 0001652561 DQWS:UnitedStatesOfAmericaMember 2022-12-31 0001652561 DQWS:SeychellesMember 2023-12-31 0001652561 DQWS:SeychellesMember 2022-12-31 0001652561 DQWS:HongKongMember 2023-12-31 0001652561 DQWS:HongKongMember 2022-12-31 0001652561 DQWS:MalaysiaMember 2023-12-31 0001652561 DQWS:MalaysiaMember 2022-12-31 0001652561 DQWS:PeoplesRepublicOfChinaPRCMember 2023-12-31 0001652561 DQWS:PeoplesRepublicOfChinaPRCMember 2022-12-31 0001652561 DQWS:UnitedStatesOfAmericaMember 2023-01-01 2023-12-31 0001652561 DQWS:HongKongMember DQWS:DSwissHKLimitedMember 2023-01-01 2023-12-31 0001652561 DQWS:HongKongMember DQWS:DSwissHKLimitedMember 2023-12-31 0001652561 srt:MinimumMember DQWS:MalaysiaMember DQWS:DSwissSdnBhdandDSwissBiotechSdnBhdMember 2023-01-01 2023-12-31 0001652561 srt:MaximumMember DQWS:MalaysiaMember DQWS:DSwissSdnBhdandDSwissBiotechSdnBhdMember 2023-01-01 2023-12-31 0001652561 DQWS:MalaysiaMember DQWS:DSwissSdnBhdandDSwissBiotechSdnBhdMember 2023-12-31 0001652561 DQWS:MalaysiaMember DQWS:DSwissSdnBhdandDSwissBiotechSdnBhdMember 2023-01-01 2023-12-31 0001652561 DQWS:CustomerAMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-12-31 0001652561 DQWS:CustomerAMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001652561 DQWS:CustomerAMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-12-31 0001652561 DQWS:CustomerAMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-12-31 0001652561 DQWS:CustomerBMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-12-31 0001652561 DQWS:CustomerBMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001652561 DQWS:CustomerBMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-12-31 0001652561 DQWS:CustomerBMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-12-31 0001652561 DQWS:CustomerCMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-12-31 0001652561 DQWS:CustomerCMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001652561 DQWS:CustomerCMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-12-31 0001652561 DQWS:CustomerCMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-12-31 0001652561 DQWS:CustomerDMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-12-31 0001652561 DQWS:CustomerDMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001652561 DQWS:CustomerDMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-12-31 0001652561 DQWS:CustomerDMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-12-31 0001652561 DQWS:CustomerEMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-12-31 0001652561 DQWS:CustomerEMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001652561 DQWS:CustomerEMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-12-31 0001652561 DQWS:CustomerEMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-12-31 0001652561 DQWS:CustomersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-12-31 0001652561 DQWS:CustomersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001652561 DQWS:CustomersMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-12-31 0001652561 DQWS:CustomersMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-12-31 0001652561 DQWS:VendorAMember us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember 2023-01-01 2023-12-31 0001652561 DQWS:VendorAMember us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember 2022-01-01 2022-12-31 0001652561 DQWS:VendorAMember us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember 2023-12-31 0001652561 DQWS:VendorAMember us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember 2022-12-31 0001652561 DQWS:VendorBMember us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember 2023-01-01 2023-12-31 0001652561 DQWS:VendorBMember us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember 2022-01-01 2022-12-31 0001652561 DQWS:VendorBMember us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember 2023-12-31 0001652561 DQWS:VendorBMember us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember 2022-12-31 0001652561 DQWS:VendorCMember us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember 2023-01-01 2023-12-31 0001652561 DQWS:VendorCMember us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember 2022-01-01 2022-12-31 0001652561 DQWS:VendorCMember us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember 2023-12-31 0001652561 DQWS:VendorCMember us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember 2022-12-31 0001652561 DQWS:VendorsMember us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember 2023-01-01 2023-12-31 0001652561 DQWS:VendorsMember us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember 2022-01-01 2022-12-31 0001652561 DQWS:VendorsMember us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember 2023-12-31 0001652561 DQWS:VendorsMember us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember 2022-12-31 0001652561 us-gaap:AccountingStandardsUpdate201602Member 2022-01-01 0001652561 us-gaap:AccountingStandardsUpdate201602Member 2023-01-01 2023-12-31 0001652561 us-gaap:AccountingStandardsUpdate201602Member 2022-01-01 2022-12-31 0001652561 DQWS:RelatedPartyAMember 2023-01-01 2023-12-31 0001652561 DQWS:RelatedPartyAMember 2022-01-01 2022-12-31 0001652561 DQWS:RelatedPartyBMember 2023-01-01 2023-12-31 0001652561 DQWS:RelatedPartyBMember 2022-01-01 2022-12-31 0001652561 DQWS:RelatedPartyCMember 2023-01-01 2023-12-31 0001652561 DQWS:RelatedPartyCMember 2022-01-01 2022-12-31 0001652561 DQWS:RelatedPartyAMember 2023-12-31 0001652561 DQWS:NVMember 2023-01-01 2023-12-31 0001652561 DQWS:NVMember 2023-12-31 0001652561 country:SC 2023-12-31 0001652561 country:HK 2023-12-31 0001652561 country:MY 2023-12-31 0001652561 DQWS:NVMember 2022-01-01 2022-12-31 0001652561 DQWS:NVMember 2022-12-31 0001652561 country:SC 2022-12-31 0001652561 country:HK 2022-12-31 0001652561 country:MY 2022-12-31 iso4217:USD shares iso4217:USD shares DQWS:Integer iso4217:MYR shares iso4217:MYR pure false FY 0001652561 No 10-K true 2023-12-31 --12-31 2023 false 333-208083 DSwiss, Inc. NV 47-4215595 Unit 18-11, 18-12 & 18-01, Tower A, Vertical Business Suite Avenue 3, Bangsar South No.8 Jalan Kerinchi 59200 Kuala Lumpur MY (603) 2770-4032 No No Yes Non-accelerated Filer true true false false false 0 0 206904585 JP CENTURION & PARTNERS PLT 6723 Kuala Lumpur, Malaysia 249110 214269 36148 17492 24532 21749 299 745 6872 7483 316961 261738 48105 72179 2427 3459 44548 50532 120186 367493 381924 99360 29539 174714 154710 21039 16515 44548 295113 245312 15965 38461 15965 38461 311078 283773 0.0001 0.0001 200000000 200000000 0 0 0 0 0.0001 0.0001 600000000 600000000 206904585 206904585 206904585 206904585 20690 20690 1395426 1395426 50452 -5846 -1410153 -1324002 56415 86268 11883 56415 98151 367493 381924 1470071 1849047 1110846 1404054 359225 444993 6904 4823 367647 402412 -1342 -1303 2919 6212 43099 42310 -48878 -2421 657 516 -49535 -2937 11354 56298 27139 6763 12848 -0.0002 -0.0002 -0.0001 -0.0001 206904585 206904585 206904585 206904585 206904585 20690 1395426 -32985 -1309711 589 74009 27139 -60 27079 -14291 11354 -2937 206904585 20690 1395426 -5846 -1324002 11883 98151 206904585 20690 1395426 -5846 -1324002 11883 98151 56298 56298 -36616 -11883 -48499 -49535 -49535 -49535 -49535 206904585 20690 1395426 50452 -1410153 56415 206904585 20690 1395426 50452 -1410153 56415 -48878 -2421 64933 72441 1030 1029 -26440 15551 25180 14702 -329 -8707 22967 -42440 3606 -28995 -42862 -42212 45533 23250 238 822 45295 22428 373 14376 1 -372 -14376 -38284 15890 15671 -15890 -53955 5808 25626 34841 -20277 214269 234546 249110 214269 238 141 406 421 <p id="xdx_803_eus-gaap--BusinessDescriptionAndBasisOfPresentationTextBlock_z86sesSf73r2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1. <span id="xdx_824_zMeWtxMkNinc">ORGANIZATION AND BUSINESS BACKGROUND</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DSwiss, Inc., a Nevada corporation (“the Company”) was incorporated under the laws of the State of Nevada on May 28, 2015.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DSwiss, Inc. operates through its wholly owned subsidiary, DSwiss Holding Limited, a Company organized under the laws of Seychelles.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The principal activity of the Company and its subsidiaries is to supply high-quality health and beauty products, including beverages to assist in weight management, anti-aging creams, and products designed to improve the overall health system in our body.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have historically conducted our business through DSwiss Sdn Bhd, a private limited liability company, incorporated in Malaysia. DSwiss Holding Limited, incorporated in Seychelles, is an investment holding company with <span id="xdx_904_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_c20231231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--DSwissHoldingLimitedMember__srt--StatementGeographicalAxis__country--HK_zAE8PDv40j06" title="Equity ownership interest rate percentage">100%</span> equity interest in DSwiss (HK) Limited, a company incorporated in Hong Kong, which subsequent hold <span id="xdx_909_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_c20231231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--DSwissSdnBhdMember__srt--StatementGeographicalAxis__country--MY_zrZLTpssbkLg" title="Equity ownership interest rate percentage">100%</span> equity interest in DSwiss Sdn. Bhd. On August 31, 2015, DSwiss, Inc. was restructured to be the holding company parent to, and succeed to the operations of, DSwiss Holding Limited. The former unit holder of DSwiss Holding Limited became the unit holder of DSwiss, Inc. and DSwiss Holding Limited became a wholly-owned subsidiary of DSwiss, Inc. This transaction was accounted for as a transaction among entities under common control and the assets, liabilities, revenues and expenses of DSwiss Holding Limited were carried over to and combined with DSwiss, Inc. at historical cost, and as if the transfer occurred at the beginning of the period. Prior periods have been retrospectively adjusted for comparative purposes.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have invested in DSwiss Biotech Sdn Bhd, a Company incorporated in Malaysia, and owned <span id="xdx_907_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_c20231231__srt--StatementGeographicalAxis__country--MY__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--DSwissBiotechMember_z3USFwZHoH61" title="Equity ownership interest rate percentage">40%</span> equity interest. <span style="background-color: white">On January 18, 2023, DSwiss (HK) Limited acquired <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230117__20230118__srt--StatementGeographicalAxis__country--HK__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--DSwissBiotechMember_zY0NKG6GYgC5" title="Stock issued during period, shares, new issues">150,000</span> shares, representing <span id="xdx_907_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_c20230118__srt--StatementGeographicalAxis__country--HK__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--DSwissBiotechMember_zeyIhMwXXsBb" title="Equity ownership interest rate percentage">60%</span> equity interest in DSwiss Biotech Sdn. Bhd., from the other party with consideration of RM <span id="xdx_906_eus-gaap--SharesIssuedPricePerShare_iI_pid_uMYRPShare_c20230118__srt--OwnershipAxis__custom--DSwissHKLimitedMember_zevmxIvRPR12" title="Consideration price per share">1</span>. After such acquisition, DSwiss Biotech Sdn. Bhd. became a wholly owned subsidiary of DSwiss (HK) Limited.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89F_eus-gaap--ScheduleOfVariableInterestEntitiesTextBlock_zsT8mjUrtQ8a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company, through its subsidiaries, mainly supplies high quality beauty products. Details of the Company’s subsidiaries:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B8_zDKSkKzFO5x7" style="display: none">SCHEDULE OF VARIABLE INTEREST ENTITY</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Company name</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Place and date of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>incorporation</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Particulars of issued capital</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Principal activities</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Proportional of ownership</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>interest and</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>voting power</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>held</b></span></p></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 22%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--VariableInterestEntityTypeOfEntity_c20230101__20231231__dei--LegalEntityAxis__custom--DSwissHoldingLimitedMember_ziUeIoGoFgDf" title="Company name">DSwiss Holding Limited</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 14%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_ecustom--PlaceOfIncorporation_c20230101__20231231__dei--LegalEntityAxis__custom--DSwissHoldingLimitedMember_fKDEpKDIp_zV2aL2DG5mr1" title="Place of incorporation">Seychelles</span>,</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_edei--EntityIncorporationDateOfIncorporation_dd_c20230101__20231231__dei--LegalEntityAxis__custom--DSwissHoldingLimitedMember_fKDEpKDIp_zj8ZwzMgpJr" title="Date of incorporation">May 28, 2015</span></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 24%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_ecustom--ParticularsOfIssuedCapital_c20230101__20231231__dei--LegalEntityAxis__custom--DSwissHoldingLimitedMember_z7Xy4zZipKY5" title="Particulars of issued capital">1 share of ordinary share of US$1 each</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 15%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--VariableInterestEntityVIEActivitiesOfVIE_c20230101__20231231__dei--LegalEntityAxis__custom--DSwissHoldingLimitedMember_zPjwlxAYb5K6" title="Principal activities">Investment holding</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 14%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--VariableInterestEntityOwnershipPercentage_c20230101__20231231__dei--LegalEntityAxis__custom--DSwissHoldingLimitedMember_zh9HmmZypLy2" title="Proportional of ownership interest and voting power held">100%</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eus-gaap--VariableInterestEntityTypeOfEntity_c20230101__20231231__dei--LegalEntityAxis__custom--DSwissHKLimitedMember_ztzDWbikqV6h" title="Company name">DSwiss (HK) Limited</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_ecustom--PlaceOfIncorporation_c20230101__20231231__dei--LegalEntityAxis__custom--DSwissHKLimitedMember_zs7tM9rFoelg">Hong Kong</span>,</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_edei--EntityIncorporationDateOfIncorporation_c20230101__20231231__dei--LegalEntityAxis__custom--DSwissHKLimitedMember_zP9JdnbW5xDc" title="Date of incorporation">May 28, 2015</span></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_ecustom--ParticularsOfIssuedCapital_c20230101__20231231__dei--LegalEntityAxis__custom--DSwissHKLimitedMember_zOXoaimCrZH9" title="Particulars of issued capital">1 share of ordinary share of HK$1 each</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--VariableInterestEntityVIEActivitiesOfVIE_c20230101__20231231__dei--LegalEntityAxis__custom--DSwissHKLimitedMember_zD1b7Whix258" title="Principal activities">Supply of beauty products</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_eus-gaap--VariableInterestEntityOwnershipPercentage_c20230101__20231231__dei--LegalEntityAxis__custom--DSwissHKLimitedMember_zu3rYB9e9c2b" title="Proportional of ownership interest and voting power held">100%</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--VariableInterestEntityTypeOfEntity_c20230101__20231231__dei--LegalEntityAxis__custom--DSwissSdnBhdMember_fKDEpKDIp_z7YB2P5dmYtc" title="Company name">DSwiss Sdn Bhd</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_ecustom--PlaceOfIncorporation_c20230101__20231231__dei--LegalEntityAxis__custom--DSwissSdnBhdMember_fKDEpKDIp_zbVJChc0AHCh" title="Place of incorporation">Malaysia</span>,</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_edei--EntityIncorporationDateOfIncorporation_dd_c20230101__20231231__dei--LegalEntityAxis__custom--DSwissSdnBhdMember_fKDEpKDIp_zwJcbaMMAfVl" title="Date of incorporation">March 10, 2011</span></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_ecustom--ParticularsOfIssuedCapital_c20230101__20231231__dei--LegalEntityAxis__custom--DSwissSdnBhdMember_zSHoCo0ncyFi" title="Particulars of issued capital">2 shares of ordinary share of RM 1 each</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--VariableInterestEntityVIEActivitiesOfVIE_c20230101__20231231__dei--LegalEntityAxis__custom--DSwissSdnBhdMember_zMaR6XZNFa04" title="Principal activities">Supply of beauty products</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--VariableInterestEntityOwnershipPercentage_c20230101__20231231__dei--LegalEntityAxis__custom--DSwissSdnBhdMember_zEvfjQLFdB66" title="Proportional of ownership interest and voting power held">100%</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eus-gaap--VariableInterestEntityTypeOfEntity_c20230101__20231231__dei--LegalEntityAxis__custom--DSwissBiotechSdnBhdMember_fKDEpKDIp_zGOnOGaFXZI" title="Company name">DSwiss Biotech Sdn Bhd</span> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_ecustom--PlaceOfIncorporation_c20230101__20231231__dei--LegalEntityAxis__custom--DSwissBiotechSdnBhdMember_fKDEpKDIp_z3Wyu97VbhR3" title="Place of incorporation">Malaysia</span>,</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_edei--EntityIncorporationDateOfIncorporation_dd_c20230101__20231231__dei--LegalEntityAxis__custom--DSwissBiotechSdnBhdMember_fKDEpKDIp_zuXHb7sezJw3" title="Date of incorporation">March 17, 2016</span></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_ecustom--ParticularsOfIssuedCapital_c20230101__20231231__dei--LegalEntityAxis__custom--DSwissBiotechSdnBhdMember_zQNHY1zzSFCj" title="Particulars of issued capital">250,000 shares of ordinary share of RM 1 each</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_eus-gaap--VariableInterestEntityVIEActivitiesOfVIE_c20230101__20231231__dei--LegalEntityAxis__custom--DSwissBiotechSdnBhdMember_zXg8OFLqcfih" title="Principal activities">Supply of biotech products</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_eus-gaap--VariableInterestEntityOwnershipPercentage_c20230101__20231231__dei--LegalEntityAxis__custom--DSwissBiotechSdnBhdMember_z34lLM4wJOal" title="Proportional of ownership interest and voting power held">100%</span></span></td></tr> </table> <p id="xdx_8A8_zok77pguA261" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DSWISS, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Business Overview</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">One of the leading one-stop ODM/OEM manufacturing companies, DSwiss is a premier biotech nutraceutical firm that offers premium healthcare, skincare, and personal care products. At DSwiss, we procure excellent and precise formulation using the finest natural ingredients, developing effective solutions with alluring favours in a variety of forms. DSwiss addresses a distinct demand in the market for a manufacturer who could ensure the quality of the ingredient sources and offer efficient one-stop service from raw material, product development, manufacturing and packaging.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since our founding, we have experienced tremendous growth in Malaysia. We offer exceptional lifestyle solutions to consumers all over the world thanks to our over 10 years of continuous innovation and work in the health and beauty business. Our company’s Chief Executive Officer, Vincent Leong has led it with a strong hand, and as a result, our products are now consumed around the world, such as Malaysia, Singapore, Indonesia, Hong Kong, Australia, Taiwan, Macau, and China. With the help of our distributors, we have so far extended throughout Asia, and we are adamant about extending our geographic reach into untapped markets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With a team of professionals at the helm, DSwiss is assured of providing the best products and attending client’s needs from consultations to products. To fulfil customer needs, we carry out research and development based on our philosophy of “creating beauty, health, and the ecosystem”. Our cutting-edge research and development team has always been exploring new product lines and integrating the most recent science and technology, which will enable us to produce more evidence-based, high-value added formulations and products and maintain our competitive position in the market.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With our extensive years of expertise in the OEM and ODM services industry, we offer comprehensive solutions to our customers. In addition to business consultancy, DSwiss offers useful guidance on current market trends as we all as marketing solutions and support to assist our clients’ business endeavours. Versatility and reliability are evidently the driving principles behind DSwiss, who manufactures products using high-grade ingredients and materials at every stage of research, development, and production.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As advocates of natural and high-quality active ingredients, we actively seek for and select the best ingredients, as we are dedicated to adhering to policies under rigorous quality control and assurance criteria, thereby maximizing the safety and efficacy of our products. We dedicate ourselves to maintaining the highest standard in our products in order to provide assurance and a continual commitment to producing high-quality products in accordance with the strict specifications and guidelines specified out by Ministry of Health (“MOH”) Malaysia. Each step of production process has quality control built in and implemented. We guarantee the highest quality product using precise production techniques and specialised equipment, promising ongoing improvements and enhancements based on customer feedback. DSwiss takes pride in offering the best results in customisable solutions for health supplements and beauty product manufacturing.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 1 1 0.40 150000 0.60 1 <p id="xdx_89F_eus-gaap--ScheduleOfVariableInterestEntitiesTextBlock_zsT8mjUrtQ8a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company, through its subsidiaries, mainly supplies high quality beauty products. Details of the Company’s subsidiaries:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B8_zDKSkKzFO5x7" style="display: none">SCHEDULE OF VARIABLE INTEREST ENTITY</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Company name</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Place and date of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>incorporation</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Particulars of issued capital</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Principal activities</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Proportional of ownership</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>interest and</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>voting power</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>held</b></span></p></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 22%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--VariableInterestEntityTypeOfEntity_c20230101__20231231__dei--LegalEntityAxis__custom--DSwissHoldingLimitedMember_ziUeIoGoFgDf" title="Company name">DSwiss Holding Limited</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 14%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_ecustom--PlaceOfIncorporation_c20230101__20231231__dei--LegalEntityAxis__custom--DSwissHoldingLimitedMember_fKDEpKDIp_zV2aL2DG5mr1" title="Place of incorporation">Seychelles</span>,</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_edei--EntityIncorporationDateOfIncorporation_dd_c20230101__20231231__dei--LegalEntityAxis__custom--DSwissHoldingLimitedMember_fKDEpKDIp_zj8ZwzMgpJr" title="Date of incorporation">May 28, 2015</span></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 24%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_ecustom--ParticularsOfIssuedCapital_c20230101__20231231__dei--LegalEntityAxis__custom--DSwissHoldingLimitedMember_z7Xy4zZipKY5" title="Particulars of issued capital">1 share of ordinary share of US$1 each</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 15%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--VariableInterestEntityVIEActivitiesOfVIE_c20230101__20231231__dei--LegalEntityAxis__custom--DSwissHoldingLimitedMember_zPjwlxAYb5K6" title="Principal activities">Investment holding</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 14%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--VariableInterestEntityOwnershipPercentage_c20230101__20231231__dei--LegalEntityAxis__custom--DSwissHoldingLimitedMember_zh9HmmZypLy2" title="Proportional of ownership interest and voting power held">100%</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eus-gaap--VariableInterestEntityTypeOfEntity_c20230101__20231231__dei--LegalEntityAxis__custom--DSwissHKLimitedMember_ztzDWbikqV6h" title="Company name">DSwiss (HK) Limited</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_ecustom--PlaceOfIncorporation_c20230101__20231231__dei--LegalEntityAxis__custom--DSwissHKLimitedMember_zs7tM9rFoelg">Hong Kong</span>,</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_edei--EntityIncorporationDateOfIncorporation_c20230101__20231231__dei--LegalEntityAxis__custom--DSwissHKLimitedMember_zP9JdnbW5xDc" title="Date of incorporation">May 28, 2015</span></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_ecustom--ParticularsOfIssuedCapital_c20230101__20231231__dei--LegalEntityAxis__custom--DSwissHKLimitedMember_zOXoaimCrZH9" title="Particulars of issued capital">1 share of ordinary share of HK$1 each</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--VariableInterestEntityVIEActivitiesOfVIE_c20230101__20231231__dei--LegalEntityAxis__custom--DSwissHKLimitedMember_zD1b7Whix258" title="Principal activities">Supply of beauty products</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_eus-gaap--VariableInterestEntityOwnershipPercentage_c20230101__20231231__dei--LegalEntityAxis__custom--DSwissHKLimitedMember_zu3rYB9e9c2b" title="Proportional of ownership interest and voting power held">100%</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--VariableInterestEntityTypeOfEntity_c20230101__20231231__dei--LegalEntityAxis__custom--DSwissSdnBhdMember_fKDEpKDIp_z7YB2P5dmYtc" title="Company name">DSwiss Sdn Bhd</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_ecustom--PlaceOfIncorporation_c20230101__20231231__dei--LegalEntityAxis__custom--DSwissSdnBhdMember_fKDEpKDIp_zbVJChc0AHCh" title="Place of incorporation">Malaysia</span>,</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_edei--EntityIncorporationDateOfIncorporation_dd_c20230101__20231231__dei--LegalEntityAxis__custom--DSwissSdnBhdMember_fKDEpKDIp_zwJcbaMMAfVl" title="Date of incorporation">March 10, 2011</span></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_ecustom--ParticularsOfIssuedCapital_c20230101__20231231__dei--LegalEntityAxis__custom--DSwissSdnBhdMember_zSHoCo0ncyFi" title="Particulars of issued capital">2 shares of ordinary share of RM 1 each</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--VariableInterestEntityVIEActivitiesOfVIE_c20230101__20231231__dei--LegalEntityAxis__custom--DSwissSdnBhdMember_zMaR6XZNFa04" title="Principal activities">Supply of beauty products</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--VariableInterestEntityOwnershipPercentage_c20230101__20231231__dei--LegalEntityAxis__custom--DSwissSdnBhdMember_zEvfjQLFdB66" title="Proportional of ownership interest and voting power held">100%</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eus-gaap--VariableInterestEntityTypeOfEntity_c20230101__20231231__dei--LegalEntityAxis__custom--DSwissBiotechSdnBhdMember_fKDEpKDIp_zGOnOGaFXZI" title="Company name">DSwiss Biotech Sdn Bhd</span> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_ecustom--PlaceOfIncorporation_c20230101__20231231__dei--LegalEntityAxis__custom--DSwissBiotechSdnBhdMember_fKDEpKDIp_z3Wyu97VbhR3" title="Place of incorporation">Malaysia</span>,</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_edei--EntityIncorporationDateOfIncorporation_dd_c20230101__20231231__dei--LegalEntityAxis__custom--DSwissBiotechSdnBhdMember_fKDEpKDIp_zuXHb7sezJw3" title="Date of incorporation">March 17, 2016</span></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_ecustom--ParticularsOfIssuedCapital_c20230101__20231231__dei--LegalEntityAxis__custom--DSwissBiotechSdnBhdMember_zQNHY1zzSFCj" title="Particulars of issued capital">250,000 shares of ordinary share of RM 1 each</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_eus-gaap--VariableInterestEntityVIEActivitiesOfVIE_c20230101__20231231__dei--LegalEntityAxis__custom--DSwissBiotechSdnBhdMember_zXg8OFLqcfih" title="Principal activities">Supply of biotech products</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_eus-gaap--VariableInterestEntityOwnershipPercentage_c20230101__20231231__dei--LegalEntityAxis__custom--DSwissBiotechSdnBhdMember_z34lLM4wJOal" title="Proportional of ownership interest and voting power held">100%</span></span></td></tr> </table> DSwiss Holding Limited Seychelles 2015-05-28 1 share of ordinary share of US$1 each Investment holding 1 DSwiss (HK) Limited Hong Kong 2015-05-28 1 share of ordinary share of HK$1 each Supply of beauty products 1 DSwiss Sdn Bhd Malaysia 2011-03-10 2 shares of ordinary share of RM 1 each Supply of beauty products 1 DSwiss Biotech Sdn Bhd Malaysia 2016-03-17 250,000 shares of ordinary share of RM 1 each Supply of biotech products 1 <p id="xdx_80B_ecustom--GoingConcernUncertaintiesTextBlock_zug0F5tWBZj7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2. <span id="xdx_821_z8gDnRKPIaq9">GOING CONCERN UNCERTAINTIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying financial statements have been prepared using the going concern basis of accounting, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2023, the Company suffered an accumulated deficit of $<span id="xdx_906_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pp0p0_di_c20231231_zhErWfKlz6n" title="Accumulated deficit">1,410,153</span>. The continuation of the Company as a going concern through December 31, 2023 is dependent upon improving the profitability and the continuing financial support from its major stockholders. Management believes the existing major shareholders or external financing will provide the additional cash to meet the Company’s obligations as they become due.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There is no assurance that the Company will able to maintain profitable in the future, which raise substantial doubt about the Company’s ability to continue as a going concern. These financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result in the Company not being able to continue as a going concern.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> -1410153 <p id="xdx_80E_eus-gaap--SignificantAccountingPoliciesTextBlock_zSNXuBqxokR6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3. <span id="xdx_82B_zhfvp1WV7nO4">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying consolidated financial statements reflect the application of certain significant accounting policies as described in this note and elsewhere in the accompanying consolidated financial statements and notes.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zdrUVgnlO3ki" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_864_zUvFy0Jn5OMf">Basis of presentation</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These accompanying consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“US GAAP”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_eus-gaap--ConsolidationPolicyTextBlock_ziRQM3VdYGek" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_862_zqnXBCBl8lti">Basis of consolidation</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The condensed consolidated financial statements include the accounts of the Company and its subsidiaries in which the Company is the primary beneficiary. All inter-company accounts and transactions have been eliminated upon consolidation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DSWISS, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_eus-gaap--UseOfEstimates_zn0QQtZkQBBi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_864_zURETB8K0vB6">Use of estimates</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In preparing these consolidated financial statements, management makes estimates and assumptions that affect the reported amounts of assets and liabilities in the balance sheets, and revenues and expenses during the periods reported. Actual results may differ from these estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84E_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zn8KzWtSQaG9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86E_zsSmn95u2sie">Cash and cash equivalents</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash and cash equivalents are carried at cost and represent cash on hand, time deposits placed with banks or other financial institutions and all highly liquid investments with an original maturity of six months or less as of the purchase date of such investments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_844_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zjE0x9PL8Lm5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_865_zoRTfiCWk04l">Property and equipment</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_898_ecustom--SummaryOfPropertyAndEquipmentUsefulLifeTableTextBlock_zwwwsW6nRxuh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment are stated at cost less accumulated depreciation and impairment. Depreciation of plant, equipment and software are calculated on the straight-line method over their estimated useful lives or lease terms generally as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B3_zuyet9lN2Swc" style="display: none">SCHEDULE OF PROPERTY AND EQUIPMENT USEFUL LIFE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1.5pt solid; width: 78%; font-weight: bold">Classification</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 20%; text-align: center">Estimated useful lives</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Computer and software</td><td> </td> <td style="text-align: center"><span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ComputerAndSoftwareMember_zH3V9jxMQ5x4" title="Property and equipment, estimated useful lives">5</span> years</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Furniture and Fittings</td><td> </td> <td style="text-align: center"><span id="xdx_903_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zvJT0h6amYy" title="Property and equipment, estimated useful lives">5</span> years</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Office equipment</td><td> </td> <td style="text-align: center"><span id="xdx_908_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_z1C4kFKpH2q6" title="Property and equipment, estimated useful lives">10</span> years</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Motor vehicle</td><td> </td> <td style="text-align: center"><span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MotorVehiclesMember_zd1cD0WCOXi8" title="Property and equipment, estimated useful lives">5</span> years</td></tr> </table> <p id="xdx_8A9_zH5WVw2C7wse" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_eus-gaap--IntangibleAssetsFiniteLivedPolicy_z1AZDIHeldWb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_869_zIZ5lJ9gdW5">Intangible assets</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible assets are stated at cost less accumulated amortization. Intangible assets represented the registration costs of trademarks in Malaysia and Hong Kong which are amortized on a straight-line basis over a useful life of <span id="xdx_901_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dc_c20231231_z1zRe9T4mJ41" title="Intangible asset, useful life">ten years</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company follows ASC Topic 350 in accounting for intangible assets, which requires impairment losses to be recorded when indicators of impairment are present and the undiscounted cash flows estimated to be generated by the assets are less than the assets’ carrying amounts. There were <span id="xdx_906_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_pp0p0_do_c20230101__20231231_zuu3gXIIRLwf" title="Impairment loss">no</span> impairment losses recorded on intangible assets for the year ended December 31, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DSWISS, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_eus-gaap--LesseeLeasesPolicyTextBlock_zDQ679EPOWF2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_869_zB4iSj780dxa">Leases</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The company determines if an arrangement is a lease at inception. Operating leases are included in operating in operating lease right-of-use (“ROU”) as assets, operating lease non-current liabilities, and operating lease current liabilities in our consolidated balance sheet. Finance leases are property and equipment, other current liabilities, and other non-current liabilities in the consolidated balance sheet.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ROU assets represent the right to use an asset for the lease term and lease liability represent the obligation to make lease payment arising from the lease. Operating lease ROU assets and liabilities are recognized at the commencement date based on the present value of lease payments over lease term. As most of the leases doesn’t provide an implicit rate. The company generally use the incremental borrowing rate on the estimated rate of interest for collateralized borrowing over a similar term of the lease payments at commencement date. The operating ROU asset also includes any lease payments made and exclude lease incentives. Lease expense for lease payment is recognized on a straight -line basis over lease term. The Company adopted Public Bank Berhad’s base rate lending rate as a reference for discount rate.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leases that transfer substantially all the rewards and risks of ownership to the lessee, other than legal title, are accounted for as finance leases. <span id="xdx_908_eus-gaap--LesseeFinanceLeaseDescription_c20230101__20231231_zZoQxmY0vxB5" title="Finance lease, description">Substantially all of the risks or benefits of ownership are deemed to have been transferred if any one of the four criteria is met: (i) transfer of ownership to the lessee at the end of the lease term, (ii) the lease containing a bargain purchase option, (iii) the lease term exceeding 75% of the estimated economic life of the leased asset, (iv) the present value of the minimum lease payments exceeding 90% of the fair value.</span> At the inception of a finance lease, the Company as the lessee records an asset and an obligation at an amount equal to the present value of the minimum lease payments. The leased asset is amortized over the shorter of the lease term or its estimated useful life if title does not transfer to the Company, while the leased asset is depreciated in accordance with the Company’s depreciation policy if the title is to eventually transfer to the Company. The periodic rent payments made during the lease term are allocated between a reduction in the obligation and interest element using the effective interest method in accordance with the provisions of ASC Topic 835-30, “Imputation of Interest”.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_eus-gaap--InventoryPolicyTextBlock_z7dsvxISggB4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86A_zjk4Q07D1oNf">Inventories</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventories consisting of products available for sell, are stated at the lower of cost or market value. Cost of inventory is determined using the first-in, first-out (FIFO) method. Inventory reserve is recorded to write down the cost of inventory to the estimated market value due to slow-moving merchandise and damaged goods, which is dependent upon factors such as historical and forecasted consumer demand, and promotional environment. The Company takes ownership, risks and rewards of the products purchased. Write downs are recorded in cost of revenues in the Condensed Consolidated Statements of Operations and Comprehensive Income.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84A_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zrFn5UyhC1Id" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_867_zVP5BfAQ3iHk">Revenue recognition</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company follows the guidance of Accounting Standards Codification (ASC) 606, <i>Revenue from Contracts</i>. ASC 606 creates a five-step model that requires entities to exercise judgment when considering the terms of contracts, which includes (1) identifying the contracts or agreements with a customer, (2) identifying our performance obligations in the contract or agreement, (3) determining the transaction price, (4) allocating the transaction price to the separate performance obligations, and (5) recognizing revenue as each performance obligation is satisfied. The Company only applies the five-step model to contracts when it is probable that the Company will collect the consideration it is entitled to in exchange for the services it transfers to its clients.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue from trading of retail goods is recognized when title and risk of loss are transferred and there are no continuing obligations to the customer. Title and the risks and rewards of ownership transfer to and accepted by the customer when the products are collected by the customer at the Company’s office. Revenue is recorded net of sales discounts, returns, allowances, and other adjustments that are based upon management’s best estimates and historical experience and are provided for in the same period as the related revenues are recorded.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company mainly derives its revenue from the sale of healthy food products. Generally, the Company recognizes revenue when OEM, Home brand and medical consumables products are sold and accepted by the customers and there are no continuing obligations to the customer.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DSWISS, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_eus-gaap--CostOfSalesPolicyTextBlock_zspGnAn3OI93" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_864_z1Gcn8i7U6rg">Cost of revenue</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost of revenue includes the purchase cost of retail goods for re-sale to customers and packing materials (such as boxes). It excludes purchasing and receiving costs, inspection costs, warehousing costs, internal transfer costs and other costs of distribution network in cost of revenues.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84C_eus-gaap--ShippingAndHandlingCostPolicyTextBlock_zIR35zMJH2v3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_864_zEUrsBg40Ou5">Shipping and handling fees</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shipping and handling fees, if billed to customers, are included in revenue. Shipping and handling fees associated with inbound and outbound freight are expensed as incurred and included in selling and distribution expenses.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84C_eus-gaap--SellingGeneralAndAdministrativeExpensesPolicyTextBlock_zJWatqW7IzE7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_866_zyANRtmKReh7">Selling and distribution expenses</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Selling and distribution expenses are primarily comprised of travelling and accommodation, transportation fees such as petrol, toll and parking and shipping and handling fees.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_eus-gaap--IncomeTaxPolicyTextBlock_zGDbSUGQXGWk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_867_zX7t6LLezHK4">Income taxes</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The provision of income taxes is determined in accordance with the provisions of ASC Topic 740, “Income Taxes” (“ASC 740”). Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted income tax rates expected to apply to taxable income in the periods in which those temporary differences are expected to be recovered or settled. Any effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC 740 prescribes a comprehensive model for how companies should recognize, measure, present, and disclose in their financial statements uncertain tax positions taken or expected to be taken on a tax return. Under ASC 740, tax positions must initially be recognized in the financial statements when it is more likely than not the position will be sustained upon examination by the tax authorities. Such tax positions must initially and subsequently be measured as the largest amount of tax benefit that has a <span id="xdx_900_eus-gaap--IncomeTaxExaminationLikelihoodOfUnfavorableSettlement_c20230101__20231231_z8YJsL5wv1ye" title="Largest amount of tax benefit, description">greater than 50%</span> likelihood of being realized upon ultimate settlement with the tax authority assuming full knowledge of the position and relevant facts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company conducts much of its businesses activities in Hong Kong and is subject to tax in this jurisdiction. As a result of its business activities, the Company will file separate tax returns that are subject to examination by the foreign tax authorities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84A_eus-gaap--EarningsPerSharePolicyTextBlock_zlDMnIOmoOa7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_866_z3neBWLghYt3">Net profit per share</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company calculates net profit per share in accordance with ASC Topic 260 “<i>Earnings per share</i>”. Basic profit per share is computed by dividing the net profit by the weighted average number of common shares outstanding during the period. Diluted profit per share is computed similar to basic profit per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common stock equivalents had been issued and if the additional common shares were dilutive.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DSWISS, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84A_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zGPSg13hYaVd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_864_zDdzYsrd5gK3">Foreign currencies translation</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency using the applicable exchange rates at the balance sheet dates. The resulting exchange differences are recorded in the Condensed Consolidated Statements of Operations and Comprehensive Income</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The reporting currency of the Company is United States Dollars (“US$”) and the accompanying financial statements have been expressed in US$. In addition, the Company’s subsidiaries and VIEs in Malaysia, Hong Kong and China maintains their books and record in their local currency, Ringgits Malaysia (“MYR”), Hong Kong Dollars (“HK$”) and Chinese Renminbi (“RMB”) respectively, which is functional currency as being the primary currency of the economic environment in which the entity operates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In general, for consolidation purposes, assets and liabilities of its subsidiaries whose functional currency is not US$ are translated into US$, in accordance with ASC Topic 830-30, “<i>Translation of Financial Statement”</i>, using the exchange rate on the balance sheet date. Revenues and expenses are translated at average rates prevailing during the period. The gains and losses resulting from translation of financial statements of foreign subsidiary are recorded as a separate component of accumulated other comprehensive income within the statements of stockholders’ equity.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89F_eus-gaap--ScheduleOfIntercompanyForeignCurrencyBalancesTextBlock_zSI74TQmnlOi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Translation of amounts from MYR into US$1, HK$ into US$1 and RMB into US$1 has been made at the following exchange rates for the respective periods:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B4_zvJmJVi69Jn1" style="display: none">SCHEDULE OF FOREIGN CURRENCIES TRANSLATION</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">As of and for the year ended <br/>December 31,</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2023</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left">Year-end MYR : US$1 exchange rate</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98D_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20231231__us-gaap--AwardTypeAxis__custom--YearEndMYRMember_zfhZandOKXU2" style="width: 14%; text-align: right" title="Foreign currency exchange rate, translation">4.59</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_981_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20221231__us-gaap--AwardTypeAxis__custom--YearEndMYRMember_zDdkoZgdwPqb" style="width: 14%; text-align: right" title="Foreign currency exchange rate, translation">4.42</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Year-average MYR : US$1 exchange rate</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20231231__us-gaap--AwardTypeAxis__custom--YearAverageMYRMember_zlYTqnZrCTN4" style="text-align: right" title="Foreign currency exchange rate, translation">4.56</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20221231__us-gaap--AwardTypeAxis__custom--YearAverageMYRMember_zk1c2GfS5VNj" style="text-align: right" title="Foreign currency exchange rate, translation">4.41</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Year-end HK$ : US$1 exchange rate</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20231231__us-gaap--AwardTypeAxis__custom--YearEndHKMember_zPrS2TJ0roui" style="text-align: right" title="Foreign currency exchange rate, translation">7.81</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20221231__us-gaap--AwardTypeAxis__custom--YearEndHKMember_zejANEuin7Ze" style="text-align: right" title="Foreign currency exchange rate, translation">7.81</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Year-average HK$ : US$1 exchange rate</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20231231__us-gaap--AwardTypeAxis__custom--YearAverageHKMember_zqRE5HkvGFNa" style="text-align: right" title="Foreign currency exchange rate, translation">7.83</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20221231__us-gaap--AwardTypeAxis__custom--YearAverageHKMember_zZi0RIT3JqFk" style="text-align: right" title="Foreign currency exchange rate, translation">7.83</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Year-end RMB : US$1 exchange rate</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20231231__us-gaap--AwardTypeAxis__custom--YearEndRMBMember_z5g11FuT7s5e" style="text-align: right" title="Foreign currency exchange rate, translation">7.10</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20221231__us-gaap--AwardTypeAxis__custom--YearEndRMBMember_zavHL1NXFdrg" style="text-align: right" title="Foreign currency exchange rate, translation">6.92</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Year-average RMB : US$1 exchange rate</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20231231__us-gaap--AwardTypeAxis__custom--YearAverageRMBMember_zaP21SyvzS2" style="text-align: right" title="Foreign currency exchange rate, translation">7.08</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20221231__us-gaap--AwardTypeAxis__custom--YearAverageRMBMember_zF0c1LKovSh3" style="text-align: right" title="Foreign currency exchange rate, translation">6.75</td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8AF_ztHUSMthrlHl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_ecustom--RelatedPartiesPolicyTextBlock_zIpRdBCwpwn8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86D_zAktH6Jx2Sx5">Related parties</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Parties, which can be a corporation or individual, are considered to be related if the Company has the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operating decisions. Companies are also considered to be related if they are subject to common control or common significant influence.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zLbMpuhMNnec" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_867_zGZFD6TYDT0l">Fair value of financial instruments:</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The carrying value of the Company’s financial instruments: cash and cash equivalents, subscription receivables, prepayment and deposits, accounts payable, and other payables and accrued liabilities approximate at their fair values because of the short-term nature of these financial instruments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DSWISS, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company also follows the guidance of the ASC Topic 820-10, “<i>Fair Value Measurements and Disclosures</i>” (“ASC 820-10”), with respect to financial assets and liabilities that are measured at fair value. ASC 820-10 establishes a three-tier fair value hierarchy that prioritizes the inputs used in measuring fair value as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1: Observable inputs such as quoted prices in active markets;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2: Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3: Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value estimates are made at a specific point in time based on relevant market information about the financial instrument. These estimates are subjective in nature and involve uncertainties and matters of significant judgment and, therefore, cannot be determined with precision. Changes in assumptions could significantly affect the estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zReLSo0QSrqb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86A_z40yojvc4j6c">Recently Adopted Accounting Standards</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In June 2016, the FASB issued Accounting Standards Update No. 2016-13, Financial Instruments – Credit Losses (Topics 326): Measurement of Credit Losses on Financial Instruments, which introduced the expected credit losses methodology for the measurement of credit losses on financial assets measured at amortized cost basis, replacing the previous incurred loss methodology. In November 2019, the FASB issued ASU 2019-10 highlighted the adoption timeline. For smaller reporting entities, Topic 326 is effective for annual periods beginning after December 15, 2022, including interim period within those fiscal years, of which is effective for the Company on January 1, 2023 as the Company is qualified as a smaller reporting company. The adoption of this standard did not have a material impact on the Company’s consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Credit loss rate is determined by historical collection based on aging schedule, adjusted for current conditions using reasonable and supportable forecast. Based on the aging categorization and the adjusted loss per category, an allowance for credit losses is calculated by multiplying the adjusted loss rate with the amortized cost in the respective age category.</span></p> <p id="xdx_85C_zkSYm9WKypBl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DSWISS, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zdrUVgnlO3ki" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_864_zUvFy0Jn5OMf">Basis of presentation</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These accompanying consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“US GAAP”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_eus-gaap--ConsolidationPolicyTextBlock_ziRQM3VdYGek" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_862_zqnXBCBl8lti">Basis of consolidation</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The condensed consolidated financial statements include the accounts of the Company and its subsidiaries in which the Company is the primary beneficiary. All inter-company accounts and transactions have been eliminated upon consolidation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DSWISS, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_eus-gaap--UseOfEstimates_zn0QQtZkQBBi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_864_zURETB8K0vB6">Use of estimates</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In preparing these consolidated financial statements, management makes estimates and assumptions that affect the reported amounts of assets and liabilities in the balance sheets, and revenues and expenses during the periods reported. Actual results may differ from these estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84E_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zn8KzWtSQaG9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86E_zsSmn95u2sie">Cash and cash equivalents</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash and cash equivalents are carried at cost and represent cash on hand, time deposits placed with banks or other financial institutions and all highly liquid investments with an original maturity of six months or less as of the purchase date of such investments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_844_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zjE0x9PL8Lm5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_865_zoRTfiCWk04l">Property and equipment</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_898_ecustom--SummaryOfPropertyAndEquipmentUsefulLifeTableTextBlock_zwwwsW6nRxuh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment are stated at cost less accumulated depreciation and impairment. Depreciation of plant, equipment and software are calculated on the straight-line method over their estimated useful lives or lease terms generally as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B3_zuyet9lN2Swc" style="display: none">SCHEDULE OF PROPERTY AND EQUIPMENT USEFUL LIFE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1.5pt solid; width: 78%; font-weight: bold">Classification</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 20%; text-align: center">Estimated useful lives</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Computer and software</td><td> </td> <td style="text-align: center"><span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ComputerAndSoftwareMember_zH3V9jxMQ5x4" title="Property and equipment, estimated useful lives">5</span> years</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Furniture and Fittings</td><td> </td> <td style="text-align: center"><span id="xdx_903_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zvJT0h6amYy" title="Property and equipment, estimated useful lives">5</span> years</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Office equipment</td><td> </td> <td style="text-align: center"><span id="xdx_908_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_z1C4kFKpH2q6" title="Property and equipment, estimated useful lives">10</span> years</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Motor vehicle</td><td> </td> <td style="text-align: center"><span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MotorVehiclesMember_zd1cD0WCOXi8" title="Property and equipment, estimated useful lives">5</span> years</td></tr> </table> <p id="xdx_8A9_zH5WVw2C7wse" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_898_ecustom--SummaryOfPropertyAndEquipmentUsefulLifeTableTextBlock_zwwwsW6nRxuh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment are stated at cost less accumulated depreciation and impairment. Depreciation of plant, equipment and software are calculated on the straight-line method over their estimated useful lives or lease terms generally as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B3_zuyet9lN2Swc" style="display: none">SCHEDULE OF PROPERTY AND EQUIPMENT USEFUL LIFE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1.5pt solid; width: 78%; font-weight: bold">Classification</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 20%; text-align: center">Estimated useful lives</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Computer and software</td><td> </td> <td style="text-align: center"><span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ComputerAndSoftwareMember_zH3V9jxMQ5x4" title="Property and equipment, estimated useful lives">5</span> years</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Furniture and Fittings</td><td> </td> <td style="text-align: center"><span id="xdx_903_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zvJT0h6amYy" title="Property and equipment, estimated useful lives">5</span> years</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Office equipment</td><td> </td> <td style="text-align: center"><span id="xdx_908_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_z1C4kFKpH2q6" title="Property and equipment, estimated useful lives">10</span> years</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Motor vehicle</td><td> </td> <td style="text-align: center"><span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MotorVehiclesMember_zd1cD0WCOXi8" title="Property and equipment, estimated useful lives">5</span> years</td></tr> </table> P5Y P5Y P10Y P5Y <p id="xdx_84D_eus-gaap--IntangibleAssetsFiniteLivedPolicy_z1AZDIHeldWb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_869_zIZ5lJ9gdW5">Intangible assets</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible assets are stated at cost less accumulated amortization. Intangible assets represented the registration costs of trademarks in Malaysia and Hong Kong which are amortized on a straight-line basis over a useful life of <span id="xdx_901_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dc_c20231231_z1zRe9T4mJ41" title="Intangible asset, useful life">ten years</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company follows ASC Topic 350 in accounting for intangible assets, which requires impairment losses to be recorded when indicators of impairment are present and the undiscounted cash flows estimated to be generated by the assets are less than the assets’ carrying amounts. There were <span id="xdx_906_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_pp0p0_do_c20230101__20231231_zuu3gXIIRLwf" title="Impairment loss">no</span> impairment losses recorded on intangible assets for the year ended December 31, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DSWISS, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> P10Y 0 <p id="xdx_845_eus-gaap--LesseeLeasesPolicyTextBlock_zDQ679EPOWF2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_869_zB4iSj780dxa">Leases</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The company determines if an arrangement is a lease at inception. Operating leases are included in operating in operating lease right-of-use (“ROU”) as assets, operating lease non-current liabilities, and operating lease current liabilities in our consolidated balance sheet. Finance leases are property and equipment, other current liabilities, and other non-current liabilities in the consolidated balance sheet.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ROU assets represent the right to use an asset for the lease term and lease liability represent the obligation to make lease payment arising from the lease. Operating lease ROU assets and liabilities are recognized at the commencement date based on the present value of lease payments over lease term. As most of the leases doesn’t provide an implicit rate. The company generally use the incremental borrowing rate on the estimated rate of interest for collateralized borrowing over a similar term of the lease payments at commencement date. The operating ROU asset also includes any lease payments made and exclude lease incentives. Lease expense for lease payment is recognized on a straight -line basis over lease term. The Company adopted Public Bank Berhad’s base rate lending rate as a reference for discount rate.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leases that transfer substantially all the rewards and risks of ownership to the lessee, other than legal title, are accounted for as finance leases. <span id="xdx_908_eus-gaap--LesseeFinanceLeaseDescription_c20230101__20231231_zZoQxmY0vxB5" title="Finance lease, description">Substantially all of the risks or benefits of ownership are deemed to have been transferred if any one of the four criteria is met: (i) transfer of ownership to the lessee at the end of the lease term, (ii) the lease containing a bargain purchase option, (iii) the lease term exceeding 75% of the estimated economic life of the leased asset, (iv) the present value of the minimum lease payments exceeding 90% of the fair value.</span> At the inception of a finance lease, the Company as the lessee records an asset and an obligation at an amount equal to the present value of the minimum lease payments. The leased asset is amortized over the shorter of the lease term or its estimated useful life if title does not transfer to the Company, while the leased asset is depreciated in accordance with the Company’s depreciation policy if the title is to eventually transfer to the Company. The periodic rent payments made during the lease term are allocated between a reduction in the obligation and interest element using the effective interest method in accordance with the provisions of ASC Topic 835-30, “Imputation of Interest”.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> Substantially all of the risks or benefits of ownership are deemed to have been transferred if any one of the four criteria is met: (i) transfer of ownership to the lessee at the end of the lease term, (ii) the lease containing a bargain purchase option, (iii) the lease term exceeding 75% of the estimated economic life of the leased asset, (iv) the present value of the minimum lease payments exceeding 90% of the fair value. <p id="xdx_847_eus-gaap--InventoryPolicyTextBlock_z7dsvxISggB4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86A_zjk4Q07D1oNf">Inventories</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventories consisting of products available for sell, are stated at the lower of cost or market value. Cost of inventory is determined using the first-in, first-out (FIFO) method. Inventory reserve is recorded to write down the cost of inventory to the estimated market value due to slow-moving merchandise and damaged goods, which is dependent upon factors such as historical and forecasted consumer demand, and promotional environment. The Company takes ownership, risks and rewards of the products purchased. Write downs are recorded in cost of revenues in the Condensed Consolidated Statements of Operations and Comprehensive Income.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84A_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zrFn5UyhC1Id" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_867_zVP5BfAQ3iHk">Revenue recognition</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company follows the guidance of Accounting Standards Codification (ASC) 606, <i>Revenue from Contracts</i>. ASC 606 creates a five-step model that requires entities to exercise judgment when considering the terms of contracts, which includes (1) identifying the contracts or agreements with a customer, (2) identifying our performance obligations in the contract or agreement, (3) determining the transaction price, (4) allocating the transaction price to the separate performance obligations, and (5) recognizing revenue as each performance obligation is satisfied. The Company only applies the five-step model to contracts when it is probable that the Company will collect the consideration it is entitled to in exchange for the services it transfers to its clients.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue from trading of retail goods is recognized when title and risk of loss are transferred and there are no continuing obligations to the customer. Title and the risks and rewards of ownership transfer to and accepted by the customer when the products are collected by the customer at the Company’s office. Revenue is recorded net of sales discounts, returns, allowances, and other adjustments that are based upon management’s best estimates and historical experience and are provided for in the same period as the related revenues are recorded.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company mainly derives its revenue from the sale of healthy food products. Generally, the Company recognizes revenue when OEM, Home brand and medical consumables products are sold and accepted by the customers and there are no continuing obligations to the customer.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DSWISS, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_eus-gaap--CostOfSalesPolicyTextBlock_zspGnAn3OI93" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_864_z1Gcn8i7U6rg">Cost of revenue</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost of revenue includes the purchase cost of retail goods for re-sale to customers and packing materials (such as boxes). It excludes purchasing and receiving costs, inspection costs, warehousing costs, internal transfer costs and other costs of distribution network in cost of revenues.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84C_eus-gaap--ShippingAndHandlingCostPolicyTextBlock_zIR35zMJH2v3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_864_zEUrsBg40Ou5">Shipping and handling fees</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shipping and handling fees, if billed to customers, are included in revenue. Shipping and handling fees associated with inbound and outbound freight are expensed as incurred and included in selling and distribution expenses.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84C_eus-gaap--SellingGeneralAndAdministrativeExpensesPolicyTextBlock_zJWatqW7IzE7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_866_zyANRtmKReh7">Selling and distribution expenses</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Selling and distribution expenses are primarily comprised of travelling and accommodation, transportation fees such as petrol, toll and parking and shipping and handling fees.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_eus-gaap--IncomeTaxPolicyTextBlock_zGDbSUGQXGWk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_867_zX7t6LLezHK4">Income taxes</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The provision of income taxes is determined in accordance with the provisions of ASC Topic 740, “Income Taxes” (“ASC 740”). Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted income tax rates expected to apply to taxable income in the periods in which those temporary differences are expected to be recovered or settled. Any effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC 740 prescribes a comprehensive model for how companies should recognize, measure, present, and disclose in their financial statements uncertain tax positions taken or expected to be taken on a tax return. Under ASC 740, tax positions must initially be recognized in the financial statements when it is more likely than not the position will be sustained upon examination by the tax authorities. Such tax positions must initially and subsequently be measured as the largest amount of tax benefit that has a <span id="xdx_900_eus-gaap--IncomeTaxExaminationLikelihoodOfUnfavorableSettlement_c20230101__20231231_z8YJsL5wv1ye" title="Largest amount of tax benefit, description">greater than 50%</span> likelihood of being realized upon ultimate settlement with the tax authority assuming full knowledge of the position and relevant facts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company conducts much of its businesses activities in Hong Kong and is subject to tax in this jurisdiction. As a result of its business activities, the Company will file separate tax returns that are subject to examination by the foreign tax authorities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> greater than 50% <p id="xdx_84A_eus-gaap--EarningsPerSharePolicyTextBlock_zlDMnIOmoOa7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_866_z3neBWLghYt3">Net profit per share</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company calculates net profit per share in accordance with ASC Topic 260 “<i>Earnings per share</i>”. Basic profit per share is computed by dividing the net profit by the weighted average number of common shares outstanding during the period. Diluted profit per share is computed similar to basic profit per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common stock equivalents had been issued and if the additional common shares were dilutive.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DSWISS, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84A_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zGPSg13hYaVd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_864_zDdzYsrd5gK3">Foreign currencies translation</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency using the applicable exchange rates at the balance sheet dates. The resulting exchange differences are recorded in the Condensed Consolidated Statements of Operations and Comprehensive Income</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The reporting currency of the Company is United States Dollars (“US$”) and the accompanying financial statements have been expressed in US$. In addition, the Company’s subsidiaries and VIEs in Malaysia, Hong Kong and China maintains their books and record in their local currency, Ringgits Malaysia (“MYR”), Hong Kong Dollars (“HK$”) and Chinese Renminbi (“RMB”) respectively, which is functional currency as being the primary currency of the economic environment in which the entity operates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In general, for consolidation purposes, assets and liabilities of its subsidiaries whose functional currency is not US$ are translated into US$, in accordance with ASC Topic 830-30, “<i>Translation of Financial Statement”</i>, using the exchange rate on the balance sheet date. Revenues and expenses are translated at average rates prevailing during the period. The gains and losses resulting from translation of financial statements of foreign subsidiary are recorded as a separate component of accumulated other comprehensive income within the statements of stockholders’ equity.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89F_eus-gaap--ScheduleOfIntercompanyForeignCurrencyBalancesTextBlock_zSI74TQmnlOi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Translation of amounts from MYR into US$1, HK$ into US$1 and RMB into US$1 has been made at the following exchange rates for the respective periods:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B4_zvJmJVi69Jn1" style="display: none">SCHEDULE OF FOREIGN CURRENCIES TRANSLATION</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">As of and for the year ended <br/>December 31,</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2023</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left">Year-end MYR : US$1 exchange rate</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98D_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20231231__us-gaap--AwardTypeAxis__custom--YearEndMYRMember_zfhZandOKXU2" style="width: 14%; text-align: right" title="Foreign currency exchange rate, translation">4.59</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_981_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20221231__us-gaap--AwardTypeAxis__custom--YearEndMYRMember_zDdkoZgdwPqb" style="width: 14%; text-align: right" title="Foreign currency exchange rate, translation">4.42</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Year-average MYR : US$1 exchange rate</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20231231__us-gaap--AwardTypeAxis__custom--YearAverageMYRMember_zlYTqnZrCTN4" style="text-align: right" title="Foreign currency exchange rate, translation">4.56</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20221231__us-gaap--AwardTypeAxis__custom--YearAverageMYRMember_zk1c2GfS5VNj" style="text-align: right" title="Foreign currency exchange rate, translation">4.41</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Year-end HK$ : US$1 exchange rate</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20231231__us-gaap--AwardTypeAxis__custom--YearEndHKMember_zPrS2TJ0roui" style="text-align: right" title="Foreign currency exchange rate, translation">7.81</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20221231__us-gaap--AwardTypeAxis__custom--YearEndHKMember_zejANEuin7Ze" style="text-align: right" title="Foreign currency exchange rate, translation">7.81</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Year-average HK$ : US$1 exchange rate</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20231231__us-gaap--AwardTypeAxis__custom--YearAverageHKMember_zqRE5HkvGFNa" style="text-align: right" title="Foreign currency exchange rate, translation">7.83</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20221231__us-gaap--AwardTypeAxis__custom--YearAverageHKMember_zZi0RIT3JqFk" style="text-align: right" title="Foreign currency exchange rate, translation">7.83</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Year-end RMB : US$1 exchange rate</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20231231__us-gaap--AwardTypeAxis__custom--YearEndRMBMember_z5g11FuT7s5e" style="text-align: right" title="Foreign currency exchange rate, translation">7.10</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20221231__us-gaap--AwardTypeAxis__custom--YearEndRMBMember_zavHL1NXFdrg" style="text-align: right" title="Foreign currency exchange rate, translation">6.92</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Year-average RMB : US$1 exchange rate</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20231231__us-gaap--AwardTypeAxis__custom--YearAverageRMBMember_zaP21SyvzS2" style="text-align: right" title="Foreign currency exchange rate, translation">7.08</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20221231__us-gaap--AwardTypeAxis__custom--YearAverageRMBMember_zF0c1LKovSh3" style="text-align: right" title="Foreign currency exchange rate, translation">6.75</td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8AF_ztHUSMthrlHl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89F_eus-gaap--ScheduleOfIntercompanyForeignCurrencyBalancesTextBlock_zSI74TQmnlOi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Translation of amounts from MYR into US$1, HK$ into US$1 and RMB into US$1 has been made at the following exchange rates for the respective periods:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B4_zvJmJVi69Jn1" style="display: none">SCHEDULE OF FOREIGN CURRENCIES TRANSLATION</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">As of and for the year ended <br/>December 31,</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2023</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left">Year-end MYR : US$1 exchange rate</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98D_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20231231__us-gaap--AwardTypeAxis__custom--YearEndMYRMember_zfhZandOKXU2" style="width: 14%; text-align: right" title="Foreign currency exchange rate, translation">4.59</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_981_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20221231__us-gaap--AwardTypeAxis__custom--YearEndMYRMember_zDdkoZgdwPqb" style="width: 14%; text-align: right" title="Foreign currency exchange rate, translation">4.42</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Year-average MYR : US$1 exchange rate</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20231231__us-gaap--AwardTypeAxis__custom--YearAverageMYRMember_zlYTqnZrCTN4" style="text-align: right" title="Foreign currency exchange rate, translation">4.56</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20221231__us-gaap--AwardTypeAxis__custom--YearAverageMYRMember_zk1c2GfS5VNj" style="text-align: right" title="Foreign currency exchange rate, translation">4.41</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Year-end HK$ : US$1 exchange rate</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20231231__us-gaap--AwardTypeAxis__custom--YearEndHKMember_zPrS2TJ0roui" style="text-align: right" title="Foreign currency exchange rate, translation">7.81</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20221231__us-gaap--AwardTypeAxis__custom--YearEndHKMember_zejANEuin7Ze" style="text-align: right" title="Foreign currency exchange rate, translation">7.81</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Year-average HK$ : US$1 exchange rate</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20231231__us-gaap--AwardTypeAxis__custom--YearAverageHKMember_zqRE5HkvGFNa" style="text-align: right" title="Foreign currency exchange rate, translation">7.83</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20221231__us-gaap--AwardTypeAxis__custom--YearAverageHKMember_zZi0RIT3JqFk" style="text-align: right" title="Foreign currency exchange rate, translation">7.83</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Year-end RMB : US$1 exchange rate</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20231231__us-gaap--AwardTypeAxis__custom--YearEndRMBMember_z5g11FuT7s5e" style="text-align: right" title="Foreign currency exchange rate, translation">7.10</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20221231__us-gaap--AwardTypeAxis__custom--YearEndRMBMember_zavHL1NXFdrg" style="text-align: right" title="Foreign currency exchange rate, translation">6.92</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Year-average RMB : US$1 exchange rate</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20231231__us-gaap--AwardTypeAxis__custom--YearAverageRMBMember_zaP21SyvzS2" style="text-align: right" title="Foreign currency exchange rate, translation">7.08</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20221231__us-gaap--AwardTypeAxis__custom--YearAverageRMBMember_zF0c1LKovSh3" style="text-align: right" title="Foreign currency exchange rate, translation">6.75</td><td style="text-align: left"> </td></tr> </table> 4.59 4.42 4.56 4.41 7.81 7.81 7.83 7.83 7.10 6.92 7.08 6.75 <p id="xdx_84B_ecustom--RelatedPartiesPolicyTextBlock_zIpRdBCwpwn8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86D_zAktH6Jx2Sx5">Related parties</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Parties, which can be a corporation or individual, are considered to be related if the Company has the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operating decisions. Companies are also considered to be related if they are subject to common control or common significant influence.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zLbMpuhMNnec" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_867_zGZFD6TYDT0l">Fair value of financial instruments:</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The carrying value of the Company’s financial instruments: cash and cash equivalents, subscription receivables, prepayment and deposits, accounts payable, and other payables and accrued liabilities approximate at their fair values because of the short-term nature of these financial instruments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DSWISS, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company also follows the guidance of the ASC Topic 820-10, “<i>Fair Value Measurements and Disclosures</i>” (“ASC 820-10”), with respect to financial assets and liabilities that are measured at fair value. ASC 820-10 establishes a three-tier fair value hierarchy that prioritizes the inputs used in measuring fair value as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1: Observable inputs such as quoted prices in active markets;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2: Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3: Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value estimates are made at a specific point in time based on relevant market information about the financial instrument. These estimates are subjective in nature and involve uncertainties and matters of significant judgment and, therefore, cannot be determined with precision. Changes in assumptions could significantly affect the estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zReLSo0QSrqb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86A_z40yojvc4j6c">Recently Adopted Accounting Standards</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In June 2016, the FASB issued Accounting Standards Update No. 2016-13, Financial Instruments – Credit Losses (Topics 326): Measurement of Credit Losses on Financial Instruments, which introduced the expected credit losses methodology for the measurement of credit losses on financial assets measured at amortized cost basis, replacing the previous incurred loss methodology. In November 2019, the FASB issued ASU 2019-10 highlighted the adoption timeline. For smaller reporting entities, Topic 326 is effective for annual periods beginning after December 15, 2022, including interim period within those fiscal years, of which is effective for the Company on January 1, 2023 as the Company is qualified as a smaller reporting company. The adoption of this standard did not have a material impact on the Company’s consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Credit loss rate is determined by historical collection based on aging schedule, adjusted for current conditions using reasonable and supportable forecast. Based on the aging categorization and the adjusted loss per category, an allowance for credit losses is calculated by multiplying the adjusted loss rate with the amortized cost in the respective age category.</span></p> <p id="xdx_800_eus-gaap--VariableInterestEntityDisclosureTextBlock_zRaLTjiiQ4X9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>4. <span id="xdx_829_zMK3YKz1Y691">VIE STRUCTURE AND ARRANGEMENTS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 27, 2016, DSwiss (HK) Limited (“DSHK”) entered into a Management Services Agreement (the “Management Services Agreement I”) which entitles DSHK to substantially entitled to all of the economic benefits of DSwiss Biotech Sdn Bhd (“DSBT”) in consideration of services provided by DSHK to DSBT. Pursuant to the Management Services Agreement I, DSHK has the exclusive right to provide to DSBT management, financial and other services related to the operation of DSBT’s business, and DSBT is required to take all commercially reasonable efforts to permit and facilitate the provision of the services provided by DSHK. As compensation for providing the services, DSHK is entitled to receive a fee from DSBT, upon demand, equal to <span id="xdx_904_ecustom--PercentageOfAnnualNetProfitToBeReceivedAsFee_dp_uPure_c20160626__20160627__us-gaap--TypeOfArrangementAxis__custom--ManagementServicesAgreementIMember__dei--LegalEntityAxis__custom--DSwissHKLimitedMember_z9LqoRLHlLqc" title="Percentage of annual net profit to be received as fee">100%</span> of the annual net profits of DSBT during the term of the Management Services Agreement I. DSHK may also request, on ad hoc basis, quarterly payments of the aggregate fee, which payments will be credited against DSBT’s future payment obligations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Management Services Agreement I also provides DSHK, or its designee, with a right of first refusal to acquire all or any portion of the equity of DSBT upon any proposal by the sole shareholder of DSBT to transfer such equity. In addition, at the sole discretion of DSHK, DSBT is obligated to transfer to DSHK, or its designee, any part or all of the business, personnel, assets and operations of DSBT which may be lawfully conducted, employed, owned or operated by DSHK, including:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) business opportunities presented to, or available to DSBT may be pursued and contracted for in the name of DSHK rather than DSBT, and at its discretion, DSHK may employ the resources of DSBT to secure such opportunities;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) any tangible or intangible property of DSBT, any contractual rights, any personnel, and any other items or things of value held by DSBT may be transferred to DSHK at book value;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) real property, personal or intangible property, personnel, services, equipment, supplies and any other items useful for the conduct of the business may be obtained by DSHK by acquisition, lease, license or otherwise, and made available to DSBT on terms to be determined by agreement between DSHK and DSBT;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) contracts entered into in the name of DSBT may be transferred to DSHK, or the work under such contracts may be subcontracted, in whole or in part, to DSHK, on terms to be determined by agreement between DSHK and DSBT; and</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) any changes to, or any expansion or contraction of, the business may be carried out in the exercise of the sole discretion of DSHK, and in the name of and at the expense of, DSHK; provided, however, that none of the foregoing may cause or have the effect of terminating (without being substantially replaced under the name of DSHK) or adversely affecting any license, permit or regulatory status of DSBT.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In addition, DSHK entered into certain agreements with Jervey Choon, (the “DSBT shareholder”), including</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a Call Option Agreement allowing DSHK to acquire the shares of DSBT as permitted by Malaysia laws;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a Shareholders’ Voting Rights Proxy Agreement that provides DSHK with the voting rights of the DSBT; and</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an Equity Pledge Agreement that pledges the shares in DSBT.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This VIE structure provides DSHK, a wholly-owned subsidiary of DSwiss Holding Limited, which is the wholly-owned subsidiary of DSwiss Inc, with control over the operations and benefits of DSBT without having a direct equity ownership in DSBT.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 18, 2023, DSwiss (HK) Limited acquired <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20230118__20230118__srt--OwnershipAxis__custom--DSwissHKLimitedMember_ze2vQ4v9Cqla" title="Number of shares, acquired">150,000</span> shares, representing <span id="xdx_906_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20230118__srt--OwnershipAxis__custom--DSwissHKLimitedMember_zps3SZFszc7d" title="Equity ownership interest rate percentage">60%</span> equity interest in DSwiss Biotech Sdn. Bhd., from the other party <span style="background-color: white">with consideration of RM <span id="xdx_905_eus-gaap--SharesIssuedPricePerShare_iI_pid_uMYRPShare_c20230118__srt--OwnershipAxis__custom--DSwissHKLimitedMember_zkyRNvSENK2b" title="Consideration price per share">1</span>. After such acquisition, </span>DSwiss Biotech Sdn. Bhd. became a wholly owned subsidiary of DSwiss (HK) Limited.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DSWISS, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 1 150000 0.60 1 <p id="xdx_80E_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zrebhTtKYeE6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5. <span id="xdx_822_zTX4IpOPqhAa">STOCKHOLDERS’ EQUITY</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2023 and 2022, the Company had a total of <span id="xdx_905_eus-gaap--CommonStockSharesIssued_iI_pid_c20231231_zNWQPKzeZhkl" title="Common stock shares issued"><span id="xdx_906_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20231231_zEGhWtFr2eq5" title="Common stock shares outstanding">206,904,585</span></span> and <span id="xdx_90D_eus-gaap--CommonStockSharesIssued_iI_pid_c20221231_zuwKcYWQsUfk" title="Common stock shares issued"><span id="xdx_907_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20221231_z4k1uqKQtxv3" title="Common stock shares outstanding">206,904,585</span></span> of its common stock issued and outstanding. There are <span id="xdx_907_eus-gaap--PreferredStockSharesIssued_iI_pid_do_c20231231_zm78rgDtbYMh" title="Preferred stock shares issued"><span id="xdx_90A_eus-gaap--PreferredStockSharesOutstanding_iI_pid_do_c20231231_zXfakaSRcpS" title="Preferred stock shares outstanding"><span id="xdx_903_eus-gaap--PreferredStockSharesIssued_iI_pid_do_c20221231_zQriDc5jYJXb" title="Preferred stock shares issued"><span id="xdx_90E_eus-gaap--PreferredStockSharesOutstanding_iI_pid_do_c20221231_zFvcxHMLr9pd" title="Preferred stock shares outstanding">no</span></span></span></span> shares of preferred stock issued and outstanding.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 206904585 206904585 206904585 206904585 0 0 0 0 <p id="xdx_80E_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zMOnh0llz04l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>6. <span id="xdx_824_zkXd2M9ferli">PROPERTY AND EQUIPMENT</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_898_eus-gaap--PropertyPlantAndEquipmentTextBlock_z6Ma9a3ZXDD" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B5_zb3XeJKxQcTl" style="display: none">SCHEDULE OF PLANT AND EQUIPMENT</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20231231_z76jLfyEItvb" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2023</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_491_20221231_zHDvmCMYymd6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2022</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_407_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ComputerAndSoftwareMember_zt2ZD2htAzme" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; text-align: left">Computer and software</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">102,064</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">105,535</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zeTe4RcM1b5i" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Furniture and fittings</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,144</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,144</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_zBAtBgNBUApc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Office equipment</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">21,525</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">21,152</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MotorVehiclesMember_zrATysdha5A1" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Motor vehicle</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">135,868</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">135,868</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_maPPAENzRDA_zjfZHUcpCkE2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Total property and equipment</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">265,601</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">268,699</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_msPPAENzRDA_zpDSudzvyuJl" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Accumulated depreciation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(205,600</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(187,236</td><td style="text-align: left">)</td></tr> <tr id="xdx_400_ecustom--EffectOfTranslationExchange_iNI_pp0p0_di_msPPAENzRDA_zFTcIk4e5IX8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Effect of translation exchange</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(11,896</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(9,284</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40F_eus-gaap--PropertyPlantAndEquipmentNet_iTI_pp0p0_mtPPAENzRDA_zXqElRrHRqW1" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Property and equipment, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">48,105</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">72,179</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AB_zmqp498y11wf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Depreciation expense for the year ended December 31, 2023 and December 31, 2022 were $<span id="xdx_905_eus-gaap--Depreciation_pp0p0_c20230101__20231231_zn6iXewAh9Gd" title="Depreciation expense">21,833</span> and $<span id="xdx_905_eus-gaap--Depreciation_pp0p0_c20220101__20221231_z2aaQFAkk0T3" title="Depreciation expense">30,131</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_898_eus-gaap--PropertyPlantAndEquipmentTextBlock_z6Ma9a3ZXDD" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B5_zb3XeJKxQcTl" style="display: none">SCHEDULE OF PLANT AND EQUIPMENT</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20231231_z76jLfyEItvb" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2023</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_491_20221231_zHDvmCMYymd6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2022</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_407_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ComputerAndSoftwareMember_zt2ZD2htAzme" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; text-align: left">Computer and software</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">102,064</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">105,535</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zeTe4RcM1b5i" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Furniture and fittings</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,144</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,144</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_zBAtBgNBUApc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Office equipment</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">21,525</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">21,152</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MotorVehiclesMember_zrATysdha5A1" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Motor vehicle</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">135,868</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">135,868</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_maPPAENzRDA_zjfZHUcpCkE2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Total property and equipment</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">265,601</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">268,699</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_msPPAENzRDA_zpDSudzvyuJl" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Accumulated depreciation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(205,600</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(187,236</td><td style="text-align: left">)</td></tr> <tr id="xdx_400_ecustom--EffectOfTranslationExchange_iNI_pp0p0_di_msPPAENzRDA_zFTcIk4e5IX8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Effect of translation exchange</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(11,896</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(9,284</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40F_eus-gaap--PropertyPlantAndEquipmentNet_iTI_pp0p0_mtPPAENzRDA_zXqElRrHRqW1" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Property and equipment, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">48,105</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">72,179</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 102064 105535 6144 6144 21525 21152 135868 135868 265601 268699 205600 187236 11896 9284 48105 72179 21833 30131 <p id="xdx_804_eus-gaap--IntangibleAssetsDisclosureTextBlock_zqzek5P5kmse" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>7. <span id="xdx_821_zZHq8z6Ug2Gb">INTANGIBLE ASSETS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_893_eus-gaap--ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_zbLjfj5Enpq3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B5_zg2ATstcbJ38" style="display: none">SCHEDULE OF INTANGIBLE ASSETS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20231231_zkQtRsqFRaSd" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2023</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_491_20221231_zwj6i5J94LVc" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2022</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_406_eus-gaap--FiniteLivedTrademarksGross_iI_pp0p0_maIANEGzWXd_zaQrgnIOAAU2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%">Trademarks</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">12,077</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">12,077</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_pp0p0_di_msIANEGzWXd_zF6XiXFU9nZd" style="vertical-align: bottom; background-color: White"> <td>Amortization</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(9,194</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(8,164</td><td style="text-align: left">)</td></tr> <tr id="xdx_409_ecustom--IntangibleAssetsEffectOfTranslationExchange_iNI_pp0p0_di_msIANEGzWXd_z3WBe9iU3CE" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Effect of translation exchange</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(456</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(454</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_408_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iTI_pp0p0_mtIANEGzWXd_z7JI5LwxeLye" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Intangible assets, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,427</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,459</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A8_z2sGTcrqsXCa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Amortization for the year ended December 31, 2023 and December 31, 2022 were $<span id="xdx_909_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20230101__20231231_zHVjpnGroy53" title="Amortization of intangible assets">1,030</span> and $<span id="xdx_90B_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20220101__20221231_zygq0ZmSLq0g" title="Amortization of intangible assets">1,029</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_893_eus-gaap--ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_zbLjfj5Enpq3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B5_zg2ATstcbJ38" style="display: none">SCHEDULE OF INTANGIBLE ASSETS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20231231_zkQtRsqFRaSd" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2023</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_491_20221231_zwj6i5J94LVc" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2022</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_406_eus-gaap--FiniteLivedTrademarksGross_iI_pp0p0_maIANEGzWXd_zaQrgnIOAAU2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%">Trademarks</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">12,077</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">12,077</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_pp0p0_di_msIANEGzWXd_zF6XiXFU9nZd" style="vertical-align: bottom; background-color: White"> <td>Amortization</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(9,194</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(8,164</td><td style="text-align: left">)</td></tr> <tr id="xdx_409_ecustom--IntangibleAssetsEffectOfTranslationExchange_iNI_pp0p0_di_msIANEGzWXd_z3WBe9iU3CE" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Effect of translation exchange</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(456</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(454</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_408_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iTI_pp0p0_mtIANEGzWXd_z7JI5LwxeLye" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Intangible assets, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,427</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,459</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 12077 12077 9194 8164 456 454 2427 3459 1030 1029 <p id="xdx_802_eus-gaap--OtherCurrentAssetsTextBlock_zCOAVNwL2FP3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>8. <span id="xdx_825_zxBBXOHOp1Cj">OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89A_eus-gaap--DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_zqERayDQNDze" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B9_zmKFOKarxl28" style="display: none">SCHEDULE OF OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_495_20231231_zpQ6EyF0OQZj" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2023</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_497_20221231_zwo9ZvPCxl1j" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2022</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_403_eus-gaap--OtherReceivables_iI_maPEAOAzAo0_zx1KhYmU1zJ7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; text-align: left">Other receivables</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">5,460</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0659">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--PrepaidExpenseCurrent_iI_pp0p0_maPEAOAzAo0_zfXBIvbK1Dr5" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Prepaid expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,932</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,080</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--DepositsAssets_iI_pp0p0_maPEAOAzAo0_zxor4F23D8Bg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Deposits</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">17,140</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">19,669</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iTI_pp0p0_mtPEAOAzAo0_z6UcLCOonru4" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total other receivables, prepaid expenses and deposits</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">24,532</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">21,749</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AB_zXndXg79Gtaa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89A_eus-gaap--DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_zqERayDQNDze" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B9_zmKFOKarxl28" style="display: none">SCHEDULE OF OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_495_20231231_zpQ6EyF0OQZj" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2023</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_497_20221231_zwo9ZvPCxl1j" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2022</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_403_eus-gaap--OtherReceivables_iI_maPEAOAzAo0_zx1KhYmU1zJ7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; text-align: left">Other receivables</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">5,460</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0659">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--PrepaidExpenseCurrent_iI_pp0p0_maPEAOAzAo0_zfXBIvbK1Dr5" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Prepaid expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,932</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,080</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--DepositsAssets_iI_pp0p0_maPEAOAzAo0_zxor4F23D8Bg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Deposits</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">17,140</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">19,669</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iTI_pp0p0_mtPEAOAzAo0_z6UcLCOonru4" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total other receivables, prepaid expenses and deposits</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">24,532</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">21,749</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 5460 1932 2080 17140 19669 24532 21749 <p id="xdx_807_eus-gaap--InventoryDisclosureTextBlock_zXhJ9pNXvvKc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>9. <span id="xdx_827_zfoQwr0f0gTb">INVENTORIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89A_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zc1rzuLTAyIk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BE_zyvMkEulg6qf" style="display: none">SCHEDULE OF INVENTORIES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_496_20231231_zoDJF5MUWqZ2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2023</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_497_20221231_zPenDvPco4xj" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2022</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_402_eus-gaap--InventoryFinishedGoods_iI_pp0p0_maINzv95_zjf9O20Qkxm9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; text-align: left; padding-bottom: 1.5pt">Finished goods, at cost</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 18%; text-align: right">6,872</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 18%; text-align: right">7,483</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--InventoryNet_iTI_pp0p0_mtINzv95_zGlUt7NuJ3D7" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total inventories</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">6,872</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">7,483</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A9_zH6mJ9vixdl2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DSWISS, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_89A_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zc1rzuLTAyIk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BE_zyvMkEulg6qf" style="display: none">SCHEDULE OF INVENTORIES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_496_20231231_zoDJF5MUWqZ2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2023</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_497_20221231_zPenDvPco4xj" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2022</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_402_eus-gaap--InventoryFinishedGoods_iI_pp0p0_maINzv95_zjf9O20Qkxm9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; text-align: left; padding-bottom: 1.5pt">Finished goods, at cost</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 18%; text-align: right">6,872</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 18%; text-align: right">7,483</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--InventoryNet_iTI_pp0p0_mtINzv95_zGlUt7NuJ3D7" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total inventories</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">6,872</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">7,483</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 6872 7483 6872 7483 <p id="xdx_806_eus-gaap--AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_zd6tWV27mVl5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>10. <span id="xdx_821_zrpkVgwLDdqc">OTHER PAYABLES AND ACCRUED LIABILITIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89E_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zc4MC7LXOlOj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span><span id="xdx_8BA_zJGF7jDL2PS4" style="display: none">SCHEDULE OF OTHER PAYABLE AND ACCRUED LIABILITIES</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_494_20231231_zmbaHZUciyd" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2023</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20221231_zXFRVHLoGsQa" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2022</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_401_eus-gaap--AccountsPayableOtherCurrent_iI_pp0p0_maOAPAAzLk2_zkY0aEDuz0Ag" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; text-align: left">Other payables</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">114,964</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">100,385</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_406_ecustom--AccruedAuditFeesCurrent_iI_pp0p0_maOAPAAzLk2_zl48sV7QbSvb" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Accrued audit fees</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">30,207</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">20,266</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pp0p0_maOAPAAzLk2_zA2XNjjgs1kd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Accrued other expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">15,222</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">16,683</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--AccruedProfessionalFeesCurrent_iI_pp0p0_maOAPAAzLk2_zf5hPMXx1EIe" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Accrued professional fees</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">14,321</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">17,376</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--OtherAccountsPayableAndAccruedLiabilities_iTI_pp0p0_mtOAPAAzLk2_zS3i87pUyZTk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Total payables and accrued liabilities</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">174,714</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">154,710</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A9_zUb8WVVtcT2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89E_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zc4MC7LXOlOj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span><span id="xdx_8BA_zJGF7jDL2PS4" style="display: none">SCHEDULE OF OTHER PAYABLE AND ACCRUED LIABILITIES</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_494_20231231_zmbaHZUciyd" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2023</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20221231_zXFRVHLoGsQa" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2022</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_401_eus-gaap--AccountsPayableOtherCurrent_iI_pp0p0_maOAPAAzLk2_zkY0aEDuz0Ag" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; text-align: left">Other payables</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">114,964</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">100,385</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_406_ecustom--AccruedAuditFeesCurrent_iI_pp0p0_maOAPAAzLk2_zl48sV7QbSvb" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Accrued audit fees</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">30,207</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">20,266</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pp0p0_maOAPAAzLk2_zA2XNjjgs1kd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Accrued other expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">15,222</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">16,683</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--AccruedProfessionalFeesCurrent_iI_pp0p0_maOAPAAzLk2_zf5hPMXx1EIe" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Accrued professional fees</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">14,321</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">17,376</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--OtherAccountsPayableAndAccruedLiabilities_iTI_pp0p0_mtOAPAAzLk2_zS3i87pUyZTk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Total payables and accrued liabilities</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">174,714</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">154,710</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 114964 100385 30207 20266 15222 16683 14321 17376 174714 154710 <p id="xdx_80A_eus-gaap--LesseeFinanceLeasesTextBlock_zGWJQVQ1h0c5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>11. <span id="xdx_82B_zgRgQh4E6ty4">FINANCE LEASE LIABILITIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company purchased motor vehicles with finance lease. <span id="xdx_90E_eus-gaap--LesseeFinanceLeaseDescription_c20230101__20231231__us-gaap--TypeOfArrangementAxis__custom--FirstFinanceLeaseAgreementMember_zCz4UOPlCGbg" title="Finance lease, description">The first finance lease agreement commenced on July 31, 2018 with the effective interest rate of 3.62% per annum, due through June, 2025, with principal and interest payable monthly.</span> <span id="xdx_907_eus-gaap--LesseeFinanceLeaseDescription_c20230101__20231231__us-gaap--TypeOfArrangementAxis__custom--SecondFinanceLeaseAgreementMember_zafbwCIYKsKj" title="Finance lease, description">The second finance lease agreement commenced on December 3, 2021 with the effective interest rate of 3.70% per annum, due through November, 2026, with principal and interest payable monthly.</span> The obligation under the finance lease is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89A_ecustom--ScheduleOfObligationUnderFinanceLeaseTableTextBlock_ztcvgpmxP8bg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BD_zZON6nmI0nri" style="display: none">SCHEDULE OF OBLIGATION UNDER FINANCE LEASE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20231231_zxPsUTtz47Aj" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2023</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20221231_zTkRJrDaprTk" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2022</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_400_eus-gaap--FinanceLeaseLiabilityPaymentsDue_iI_pp0p0_zO3Ma6qjhWbj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; text-align: left">Finance leases</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">38,817</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">58,768</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--FinanceLeaseLiabilityUndiscountedExcessAmount_iNI_pp0p0_di_zPQZtExkJId1" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Less: interest expense</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,813</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3,792</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40E_eus-gaap--FinanceLeaseLiability_iTI_pp0p0_zygYLlG9AE7d" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Net present value of finance leases</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">37,004</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">54,976</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--FinanceLeaseLiabilityCurrent_iI_pp0p0_zxuygoRvFSEf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Current portion</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">21,039</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">16,515</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--FinanceLeaseLiabilityNoncurrent_iI_pp0p0_zqhTyhtk0Km3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Non-current portion</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">15,965</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">38,461</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--FinanceLeaseLiability_iTI_pp0p0_zFuxXuXw7jxf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">37,004</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">54,976</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AC_zrkoI0pogJEf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_897_eus-gaap--FinanceLeaseLiabilityMaturityTableTextBlock_zrBAK1Zf2bGe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2023, the maturities of the finance leases for each of the years are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BC_zXKgd6KtalD1" style="display: none">SCHEDULE OF MATURITIES OF FINANCE LEASE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49F_20231231_zkLSVVKCHyud" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pp0p0_maFLLPDzFyD_zWMukdpM03jf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; text-align: justify">2024</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">16,570</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearTwo_iI_pp0p0_maFLLPDzFyD_zEAojDulX3z5" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">2025</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">12,655</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearThree_iI_pp0p0_maFLLPDzFyD_zPaWMIgW9I2l" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1.5pt">2026</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,779</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--FinanceLeaseLiability_iTI_pp0p0_mtFLLPDzFyD_zf4mt3rCNqH2" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">37,004</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A7_zImDTW0pCGw7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DSWISS, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> The first finance lease agreement commenced on July 31, 2018 with the effective interest rate of 3.62% per annum, due through June, 2025, with principal and interest payable monthly. The second finance lease agreement commenced on December 3, 2021 with the effective interest rate of 3.70% per annum, due through November, 2026, with principal and interest payable monthly. <p id="xdx_89A_ecustom--ScheduleOfObligationUnderFinanceLeaseTableTextBlock_ztcvgpmxP8bg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BD_zZON6nmI0nri" style="display: none">SCHEDULE OF OBLIGATION UNDER FINANCE LEASE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20231231_zxPsUTtz47Aj" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2023</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20221231_zTkRJrDaprTk" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2022</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_400_eus-gaap--FinanceLeaseLiabilityPaymentsDue_iI_pp0p0_zO3Ma6qjhWbj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; text-align: left">Finance leases</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">38,817</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">58,768</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--FinanceLeaseLiabilityUndiscountedExcessAmount_iNI_pp0p0_di_zPQZtExkJId1" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Less: interest expense</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,813</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3,792</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40E_eus-gaap--FinanceLeaseLiability_iTI_pp0p0_zygYLlG9AE7d" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Net present value of finance leases</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">37,004</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">54,976</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--FinanceLeaseLiabilityCurrent_iI_pp0p0_zxuygoRvFSEf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Current portion</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">21,039</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">16,515</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--FinanceLeaseLiabilityNoncurrent_iI_pp0p0_zqhTyhtk0Km3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Non-current portion</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">15,965</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">38,461</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--FinanceLeaseLiability_iTI_pp0p0_zFuxXuXw7jxf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">37,004</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">54,976</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 38817 58768 1813 3792 37004 54976 21039 16515 15965 38461 37004 54976 <p id="xdx_897_eus-gaap--FinanceLeaseLiabilityMaturityTableTextBlock_zrBAK1Zf2bGe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2023, the maturities of the finance leases for each of the years are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BC_zXKgd6KtalD1" style="display: none">SCHEDULE OF MATURITIES OF FINANCE LEASE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49F_20231231_zkLSVVKCHyud" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pp0p0_maFLLPDzFyD_zWMukdpM03jf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; text-align: justify">2024</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">16,570</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearTwo_iI_pp0p0_maFLLPDzFyD_zEAojDulX3z5" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">2025</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">12,655</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearThree_iI_pp0p0_maFLLPDzFyD_zPaWMIgW9I2l" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1.5pt">2026</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,779</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--FinanceLeaseLiability_iTI_pp0p0_mtFLLPDzFyD_zf4mt3rCNqH2" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">37,004</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 16570 12655 7779 37004 <p id="xdx_802_eus-gaap--IncomeTaxDisclosureTextBlock_zKDQsjefDEKg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>12. <span id="xdx_828_zENUMdhQQIkb">INCOME TAXES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_893_eus-gaap--ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_zrACFPuPDih8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the year ended December 31, 2023 and year ended December 31, 2022, the local (United States) and foreign components of (loss)/profit before income taxes were comprised of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BF_ztd2C2sKbo7a" style="display: none">SCHEDULE OF COMPONENTS OF INCOME LOSS BEFORE INCOME TAXES</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_495_20230101__20231231_z8aV4opug0ui" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the year ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2023</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_496_20220101__20221231_zYhgMJpjDZbe" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the year ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2022</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Tax jurisdictions from:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_hsrt--StatementGeographicalAxis__country--US_zJvWZSTvrM5k" style="vertical-align: bottom; background-color: White"> <td style="width: 56%">- Local</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">(51,974</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">(43,174</td><td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">- Foreign, representing</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_hsrt--StatementGeographicalAxis__country--SC_zlWOxJXhbkRk" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Seychelles</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3,207</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(11,643</td><td style="text-align: left">)</td></tr> <tr id="xdx_400_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_hsrt--StatementGeographicalAxis__country--HK_zCop2o74lwqb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 10pt">Hong Kong</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3,703</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3,951</td><td style="text-align: left">)</td></tr> <tr id="xdx_40A_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_hsrt--StatementGeographicalAxis__country--MY_zFMjdJRb1se8" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; padding-left: 10pt">Malaysia</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">10,006</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">56,347</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_z7kUIlAPeR51" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Loss before income tax</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(48,878</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(2,421</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> <p id="xdx_8A9_z9ET1ETi9n16" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_890_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zLqbWURsMzO8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The provision for income taxes consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BB_zRLMaeNC937g" style="display: none">SCHEDULE OF PROVISION FOR INCOME TAXES</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_491_20230101__20231231_z08eMYibdCej" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the year ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2023</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_497_20220101__20221231_zvcFl3X9fNId" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the year ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2022</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr id="xdx_401_eus-gaap--CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_iB_zXhOvtBBSZV1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Current:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_i01_maITEBztWa_zVAHUZGzXn58" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">- Local</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0759">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0760">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--CurrentForeignTaxExpenseBenefit_i01N_di_maITEBztWa_zY0AfXFJBYP4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; padding-left: 10pt">- Foreign</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 18%; text-align: right">(657</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 18%; text-align: right">(516</td><td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_iB_ziJt8EgyQxMa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Deferred:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_i01_maITEBztWa_z8r8UXuYIr4c" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">- Local</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0768">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0769">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_i01_maITEBztWa_zp1AKX4EAMc2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; padding-left: 10pt">- Foreign</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0771">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0772">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--IncomeTaxExpenseBenefit_iNT_pp0p0_di_mtITEBztWa_ze29zYgWsBMi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Income tax expense</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(657</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(516</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> <p id="xdx_8AE_ziFcmjeh7zp6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_892_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zSjkHJ4itMJ5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table sets forth the significant components of the aggregate deferred tax assets of the Company for the year ended December 31, 2023 and 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B8_z19ewqPLXVli" style="display: none">SCHEDULE OF DEFERRED INCOME TAX ASSETS</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the year ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2023</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the year ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2022</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Deferred tax assets:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Net operating loss carry forwards</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; text-align: left">-United States of America</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iNI_pp0p0_di_c20231231__us-gaap--IncomeTaxAuthorityNameAxis__custom--UnitedStatesOfAmericaMember_zn9vZq18R7Al" style="width: 18%; text-align: right" title="Net operating loss carry forwards">(110,066</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iNI_pp0p0_di_c20221231__us-gaap--IncomeTaxAuthorityNameAxis__custom--UnitedStatesOfAmericaMember_z2lvHdvzJKfg" style="width: 18%; text-align: right" title="Net operating loss carry forwards">(99,152</td><td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">-Seychelles</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iNI_pdp0_di_c20231231__us-gaap--IncomeTaxAuthorityNameAxis__custom--SeychellesMember_zJJSWvpxzQ77" style="text-align: right" title="Net operating loss carry forwards"><span style="-sec-ix-hidden: xdx2ixbrl0783">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iNI_pdp0_di_c20221231__us-gaap--IncomeTaxAuthorityNameAxis__custom--SeychellesMember_zRJeCfT3nDC1" style="text-align: right" title="Net operating loss carry forwards"><span style="-sec-ix-hidden: xdx2ixbrl0785">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">-Hong Kong</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iNI_pp0p0_di_c20231231__us-gaap--IncomeTaxAuthorityNameAxis__custom--HongKongMember_zcFAYfrnhJBl" style="text-align: right" title="Net operating loss carry forwards">(104,743</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iNI_pp0p0_di_c20221231__us-gaap--IncomeTaxAuthorityNameAxis__custom--HongKongMember_zVGfOhzosOQd" style="text-align: right" title="Net operating loss carry forwards">(104,132</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">-Malaysia</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iNI_pp0p0_di_c20231231__us-gaap--IncomeTaxAuthorityNameAxis__custom--MalaysiaMember_ztNt7EGiaZc4" style="text-align: right" title="Net operating loss carry forwards">(31,143</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iNI_pp0p0_di_c20221231__us-gaap--IncomeTaxAuthorityNameAxis__custom--MalaysiaMember_zbkYADCkypKa" style="text-align: right" title="Net operating loss carry forwards">(36,884</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">-PRC</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98B_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iNI_pp0p0_di_c20231231__us-gaap--IncomeTaxAuthorityNameAxis__custom--PeoplesRepublicOfChinaPRCMember_zxhhkMQpKc42" style="border-bottom: Black 1.5pt solid; text-align: right" title="Net operating loss carry forwards"><span style="-sec-ix-hidden: xdx2ixbrl0795">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98F_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iNI_pp0p0_di_c20221231__us-gaap--IncomeTaxAuthorityNameAxis__custom--PeoplesRepublicOfChinaPRCMember_zNzHluGT28Ha" style="border-bottom: Black 1.5pt solid; text-align: right" title="Net operating loss carry forwards"><span style="-sec-ix-hidden: xdx2ixbrl0797">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iNI_pp0p0_di_c20231231_zxb2qOZKWVVk" style="text-align: right" title="Net operating loss carry forwards">(245,952</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iNI_pp0p0_di_c20221231_zMJUUX59DGx3" style="text-align: right" title="Net operating loss carry forwards">(240,168</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Less: valuation allowance</td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--DeferredTaxAssetsValuationAllowance_iI_pp0p0_c20231231_zhlS6U3lwtQc" style="text-align: right" title="Less: valuation allowance">245,952</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--DeferredTaxAssetsValuationAllowance_iI_pp0p0_c20221231_zF8gKECGbQ9j" style="text-align: right" title="Less: valuation allowance">240,168</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Deferred tax assets</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--DeferredTaxAssetsNet_iTI_c20231231_zXzx6g3driBf" style="border-bottom: Black 2.5pt double; text-align: right" title="Deferred tax assets"><span style="-sec-ix-hidden: xdx2ixbrl0807">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--DeferredTaxAssetsNet_iTI_c20221231_zxq9l5xAj9j7" style="border-bottom: Black 2.5pt double; text-align: right" title="Deferred tax assets"><span style="-sec-ix-hidden: xdx2ixbrl0809">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A8_zrggao8moYt1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The effective tax rate in the periods presented is the result of the mix of income earned in various tax jurisdictions that apply a broad range of income tax rates. The Company and its subsidiary that operate in various countries: United States, Seychelles, Hong Kong, Malaysia, PRC that are subject to taxes in the jurisdictions in which they operate, as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>United States of America</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is registered in the State of Nevada and is subject to the tax laws of the United States of America. As of 31 December, 2023, the operations in the United States of America incurred $<span id="xdx_90B_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20231231__us-gaap--IncomeTaxAuthorityNameAxis__custom--UnitedStatesOfAmericaMember_zYRyMlPW6YT3" title="Cumulative net operating losses">524,125</span> of cumulative net operating losses which can be carried forward to offset future taxable income, at the tax rate of <span id="xdx_90D_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_uPure_c20230101__20231231__us-gaap--IncomeTaxAuthorityNameAxis__custom--UnitedStatesOfAmericaMember_zgitqfwrzKQ" title="Income tax rate">21</span>%. <span id="xdx_904_eus-gaap--OperatingLossCarryforwardsLimitationsOnUse_c20230101__20231231__us-gaap--IncomeTaxAuthorityNameAxis__custom--UnitedStatesOfAmericaMember_zmJG0bXmbHLa" title="Net operating loss carryforwards expiration">The net operating loss carry forwards begin to expire in 2038, if unutilized.</span> The Company has provided for a full valuation allowance of $<span id="xdx_905_eus-gaap--OperatingLossCarryforwardsValuationAllowance_iI_pp0p0_c20231231__us-gaap--IncomeTaxAuthorityNameAxis__custom--UnitedStatesOfAmericaMember_zJLQx1v8Lc47" title="Valuation allowance">110,066</span> against the deferred tax assets on the expected future tax benefits from the net operating loss carry forwards as the management believes it is more likely than not that these assets will not be realized in the future.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Seychelles</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under the current laws of the Seychelles, DSwiss Holding Limited is registered as an international business company which governs by the International Business Companies Act of Seychelles and there is no income tax charged in Seychelles.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Hong Kong</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DSwiss (HK) Limited is subject to Hong Kong Profits Tax, which is charged at the statutory income tax rate of <span id="xdx_905_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_uPure_c20230101__20231231__dei--LegalEntityAxis__custom--DSwissHKLimitedMember__us-gaap--IncomeTaxAuthorityNameAxis__custom--HongKongMember_z7UdE1J1L5Kf" title="Income tax rate">16.5</span>% on its assessable income. As of December 31, 2023, the operations in the Hong Kong incurred $<span id="xdx_90A_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20231231__dei--LegalEntityAxis__custom--DSwissHKLimitedMember__us-gaap--IncomeTaxAuthorityNameAxis__custom--HongKongMember_z8lt1Zb74aJ4" title="Cumulative net operating losses">634,806</span> of cumulative net operating losses which can be carried forward to offset future taxable income, at the tax rate of <span id="xdx_90B_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_c20230101__20231231__dei--LegalEntityAxis__custom--DSwissHKLimitedMember__us-gaap--IncomeTaxAuthorityNameAxis__custom--HongKongMember_z7Ebj2rrKJz" title="Statutory income tax, rate">16.5</span>%. The Company has provided for a full valuation allowance of $<span id="xdx_909_eus-gaap--OperatingLossCarryforwardsValuationAllowance_iI_pp0p0_c20231231__dei--LegalEntityAxis__custom--DSwissHKLimitedMember__us-gaap--IncomeTaxAuthorityNameAxis__custom--HongKongMember_ztqE1rTNfQIl" title="Valuation allowance">104,743</span> against the deferred tax assets on the expected future tax benefits from the net operating loss carry forwards as the management believes it is more likely than not that these assets will not be realized in the future.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DSWISS, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Malaysia</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DSwiss Sdn Bhd and DSwiss Biotech Sdn Bhd are subject to Malaysia Corporate Tax, which is charged at the statutory income tax rate range from <span id="xdx_90D_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_c20230101__20231231__dei--LegalEntityAxis__custom--DSwissSdnBhdandDSwissBiotechSdnBhdMember__us-gaap--IncomeTaxAuthorityNameAxis__custom--MalaysiaMember__srt--RangeAxis__srt--MinimumMember_ziCXxCfAANif" title="Percentage of statutory income rate">15</span>% to <span id="xdx_907_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_c20230101__20231231__dei--LegalEntityAxis__custom--DSwissSdnBhdandDSwissBiotechSdnBhdMember__us-gaap--IncomeTaxAuthorityNameAxis__custom--MalaysiaMember__srt--RangeAxis__srt--MaximumMember_z8XkZn4bKY01" title="Statutory income tax, rate">24</span>% on its assessable income. As of December 31, 2023, the operations in the Malaysia incurred $<span id="xdx_908_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20231231__dei--LegalEntityAxis__custom--DSwissSdnBhdandDSwissBiotechSdnBhdMember__us-gaap--IncomeTaxAuthorityNameAxis__custom--MalaysiaMember_zwGnLrFbW3si" title="Cumulative net operating losses">207,619</span> of cumulative net operating losses which can be carried forward to offset future taxable income, at the tax rate of <span id="xdx_904_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_uPure_c20230101__20231231__dei--LegalEntityAxis__custom--DSwissSdnBhdandDSwissBiotechSdnBhdMember__us-gaap--IncomeTaxAuthorityNameAxis__custom--MalaysiaMember_zh8KRkq26cS2" title="Income tax rate">15</span>%. The Company has provided for a full valuation allowance of $<span id="xdx_903_eus-gaap--OperatingLossCarryforwardsValuationAllowance_iI_pp0p0_c20231231__dei--LegalEntityAxis__custom--DSwissSdnBhdandDSwissBiotechSdnBhdMember__us-gaap--IncomeTaxAuthorityNameAxis__custom--MalaysiaMember_zHLfA1mgP4y1" title="Valuation allowance">31,143</span> against the deferred tax assets on the expected future tax benefits from the net operating loss carry forwards as the management believes it is more likely than not that these assets will not be realized in the future.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_893_eus-gaap--ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_zrACFPuPDih8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the year ended December 31, 2023 and year ended December 31, 2022, the local (United States) and foreign components of (loss)/profit before income taxes were comprised of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BF_ztd2C2sKbo7a" style="display: none">SCHEDULE OF COMPONENTS OF INCOME LOSS BEFORE INCOME TAXES</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_495_20230101__20231231_z8aV4opug0ui" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the year ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2023</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_496_20220101__20221231_zYhgMJpjDZbe" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the year ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2022</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Tax jurisdictions from:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_hsrt--StatementGeographicalAxis__country--US_zJvWZSTvrM5k" style="vertical-align: bottom; background-color: White"> <td style="width: 56%">- Local</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">(51,974</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">(43,174</td><td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">- Foreign, representing</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_hsrt--StatementGeographicalAxis__country--SC_zlWOxJXhbkRk" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Seychelles</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3,207</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(11,643</td><td style="text-align: left">)</td></tr> <tr id="xdx_400_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_hsrt--StatementGeographicalAxis__country--HK_zCop2o74lwqb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 10pt">Hong Kong</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3,703</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3,951</td><td style="text-align: left">)</td></tr> <tr id="xdx_40A_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_hsrt--StatementGeographicalAxis__country--MY_zFMjdJRb1se8" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; padding-left: 10pt">Malaysia</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">10,006</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">56,347</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_z7kUIlAPeR51" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Loss before income tax</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(48,878</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(2,421</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> -51974 -43174 -3207 -11643 -3703 -3951 10006 56347 -48878 -2421 <p id="xdx_890_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zLqbWURsMzO8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The provision for income taxes consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BB_zRLMaeNC937g" style="display: none">SCHEDULE OF PROVISION FOR INCOME TAXES</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_491_20230101__20231231_z08eMYibdCej" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the year ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2023</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_497_20220101__20221231_zvcFl3X9fNId" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the year ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2022</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr id="xdx_401_eus-gaap--CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_iB_zXhOvtBBSZV1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Current:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_i01_maITEBztWa_zVAHUZGzXn58" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">- Local</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0759">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0760">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--CurrentForeignTaxExpenseBenefit_i01N_di_maITEBztWa_zY0AfXFJBYP4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; padding-left: 10pt">- Foreign</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 18%; text-align: right">(657</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 18%; text-align: right">(516</td><td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_iB_ziJt8EgyQxMa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Deferred:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_i01_maITEBztWa_z8r8UXuYIr4c" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">- Local</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0768">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0769">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_i01_maITEBztWa_zp1AKX4EAMc2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; padding-left: 10pt">- Foreign</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0771">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0772">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--IncomeTaxExpenseBenefit_iNT_pp0p0_di_mtITEBztWa_ze29zYgWsBMi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Income tax expense</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(657</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(516</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> 657 516 657 516 <p id="xdx_892_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zSjkHJ4itMJ5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table sets forth the significant components of the aggregate deferred tax assets of the Company for the year ended December 31, 2023 and 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B8_z19ewqPLXVli" style="display: none">SCHEDULE OF DEFERRED INCOME TAX ASSETS</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the year ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2023</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the year ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2022</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Deferred tax assets:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Net operating loss carry forwards</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; text-align: left">-United States of America</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iNI_pp0p0_di_c20231231__us-gaap--IncomeTaxAuthorityNameAxis__custom--UnitedStatesOfAmericaMember_zn9vZq18R7Al" style="width: 18%; text-align: right" title="Net operating loss carry forwards">(110,066</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iNI_pp0p0_di_c20221231__us-gaap--IncomeTaxAuthorityNameAxis__custom--UnitedStatesOfAmericaMember_z2lvHdvzJKfg" style="width: 18%; text-align: right" title="Net operating loss carry forwards">(99,152</td><td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">-Seychelles</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iNI_pdp0_di_c20231231__us-gaap--IncomeTaxAuthorityNameAxis__custom--SeychellesMember_zJJSWvpxzQ77" style="text-align: right" title="Net operating loss carry forwards"><span style="-sec-ix-hidden: xdx2ixbrl0783">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iNI_pdp0_di_c20221231__us-gaap--IncomeTaxAuthorityNameAxis__custom--SeychellesMember_zRJeCfT3nDC1" style="text-align: right" title="Net operating loss carry forwards"><span style="-sec-ix-hidden: xdx2ixbrl0785">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">-Hong Kong</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iNI_pp0p0_di_c20231231__us-gaap--IncomeTaxAuthorityNameAxis__custom--HongKongMember_zcFAYfrnhJBl" style="text-align: right" title="Net operating loss carry forwards">(104,743</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iNI_pp0p0_di_c20221231__us-gaap--IncomeTaxAuthorityNameAxis__custom--HongKongMember_zVGfOhzosOQd" style="text-align: right" title="Net operating loss carry forwards">(104,132</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">-Malaysia</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iNI_pp0p0_di_c20231231__us-gaap--IncomeTaxAuthorityNameAxis__custom--MalaysiaMember_ztNt7EGiaZc4" style="text-align: right" title="Net operating loss carry forwards">(31,143</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iNI_pp0p0_di_c20221231__us-gaap--IncomeTaxAuthorityNameAxis__custom--MalaysiaMember_zbkYADCkypKa" style="text-align: right" title="Net operating loss carry forwards">(36,884</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">-PRC</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98B_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iNI_pp0p0_di_c20231231__us-gaap--IncomeTaxAuthorityNameAxis__custom--PeoplesRepublicOfChinaPRCMember_zxhhkMQpKc42" style="border-bottom: Black 1.5pt solid; text-align: right" title="Net operating loss carry forwards"><span style="-sec-ix-hidden: xdx2ixbrl0795">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98F_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iNI_pp0p0_di_c20221231__us-gaap--IncomeTaxAuthorityNameAxis__custom--PeoplesRepublicOfChinaPRCMember_zNzHluGT28Ha" style="border-bottom: Black 1.5pt solid; text-align: right" title="Net operating loss carry forwards"><span style="-sec-ix-hidden: xdx2ixbrl0797">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iNI_pp0p0_di_c20231231_zxb2qOZKWVVk" style="text-align: right" title="Net operating loss carry forwards">(245,952</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iNI_pp0p0_di_c20221231_zMJUUX59DGx3" style="text-align: right" title="Net operating loss carry forwards">(240,168</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Less: valuation allowance</td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--DeferredTaxAssetsValuationAllowance_iI_pp0p0_c20231231_zhlS6U3lwtQc" style="text-align: right" title="Less: valuation allowance">245,952</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--DeferredTaxAssetsValuationAllowance_iI_pp0p0_c20221231_zF8gKECGbQ9j" style="text-align: right" title="Less: valuation allowance">240,168</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Deferred tax assets</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--DeferredTaxAssetsNet_iTI_c20231231_zXzx6g3driBf" style="border-bottom: Black 2.5pt double; text-align: right" title="Deferred tax assets"><span style="-sec-ix-hidden: xdx2ixbrl0807">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--DeferredTaxAssetsNet_iTI_c20221231_zxq9l5xAj9j7" style="border-bottom: Black 2.5pt double; text-align: right" title="Deferred tax assets"><span style="-sec-ix-hidden: xdx2ixbrl0809">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 110066 99152 104743 104132 31143 36884 245952 240168 245952 240168 524125 0.21 The net operating loss carry forwards begin to expire in 2038, if unutilized. 110066 0.165 634806 0.165 104743 0.15 0.24 207619 0.15 31143 <p id="xdx_807_eus-gaap--ConcentrationRiskDisclosureTextBlock_zLwRpc8HYoS8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>13. <span id="xdx_825_zC2LTRPas5ck">CONCENTRATIONS OF RISKS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_892_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zFCSDd1FGeeb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) Major customers</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the year ended December 31, 2023 and 2022, the customers who accounted for 10% or more of the Company’s revenues and its accounts receivable balance at year-end are presented as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BB_zhcuKGpdxMD7" style="display: none">SCHEDULE OF CONCENTRATION OF RISK</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="22" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the year ended December 31</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Revenues</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Percentage of Revenues</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Accounts Receivable, Trade</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: justify">Customer A</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember_zgyHfTe4XFdk" style="width: 6%; text-align: right" title="Revenues"><span style="-sec-ix-hidden: xdx2ixbrl0841">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember_z9JknlZxD5z2" style="width: 6%; text-align: right" title="Revenues">501,470</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_981_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember_zL2AF6HqnE2i" style="width: 6%; text-align: right" title="Percentage of revenues"><span style="-sec-ix-hidden: xdx2ixbrl0845">-</span></td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember_ztZOP1Ag9bp1" style="width: 6%; text-align: right" title="Percentage of revenues">26</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember_zEYSaKjOOmvk" style="width: 6%; text-align: right" title="Accounts receivable, trade"><span style="-sec-ix-hidden: xdx2ixbrl0849">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember_zXeCU1yGZAF3" style="width: 6%; text-align: right" title="Accounts receivable, trade"><span style="-sec-ix-hidden: xdx2ixbrl0851">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Customer B</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember_zUPwyaWDfJ1a" style="text-align: right" title="Revenues">263,195</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember_zOllu1b22I6b" style="text-align: right" title="Revenues">386,232</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember_zKodnIS9XkZ4" style="text-align: right" title="Percentage of revenues">18</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember_zanzCjVqDcig" style="text-align: right" title="Percentage of revenues">20</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember_zydKy6LoHHEl" style="text-align: right" title="Accounts receivable, trade">35,247</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember_zZ1rH9Bq15u1" style="text-align: right" title="Accounts receivable, trade"><span style="-sec-ix-hidden: xdx2ixbrl0863">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Customer C</td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember_znXAgvApgkK2" style="text-align: right" title="Revenues">230,525</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember_zyLWYpeX4Yja" style="text-align: right" title="Revenues">221,638</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember_za0SKtvjRh7c" style="text-align: right" title="Revenues">16</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember_zN7BoQih0p6h" style="text-align: right" title="Revenues">12</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember_z6FAjW8WsY4h" style="text-align: right" title="Accounts receivable, trade"><span style="-sec-ix-hidden: xdx2ixbrl0873">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember_zBAJ6iFbJsJ4" style="text-align: right" title="Accounts receivable, trade"><span style="-sec-ix-hidden: xdx2ixbrl0875">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Customer D</td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerDMember_z0JTn1NJg3O2" style="text-align: right" title="Revenues">182,786</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerDMember_zwo2eSkqy4P" style="text-align: right" title="Revenues"><span style="-sec-ix-hidden: xdx2ixbrl0879">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerDMember_za8i3iFC9kb7" style="text-align: right" title="Revenues">12</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerDMember_zRtl7dZSACn3" style="text-align: right" title="Revenues">12</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerDMember_z2OfwvPCuhgc" style="text-align: right" title="Accounts receivable, trade"><span style="-sec-ix-hidden: xdx2ixbrl0885">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerDMember_z765NTbefk03" style="text-align: right" title="Accounts receivable, trade"><span style="-sec-ix-hidden: xdx2ixbrl0887">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1.5pt">Customer E</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerEMember_zu9r55foxpV6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenues">494,182</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerEMember_zzKCNgko9yef" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenues"><span style="-sec-ix-hidden: xdx2ixbrl0891">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerEMember_zNeLhpyakDDh" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenues">33</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerEMember_zgJXt94gqdzk" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenues">12</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98B_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerEMember_zFUsylpfOH16" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accounts receivable, trade"><span style="-sec-ix-hidden: xdx2ixbrl0897">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_984_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerEMember_z2fz8EnifLb3" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accounts receivable, trade"><span style="-sec-ix-hidden: xdx2ixbrl0899">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersMember_zEGWSLklmA7c" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues">1,170,688</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersMember_zbdiIvs8je8d" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues">1,109,340</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_989_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersMember_zmtnfKEaFGm5" style="border-bottom: Black 2.5pt double; text-align: right" title="Percentage of revenues">79</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersMember_z0iWA1qijf3d" style="border-bottom: Black 2.5pt double; text-align: right" title="Percentage of revenues">58</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersMember_zkg0n3tQTYu4" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable, trade">35,247</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersMember_zdb5oKdKWy89" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable, trade"><span style="-sec-ix-hidden: xdx2ixbrl0911">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) Major vendors</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the year ended December 31, 2023 and 2022, the vendors who accounted for 10% or more of the Company’s purchases and its accounts payable balance at year-end are presented as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="22" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the year ended December 31</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Purchases</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Percentage of Purchases</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Account Payable, Trade</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left">Vendor A</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorAMember_z4n18bRQ8el8" style="width: 6%; text-align: right" title="Purchase">163,262</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorAMember_zBXIFPtsa6T1" style="width: 6%; text-align: right" title="Purchase">477,099</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorAMember_zjMelRkrCnMc" style="width: 6%; text-align: right" title="Percentage of revenues">49</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorAMember_z1UmLkgDEbOf" style="width: 6%; text-align: right" title="Percentage of revenues">23</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--AccountsPayableTradeCurrentAndNoncurrent_iI_pp0p0_c20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorAMember_zzxJBIr9syB2" style="width: 6%; text-align: right" title="Account Payable, trade">5,984</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--AccountsPayableTradeCurrentAndNoncurrent_iI_pp0p0_c20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorAMember_zCbhJrSP1zOd" style="width: 6%; text-align: right" title="Account Payable, trade">1,626</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Vendor B</td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorBMember_zXCtXEo8BWt3" style="text-align: right" title="Purchase">548,438</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorBMember_zRu6mCKMXMZd" style="text-align: right" title="Purchase">331,538</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorBMember_zP2sNAaMlmD5" style="text-align: right" title="Percentage of revenues">15</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorBMember_zDUvy4quQKWl" style="text-align: right" title="Percentage of revenues">15</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--AccountsPayableTradeCurrentAndNoncurrent_iI_pp0p0_c20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorBMember_zl4SWAI2Udcj" style="text-align: right">64,194</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--AccountsPayableTradeCurrentAndNoncurrent_iI_pp0p0_c20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorBMember_zTlWG7krDQLf" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0933">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Vendor C</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_986_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorCMember_zmdBLBZzu8Rb" style="border-bottom: Black 1.5pt solid; text-align: right" title="Purchase">164,854</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_989_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorCMember_zWyjKrixv1Z1" style="border-bottom: Black 1.5pt solid; text-align: right" title="Purchase">221,743</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorCMember_zoRs1DdNNeK5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Percentage of revenues">14</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorCMember_zOl7mkBwg361" style="border-bottom: Black 1.5pt solid; text-align: right" title="Percentage of revenues">33</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_982_eus-gaap--AccountsPayableTradeCurrentAndNoncurrent_iI_pp0p0_c20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorCMember_zOB4xePjqTM2" style="border-bottom: Black 1.5pt solid; text-align: right">22,008</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_982_eus-gaap--AccountsPayableTradeCurrentAndNoncurrent_iI_pp0p0_c20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorCMember_zHkiUOX1blY1" style="border-bottom: Black 1.5pt solid; text-align: right">16,759</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorsMember_z7bj8zCnzETb" style="border-bottom: Black 2.5pt double; text-align: right" title="Purchase">876,554</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorsMember_zQJqWVDfD4rg" style="border-bottom: Black 2.5pt double; text-align: right" title="Purchase">1,030,380</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorsMember_zciFqcaeVau9" style="border-bottom: Black 2.5pt double; text-align: right" title="Concentration risk, percentage">78</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_988_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorsMember_zU9WnYlhfHif" style="border-bottom: Black 2.5pt double; text-align: right" title="Concentration risk, percentage">71</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--AccountsPayableTradeCurrentAndNoncurrent_iI_pp0p0_c20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorsMember_z47OH0C8MwUc" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts payable, trade">92,186</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--AccountsPayableTradeCurrentAndNoncurrent_iI_pp0p0_c20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorsMember_zpXpV71wjSO4" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts payable, trade">18,385</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A7_zeyL653VqcV3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) Credit risk</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that are potentially subject to credit risk consist principally of accounts receivable. The Company believes the concentration of credit risk in its trade receivables is substantially mitigated by its ongoing credit evaluation process and relatively short collection terms. The Company does not generally require collateral from customers. The Company evaluates the need for an allowance for doubtful accounts based upon factors surrounding the credit risk of specific customers, historical trends and other information.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) Exchange rate risk</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company cannot guarantee that the current exchange rate will remain steady; therefore, there is a possibility that the Company could post the same amount of profit for two comparable periods and because of the fluctuating exchange rate actually post higher or lower profit depending on exchange rate of MYR, HK$ and RMB converted to US$ on that date. The exchange rate could fluctuate depending on changes in political and economic environments without notice.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DSWISS, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_892_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zFCSDd1FGeeb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) Major customers</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the year ended December 31, 2023 and 2022, the customers who accounted for 10% or more of the Company’s revenues and its accounts receivable balance at year-end are presented as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BB_zhcuKGpdxMD7" style="display: none">SCHEDULE OF CONCENTRATION OF RISK</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="22" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the year ended December 31</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Revenues</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Percentage of Revenues</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Accounts Receivable, Trade</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: justify">Customer A</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember_zgyHfTe4XFdk" style="width: 6%; text-align: right" title="Revenues"><span style="-sec-ix-hidden: xdx2ixbrl0841">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember_z9JknlZxD5z2" style="width: 6%; text-align: right" title="Revenues">501,470</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_981_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember_zL2AF6HqnE2i" style="width: 6%; text-align: right" title="Percentage of revenues"><span style="-sec-ix-hidden: xdx2ixbrl0845">-</span></td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember_ztZOP1Ag9bp1" style="width: 6%; text-align: right" title="Percentage of revenues">26</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember_zEYSaKjOOmvk" style="width: 6%; text-align: right" title="Accounts receivable, trade"><span style="-sec-ix-hidden: xdx2ixbrl0849">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember_zXeCU1yGZAF3" style="width: 6%; text-align: right" title="Accounts receivable, trade"><span style="-sec-ix-hidden: xdx2ixbrl0851">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Customer B</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember_zUPwyaWDfJ1a" style="text-align: right" title="Revenues">263,195</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember_zOllu1b22I6b" style="text-align: right" title="Revenues">386,232</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember_zKodnIS9XkZ4" style="text-align: right" title="Percentage of revenues">18</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember_zanzCjVqDcig" style="text-align: right" title="Percentage of revenues">20</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember_zydKy6LoHHEl" style="text-align: right" title="Accounts receivable, trade">35,247</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember_zZ1rH9Bq15u1" style="text-align: right" title="Accounts receivable, trade"><span style="-sec-ix-hidden: xdx2ixbrl0863">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Customer C</td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember_znXAgvApgkK2" style="text-align: right" title="Revenues">230,525</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember_zyLWYpeX4Yja" style="text-align: right" title="Revenues">221,638</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember_za0SKtvjRh7c" style="text-align: right" title="Revenues">16</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember_zN7BoQih0p6h" style="text-align: right" title="Revenues">12</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember_z6FAjW8WsY4h" style="text-align: right" title="Accounts receivable, trade"><span style="-sec-ix-hidden: xdx2ixbrl0873">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember_zBAJ6iFbJsJ4" style="text-align: right" title="Accounts receivable, trade"><span style="-sec-ix-hidden: xdx2ixbrl0875">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Customer D</td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerDMember_z0JTn1NJg3O2" style="text-align: right" title="Revenues">182,786</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerDMember_zwo2eSkqy4P" style="text-align: right" title="Revenues"><span style="-sec-ix-hidden: xdx2ixbrl0879">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerDMember_za8i3iFC9kb7" style="text-align: right" title="Revenues">12</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerDMember_zRtl7dZSACn3" style="text-align: right" title="Revenues">12</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerDMember_z2OfwvPCuhgc" style="text-align: right" title="Accounts receivable, trade"><span style="-sec-ix-hidden: xdx2ixbrl0885">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerDMember_z765NTbefk03" style="text-align: right" title="Accounts receivable, trade"><span style="-sec-ix-hidden: xdx2ixbrl0887">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1.5pt">Customer E</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerEMember_zu9r55foxpV6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenues">494,182</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerEMember_zzKCNgko9yef" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenues"><span style="-sec-ix-hidden: xdx2ixbrl0891">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerEMember_zNeLhpyakDDh" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenues">33</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerEMember_zgJXt94gqdzk" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenues">12</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98B_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerEMember_zFUsylpfOH16" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accounts receivable, trade"><span style="-sec-ix-hidden: xdx2ixbrl0897">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_984_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerEMember_z2fz8EnifLb3" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accounts receivable, trade"><span style="-sec-ix-hidden: xdx2ixbrl0899">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersMember_zEGWSLklmA7c" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues">1,170,688</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersMember_zbdiIvs8je8d" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues">1,109,340</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_989_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersMember_zmtnfKEaFGm5" style="border-bottom: Black 2.5pt double; text-align: right" title="Percentage of revenues">79</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersMember_z0iWA1qijf3d" style="border-bottom: Black 2.5pt double; text-align: right" title="Percentage of revenues">58</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersMember_zkg0n3tQTYu4" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable, trade">35,247</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersMember_zdb5oKdKWy89" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable, trade"><span style="-sec-ix-hidden: xdx2ixbrl0911">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) Major vendors</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the year ended December 31, 2023 and 2022, the vendors who accounted for 10% or more of the Company’s purchases and its accounts payable balance at year-end are presented as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="22" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the year ended December 31</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Purchases</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Percentage of Purchases</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Account Payable, Trade</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left">Vendor A</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorAMember_z4n18bRQ8el8" style="width: 6%; text-align: right" title="Purchase">163,262</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorAMember_zBXIFPtsa6T1" style="width: 6%; text-align: right" title="Purchase">477,099</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorAMember_zjMelRkrCnMc" style="width: 6%; text-align: right" title="Percentage of revenues">49</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorAMember_z1UmLkgDEbOf" style="width: 6%; text-align: right" title="Percentage of revenues">23</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--AccountsPayableTradeCurrentAndNoncurrent_iI_pp0p0_c20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorAMember_zzxJBIr9syB2" style="width: 6%; text-align: right" title="Account Payable, trade">5,984</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--AccountsPayableTradeCurrentAndNoncurrent_iI_pp0p0_c20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorAMember_zCbhJrSP1zOd" style="width: 6%; text-align: right" title="Account Payable, trade">1,626</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Vendor B</td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorBMember_zXCtXEo8BWt3" style="text-align: right" title="Purchase">548,438</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorBMember_zRu6mCKMXMZd" style="text-align: right" title="Purchase">331,538</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorBMember_zP2sNAaMlmD5" style="text-align: right" title="Percentage of revenues">15</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorBMember_zDUvy4quQKWl" style="text-align: right" title="Percentage of revenues">15</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--AccountsPayableTradeCurrentAndNoncurrent_iI_pp0p0_c20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorBMember_zl4SWAI2Udcj" style="text-align: right">64,194</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--AccountsPayableTradeCurrentAndNoncurrent_iI_pp0p0_c20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorBMember_zTlWG7krDQLf" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0933">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Vendor C</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_986_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorCMember_zmdBLBZzu8Rb" style="border-bottom: Black 1.5pt solid; text-align: right" title="Purchase">164,854</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_989_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorCMember_zWyjKrixv1Z1" style="border-bottom: Black 1.5pt solid; text-align: right" title="Purchase">221,743</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorCMember_zoRs1DdNNeK5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Percentage of revenues">14</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorCMember_zOl7mkBwg361" style="border-bottom: Black 1.5pt solid; text-align: right" title="Percentage of revenues">33</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_982_eus-gaap--AccountsPayableTradeCurrentAndNoncurrent_iI_pp0p0_c20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorCMember_zOB4xePjqTM2" style="border-bottom: Black 1.5pt solid; text-align: right">22,008</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_982_eus-gaap--AccountsPayableTradeCurrentAndNoncurrent_iI_pp0p0_c20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorCMember_zHkiUOX1blY1" style="border-bottom: Black 1.5pt solid; text-align: right">16,759</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorsMember_z7bj8zCnzETb" style="border-bottom: Black 2.5pt double; text-align: right" title="Purchase">876,554</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorsMember_zQJqWVDfD4rg" style="border-bottom: Black 2.5pt double; text-align: right" title="Purchase">1,030,380</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorsMember_zciFqcaeVau9" style="border-bottom: Black 2.5pt double; text-align: right" title="Concentration risk, percentage">78</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_988_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorsMember_zU9WnYlhfHif" style="border-bottom: Black 2.5pt double; text-align: right" title="Concentration risk, percentage">71</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--AccountsPayableTradeCurrentAndNoncurrent_iI_pp0p0_c20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorsMember_z47OH0C8MwUc" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts payable, trade">92,186</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--AccountsPayableTradeCurrentAndNoncurrent_iI_pp0p0_c20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorsMember_zpXpV71wjSO4" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts payable, trade">18,385</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 501470 0.26 263195 386232 0.18 0.20 35247 230525 221638 0.16 0.12 182786 0.12 0.12 494182 0.33 0.12 1170688 1109340 0.79 0.58 35247 163262 477099 0.49 0.23 5984 1626 548438 331538 0.15 0.15 64194 164854 221743 0.14 0.33 22008 16759 876554 1030380 0.78 0.71 92186 18385 <p id="xdx_802_eus-gaap--LeasesOfLesseeDisclosureTextBlock_zfH35vFYiUG1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>14. <span id="xdx_82A_zbuWXU7k4b4a">LEASE RIGHT-OF-USE ASSET AND LEASE LIABILITIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company officially adopted ASC 842 for the period on and after January 1, 2019 as permitted by ASU 2016-02. ASC 842 originally required all entities to use a “modified retrospective” transition approach that is intended to maximize comparability and be less complex than a full retrospective approach. On July 30, 2018, the FASB issued ASU 2018-11 to provide entities with relief from the costs of implementing certain aspects of the new leasing standard, ASU 2016-02 of which permits entities may elect not to recast the comparative periods presented when transitioning to ASC 842. As permitted by ASU 2018-11, the Company elect not to recast comparative periods, thusly.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of January 1, 2022, the Company recognized approximately US$<span id="xdx_903_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pp0p0_c20220101__us-gaap--AdjustmentsForNewAccountingPronouncementsAxis__us-gaap--AccountingStandardsUpdate201602Member_zUHhXzuC3044" title="Lease asset- right of use">386,451</span>, lease liability as well as right-of-use asset for all leases (with the exception of short-term leases) at the commencement date. Lease liabilities are measured at present value of the sum of remaining rental payments as of January 1, 2022, with discounted rate of <span id="xdx_901_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20220101__us-gaap--AdjustmentsForNewAccountingPronouncementsAxis__us-gaap--AccountingStandardsUpdate201602Member_zSl3o6GnZpL6" title="Discount rate of lease payment">5.40</span>% adopted from Malayan Banking Berhad’s base lending rate as a reference for discount rate.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0">As of December 31, 2023, the tenancy agreement had expired, a new and fresh tenancy agreement for renewal term has yet to be executed. The lease on premises had continued on a month- to-month basis which is terminable by the end of each month.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A single lease cost is recognized over the lease term on a generally straight-line basis. All cash payments of operating lease cost are classified within operating activities in the statement of cash flows.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The initial recognition of operating lease right and lease liability as follow:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_898_eus-gaap--OperatingLeasesOfLesseeDisclosureTextBlock_zbR0lSSGmVth" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2023, operating lease right of use asset as follow:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B7_zdbwTE7VPw12" style="display: none">SCHEDULE OF OPERATION LEASE RIGHT OF USE ASSETS</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; text-align: justify">As of January 1,</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--OperatingLeaseRightOfUseAsset_iS_pp0p0_c20230101__20231231_zMRibiKhDAIf" style="width: 18%; text-align: right" title="Operating lease right of use asset, beginning">44,548</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--OperatingLeaseRightOfUseAsset_iS_pp0p0_c20220101__20221231_z2BvM82vK3M3" style="width: 18%; text-align: right" title="Operating lease right of use asset, beginning">92,606</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Accumulated amortization</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--OperatingLeaseRightOfUseAssetAmortizationExpense_iN_pp0p0_di_c20230101__20231231_zgeJrlhmfqUa" style="text-align: right" title="Accumulated amortization">(43,099</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--OperatingLeaseRightOfUseAssetAmortizationExpense_iN_pp0p0_di_c20220101__20221231_zj0Jct791ex8" style="text-align: right" title="Accumulated amortization">(42,310</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1.5pt">Effect of translation exchange</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_982_ecustom--EffectOfTranslationExchangeOperatingLeaseRightOfUseAsset_pp0p0_c20230101__20231231_zY0lyE9bMZ83" style="border-bottom: Black 1.5pt solid; text-align: right" title="Effect of translation exchange">(1,449</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_984_ecustom--EffectOfTranslationExchangeOperatingLeaseRightOfUseAsset_pp0p0_c20220101__20221231_z6kZkv73XPKj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Effect of translation exchange">(5,748</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Balance as of December 31</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--OperatingLeaseRightOfUseAsset_iE_pp0p0_c20230101__20231231_z26gwiHQC4h4" style="border-bottom: Black 2.5pt double; text-align: right" title="Operating lease right of use asset, ending"><span style="-sec-ix-hidden: xdx2ixbrl0977">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--OperatingLeaseRightOfUseAsset_iE_pp0p0_c20220101__20221231_z3Q2FPJGUXA4" style="border-bottom: Black 2.5pt double; text-align: right" title="Operating lease right of use asset, ending">44,548</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AC_zOb2qofhKncb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_891_ecustom--ScheduleOfOperatingLeaseLiabilityDisclosureTextBlock_zSdWt1AKzNhj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2023, operating lease liability as follow:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BD_zgXewaug8u12" style="display: none">SCHEDULE OF OPERATING LEASE LIABILITY</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; text-align: justify">As of January 1,</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--OperatingLeaseLiability_iS_c20230101__20231231_zcoTqVHnXE57" style="width: 16%; text-align: right" title="Operating lease liability, beginning">44,548</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Less: gross repayment</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--OperatingLeasePayments_iN_pp0p0_di_c20230101__20231231_zKGPZD1Fa79i" style="text-align: right" title="Less: gross repayment">(44,171</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Add: imputed interest</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iI_pp0p0_c20231231_zNH1y92AFtb1" style="text-align: right" title="Add: imputed interest">1,072</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Effect of translation exchange</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98E_ecustom--EffectOfTranslationExchangeOfOperatingLeaseLiability_pp0p0_c20230101__20231231_zMf0hgvSsfw9" style="border-bottom: Black 1.5pt solid; text-align: right" title="Effect of translation exchange">(1,449</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Balance as of December 31, 2023</td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--OperatingLeaseLiability_iE_pp0p0_c20230101__20231231_zAlUmlMWbPUb" style="text-align: right" title="Operating lease liability, ending"><span style="-sec-ix-hidden: xdx2ixbrl0991">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt">Less: lease liability current portion</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--OperatingLeaseLiabilityCurrent_iNI_pp0p0_di_c20231231_zaqjeJqjZujk" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less: lease liability current portion"><span style="-sec-ix-hidden: xdx2ixbrl0993">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt">Lease liability non-current portion</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pp0p0_c20231231_zQqPREYjZ2H9" style="border-bottom: Black 2.5pt double; text-align: right" title="Lease liability non-current portion"><span style="-sec-ix-hidden: xdx2ixbrl0995">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AF_zca9QOxKu2El" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the year ended December 31, 2023 and 2022, the amortization of the operating lease right of use asset are $<span id="xdx_90D_eus-gaap--OperatingLeaseRightOfUseAssetAmortizationExpense_pp0p0_c20230101__20231231__us-gaap--AdjustmentsForNewAccountingPronouncementsAxis__us-gaap--AccountingStandardsUpdate201602Member_zgpfYtiGIKjk" title="Operating lease right of use asset, amortization">43,099</span> and $<span id="xdx_90D_eus-gaap--OperatingLeaseRightOfUseAssetAmortizationExpense_pp0p0_c20220101__20221231__us-gaap--AdjustmentsForNewAccountingPronouncementsAxis__us-gaap--AccountingStandardsUpdate201602Member_zwu7VgEFHdr6" title="Operating lease right of use asset, amortization">42,310</span> respectively.</span></p> <p id="xdx_89B_ecustom--ScheduleOfOperatingLeaseOtherInformationTableTextBlock_z4H8TFpKC7Ff" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B7_zuj0Crk5McS7" style="display: none">SCHEDULE OF OPERATING LEASE OTHER INFORMATION</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year ended December 31,</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash paid for amounts included in the measurement of lease liabilities:</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif; width: 56%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating cash flow from operating lease</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_980_eus-gaap--ProceedsFromLeasePayments_pp0p0_c20230101__20231231_zeIqm5UKhdre" style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right" title="Operating cash flow from operating lease"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">42,862</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_987_eus-gaap--ProceedsFromLeasePayments_pp0p0_c20220101__20221231_zqYmb2v1AYif" style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right" title="Operating cash flow from operating lease"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">42,212</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Right-of-use assets obtained in exchange for operating lease liabilities</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_980_eus-gaap--RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_pp0p0_c20230101__20231231_zUFAwaZIBdF3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Right-of-use assets obtained in exchange for operating lease liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1007">-</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_985_eus-gaap--RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_pp0p0_c20220101__20221231_zNJkwQ9bUwHh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Right-of-use assets obtained in exchange for operating lease liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">44,548</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Remaining lease term for operating lease (years)</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20221231_z9xxqjFsAnbd" title="Remaining lease term for operating lease (years)">1</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted average discount rate for operating lease</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_985_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20231231_zGcuR6reYTn7" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average discount rate for operating lease"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.40</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98F_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20221231_zx4zIurhZKDi" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average discount rate for operating lease"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.40</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> </table> <p id="xdx_8AE_z2sVsI6RInl3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the year ended December 31, 2023 and 2022, lease expenses were $<span id="xdx_903_eus-gaap--PaymentsForRent_c20230101__20231231_zAmNhKuyhikf" title="Lease expenses">43,099</span> and $<span id="xdx_907_eus-gaap--PaymentsForRent_c20220101__20221231_zWwIAfzFUSk4" title="Lease expenses">42,310</span> respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DSWISS, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 386451 0.0540 <p id="xdx_898_eus-gaap--OperatingLeasesOfLesseeDisclosureTextBlock_zbR0lSSGmVth" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2023, operating lease right of use asset as follow:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B7_zdbwTE7VPw12" style="display: none">SCHEDULE OF OPERATION LEASE RIGHT OF USE ASSETS</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; text-align: justify">As of January 1,</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--OperatingLeaseRightOfUseAsset_iS_pp0p0_c20230101__20231231_zMRibiKhDAIf" style="width: 18%; text-align: right" title="Operating lease right of use asset, beginning">44,548</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--OperatingLeaseRightOfUseAsset_iS_pp0p0_c20220101__20221231_z2BvM82vK3M3" style="width: 18%; text-align: right" title="Operating lease right of use asset, beginning">92,606</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Accumulated amortization</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--OperatingLeaseRightOfUseAssetAmortizationExpense_iN_pp0p0_di_c20230101__20231231_zgeJrlhmfqUa" style="text-align: right" title="Accumulated amortization">(43,099</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--OperatingLeaseRightOfUseAssetAmortizationExpense_iN_pp0p0_di_c20220101__20221231_zj0Jct791ex8" style="text-align: right" title="Accumulated amortization">(42,310</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1.5pt">Effect of translation exchange</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_982_ecustom--EffectOfTranslationExchangeOperatingLeaseRightOfUseAsset_pp0p0_c20230101__20231231_zY0lyE9bMZ83" style="border-bottom: Black 1.5pt solid; text-align: right" title="Effect of translation exchange">(1,449</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_984_ecustom--EffectOfTranslationExchangeOperatingLeaseRightOfUseAsset_pp0p0_c20220101__20221231_z6kZkv73XPKj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Effect of translation exchange">(5,748</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Balance as of December 31</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--OperatingLeaseRightOfUseAsset_iE_pp0p0_c20230101__20231231_z26gwiHQC4h4" style="border-bottom: Black 2.5pt double; text-align: right" title="Operating lease right of use asset, ending"><span style="-sec-ix-hidden: xdx2ixbrl0977">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--OperatingLeaseRightOfUseAsset_iE_pp0p0_c20220101__20221231_z3Q2FPJGUXA4" style="border-bottom: Black 2.5pt double; text-align: right" title="Operating lease right of use asset, ending">44,548</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 44548 92606 43099 42310 -1449 -5748 44548 <p id="xdx_891_ecustom--ScheduleOfOperatingLeaseLiabilityDisclosureTextBlock_zSdWt1AKzNhj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2023, operating lease liability as follow:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BD_zgXewaug8u12" style="display: none">SCHEDULE OF OPERATING LEASE LIABILITY</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; text-align: justify">As of January 1,</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--OperatingLeaseLiability_iS_c20230101__20231231_zcoTqVHnXE57" style="width: 16%; text-align: right" title="Operating lease liability, beginning">44,548</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Less: gross repayment</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--OperatingLeasePayments_iN_pp0p0_di_c20230101__20231231_zKGPZD1Fa79i" style="text-align: right" title="Less: gross repayment">(44,171</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Add: imputed interest</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iI_pp0p0_c20231231_zNH1y92AFtb1" style="text-align: right" title="Add: imputed interest">1,072</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Effect of translation exchange</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98E_ecustom--EffectOfTranslationExchangeOfOperatingLeaseLiability_pp0p0_c20230101__20231231_zMf0hgvSsfw9" style="border-bottom: Black 1.5pt solid; text-align: right" title="Effect of translation exchange">(1,449</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Balance as of December 31, 2023</td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--OperatingLeaseLiability_iE_pp0p0_c20230101__20231231_zAlUmlMWbPUb" style="text-align: right" title="Operating lease liability, ending"><span style="-sec-ix-hidden: xdx2ixbrl0991">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt">Less: lease liability current portion</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--OperatingLeaseLiabilityCurrent_iNI_pp0p0_di_c20231231_zaqjeJqjZujk" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less: lease liability current portion"><span style="-sec-ix-hidden: xdx2ixbrl0993">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt">Lease liability non-current portion</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pp0p0_c20231231_zQqPREYjZ2H9" style="border-bottom: Black 2.5pt double; text-align: right" title="Lease liability non-current portion"><span style="-sec-ix-hidden: xdx2ixbrl0995">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 44548 44171 1072 -1449 43099 42310 <p id="xdx_89B_ecustom--ScheduleOfOperatingLeaseOtherInformationTableTextBlock_z4H8TFpKC7Ff" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B7_zuj0Crk5McS7" style="display: none">SCHEDULE OF OPERATING LEASE OTHER INFORMATION</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year ended December 31,</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash paid for amounts included in the measurement of lease liabilities:</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif; width: 56%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating cash flow from operating lease</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_980_eus-gaap--ProceedsFromLeasePayments_pp0p0_c20230101__20231231_zeIqm5UKhdre" style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right" title="Operating cash flow from operating lease"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">42,862</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_987_eus-gaap--ProceedsFromLeasePayments_pp0p0_c20220101__20221231_zqYmb2v1AYif" style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right" title="Operating cash flow from operating lease"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">42,212</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Right-of-use assets obtained in exchange for operating lease liabilities</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_980_eus-gaap--RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_pp0p0_c20230101__20231231_zUFAwaZIBdF3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Right-of-use assets obtained in exchange for operating lease liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1007">-</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_985_eus-gaap--RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_pp0p0_c20220101__20221231_zNJkwQ9bUwHh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Right-of-use assets obtained in exchange for operating lease liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">44,548</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Remaining lease term for operating lease (years)</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20221231_z9xxqjFsAnbd" title="Remaining lease term for operating lease (years)">1</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted average discount rate for operating lease</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_985_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20231231_zGcuR6reYTn7" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average discount rate for operating lease"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.40</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98F_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20221231_zx4zIurhZKDi" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average discount rate for operating lease"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.40</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> </table> 42862 42212 44548 P1Y 0.0540 0.0540 43099 42310 <p id="xdx_80B_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_z5YTC7TBDln9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>15. <span id="xdx_82E_zNI51Uzyb4ha">RELATED PARTY TRANSACTIONS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_897_eus-gaap--ScheduleOfRelatedPartyTransactionsTableTextBlock_z0T6MQ4Ai1Wi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the years ended December 31, 2023 and December 31, 2022, the Company has the following transactions with related party:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B0_z1zXDFThD5Ne" style="display: none">SCHEDULE OF RELATED PARTY TRANSACTION</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the year ended </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Audited)</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the year ended </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2022</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Audited)</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Professional Fees:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 56%; text-align: left; padding-bottom: 2.5pt; padding-left: 10pt">- Related party A</td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--ProfessionalFees_pp0p0_c20230101__20231231__us-gaap--RelatedPartyTransactionAxis__custom--RelatedPartyAMember_zRTaLg54rL38" style="border-bottom: Black 2.5pt double; width: 18%; text-align: right" title="Professional Fees">13,001</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--ProfessionalFees_pp0p0_c20220101__20221231__us-gaap--RelatedPartyTransactionAxis__custom--RelatedPartyAMember_zfwghcHpKSC2" style="border-bottom: Black 2.5pt double; width: 18%; text-align: right" title="Professional Fees">12,226</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Sales</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 10pt">- Related party B</td><td> </td> <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--Revenues_pp0p0_c20230101__20231231__us-gaap--RelatedPartyTransactionAxis__custom--RelatedPartyBMember_z0FIah4CpBpk" style="text-align: right" title="Sales"><span style="-sec-ix-hidden: xdx2ixbrl1029">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--Revenues_pp0p0_c20220101__20221231__us-gaap--RelatedPartyTransactionAxis__custom--RelatedPartyBMember_zPDlU4lcjJAk" style="text-align: right" title="Sales">386,232</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 10pt">- Related party C</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_987_eus-gaap--Revenues_pp0p0_c20230101__20231231__us-gaap--RelatedPartyTransactionAxis__custom--RelatedPartyCMember_zolQZVLPcG5e" style="border-bottom: Black 2.5pt double; text-align: right" title="Sales">48,366</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_981_eus-gaap--Revenues_pp0p0_c20220101__20221231__us-gaap--RelatedPartyTransactionAxis__custom--RelatedPartyCMember_zhLb5NXl2AYb" style="border-bottom: Black 2.5pt double; text-align: right" title="Sales">24,261</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AC_zP0loWGyyxw5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The related party A is a wholly owned subsidiary of a <span id="xdx_902_eus-gaap--MinorityInterestOwnershipPercentageByNoncontrollingOwners_iI_pid_dp_uPure_c20231231__srt--OwnershipAxis__custom--RelatedPartyAMember_zSwnRnDVdjij" title="Ownership percentage">7.33</span>% shareholder of the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The related party B’s director and shareholder is the founder of the Company. Founder <span style="background-color: white">of the Company</span> resigned as director of company B on October 02, 2022 and is no longer a shareholder of company B.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The related party C’s director is the founder of the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The related party transaction is generally transacted in an arm-length basis at the current market value in the normal course of business.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_897_eus-gaap--ScheduleOfRelatedPartyTransactionsTableTextBlock_z0T6MQ4Ai1Wi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the years ended December 31, 2023 and December 31, 2022, the Company has the following transactions with related party:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B0_z1zXDFThD5Ne" style="display: none">SCHEDULE OF RELATED PARTY TRANSACTION</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the year ended </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Audited)</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the year ended </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2022</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Audited)</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Professional Fees:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 56%; text-align: left; padding-bottom: 2.5pt; padding-left: 10pt">- Related party A</td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--ProfessionalFees_pp0p0_c20230101__20231231__us-gaap--RelatedPartyTransactionAxis__custom--RelatedPartyAMember_zRTaLg54rL38" style="border-bottom: Black 2.5pt double; width: 18%; text-align: right" title="Professional Fees">13,001</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--ProfessionalFees_pp0p0_c20220101__20221231__us-gaap--RelatedPartyTransactionAxis__custom--RelatedPartyAMember_zfwghcHpKSC2" style="border-bottom: Black 2.5pt double; width: 18%; text-align: right" title="Professional Fees">12,226</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Sales</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 10pt">- Related party B</td><td> </td> <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--Revenues_pp0p0_c20230101__20231231__us-gaap--RelatedPartyTransactionAxis__custom--RelatedPartyBMember_z0FIah4CpBpk" style="text-align: right" title="Sales"><span style="-sec-ix-hidden: xdx2ixbrl1029">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--Revenues_pp0p0_c20220101__20221231__us-gaap--RelatedPartyTransactionAxis__custom--RelatedPartyBMember_zPDlU4lcjJAk" style="text-align: right" title="Sales">386,232</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 10pt">- Related party C</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_987_eus-gaap--Revenues_pp0p0_c20230101__20231231__us-gaap--RelatedPartyTransactionAxis__custom--RelatedPartyCMember_zolQZVLPcG5e" style="border-bottom: Black 2.5pt double; text-align: right" title="Sales">48,366</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_981_eus-gaap--Revenues_pp0p0_c20220101__20221231__us-gaap--RelatedPartyTransactionAxis__custom--RelatedPartyCMember_zhLb5NXl2AYb" style="border-bottom: Black 2.5pt double; text-align: right" title="Sales">24,261</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 13001 12226 386232 48366 24261 0.0733 <p id="xdx_80C_eus-gaap--SegmentReportingDisclosureTextBlock_zilVjLT0iM25" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>16. <span id="xdx_820_zqgoxuQGJFbl">SEGMENTED INFORMATION</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC 280, “Segment Reporting” establishes standards for reporting information about operating segments on a basis consistent with the Company’s internal organization structure as well as information about services categories, business segments and major customers in financial statements. In accordance with the “Segment Reporting” Topic of the ASC, the Company’s chief operating decision maker has been identified as the Chief Executive Officer and President, who reviews operating results to make decisions about allocating resources and assessing performance for the entire Company. Existing guidance, which is based on a management approach to segment reporting, establishes requirements to report selected segment information quarterly and to report annually entity-wide disclosures about products and services, major customers, and the countries in which the entity holds material assets and reports revenue. All material operating units qualify for aggregation under “Segment Reporting” due to their similar customer base and similarities in economic characteristics; nature of products and services; and procurement, manufacturing and distribution processes.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89F_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_z17m7oCJcoWg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company had no inter-segment sales for the periods presented. Summarized financial information concerning the Company’s reportable segments is shown as below:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By Geography*:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BF_zzInlYNCAfdj" style="display: none">SCHEDULE OF REPORTING SEGMENTS</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_494_20230101__20231231__srt--StatementGeographicalAxis__custom--NVMember_zP7i7tOjfhb3" style="border-bottom: Black 1.5pt solid; text-align: center">Nevada<span id="xdx_F55_zeKujPtZTZCg">*</span></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_498_20230101__20231231__srt--StatementGeographicalAxis__country--SC_z3TCaQ12Wr52" style="border-bottom: Black 1.5pt solid; text-align: center">Seychelles<span id="xdx_F5B_zKXd7D9YA7C1">*</span></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_497_20230101__20231231__srt--StatementGeographicalAxis__country--HK_znjW1DhzZEk6" style="border-bottom: Black 1.5pt solid; text-align: center">Hong Kong<span id="xdx_F55_zDoVsAWAkFA6">*</span></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_493_20230101__20231231__srt--StatementGeographicalAxis__country--MY_zQlE5qq8kqR8" style="border-bottom: Black 1.5pt solid; text-align: center">Malaysia<span id="xdx_F53_zdfxe963EVO3">*</span></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_496_20230101__20231231_zZCIGmddajje" style="border-bottom: Black 1.5pt solid; text-align: center">Total<span id="xdx_F5B_zTXRuNYOJof2">*</span></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="18" style="border-bottom: Black 1.5pt solid; text-align: center">For the year ended December 31, 2023</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Nevada</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Seychelles</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Hong Kong</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Malaysia</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Total</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_404_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zoZ4A8ZG3o94" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 35%">Revenue</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1043">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1044">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1045">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,470,071</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,470,071</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--CostOfRevenue_iN_di_zVTqEw4Crc8d" style="vertical-align: bottom; background-color: White"> <td>Cost of revenue</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1049">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1050">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1051">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,110,846</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,110,846</td><td style="text-align: left">)</td></tr> <tr id="xdx_40F_eus-gaap--DepreciationDepletionAndAmortization_iN_di_zRaan3jLQNT8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Depreciation and amortization</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1055">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1056">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1057">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(64,933</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(64,933</td><td style="text-align: left">)</td></tr> <tr id="xdx_40B_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_zhZgsqFONAS3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Net (loss)/profit before taxation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(51,974</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3,207</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3,703</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10,006</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(48,878</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_F4A_zl3szlGzEX13" style="text-align: left">Total assets</td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--Assets_iI_c20231231__srt--StatementGeographicalAxis__custom--NVMember_fKg_____zdCsCXlIH5g4" style="text-align: right">19,729</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--Assets_iI_c20231231__srt--StatementGeographicalAxis__country--SC_fKg_____z4NoR9lIJMl4" style="text-align: right">22,720</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--Assets_iI_c20231231__srt--StatementGeographicalAxis__country--HK_fKg_____zbbBDoeLbtdc" style="text-align: right">24,545</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--Assets_iI_c20231231__srt--StatementGeographicalAxis__country--MY_fKg_____zKaX74vg1N2i" style="text-align: right">300,499</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--Assets_iI_c20231231_fKg_____zgZWxgMWhzjh" style="text-align: right">367,493</td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20220101__20221231__srt--StatementGeographicalAxis__custom--NVMember_zS407KaWKua5" style="border-bottom: Black 1.5pt solid; text-align: center">Nevada<span id="xdx_F59_zFJDm3yIb5cj">*</span></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49C_20220101__20221231__srt--StatementGeographicalAxis__country--SC_ztsEpQLlZfU6" style="border-bottom: Black 1.5pt solid; text-align: center">Seychelles<span id="xdx_F5B_zNWRyQ7gszu5">*</span></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_498_20220101__20221231__srt--StatementGeographicalAxis__country--HK_zVfRseRehCgb" style="border-bottom: Black 1.5pt solid; text-align: center">Hong Kong<span id="xdx_F56_zz9D5pZunJ17">*</span></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_491_20220101__20221231__srt--StatementGeographicalAxis__country--MY_zeqqSZ8Y2wp7" style="border-bottom: Black 1.5pt solid; text-align: center">Malaysia<span id="xdx_F5F_zqVYkKl4opAd">*</span></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_491_20220101__20221231_zbA7BPX1mDc3" style="border-bottom: Black 1.5pt solid; text-align: center">Total<span id="xdx_F50_zpEeExmmtf6g">*</span></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="18" style="border-bottom: Black 1.5pt solid; text-align: center">For the year ended December 31, 2022</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Nevada</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Seychelles</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Hong Kong</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Malaysia</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Total</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_404_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zJJ5baWUIN9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 35%">Revenue</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1072">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1073">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1074">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,849,047</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,849,047</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--CostOfRevenue_iN_di_znw4Tp0lMiyj" style="vertical-align: bottom; background-color: White"> <td>Cost of revenue</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1078">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1079">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1080">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,404,054</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,404,054</td><td style="text-align: left">)</td></tr> <tr id="xdx_40F_eus-gaap--DepreciationDepletionAndAmortization_iN_di_zu9oDSReRxz" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Depreciation and amortization</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1084">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1085">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1086">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(72,441</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(72,441</td><td style="text-align: left">)</td></tr> <tr id="xdx_405_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_zipp93zZJzdf" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Net (loss) / profit before taxation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(43,174</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(11,643</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3,951</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">56,347</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(2,421</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_F4B_zROcLFx4EZok" style="text-align: left">Total assets</td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--Assets_iI_c20221231__srt--StatementGeographicalAxis__custom--NVMember_fKg_____zj4CkyG5DAP2" style="text-align: right" title="Total assets">27,294</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--Assets_iI_c20221231__srt--StatementGeographicalAxis__country--SC_fKg_____zih2QX6Ase83" style="text-align: right" title="Total assets">7,056</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--Assets_iI_c20221231__srt--StatementGeographicalAxis__country--HK_fKg_____zA4X90AEzmMl" style="text-align: right" title="Total assets">14,264</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--Assets_iI_c20221231__srt--StatementGeographicalAxis__country--MY_fKg_____zjztYX08NJW1" style="text-align: right" title="Total assets">333,310</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--Assets_iI_c20221231_fKg_____zOtt4GcHnY08" style="text-align: right" title="Total assets">381,924</td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right"><span id="xdx_F00_z9FdURSxFgO6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">*</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span id="xdx_F16_zFMkyr4dJmz4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues and costs are attributed to countries based on the location of customers.</span></td> </tr></table> <p id="xdx_8A6_zb7jwjENni5a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_89F_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_z17m7oCJcoWg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company had no inter-segment sales for the periods presented. Summarized financial information concerning the Company’s reportable segments is shown as below:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By Geography*:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BF_zzInlYNCAfdj" style="display: none">SCHEDULE OF REPORTING SEGMENTS</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_494_20230101__20231231__srt--StatementGeographicalAxis__custom--NVMember_zP7i7tOjfhb3" style="border-bottom: Black 1.5pt solid; text-align: center">Nevada<span id="xdx_F55_zeKujPtZTZCg">*</span></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_498_20230101__20231231__srt--StatementGeographicalAxis__country--SC_z3TCaQ12Wr52" style="border-bottom: Black 1.5pt solid; text-align: center">Seychelles<span id="xdx_F5B_zKXd7D9YA7C1">*</span></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_497_20230101__20231231__srt--StatementGeographicalAxis__country--HK_znjW1DhzZEk6" style="border-bottom: Black 1.5pt solid; text-align: center">Hong Kong<span id="xdx_F55_zDoVsAWAkFA6">*</span></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_493_20230101__20231231__srt--StatementGeographicalAxis__country--MY_zQlE5qq8kqR8" style="border-bottom: Black 1.5pt solid; text-align: center">Malaysia<span id="xdx_F53_zdfxe963EVO3">*</span></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_496_20230101__20231231_zZCIGmddajje" style="border-bottom: Black 1.5pt solid; text-align: center">Total<span id="xdx_F5B_zTXRuNYOJof2">*</span></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="18" style="border-bottom: Black 1.5pt solid; text-align: center">For the year ended December 31, 2023</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Nevada</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Seychelles</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Hong Kong</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Malaysia</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Total</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_404_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zoZ4A8ZG3o94" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 35%">Revenue</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1043">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1044">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1045">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,470,071</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,470,071</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--CostOfRevenue_iN_di_zVTqEw4Crc8d" style="vertical-align: bottom; background-color: White"> <td>Cost of revenue</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1049">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1050">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1051">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,110,846</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,110,846</td><td style="text-align: left">)</td></tr> <tr id="xdx_40F_eus-gaap--DepreciationDepletionAndAmortization_iN_di_zRaan3jLQNT8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Depreciation and amortization</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1055">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1056">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1057">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(64,933</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(64,933</td><td style="text-align: left">)</td></tr> <tr id="xdx_40B_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_zhZgsqFONAS3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Net (loss)/profit before taxation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(51,974</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3,207</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3,703</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10,006</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(48,878</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_F4A_zl3szlGzEX13" style="text-align: left">Total assets</td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--Assets_iI_c20231231__srt--StatementGeographicalAxis__custom--NVMember_fKg_____zdCsCXlIH5g4" style="text-align: right">19,729</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--Assets_iI_c20231231__srt--StatementGeographicalAxis__country--SC_fKg_____z4NoR9lIJMl4" style="text-align: right">22,720</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--Assets_iI_c20231231__srt--StatementGeographicalAxis__country--HK_fKg_____zbbBDoeLbtdc" style="text-align: right">24,545</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--Assets_iI_c20231231__srt--StatementGeographicalAxis__country--MY_fKg_____zKaX74vg1N2i" style="text-align: right">300,499</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--Assets_iI_c20231231_fKg_____zgZWxgMWhzjh" style="text-align: right">367,493</td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20220101__20221231__srt--StatementGeographicalAxis__custom--NVMember_zS407KaWKua5" style="border-bottom: Black 1.5pt solid; text-align: center">Nevada<span id="xdx_F59_zFJDm3yIb5cj">*</span></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49C_20220101__20221231__srt--StatementGeographicalAxis__country--SC_ztsEpQLlZfU6" style="border-bottom: Black 1.5pt solid; text-align: center">Seychelles<span id="xdx_F5B_zNWRyQ7gszu5">*</span></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_498_20220101__20221231__srt--StatementGeographicalAxis__country--HK_zVfRseRehCgb" style="border-bottom: Black 1.5pt solid; text-align: center">Hong Kong<span id="xdx_F56_zz9D5pZunJ17">*</span></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_491_20220101__20221231__srt--StatementGeographicalAxis__country--MY_zeqqSZ8Y2wp7" style="border-bottom: Black 1.5pt solid; text-align: center">Malaysia<span id="xdx_F5F_zqVYkKl4opAd">*</span></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_491_20220101__20221231_zbA7BPX1mDc3" style="border-bottom: Black 1.5pt solid; text-align: center">Total<span id="xdx_F50_zpEeExmmtf6g">*</span></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="18" style="border-bottom: Black 1.5pt solid; text-align: center">For the year ended December 31, 2022</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Nevada</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Seychelles</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Hong Kong</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Malaysia</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Total</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_404_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zJJ5baWUIN9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 35%">Revenue</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1072">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1073">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1074">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,849,047</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,849,047</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--CostOfRevenue_iN_di_znw4Tp0lMiyj" style="vertical-align: bottom; background-color: White"> <td>Cost of revenue</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1078">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1079">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1080">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,404,054</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,404,054</td><td style="text-align: left">)</td></tr> <tr id="xdx_40F_eus-gaap--DepreciationDepletionAndAmortization_iN_di_zu9oDSReRxz" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Depreciation and amortization</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1084">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1085">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1086">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(72,441</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(72,441</td><td style="text-align: left">)</td></tr> <tr id="xdx_405_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_zipp93zZJzdf" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Net (loss) / profit before taxation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(43,174</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(11,643</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3,951</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">56,347</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(2,421</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_F4B_zROcLFx4EZok" style="text-align: left">Total assets</td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--Assets_iI_c20221231__srt--StatementGeographicalAxis__custom--NVMember_fKg_____zj4CkyG5DAP2" style="text-align: right" title="Total assets">27,294</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--Assets_iI_c20221231__srt--StatementGeographicalAxis__country--SC_fKg_____zih2QX6Ase83" style="text-align: right" title="Total assets">7,056</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--Assets_iI_c20221231__srt--StatementGeographicalAxis__country--HK_fKg_____zA4X90AEzmMl" style="text-align: right" title="Total assets">14,264</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--Assets_iI_c20221231__srt--StatementGeographicalAxis__country--MY_fKg_____zjztYX08NJW1" style="text-align: right" title="Total assets">333,310</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--Assets_iI_c20221231_fKg_____zOtt4GcHnY08" style="text-align: right" title="Total assets">381,924</td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right"><span id="xdx_F00_z9FdURSxFgO6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">*</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span id="xdx_F16_zFMkyr4dJmz4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues and costs are attributed to countries based on the location of customers.</span></td> </tr></table> 1470071 1470071 1110846 1110846 64933 64933 -51974 -3207 -3703 10006 -48878 19729 22720 24545 300499 367493 1849047 1849047 1404054 1404054 72441 72441 -43174 -11643 -3951 56347 -2421 27294 7056 14264 333310 381924 <p id="xdx_80A_eus-gaap--SubsequentEventsTextBlock_zvNzILBNzDCg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>17. <span id="xdx_823_zQdz1UmsH89d">SUBSEQUENT EVENTS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In accordance with ASC Topic 855, “<i>Subsequent Events</i>”, which establishes general standards of accounting for and disclosure of events that occur after the balance sheet date but before financial statements are issued, the Company has evaluated all events or transactions that occurred after December 31, 2023 up through the date the Company issued the audited consolidated financial statements.</span></p> Revenues and costs are attributed to countries based on the location of customers.

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end GRAPHIC 14 form10-k_011.jpg begin 644 form10-k_011.jpg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audit_001.jpg begin 644 audit_001.jpg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end EX-101.SCH 16 dqws-20231231.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Consolidated Statements of Operations and Comprehensive Income link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Consolidated Statements of Changes in Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - ORGANIZATION AND BUSINESS BACKGROUND link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - GOING CONCERN UNCERTAINTIES link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - VIE STRUCTURE AND ARRANGEMENTS link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - STOCKHOLDERS’ EQUITY link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - PROPERTY AND EQUIPMENT link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - INTANGIBLE ASSETS link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - INVENTORIES link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - FINANCE LEASE LIABILITIES link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - INCOME TAXES link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - CONCENTRATIONS OF RISKS link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - LEASE RIGHT-OF-USE ASSET AND LEASE LIABILITIES link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - RELATED PARTY TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - SEGMENTED INFORMATION link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - ORGANIZATION AND BUSINESS BACKGROUND (Tables) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - PROPERTY AND EQUIPMENT (Tables) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - INTANGIBLE ASSETS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - INVENTORIES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - FINANCE LEASE LIABILITIES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - INCOME TAXES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - CONCENTRATIONS OF RISKS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - LEASE RIGHT-OF-USE ASSET AND LEASE LIABILITIES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - RELATED PARTY TRANSACTIONS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000037 - Disclosure - SEGMENTED INFORMATION (Tables) link:presentationLink link:calculationLink link:definitionLink 00000038 - Disclosure - SCHEDULE OF VARIABLE INTEREST ENTITY (Details) link:presentationLink link:calculationLink link:definitionLink 00000039 - Disclosure - ORGANIZATION AND BUSINESS BACKGROUND (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000040 - Disclosure - GOING CONCERN UNCERTAINTIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000041 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT USEFUL LIFE (Details) link:presentationLink link:calculationLink link:definitionLink 00000042 - Disclosure - SCHEDULE OF FOREIGN CURRENCIES TRANSLATION (Details) link:presentationLink link:calculationLink link:definitionLink 00000043 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000044 - Disclosure - VIE STRUCTURE AND ARRANGEMENTS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000045 - Disclosure - STOCKHOLDERS’ EQUITY (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000046 - Disclosure - SCHEDULE OF PLANT AND EQUIPMENT (Details) link:presentationLink link:calculationLink link:definitionLink 00000047 - Disclosure - PROPERTY AND EQUIPMENT (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000048 - Disclosure - SCHEDULE OF INTANGIBLE ASSETS (Details) link:presentationLink link:calculationLink link:definitionLink 00000049 - Disclosure - INTANGIBLE ASSETS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000050 - Disclosure - SCHEDULE OF OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS (Details) link:presentationLink link:calculationLink link:definitionLink 00000051 - Disclosure - SCHEDULE OF INVENTORIES (Details) link:presentationLink link:calculationLink link:definitionLink 00000052 - Disclosure - SCHEDULE OF OTHER PAYABLE AND ACCRUED LIABILITIES (Details) link:presentationLink link:calculationLink link:definitionLink 00000053 - Disclosure - SCHEDULE OF OBLIGATION UNDER FINANCE LEASE (Details) link:presentationLink link:calculationLink link:definitionLink 00000054 - Disclosure - SCHEDULE OF MATURITIES OF FINANCE LEASE (Details) link:presentationLink link:calculationLink link:definitionLink 00000055 - Disclosure - FINANCE LEASE LIABILITIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000056 - Disclosure - SCHEDULE OF COMPONENTS OF INCOME LOSS BEFORE INCOME TAXES (Details) link:presentationLink link:calculationLink link:definitionLink 00000057 - Disclosure - SCHEDULE OF PROVISION FOR INCOME TAXES (Details) link:presentationLink link:calculationLink link:definitionLink 00000058 - Disclosure - SCHEDULE OF DEFERRED INCOME TAX ASSETS (Details) link:presentationLink link:calculationLink link:definitionLink 00000059 - Disclosure - INCOME TAXES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000060 - Disclosure - SCHEDULE OF CONCENTRATION OF RISK (Details) link:presentationLink link:calculationLink link:definitionLink 00000061 - Disclosure - SCHEDULE OF OPERATION LEASE RIGHT OF USE ASSETS (Details) link:presentationLink link:calculationLink link:definitionLink 00000062 - Disclosure - SCHEDULE OF OPERATING LEASE LIABILITY (Details) link:presentationLink link:calculationLink link:definitionLink 00000063 - Disclosure - SCHEDULE OF OPERATING LEASE OTHER INFORMATION (Details) link:presentationLink link:calculationLink link:definitionLink 00000064 - Disclosure - LEASE RIGHT-OF-USE ASSET AND LEASE LIABILITIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000065 - Disclosure - SCHEDULE OF RELATED PARTY TRANSACTION (Details) link:presentationLink link:calculationLink link:definitionLink 00000066 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000067 - Disclosure - SCHEDULE OF REPORTING SEGMENTS (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 17 dqws-20231231_cal.xml XBRL CALCULATION FILE EX-101.DEF 18 dqws-20231231_def.xml XBRL DEFINITION FILE EX-101.LAB 19 dqws-20231231_lab.xml XBRL LABEL FILE Equity Components [Axis] Common Stock [Member] Additional Paid-in Capital [Member] AOCI Attributable to Parent [Member] Retained Earnings [Member] Noncontrolling Interest [Member] Investment, Name [Axis] DSwiss Holding Limited [Member] Geographical [Axis] HONG KONG DSwiss Sdn Bhd [Member] MALAYSIA DSwiss Biotech [Member] Ownership [Axis] DSwiss (HK) Limited [Member] Legal Entity [Axis] DSwiss Biotech Sdn Bhd [Member] Long-Lived Tangible Asset [Axis] Computer and Software [Member] Furniture and Fixtures [Member] Office Equipment [Member] Motor Vehicles [Member] Award Type [Axis] Year-end MYR [Member] Year-average MYR [Member] Year-end HK [Member] Year-average HK [Member] Year-end RMB [Member] Year-average RMB [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Management Services Agreement I [Member] First Finance Lease Agreement [Member] Second Finance Lease Agreement [Member] UNITED STATES SEYCHELLES Income Tax Authority, Name [Axis] United States of America [Member] Seychelles [Member] Hong Kong [Member] Malaysia [Member] People's Republic of China (PRC) [Member] DSwiss Sdn Bhd and DSwiss Biotech Sdn Bhd [Member] Statistical Measurement [Axis] Minimum [Member] Maximum [Member] Concentration Risk Benchmark [Axis] Revenue Benchmark [Member] Concentration Risk Type [Axis] Customer Concentration Risk [Member] Customer [Axis] Customer A [Member] Accounts Receivable [Member] Customer B [Member] Customer C [Member] Customer D [Member] Customer E [Member] Customers [Member] Cost of Goods and Service Benchmark [Member] Supplier Concentration Risk [Member] Vendor A [Member] Accounts Payable [Member] Vendor B [Member] Vendor C [Member] Vendors [Member] Accounting Standards Update [Axis] Accounting Standards Update 2016-02 [Member] Related Party Transaction [Axis] Related Party A [Member] Related Party B [Member] Related Party C [Member] NV [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Document Financial Statement Error Correction [Flag] Auditor Name Auditor Firm ID Auditor Location Statement of Financial Position [Abstract] ASSETS CURRENT ASSETS Cash and cash equivalents Accounts receivable Other receivables, prepaid expenses, and deposit Tax recoverable Inventories Total current assets NON-CURRENT ASSETS Property and equipment, net Intangible assets, net Operating lease right-of-use assets, net Total non-current assets TOTAL ASSETS LIABILITIES AND STOCKHOLDERS’ EQUITY CURRENT LIABILITIES Accounts payable Other payables and accrued liabilities Finance lease liability Operating lease liability Total current liabilities NON-CURRENT LIABILITY Finance lease liability Total non-current liability TOTAL LIABILITIES STOCKHOLDERS’ EQUITY Preferred stock, $0.0001 par value, 200,000,000 shares authorized, None issued and outstanding Common stock, $0.0001 par value, 600,000,000 shares authorized, 206,904,585 shares and 206,904,585 shares issued and outstanding as of December 31, 2023 and 2022 respectively Additional paid-in capital Accumulated other comprehensive income/(loss) Accumulated deficit TOTAL DSWISS, INC. STOCKHOLDERS’ EQUITY NON-CONTROLLING INTEREST TOTAL STOCKHOLDERS’ EQUITY TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY Preferred stock, par value Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Income Statement [Abstract] REVENUE COST OF REVENUE GROSS PROFIT OTHER INCOME SELLING, GENERAL AND ADMINISTRATIVE EXPENSES OPERATING EXPENSES FINANCE COST LEASE EXPENSES LOSS BEFORE INCOME TAX INCOME TAXES PROVISION NET LOSS Non-Controlling Interests Other comprehensive income: - Foreign currency translation adjustment COMPREHENSIVE INCOME Net loss per share - basic Net loss per share - diluted Weighted average number of common shares outstanding - basic Weighted average number of common shares outstanding - diluted Statement [Table] Statement [Line Items] Balance Balance, shares Foreign currency translation adjustment Net gain (loss) Changes in ownership interests in an associate Balance Balance, shares Statement of Cash Flows [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES: Loss before tax Adjustments to reconcile net loss to net cash generated from operating activities: Depreciation and amortization Amortization for intangible assets Changes in operating assets and liabilities: Accounts receivable Accounts payable Inventories Other payables and accrued liabilities Other receivables, prepaid expenses, and deposit Reduction in lease liability Cash generated from operating activities Taxation paid Net cash generated from operating activities CASH FLOWS FROM INVESTING ACTIVITIES: Purchase of property and equipment Disposal of property and equipment Net cash used in investing activities CASH FLOWS FROM FINANCING ACTIVITIES: Repayment to directors Repayment of finance lease Net cash used in financing activities Effect of exchange rate changes on cash and cash equivalents Net change in cash and cash equivalents Cash and cash equivalents, beginning of year CASH AND CASH EQUIVALENTS, END OF YEAR SUPPLEMENTAL CASH FLOWS INFORMATION Income taxes paid Interest paid Accounting Policies [Abstract] ORGANIZATION AND BUSINESS BACKGROUND Going Concern Uncertainties GOING CONCERN UNCERTAINTIES SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Organization, Consolidation and Presentation of Financial Statements [Abstract] VIE STRUCTURE AND ARRANGEMENTS Equity [Abstract] STOCKHOLDERS’ EQUITY Property, Plant and Equipment [Abstract] PROPERTY AND EQUIPMENT Goodwill and Intangible Assets Disclosure [Abstract] INTANGIBLE ASSETS Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS Inventory Disclosure [Abstract] INVENTORIES Payables and Accruals [Abstract] OTHER PAYABLES AND ACCRUED LIABILITIES Finance Lease Liabilities FINANCE LEASE LIABILITIES Income Tax Disclosure [Abstract] INCOME TAXES Risks and Uncertainties [Abstract] CONCENTRATIONS OF RISKS Leases [Abstract] LEASE RIGHT-OF-USE ASSET AND LEASE LIABILITIES Related Party Transactions [Abstract] RELATED PARTY TRANSACTIONS Segment Reporting [Abstract] SEGMENTED INFORMATION Subsequent Events [Abstract] SUBSEQUENT EVENTS Basis of presentation Basis of consolidation Use of estimates Cash and cash equivalents Property and equipment Intangible assets Leases Inventories Revenue recognition Cost of revenue Shipping and handling fees Selling and distribution expenses Income taxes Net profit per share Foreign currencies translation Related parties Fair value of financial instruments: Recently Adopted Accounting Standards SCHEDULE OF VARIABLE INTEREST ENTITY SCHEDULE OF PROPERTY AND EQUIPMENT USEFUL LIFE SCHEDULE OF FOREIGN CURRENCIES TRANSLATION SCHEDULE OF PLANT AND EQUIPMENT SCHEDULE OF INTANGIBLE ASSETS SCHEDULE OF OTHER RECEIVABLES, PREPAID EXPENSES AND DEPOSITS SCHEDULE OF INVENTORIES SCHEDULE OF OTHER PAYABLE AND ACCRUED LIABILITIES SCHEDULE OF OBLIGATION UNDER FINANCE LEASE SCHEDULE OF MATURITIES OF FINANCE LEASE SCHEDULE OF COMPONENTS OF INCOME LOSS BEFORE INCOME TAXES SCHEDULE OF PROVISION FOR INCOME TAXES SCHEDULE OF DEFERRED INCOME TAX ASSETS SCHEDULE OF CONCENTRATION OF RISK SCHEDULE OF OPERATION LEASE RIGHT OF USE ASSETS SCHEDULE OF OPERATING LEASE LIABILITY SCHEDULE OF OPERATING LEASE OTHER INFORMATION SCHEDULE OF RELATED PARTY TRANSACTION SCHEDULE OF REPORTING SEGMENTS Company name Place of incorporation Date of incorporation Particulars of issued capital Principal activities Proportional of ownership interest and voting power held Equity ownership interest rate percentage Stock issued during period, shares, new issues Consideration price per share Accumulated deficit Property, Plant and Equipment [Table] Property, Plant and Equipment [Line Items] Property and equipment, estimated useful lives Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Foreign currency exchange rate, translation Intangible asset, useful life Impairment loss Finance lease, description Largest amount of tax benefit, description Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Percentage of annual net profit to be received as fee Number of shares, acquired Equity ownership interest rate percentage Common stock shares issued Common stock shares outstanding Preferred stock shares issued Preferred stock shares outstanding Total property and equipment Accumulated depreciation Effect of translation exchange Property and equipment, net Depreciation expense Trademarks Amortization Effect of translation exchange Intangible assets, net Amortization of intangible assets Other receivables Prepaid expenses Deposits Total other receivables, prepaid expenses and deposits Finished goods, at cost Total inventories Other payables Accrued audit fees Accrued other expenses Accrued professional fees Total payables and accrued liabilities Schedule Of Obligation Under Finance Lease Finance leases Less: interest expense Total Current portion Non-current portion Schedule Of Maturities Of Finance Lease 2024 2025 2026 Loss before income tax Current: - Local - Foreign Deferred: - Local - Foreign Income tax expense Operating Loss Carryforwards [Table] Operating Loss Carryforwards [Line Items] Net operating loss carry forwards Less: valuation allowance Deferred tax assets Cumulative net operating losses Income tax rate Net operating loss carryforwards expiration Valuation allowance Statutory income tax, rate Concentration Risk [Table] Concentration Risk [Line Items] Revenues Concentration risk, percentage Accounts receivable, trade Purchase Accounts payable, trade Operating lease right of use asset, beginning Accumulated amortization Effect of translation exchange Operating lease right of use asset, ending Operating lease liability, beginning Less: gross repayment Add: imputed interest Effect of translation exchange Operating lease liability, ending Less: lease liability current portion Lease liability non-current portion Operating cash flow from operating lease Right-of-use assets obtained in exchange for operating lease liabilities Remaining lease term for operating lease (years) Weighted average discount rate for operating lease Lease asset- right of use Discount rate of lease payment Operating lease right of use asset, amortization Lease expenses Schedule of Related Party Transactions, by Related Party [Table] Related Party Transaction [Line Items] Professional Fees Sales Ownership percentage Schedule of Revenues from External Customers and Long-Lived Assets [Table] Revenues from External Customers and Long-Lived Assets [Line Items] Revenue Cost of revenue Depreciation and amortization Net (loss) / profit before taxation Total assets Finance expenses. Net income loss attributable to minority interest. Noncontrolling interest changes in ownership interests in associate. Increase decrease in reduction in lease liability. Taxation paid. D Swiss Holding Limited [Member] D Swiss Sdn Bhd [Member] D Swiss Biotech [Member] D Swiss HK Limited [Member] Place of incorporation. DSwiss Biotech Sdn Bhd [Member] Particulars of Issued Capital. Proceeds from disposal of property and equipment. Going Concern Uncertainties [Text Block] Summary of Property and Equipment Useful Life [Table Text Block] Computer and Software [Member] Motor Vehicles [Member] Related Parties [Policy Text Block] Percentage of annual net profit to be received as fee. Management Services Agreement I [Member] Effect of translation exchange. Intangible assets, Effect of translation exchange. Accrued audit fees current. First Finance Lease Agreement [Member] Second Finance Lease Agreement [Member] Schedule of Obligation Under Finance Lease [Table Tex tBlock] United States of America [Member] Hong Kong [Member] Seychelles [Member] Malaysia [Member] People's Republic of China (PRC) [Member] DSwiss Sdn Bhd and DSwiss Biotech Sdn Bhd [Member] Customer A [Member] Customer B [Member] Customer C [Member] Customer D [Member] Customer E [Member] Customers [Member] Vendor A [Member] Vendor B [Member] Vendor C [Member] Vendors [Member] Effect of translation exchange of operating lease right of use asset. Schedule Of Operating Lease Liability Disclosure [Text Block] Effect of translation exchange of operating lease liability. Schedule of Operating Lease Other Information [Table Text Block] Related Party A [Member] Related Party B [Member] Related Party C [Member] NV [Member] Year-end MYR [Member] Year-average MYR [Member] Year-end HK [Member] Year-end RMB [Member] Year-average RMB [Member] Year-average HK [Member] Assets, Current Assets, Noncurrent Liabilities, Current Liabilities, Noncurrent Liabilities Equity, Attributable to Parent Equity, Including Portion Attributable to Noncontrolling Interest Liabilities and Equity Cost of Revenue Gross Profit Selling, General and Administrative Expense FinanceExpenses Operating Lease, Expense Income Tax Expense (Benefit) NetIncomeLossAttributableToMinorityInterest Comprehensive Income (Loss), Net of Tax, Attributable to Parent Shares, Outstanding Increase (Decrease) in Accounts Receivable Increase (Decrease) in Accounts Payable, Trade Increase (Decrease) in Inventories Increase (Decrease) in Other Accounts Payable and Accrued Liabilities Increase (Decrease) in Prepaid Expense and Other Assets Net Cash Provided by (Used in) Operating Activities, Continuing Operations TaxationPaid Net Cash Provided by (Used in) Operating Activities Payments to Acquire Property, Plant, and Equipment Net Cash Provided by (Used in) Investing Activities Finance Lease, Principal Payments Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations Equity [Text Block] Cash and Cash Equivalents, Policy [Policy Text Block] Inventory, Policy [Policy Text Block] Subsidiary, Ownership Percentage, Parent Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment EffectOfTranslationExchange Finite-Lived Intangible Assets, Accumulated Amortization IntangibleAssetsEffectOfTranslationExchange Finance Lease, Liability, Undiscounted Excess Amount Finance Lease, Liability Current Foreign Tax Expense (Benefit) Deferred State and Local Income Tax Expense (Benefit) Deferred Tax Assets, Operating Loss Carryforwards Deferred Tax Assets, Net of Valuation Allowance Operating Lease, Liability Operating Lease, Payments EffectOfTranslationExchangeOfOperatingLeaseLiability Depreciation, Depletion and Amortization EX-101.PRE 20 dqws-20231231_pre.xml XBRL PRESENTATION FILE XML 22 R1.htm IDEA: XBRL DOCUMENT v3.24.1
Cover - USD ($)
 12 Months Ended
Dec. 31, 2023
Jun. 30, 2023
Cover [Abstract]    
Document Type 10-K  
Amendment Flag false  
Document Annual Report true  
Document Transition Report false  
Document Period End Date Dec. 31, 2023  
Document Fiscal Period Focus FY  
Document Fiscal Year Focus 2023  
Current Fiscal Year End Date --12-31  
Entity File Number 333-208083  
Entity Registrant Name DSwiss, Inc.  
Entity Central Index Key 0001652561  
Entity Tax Identification Number 47-4215595  
Entity Incorporation, State or Country Code NV  
Entity Address, Address Line One Unit 18-11, 18-12 & 18-01, Tower A, Vertical Business Suite  
Entity Address, Address Line Two Avenue 3, Bangsar South  
Entity Address, Address Line Three No.8 Jalan Kerinchi  
Entity Address, City or Town Kuala Lumpur  
Entity Address, Country MY  
Entity Address, Postal Zip Code 59200  
City Area Code (603)  
Local Phone Number 2770-4032  
Entity Well-known Seasoned Issuer No  
Entity Voluntary Filers No  
Entity Current Reporting Status Yes  
Entity Interactive Data Current No  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company true  
Elected Not To Use the Extended Transition Period false  
Entity Shell Company false  
Entity Public Float   $ 0
Entity Common Stock, Shares Outstanding 206,904,585  
Document Financial Statement Error Correction [Flag] false  
Auditor Name JP CENTURION & PARTNERS PLT  
Auditor Firm ID 6723  
Auditor Location Kuala Lumpur, Malaysia